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The Design and Delivery of a Patient Informed Intervention to Improve Adherence to a Gluten 
Free Diet in Adults with Coeliac Disease 
Coeliac Disease (CD) affects 1% of the UK population, with no cure, the only available treatment is strict 
adherence to a Gluten Free diet (GFD). It is estimated that 53% to 76% of patients are not adherent to 
a GFD and this may lead to variety of health related complications. The PhD comprised of three studies; 
1, a quantitative exploration of dietary adherence and demographics of CD followed by 2, qualitative 
interviews to explore patients view in the design of an intervention to increase adherence to a GFD and 
3, the design, delivery and evaluation of the intervention. 
PhD Aims 
To collect information about adherence to a GFD, causes behind low adherence in a mixed cohort of 
adults diagnosed with CD. 
Explore patient preference for a healthcare professional led intervention to promote gluten free dietary 
adherence in patients with coeliac disease.  
Evaluate telephonic clinic intervention in increasing adherence to a gluten free diet in patients with CD, 
not adhering to the GFD.  
Methods  
Patients diagnosed with histology confirmed CD were invited to participate. Study I, 375 adults with CD 
provided cross sectional data collected using validated CDAT and Butterworth questionnaires. Study II, 
patients with coeliac disease engaged in individual qualitative telephone interview to explore the 
acceptability interventions to promote GF dietary adherence. Study III, 125 patients (non-adherent 
intervention group =30) with CD completed baseline CDAT, DASS, CDQoL, GF knowledge 
questionnaires. The non-adherent group took part in a 1 hour telephonic clinic inclusive of CD and GFD 
knowledge and behaviour change. Both groups were followed up at three and six months. 
Results: 
In Study I Gluten free dietary adherence, CDAT score ranged from 7 to 30 with 61% of patients adhering 
to a GFD. There were no significant differences between GFD adherence based on ethnicity, age, nor 
gender. Membership of Coeliac UK, affordability of gluten free foods and understanding food labelling 
were significant factors in GFD adherence. In study II, Caucasians (n=28) and South Asians (n=9) (M=8, 
ii 
 
F=29) were interviewed, 30 were considered non-adherent to the GFD. Participants perceived telephone 
clinics as easy, flexible and convenient, it was the most favoured intervention. Thereafter, in study III, 
there was a significant improvement in GFD adherence, evidenced by change in CDAT score in non-
adherent intervention group (n=30) at three (13.20±1.6) and six months (13.23±1.6) post intervention 
compared with baseline values (15.7± 0.83, p<0.01). Significant increase in knowledge score at three 
month post intervention (15.07±1.17) was also observed as compared to baseline (13.27±1.48, p<0.01), 
whereas health related QoL remained similar.  
 
Discussion and conclusion: 
Patient dietary adherence was 60% in study I as defined by no gluten (except inadvertent intake), is 
close to the reported value (62%) by Butterworth et al (2004). The study was graded as one of the 
strongest evidence by the government of UK in relation to consultation prescription of gluten free diet 
and cited in several recent papers.   Study II has given a unique view of a multi-ethnic population to 
inform interventions aimed at increasing adherence to a GFD. Study III indicates that telephonic 
intervention can increase in both adherence as well as knowledge scores in adults with coeliac disease 
who were not adhering to the GFD. Data from this PhD has influenced government prescribing 
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Coeliac disease (CD) is a T cell-mediated chronic autoimmune disorder characterised by permanent 
intolerance to gluten (Shan et al., 2002) in genetically predisposed individuals (Megiorni & Pizzuti, 2012). 
Gluten is a protein composite found in wheat, rye, barley and related plant species (Farrell & Kelly, 
2002). Histologically, CD is characterised by villous atrophy (VA) of the small bowel mucosa (SBM) 
(Marsh, 1990), which leads to malabsorption of micronutrients (Di Sabatino & Corazza, 2009, Reilly et 
al., 2012) and when symptomatic leads to diarrhoea, weight loss and abdominal pain (Rampertab et al., 
2006). In the majority of cases the condition responds to a gluten-free diet (GFD) (Rubio-Tapia et al., 
2010), only to relapse after reintroduction of gluten into the diet (Silvester & Rashid, 2007, Jacobsson 
et al., 2012). CD has several synonyms: gluten-sensitive enteropathy (O’Grady et al., 1984), coeliac 
sprue (Austin & Dobbins, 1988), coeliac syndrome (Pink & Creamer, 1967) and non-tropical sprue 
(Cooke & Smith, 1966). Likewise, there are many other regional names; for example, it is known as la 
maladie cœliaque in French (Malamut, 2012) or Zöliakie in German (Holtmeier, 2005), but the term 
‘coeliac disease’, which is also spelled as “celiac disease”, will be used extensively in this document, as 
it is widely recognised and understood in Europe, the United States and the rest of the English-speaking 
world.  
The clinical presentation of CD is variable and based on the presence or absence of symptoms (West 
et al., 2007).  Additionally, CD is a multi-system disorder ( Kochhar et al., 2016) and apart from damage 
to the SBM, it may also affect other organs such as the skin (Collin et al., 2017), bone (Bianchi & 
Bardella, 2008), liver (Duggan & Duggan, 2005), thyroid (Metso et al., 2012), pancreas (Leeds et al., 
2007), nervous system (Cicarelli et al., 2003) and heart (Emilsson et al., 2013). Being a multisystem 
disorder, physicians should remain vigilant about the long-term complications of CD, which might include 
osteoporosis (Meyer et al., 2001), anaemia (Mahadev et al., 2018) and more serious complications such 
as intestinal lymphoma (Catassi et al., 2005).  
A GFD is the only practical and successful treatment currently available (Herman et al., 2012, McAllister 
et al., 2018, Rostami et al., 2017), but adherence to a GFD is extremely challenging (Zarkadas et al., 
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2013, Zarkadas et al., 2006) and several published studies estimated  the adherence rate to range from 
53% to 76% (Hall et al., 2013, Villafuerte‐Galvez et al., 2015, Casellas et al., 2015, Rajpoot et al., 2015, 
Sainsbury et al., 2018). 
A GFD is difficult to follow (Olsson et al., 2008) and many patients refer to the social and practical issues 
in regard to following a strict GFD (Hall et al., 2009). Based on studies to date, there is limited available 
information on factors affecting adherence with a GFD (Errichiello et al., 2010, Villafuerte‐Galvez et al., 
2015, Halmos, Deng et al., 2018); for this reason regular follow-ups in specialised CD clinics are advised 
to monitor adherence, provide appropriate support and take necessary actions in case of dietary 
transgressions (Pietzak, 2005), as this may improve and maintain adherence to a GFD (Rajpoot et al., 
2015).  
The literature review will focus on the definition of CD, followed by a brief historical perspective and 
related epidemiology, as well as an overview of the background pathology. The clinical features of CD 
will then be narrated briefly, followed by a detailed discussion on adherence to a GFD and possible 

















Definition and historical account of Coeliac Disease 
 
Earlier attempts to define CD mainly concentrated on clinical and histological aspects, being defined by 
Meeuwisse (1970) as:  
'A permanent condition of gluten intolerance with mucosal flattening that reversed on a gluten-free diet 
(GFD) and then relapsed on re-introduction of gluten.' 
This definition has noticeably taken into account the histological appearance of CD and the entire 
definition hinges upon abnormal SBM after exposure to gluten. Over time, as research has explored 
clinical, histological, epidemiological and then genetic aspects of the disease, the definition of CD has 
evolved as well (Walker-Smith et al., 1990). In search of a holistic definition, several years ago 
Ludvigsson et al (2013b), after evaluation of a number of studies (n=300), proposed a new consensus 
definition termed the ‘Oslo definition’. This conclusive definition took into account various deficiencies 
previous definitions had, and these were addressed in the light of modern research. CD according to 
this definition is: 
 'A chronic small intestinal immune-mediated enteropathy precipitated by exposure to dietary gluten in 
genetically predisposed individuals' (Ludvigson et al., 2013).   
This definition is simple and encompasses different levels of CD: namely dietary aetiology, pathology 
and genetic predisposition. Moreover, the definition was proposed by a multidisciplinary task force of 16 
expert physicians from seven countries, after a thorough search of the electronic database involving 
group discussion, web surveys, consensus statements and detailed feedback. As a result, the definition 
makes the terminology clearer and the basic purpose of developing this definition was to validate terms 
in relation to CD and aid in clinical management and future research. The table below shows the 











Table 1: Novel terms in the Oslo definition along with discarded terms. Modified from Leonard & Vasagar (2014). 
Suggested Terms Characteristics Related terms out of favour 
Classical CD Signs and symptoms of malabsorption; e.g. diarrhoea 
and poor growth. 
Typical CD 
Non-classical CD Symptoms other than malabsorption Atypical CD 
Subclinical CD Clinical and laboratory signs of CD without symptoms 
sufficient to suggest testing 
Asymptomatic/ Silent CD 
Symptomatic CD GI or extra-intestinal symptoms occurring due to gluten 
ingestion 
Overt CD 
Potential CD Positive serological testing with normal small bowel 
biopsy 
Latent CD 
Refractory CD Persistent symptoms and enteropathy despite strict GFD 
for more than 12 months 
 
 
There is however some criticism of the definition and researchers have pointed out the lack of novelty 
in the definition or an evidence based consensus in the development of the definition (Di Sabatino & 
Corazza, 2013, Mäki, 2012). However, following the publication of this definition, it appeared in 
numerous (n=960) review articles and studies (Czaja-Bulsa, 2015, Marsh, 2013, Kocsis et al., 2013, 
Kenrick & Day, 2014) and has been cited by the British Society of Gastroenterology (BSG)  in their up-
to-date guidelines on CD (Ludvigsson et al., 2014b). It is felt that, despite these observations, the 
definition per se is practical, the process to adapt the definition was methodologically sound and equally 
there is no study to prove its triviality, hence this definition will be referred to in this document.   
 
Historical perspective of Coeliac Disease 
 
CD was first described by Aretaeus of Cappadocia (present-day Turkey) in 250 AD (TekıNer, 2015). He 
referred to the condition as ‘koiliakos’ (κοιλιακός), i.e. to do with the bowels or abdomen, although, prior 
to this, intestinal disease and malabsorption was referred to in 15 BC Indian literature (Bures, 2018). 
The term came to English as ‘coeliac’ with Francis Adams’ translation of these observations from Greek 
to English (Adams, 1856). The dietary link with CD was first described in 1888 by Samuel Gee, a British 
physician, in his book “On the Coeliac Affection” (Gee & Gibbons, 1939). Initially, it was postulated that 
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a toxic component in the diet was responsible for the disease, yet no such component was identified 
over the next 70 years, despite multiple attempts (Losowsky, 2008, Booth, 1989).  
  
The final breakthrough came during World War II, following vigilant observations made by Dutch 
paediatrician Willem Karel Dicke on a cohort of young children suffering from chronic diarrhoea and 
weight loss (Dicke, 1941). One famous account describes how, when the Nazi regime blocked supply 
routes, cereals to make bread were in extreme shortage and were replaced with non-wheat containing 
alternatives. This subsequently led to symptomatic improvement and Dicke became convinced that it 
was the absence of wheat-related products that brought about improvements in the symptoms of CD 
(Dicke, 1950). Principal historical developments are shown in the chart below (Fig No 1). 
 
 
  Figure 1: Principal historical developments in relation to CD. 
 
Over the past 25 years, insight into CD has undergone major development and new information has 
emerged about its epidemiology, patho-physiology, diagnostics and management. Indeed, the key 
patho-physiological steps and role of tissue transglutaminase (tTG) in relation to CD have been 
discovered (Molberg et al., 1998). At the dawn of the new century, clinico-pathological understanding 
further increased and enteropathy-associated T cell lymphoma (EATL) was described (Cellier et al., 
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2000b). Similarly, non-dietary treatments (Schuppan & Junker, 2007) and the role of IL-15 (Mention et 
al., 2003) were also explored. At the molecular level, the structural interaction between T-cell receptor 
(TCR) HLA and tissue glutaminase has been the subject of recent research (Petersen et al., 2014, Chen 
et al., 2015). In addition, novel methods of intervention have been proposed by researchers to increase 
adherence with a GFD (Sainsbury, Mullan & Sharpe, 2013b). Very recently, sensitive urine tests have 
been developed to detect Gluten Immunogenic Peptides (GIP) in patients not adhering to a GFD 
(Moreno et al., 2017). Nonetheless, one of the key issues still needing to be addressed is the 
development of a cost-effective, patient-friendly, widely accessible and effective therapeutic strategy 























Pathology and pathogenesis of Coeliac Disease 
 
CD is one of the classic examples where a number of genetic, environmental and immune factors 
interact and give rise to disease of varying degrees of severity, as it is the close interaction between an 
environmental agent and a host with appropriate genes that allows it to develop.  
 
Role of genetic predisposition in Coeliac Disease  
Among these factors, genes are non-modifiable and have long been known to cause CD (Corazza et 
al., 1992). The intra-familial occurrence of CD and concordance rates for CD in monozygotic twins (as 
suggested by family studies) show that genetic factors are important causative agents in CD 
pathogenesis (Schmitz, 1997, Ellis, 1981, Wijmenga & Gutierrez-Achury, 2014). Moreover, research in 
the area of genetic linkage shows that CD has a strong association with HLA-DQ genes and patients 
who carry DQ2 or DQ8 alleles (Karell et al., 2003). Almost all patients with CD carry a subtype HLA-
DQ8, which means that if this haplotype is not present, the likelihood of CD is very rare. In other words, 
this has a negative predictive value in the diagnosis of CD (Lebwohl et al., 2014b) and helps in the 
exclusion of CD in equivocal cases (Kaukinen et al., 2002a). Yet, this notion might not be universally 
true, as suggested by a Spanish systematic review, which found 3% of HLA negative patient were later 
diagnosed with CD (Fernandez-Banares et al., 2017). The exact clinical significance of this finding is 
not clear.  
Allied to this concept, the genetics of CD have been studied in Indian patients and were found to be 
related to the same HLA alleles as in Western Europeans (Amarapurkar et al., 2016), but this is an 
under-researched area that few studies have explored (Agrawal et al., 2000, Kaur et al., 2002, 
Shanmugalakshmi et al., 2003, Senapati et al., 2015). It is therefore considered that this area is in need 
of further research.  
Role of gluten in the pathogenesis of Coeliac Disease 
The most established and modifiable factor is the environmental agent for CD, which is found in wheat 
protein. Wheat (Triticum aestivum) itself comes from the family of grains that is divided into two groups, 
namely Festucoideae and Panicoideae. The former is further divided into three tribes and wheat belongs 
to the Triticeae tribe along with rye and barley (Kasarda et al., 1984). Oats belong to a related tribe and 
it is this taxonomic remoteness that makes oats relatively safe for consumption in CD (Cooper et al., 
2013). Correspondingly, rice, corn, sorghum and millet – although grains – are taxonomically different 
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from wheat and are thus safe to consume in CD. The taxonomic relationship of the wheat family is 
shown in the figure below (Fig No 2). 
 
 
Figure 2: Taxonomic relationship of the major cereal grains. Modified and redrawn from Sleisenger’s gastroenterology 
(Feldman et al., 2015).   
 
Wheat proteins are classified on the basis of their solubility characteristics and fall into four general 
groups: prolamins, glutenins, globulins and minor albumins (which are soluble in alcohol, dilute acid, 
normal saline and water respectively) (Feldman et al., 2015, DuPont et al., 2005). Gluten is a combined 
term for both prolamin and glutenin (Biesiekierski, 2017). Although most studies performed suggest that 
prolamin is the toxic component, there is also evidence to suggest that glutenins can be toxic in this 
context (De Vincenzi et al., 1996). Gluten from wheat is known as gliaden, as opposed to gluten from 
rye (secalin) and barley (hordein). Electro-physiologically, gliadin can be separated into four fractions 
(α-, β-, γ-, ω- gliadins) (Ciclitira & Ellis, 1987). Gluten is capable of activating T cells to generate 
lymphocytic inflammation (Vader et al., 2002).  
Role of the immune system in CD 
Both humoral and cellular immune responses directed against polyamines play a major role in the 
pathogenesis of CD, as shown by the substantial recruitment of B cells in the lamina propria of the small 
intestine and presence of antibodies to gliaden in the sera of patients with active CD (Troncone & 
Discepolo, 2014, Lindfors et al., 2010). The target autoantigen here is tTG. There is evidence to suggest 





as well as a recruiter of other inflammatory cells (Maiuri et al., 2003). These events are summarised in 




Figure 3: Pathogenesis of CD: 1: Antigen presentation 2: Activation of T cells 3: Immune interplay between T and B 
cells 4: Inflammation in small intestine. Modified and redrawn from (Kagnoff, 2005, Plenge, 2010). 
 
 
The proposed sequence of events is: luminal breakdown of gluten which releases the toxic gluten 
peptides; these are taken up by the luminal cells and absorbed; antigen presenting cells process these 
peptides, leading to the activation of both T (Jabri & Sollid, 2017) and B cells (Hietikko et al., 2018); this 
leads to inflammation of the intestinal mucosa. On gross examination, the duodenum may appear 
“scalloped” (Oxentenko et al., 2002) and the histology shows characteristic VA as standardised by 
Marsh and Crowe (1995) and latter modified by other researcher (Antonioli, 2003, Das et al., 2019). A 
detailed discussion of these histopathological findings is beyond the scope of this work, but a summary 






Table 2: Modified Marsh Classification. Adapted from Antonioli (2003). 
Type IEL/100 EI D IEL/100 EI J CH Villi 
0 <40 <30 Normal Normal 
1 >40 >30 Normal Normal 
2 >40 >30 Increased Normal 
2a >40 >30 Increased Mild atrophy 
3b >40 >30 Increased Marked atrophy 
3c >40 >30 Increased Complete atrophy 
Abbreviations/ explanation: IEL/ 100 enterocytes (E) intraepithelial lymphocytes (I) per 100 enterocytes, duodenum (D),  
Jejunum (J), cryptic hyperplasia (CH). Severity: Normal to increasing 0 -3c. 
 
Additionally, there may be other confounders affecting the expression of the disease, because this 
simple model does not explain all the clinical behaviours of CD. The protective effect of breast feeding 
was referred to in the literature as early as 1983 (Ivarsson et al., 2002) and later a meta-analysis 
(Akobeng et al., 2006) of carefully selected studies (n=6) examined the risk of CD and reported that it 
was significantly increased in infants who were fed gluten at the time of breast feeding, as compared to 
those who were not (pooled odds ratio 0.48, 95% CI 0.40 to 0.59). Subsequently, a large two phased 
cross sectional screening study (n=13279) reported the protective effect of prolonged breast feeding 
and suggested a gradual introduction of gluten into the diet when weaning (Ivarsson et al., 2013).  
Similarly, two prospective cohort studies examined the duration of breastfeeding and time of introduction 
of gluten into the diet and found that longer duration of breastfeeding (Lionetti et al., 2012) and late 
introduction of gluten may offer protection against CD (Aronsson et al., 2016), but a later systematic 
review did not give clear guidance about the duration of breastfeeding as such (Silano et al., 2016). It is 
thus concluded that early introduction of gluten and early weaning do play some role in the causation of 
CD and gradual introduction of gluten is favourable. However, the exact mechanism is not clear and 
more research is needed in this area. 
Rotavirus infection has been found to cause CD in genetically predisposed individuals, as suggested by 
a prospective cohort study (Stene et al., 2006). This longitudinal study (n=1931) involved infants who 
were genetically susceptible to CD at birth on account of their HLA and were followed up with serological 
tests for CD and Rotavirus. However, the diagnosis of Rotavirus was not clinical; rather it was based on 
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serology. In the same year, another study (n=60) examined patients’ sera for peptide sequence and this 
shared a high degree of homology with the Rotavirus, suggesting a possible role in the causation of CD 
(Zanoni et al., 2006). These findings were further confirmed by the same group in a later study (Dolcino 
et al., 2013). The same author also implicated the role of Rotavirus in non-coeliac gluten sensitivity in a 
recent study (Puccetti et al., 2018). These studies are not conclusive, but do point towards the fact that 
CD may be prevented by avoiding Rotavirus infection; but the oral vaccine developed against Rotavirus 
did not alter the risk of CD (Vaarala et al., 2017). Additionally, the whole notion of Rotavirus causing CD 
was questioned by Ziberna and colleagues (2016). It is felt that this is an evolving area and more 
research is needed here.  
There are other factors which may play a role in relation to CD. Cammarota (2000) published a case 
report where a 42 year old patient with Hepatitis C developed CD after initiation of Interferon treatment: 
a finding later confirmed by a retrospective case series (Durante-Mangoni et al., 2004). Similarly, 
another author suggested that there might be an epidemiological link between Hepatitis C and CD 
(Colombo et al., 2003). Likewise, increased birth weight was yet another factor linked with the causation 
of CD, in a retrospective Swedish study (Kuja-Halkola et al., 2017). However, the author admits that, 
when comparing discordant twin pairs in within-twin pair analyses, no significant difference was found, 
suggesting that high birth weight does not play a definitive role in causing CD. Other factors, such as 
mode of delivery and maternal antibiotic intake during gestation, were examined in a population cohort 
study (n=54) and there was some suggestion that antibiotic intake may cause CD (Pozo-Rubio et al., 
2013). This study however indirectly inferred the causative role lymphocyte activation, which may or 
may not be related to the CD.  It is thus accepted that genetics alone cannot explain the causation of 








Epidemiology of Coeliac Disease 
 
Ethnicity, Sex and Age 
 
Previously, it was thought that CD was primarily a Western European disease that followed the 
Caucasian race through the route of their migration to the United States and Australia (Johnston et al., 
1998). Yet this is not entirely true. With the introduction of sensitive serology, CD is now also being 
diagnosed in areas where wheat is the main dietary staple, such as the Indian subcontinent, North West 
and East Africa, the Middle East and South America (Akbari et al., 2006, Dalgic et al., 2011, 
Bhattacharya et al., 2009, Malekzadeh et al., 2005). Additionally, there are gender differences: research 
shows that there is a clear female preponderance in the diagnosis of CD, ranging from 60 to 70% of the 
diagnosed and undiagnosed cases (Bai et al., 2005, Dixit et al., 2014, Shah & Leffler, 2010, Ivarsson et 
al., 2003, Jansson-Knodell et al., 2018), although there is a suggestion that the difference disappears 
with advancing age (Fasano et al., 2003). This apparent discrepancy remains unexplained and one may 
argue that there are gender differences in health-related help-seeking behaviour (Oliver et al., 2005), by 
the observation that females tend to visit their GP more often (Vedsted & Christensen, 2005, Corney, 
1990) than their male counterparts (Galdas et al., 2005). Additionally, anaemia, a presenting sign of CD 
(Harper et al., 2007), which is common in pregnancy (Goonewardene et al., 2012) and osteoporosis, a 
commonly reported condition in females (Cawthon, 2011), is associated with CD and may necessitate 
CD testing, which may then increase the number of diagnosed females cases. A recent meta-analysis 
looking at data from 87 studies (n= 291,969) showed that the pooled prevalence of CD among females 
was 0.589% as compared to males (0.415%), with females carrying a higher risk of undetected CD 
(Jansson-Knodell et al., 2018). However, evidence to explain this gender disparity is insufficient and it 
appears to be multifactorial in nature and more research is needed to explore this discrepancy between 
genders.  
CD affects all age groups and is not just a paediatric disease. Currently, a quarter of cases are 
diagnosed in patients aged 60 or above (Vilppula et al., 2009), with a mean age of 45 years (Rubio-
Tapia et al., 2012) and rising (Mukherjee et al., 2010). Increasingly, cases of the subclinical disease are 
being diagnosed, after investigation through case finding of first-degree relatives of CD-affected 
individuals (Tajuddin et al., 2009). Nonetheless, the general trend identified in the presentation of CD is 
increasing age at diagnosis, along with a shift from classical to non-classical CD, as suggested by 
retrospective cohorts spanning more than 55 years (Castro et al., 2017, Whyte & Jenkins, 2013).   
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Incidence of Coeliac Disease 
 
The incidence of CD has been estimated in several population-based research studies and a wide range 
between 2-13/100,000 per year is reported, which is multifactorial (Rewers, 2005). A US based study 
spanning over 50 years has estimated incidence to be 2.1/100,000 per year (Murray et al., 2003a), but 
this might be marred by diagnostic bias, as sensitive endoscopic and serological tests to diagnose CD 
have evolved over the past 40 years. Similarly, an extensive review covering the European and 
Mediterranean region estimates that the incidence ranges from 0.1 to 3.7/1000 live births in the child 
population and from 1.3 to 39/100,000/year in the adult population (Altobelli et al., 2014). Nonetheless, 
it is accepted that all adults diagnosed in such studies may not necessarily have been true new cases 
(incidence), as the condition may well have been subclinical and have been present for decades and 
hence undetected, which could have falsely inflated the incidence rate (Rewers, 2005).  
Two associated phenomena in this regard are the geographic variability of the incidence of CD and 
rising levels of incidence worldwide. For example, in Europe the incidence of CD is especially high in 
the Scandinavian (Ivarsson et al., 2000) and Celtic populations (Maki et al., 2003), where the reported 
incidence is around 3.5 per 1000 live births (Cavell et al., 1992). Genetic factors are not the sole cause 
for this regional diversity however, as Denmark has an approximate incidence which is 40-fold lower 
than the Norwegian population (Weile et al., 1995), despite the fact that they share the same gene pool. 
This notion is further supported by the presence of discordance between monozygotic twins in the 
expression of CD (Bardella et al., 2000). It is thus accepted that this area needs more research. 
Secondly, the incidence of CD is on the rise and this has been reported by several studies (Ludvigsson 
et al., 2014a, Ludvigsson et al., 2013a, Murray et al., 2003b, Canavan et al., 2014), but the exact reason 
for this rise is not clear and is thought to be multifactorial. The rise in incidence is complex and could be 
partly attributed to refining the diagnostic criteria and, more importantly, the availability of sensitive 
serological tests (Lohi et al., 2007); but the design and selection of participants can also affect the 
incidence of CD. Methodology of the study may play a role, as in the systematic review by Kang et al. 
(2013), which identified 15 studies that primarily used blood donors when looking at the incidence of 
CD; it is clear that this will lead to selection bias, as blood donors are less likely to be anaemic (one of 
the main laboratory findings for CD) (Harper et al., 2007). Additionally, there are a number of studies 
that point towards environmental factors and regard part of this rise in incidence as a true increase 
(Ivarsson et al., 2013, Lohi et al., 2007). Industrial usage of gluten is conceivably one such factor leading 
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to an increase in the incidence of CD (Catassi et al., 2014), but no strong evidence exists to support this 
notion.  
Similarly, other factors like differences in human leukocyte antigen (HLA) or variability in the infant 
formula at the time when gluten is introduced into the infant’s diet might well play a part (Norris et al., 
2005). A methodologically superior later study suggested that this increase in the diagnosis may be up 
to two fold in genetically predisposed children, if gluten is consumed before the age two (Aronsson et 
al., 2016). It is, however, accepted that it is difficult to give a detailed account of this complex area partly 
because of its multifactorial nature and the paucity of research in this area.  
Incidence of CD has been estimated in the UK as well and there is clear geographical variation. In 
England, for example, the reported incidence of CD is 8.7/100,000 per year as suggested by histo-
pathologically diagnosed cases (Fowell et al., 2006). The study examined all referrals to a 
gastroenterology department (from 1992 – 2002) and may well have been affected by referral bias. 
Similarly a Scotland based study estimated incidence to be 11.7/100 000 per year. Yet another non-
geographically bound UK based study (West et al., 2014) reported it to be 19.1/100.000 per year and 
demonstrated a geographical difference between Northern Ireland (22.3) and London (10). It is felt that 
the latter study is close to the true estimate of incidence, as it is not geographically bound and has 
accessed a more thorough database instead of relying on referrals in a single department.   
Following the general trend, four studies have reported an increase in the incidence of CD in the UK 
from 1960 to early 2000, with two of them using the same population (Hurley et al., 2012, White et al., 
2013, West et al., 2014, Hawkes et al., 2000). It is accepted that a re-analysis of all evidence for UK 
based studies needs to be done, followed by population based research.  It is also accepted that the 
aetiology of CD is multifactorial and may well explain this rise in incidence. To address this question, 
however, it is suggested that further research is needed in this area. One possible study design might 
be the mass screening of a given population followed by similar screening after a quinquennium with 
longer follow ups. 
Prevalence  
 
Reported prevalence of CD (proportion of patients with CD at a given time) ranges from 1:70 to 1:300 
in most of the world’s populations (Gujral et al., 2012); there is also a suggestion that the prevalence 
has increased over time (Rubio-Tapia et al., 2009, Riddle et al., 2012). Moreover, variability is seen in 
different populations, with the reported prevalence being very low in Chinese (Yuan et al., 2017) and 
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related ethnicities (Cummins & Roberts‐Thomson, 2009), whereas those with the highest prevalence of 
CD (5.1%) are in a North African tribal population (Barada et al., 2010). This remains unexplained and 
may have an environmental cause such as high gluten intake or the presence of a high carrier rate of 
HLA type DQ2 and DQ8 genes and more research is needed.   
Following global trends, the overall prevalence rate for CD in northern Europe is 1% (Feldman et al., 
2015), yet it has long been known that geographic variation exists in the reported prevalence of CD in 
Europe (Pittschieler & Ladinser, 1996), which ranges from 0.7% to 2.4 % (Mustalahti et al., 2010). 
Similarly, in the UK, the estimated prevalence for CD ranges from 0.5% to 1% (Ciclitira et al., 2010, 
Aggarwal et al., 2012, Sanders et al., 2001). The reported variation in population-based studies is 
determined in part by the design of the study and the diagnostic criteria used, HLA of the subject 
population and variation in pathological reporting.  
Prevalence is dependent on the age of the patient and increases with age, as 25% of adults are 
diagnosed with CD after the age of 60, as suggested by a recent review (Collin et al., 2018). Similarly, 
in children for example, the prevalence rate is 1:285 as suggested by a US based study (Fasano et al., 
2003). Likewise, an Italian study with substantial power (n=17,201) estimated the prevalence in school-
going children (between the ages of 6 and 15) to be 1:184, which means that for each diagnosed 
individual in Italy there are thought to be seven undiagnosed cases of CD (Catassi et al., 1996). In 
contrast, the prevalence in adults of positive serology for CD is found to be higher and close to 1:105 
(Fasano et al., 2003). Additionally, prevalence for VA is 1:99 (Maki et al., 2003) and for active disease 
is around 1:1750 (Murray et al., 2003b). Furthermore, the prevalence also varies if other factors are 
considered, such as patients with type I diabetes and people with affected first-degree relatives, where 
the prevalence is between 20% and 15% respectively (Dubé et al., 2005). 
Prevalence is also dependant on the testing methodology (serology, histology or a combination) used 
to diagnose CD. In this context, one US-based study (n=13,145) measured prevalence in both the 
general population and high-risk groups (i.e. close relatives of diagnosed CD patients or symptomatic 
patients) by both serology and histology. The reported prevalence was 1:22 to 1:56 in at-risk groups and 
1:133 in the not at-risk population. It is nonetheless possible that the study missed a number of cases, 
as serology is not 100% sensitive (Sayed et al., 2012). Globally, studies which measure prevalence 
using biopsies report prevalence in the range of 1:300 to 1:500 (Fasano, 1996, Størdal et al., 2013, Al-
Hussaini et al., 2017), which is more objective in terms of diagnosis.  
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Notwithstanding the fact that the studies above rely on data available from diagnostic tests, retrospective 
clinical case findings and questionnaires, true epidemiological indices might not be known, as CD has 
a protean clinical nature and remains an under-diagnosed or misdiagnosed condition (Lohi et al., 2007). 
This is because the symptoms are vague, overlap with irritable bowel syndrome (IBS) and may coexist 
with other similar diseases. For example, a study (n=100) which evaluated the presence of CD in 
patients presenting with symptoms of IBS (by performing serology and duodenal biopsies) found that 
8% of patients had serological as well as histological evidence of CD (Shalaby et al., 2016).  
Moreover, the prevalence of asymptomatic CD in the general population is 0.75% (1 in 132), as 
suggested by a Swedish study (n=1450) examining asymptomatic students, which makes it difficult for 
asymptomatic individuals to qualify for serological testing if relying on symptoms or reporting to their 
family doctors; hence they may evade diagnosis. Furthermore, in underdeveloped countries it is 
assumed that limited access to diagnostic testing may further underestimate the true prevalence, but 
research studies are needed to test this assumption.   
Mass screening may be one solution to detect all cases, but it is not known whether this is the best 
strategy for both patients and the health system, as a critique by Evans et al., (2009) explained. In 
addition, there are economic implications for the NHS and this could also affect the quality of life for 
patients who are asymptomatic but have been diagnosed with CD (Paavola et al., 2012). It may, 
however, offer early recognition and treatment of the condition and thus reduce the risk of associated 
malignancy, but a population cohort with longer follow-up is required to make a case for such an 
intervention.  
Being a global disease, in wheat-cultivating regions in particular, CD affects the South East Asian 
population as well. Over recent decades, South Asians (SA) have migrated in huge numbers to 
westernised countries in Europe and the Americas (Casanova, 2007). Naturally this means that their 
genetic predisposition to CD has been taken along with them, as shown by research involving immigrant 
populations (Walker-Smith, 1973, Sher et al., 1993, Butterworth et al., 2005, Walia et al., 1966, Khoshoo 
& Bhan, 1989). These studies were primarily population-based cohorts and involved both retrospective 
and prospective methodologies. Prior to that, it was anecdotally known that when rice was replaced with 
varieties of wheat-containing grains in summer, the incidence of diarrhoea increased – known as 
‘summer diarrhoea’ in the indigenous areas (Sher et al., 1993). Early this century, well-designed 
prospective epidemiological studies were conducted and one study (n=4347) is particularly worth 
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mentioning. Children aged 3 to 17 were enrolled in the study and checked for CD (Sood et al., 2006); 
only 14 were found to have duodenal changes consistent with CD.  Thus the reported prevalence of 
biopsy-proven CD was 1:310.  The study, however, may be criticised for the fact that diarrhoea is a 
common symptom in North India and, due to infectious aetiologies and anti-tTG, cases of CD were 
conceivably missed; hence adjustment may be needed to interpret the results.  
The prevalence of cryptogenic cirrhosis has been reported to be as high as 10% in a subgroup of Indian 
patients (Maiwall et al., 2014), yet this overestimation can be explained by the fact that CD itself causes 
chronic liver disease. Considering these pitfalls, three well-designed and high-powered studies reported 
the prevalence to be close to1% (Bhattacharya et al., 2009, Makharia et al., 2011, R. Kochhar, Sachdev 
et al., 2012), which is around the value reported in Western literature (Ciclitira et al., 2010, Aggarwal et 
al., 2012, Sanders et al., 2001). In contrast to North India, CD is considered to be rare in South India 
(Sathiyasekeran & Shivbalan, 2005, Ramakrishna et al., 2016), although this may be related to under-
reporting of the disease (Yachha et al., 2006) and lack of high quality studies (Ramachandran & Jacob, 
2016).  
The prevalence and clinical presentation of CD are similar in Pakistan and North India (Rashid & Khan, 
2009, Z. Abbas et al., 2013). Two studies examined the symptomatic presentation of CD. The first was 
a retrospective study (n=77) which reported the typical presentation of CD was diarrhoea and it was the 
presenting symptom in 65% of the patients (Abbas et al., 2013). The second study (n=66) was 
prospective and reported the main symptom of CD as diarrhoea in half of the patients (Masood & Ali 
Shaikh, 2014).  Reported high frequency and equally high variability of a symptom may be explained by 
the fact that diarrhoeal illnesses are common in Pakistan due to infectious aetiologies, and it is quite 
possible that atypical CD patients with infectious diarrhoea have been included in these studies.  
Yet another study which examined the paediatric age group (n=66), in a 5 year prospective cohort, 
reported abdominal distension as the main presenting feature (Aziz et al., 2017). HLA association was 
also explored in a study which found that HLA-DRB1*03 is associated with CD in Pakistan (Saleem et 
al., 2013). This case-control study was low powered. It is nonetheless accepted that this area is under-
researched in Pakistan and more prospective epidemiological studies with high power are required.   
The incidence of CD is increasing on the subcontinent also and one study reported that this situation is 
in parallel with the Western trend (Sood et al., 2001). Following this, in 2009, the Indian task force for 
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CD reported that the incidence of CD in India is no different from the rest of the world (Gupta et al., 
2009). It is thus considered that the epidemiological characteristics of CD in SA are indistinguishable 
from the rest of the world’s population as suggested by meta-analysis (Singh et al., 2016), although this 
area still requires high-powered and prospective studies.   
Studies examining SA resident in Britain are sparse, but worth noting is a seminal study (n=130) by 
Butterworth and colleagues (2005) on British Asians, comparing the population with indigenous 
Caucasians in a case-matched manner. The study reported that prevalence in the Caucasian population 
and SA was 1:356 and 1:193 respectively (p<0001). This significant difference in prevalence was 
reversed when analysed for age 65 and above. There was no difference in the mean age of presentation 
between the two groups, which ranged from 34 to 36 years. The study was prospective and low powered. 
Similarly, a Leicestershire-based study (n=106) retrospectively examined the incidence of CD in 
Punjabis and Gujarati population settled in Leicestershire from India/Africa. It was found that they 
developed the disorder 2.7 times more often than white Europeans (Sher et al., 1993).  
Later, a retrospective study (n=1305) found that 0.6% of Asians were diagnosed with CD in the 
Derbyshire area in the UK (Holmes & Moor, 2012). The study pointed to the previous observation of 
increased diagnosis of CD among Asians and agreed with Sher and colleagues (1993). Although well 















Clinical presentation of Coeliac Disease  
 
The clinical presentation of CD is not straightforward and the initial classical description of CD in the 
literature, comprising chronic diarrhoea, generalising wasting and severe malnutrition (Plotkin & 
Isselbacher, 1964) is rare nowadays – especially in the developed world (Dixit et al., 2014, Reilly et al., 
2012). Symptoms of CD may not reliably correlate with the degree of inflammation in the SBM (Cronin 
et al., 2018).This is because CD involves the duodenum in a patchy fashion (Hopper et al., 2008), 
leading to VA of variable severity, hence variable degrees of malabsorption (Yachha et al., 1993). The 
critical decrease in small bowel surface area to cause malabsorption may not be achieved in all patients 
and this may partly explain the variability in clinical presentation of CD (Rampertab et al., 2006). It could 
best be described as an iceberg model (Admou et al., 2012) based on the presence or absence of 
symptoms (Fig No 4).   
 
Figure 4: Coeliac Disease iceberg. Modified extensively and redrawn from Sleisenger’s gastroenterology (Feldman et 
al., 2015) in the light of the Oslo conference (Ludvigsson et al., 2013b).  
 
The tip of the iceberg displays the symptomatic disease and includes classical CD, which was first 
described by Gee (1939) and presents with diarrhoea, weight loss and abdominal pain (classic 
symptoms) with supporting serological and histological evidence (Wahab et al., 2002). This pattern of 
20 
 
presentation is decreasing, as suggested by an extensive Irish study (n=749) examining the health 
records of CD patients from 1960 to 2015 (Castro et al., 2017). The second type (non-classical CD) 
presents with no signs or symptoms of malabsorption, although mono or oligo symptoms may be 
present. These symptoms were reviewed by Admou and colleagues (2012), who enumerated a number 
of symptoms and laboratory signs such as: anaemia, vomiting, constipation, headache, neuropathy and 
short stature. This type of CD is often missed in clinical settings because of its protean nature of 
presentation (Singh & Makharia, 2014). The third type in this group is the submerged portion consisting 
of subclinical or silent CD, which has fully expressed serology and associated enteropathy but no 
symptoms; this is the most common type (Rampertab et al., 2006).  
The final type in the above figure is potential CD, which has the required HLA and positive serology but 
does not have abnormal SBM (Sperandeo et al., 2011). A study utilizing MRI to detect a metabolic 
signature suggests that there is increased metabolic activity on MRI when this group is exposed to 
gluten (Bernini et al., 2010), but the clinical significance of this study is not clear. Not shown in the 
iceberg model are two other types of CD, based on the clinical response to a GFD: namely 
nonresponsive and refractory CD, which will be referred to later in the review. The consensus 
conference in Oslo (2014) adopted these terms, with slight modification, as standard terminology in the 
description of CD and these are given in table 1 in the previous section (page 4).   
Research in the Indian population has also looked at the presentation of CD and one study (n=96) found 
that 67.7% of cases presented with diarrhoea, whereas 18.7% presented with refractory iron-deficiency 
anaemia and 9.4% with abdominal symptoms (Sood et al., 2003). The study clearly reports different 
modes of presentation from the European studies; however, the research itself has examined the 
hospital records of patients retrospectively and is therefore affected by the selection bias of a cohort of 
patients who were symptomatic enough to be hospitalised, thus excluding CD with minor symptoms.  
A decade later, a study with prospective methodology and higher power (n=381) found that abdominal 
pain (and not diarrhoea) was a predominant presenting symptom (Bhattacharya et al., 2013). This study 
again selected patients from a tertiary centre and may have been affected by selection bias, because 
difficult and complicated cases are referred to tertiary centres. Similarly, a retrospective study (n=434) 
concluded that an atypical presentation was more common in Indian adult populations by comparing 
adults and children (Kochhar et al., 2012). Later, another study (n=233) retrospectively analysed health 
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records for the presentation of CD and found that 40% of adult Indian CD patients presented atypically 
(Sharma et al., 2013).  
Earlier, a retrospective cohort study by (Butterworth et al., 2005) analysed 130 clinical attendances of 
CD patients and noted significant differences in the presentation between SA and Caucasian patients, 
including a younger age of presentation; this was later confirmed by another  British study examining 
2410 (SA n = 191) health records (Holmes & Muirhead, 2017). Butterworth et al., (2005) also reported 
a lower presence of IBS like illness, higher levels of alkaline phosphatase and lower DQ2-positivity 
status in the Asian (n=40) group, but the study was retrospective. It is likewise accepted that there is 
limited literature specifically looking into CD in the SA population (Yachha & Poddar, 2007, Malekzadeh 
et al., 2005) and further research is needed, with high-powered prospective studies and longer follow 




There is huge variability in the gastrointestinal manifestations of CD between patients: it may present 
with diarrhoea, weight loss, abdominal pain, bloating and flatulence, yet it is accepted that none of these 
symptoms is specific for CD (van der Windt et al., 2010).  Very rarely, a patient may present with severe 
weakness, abdominal pain, lassitude, electrolyte disturbance and dehydration as a result of severe 
diarrhoea; this is called a coeliac crisis (Parry & Acharya, 2010). There is evidence to suggest that CD 
presenting with abdominal symptoms is no longer the predominant clinical picture (Rampertab et al., 
2006).  
Abdominal symptoms such as discomfort, pain and accompanying bloating or increased flatulence are 
a common presentation of IBS (Wahnschaffe et al., 2001); hence, such patients may have been treated 
for IBS for years. This was investigated in a UK-based study (n=300) where patients with symptoms of 
IBS along with a similar number of asymptomatic healthy (age and sex matched) controls were tested 
for CD; 4.6% (n=14) were found to be suffering from CD in the IBS arm of the study compared with 
asymptomatic healthy individuals (Sanders et al., 2001). A later meta-analysis by Sainsbury and 
colleagues (2013) concluded that 38% of patients with CD had symptoms of IBS. The clinical point here 






CD has a spectrum of presentation as explained above, and may also present with symptoms and signs 
that are extra-intestinal (EI) in nature (Gasbarrini et al., 2014), affecting different systems namely: skin 
(Collin et al., 2017), bone (Bianchi & Bardella, 2008), liver (Duggan & Duggan, 2005), thyroid (Metso et 
al., 2012), pancreas (Leeds et al., 2007), nervous system (Cicarelli et al., 2003) and heart (Emilsson et 
al., 2013). Moreover, EI symptoms are more common in elderly patients, being caused by chronic 
nutrient malabsorption; they can potentially affect any organ system. The figure below shows the 
involvement of different systems and related pathologies in relation to CD (Fig No 5). 
 
Figure 5: CD as a multi-system disease. Modified and redrawn from (Jnawali et al., 2016). 
 
In terms of frequency, the most common EI presentations (>10%) are iron deficiency anaemia and skin 
diseases such as alopecia and Dermatitis Herpetiformis (DH). These are followed by (between 1 to 
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10%) osteoporosis, oral aphthous ulcers, dental issues, amenorrhoea and finally (<1%) rare issues such 
as: atopy, erythema nodosum, myositis and electrocardiogram abnormalities (Gasbarrini et al., 2014).   
Anaemia is a common EI manifestation in all age groups (Smukalla et al., 2014) and may even be the 
presenting feature (Green, 2005). It is mainly caused by impaired absorption of iron leading to classical 
microcytic anaemia, but may well be multifactorial (Berry et al., 2018); occult gastrointestinal bleeding 
and anaemia of chronic disease may also play some role (Mant et al., 2006, Bergamaschi et al., 2008). 
It affects 10 to 41% of patients with CD (Harper et al., 2007, Dahele & Ghosh, 2001, Rampertab et al., 
2006). The reported variability in these studies is related to the methodology used, definition of anaemia 
and multifactorial nature of anaemia. Anaemia associated with B12 deficiency (Harper et al., 2007) and 
folic acid deficiency (Howard et al., 2002) is rare. 
Alongside malabsorption of iron, CD may also precipitate calcium malabsorption, leading to its effect on 
bone health (Capriles et al., 2009, Bianchi & Bardella, 2008), which may take several forms such as 
osteopenia (Di Stefano et al., 2000), osteoporosis (Mahadev et al., 2018, Laszkowska et al., 2018) and  
fracture (Olmos et al., 2008). Several studies have examined bone health in relation to CD and one 
concluded that there is a significantly reduced bone density between patients with CD and the normal 
population (Kavak et al., 2003). However, the study examined a paediatric group in which their bones 
are still in the growth phase, hence difficult to standardise; additionally it was a low powered study 
(n=34). In contrast to this, two earlier well-designed studies in this area estimated that 70% of patients 
with active CD have osteopenia (Corazza et al., 1995) and 25% have osteoporosis (Kemppainen et al., 
1999b). The former study compared healthy volunteers (n=24) along with 31 patients with CD and 
concluded that the bone mineral density of untreated CD patients was significantly lower than that in the 
healthy volunteers.  The latter study followed up a cohort of patients (n=28) for five years and noticed 
improvements in the osteoporosis with a GFD. A recent systematic review with meta-analysis concluded 
that there was no significant difference between osteoporosis in CD and the rest of the general 
population and questioned the rationale of routine screening, but accepted that this area needed more 
research (Mahadev et al., 2018).     
 
A small but significant increase in fracture risk has been reported by a detailed systematic review and 
meta-analysis, but the author accepted the variability (both qualitative and quantitative) among the eight 
selected studies (n=20955) and urged the need for more research (Olmos et al., 2008). A subsequent 
prospective cohort study agreed with the findings of the meta-analysis (Heikkilä, et al., 2015). A recently 
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published study confirmed the increased risk of fracture in CD in combination with diabetes (Thong et 
al., 2018). Although the study had reasonable power (n=346), it was a retrospective cross sectional 
study. Similarly, another recent retrospective cohort study examining the risk of fractures in CD (n=1233) 
in comparison to healthy individuals (n=6167) did not find a significant difference (Canova et al., 2018), 
but the study only examined the heath records of adolescent patients. Based on this evidence, the BSG 
recommendation is to measure the bone density of patients with CD at regular intervals (Ludvigsson et 
al., 2014b).  
In relation to the nervous system, both central and peripheral environments are affected by CD (Chin et 
al., 2003). One study found that neurological symptoms are 54% more common when compared to the 
general population (Zelnik et al., 2004); however, the study was questionnaire-based and may have 
been affected by recall bias. Sensory ganglionopathy (Hadjivassiliou et al., 2010) and ataxia, related to 
cerebellar dysfunction in CD (Bushara et al., 2001), are believed to be caused by immunological 
mechanisms (Green et al., 2005, Alaedini et al., 2002, Briani et al., 2008). Epilepsy and other seizure 
disorders are also common in CD (Pratesi et al., 2003). Likewise, CD can affect the reproductive system 
and may lead to amenorrhea, delayed menarche and infertility; these symptoms need investigation in 
CD patients as concluded by a meta-analysis (Tersigni et al., 2014).   
Associated conditions 
 
CD is related to a range of other autoimmune diseases such as Type 1 Diabetes Mellitus (T1DM)  
(Camarca et al., 2012), Down syndrome (Du et al., 2017), pulmonary haemosiderosis  (Khemiri et al., 
2008), recurrent pancreatitis (Ludvigsson et al., 2007) and thyroid disorders (Teixeira et al., 2014). Out 
of all the conditions, T1DM has the strongest association and the co-existence of CD and T1DM is partly 
due to the DQ alleles they share (Smyth et al., 2008). The prevalence of CD in T1DM patients ranges 
from 3-8% according to an early study (Cronin et al., 1997). A UK based study (n=113) found the 
prevalence to be 4.4%, which falls between the previously reported range of 3-8% (Goh & Banerjee, 
2007). An Indian study (n=189) reported the prevalence to be 11.1%, which is higher than the reported 
range (Bhadada et al., 2011). Although there is a difference in power between these studies, the 
methodology is similar and it may be argued that racial differences exist, but more research is needed 




CD is also associated with autoimmune thyroiditis and frequently leads to underactivity of the gland 
(Volta et al., 2001). IgA deficiency is also common (2%) and can lead to diagnostic confusion if only IgA 
tTG is measured, which thus leads to false negative results (McGowan et al., 2008). Similarly, 
inflammatory bowel disease (Yang et al., 2005) or microscopic colitis (Stewart et al., 2011) and CD may 
coexist and create diagnostic confusion. 
CD affects the skin as well and there is a well-known association between Dermatitis Herpetiformis (DH) 
and CD. A papulo-vesicular and intensely pruritic rash, it involves the extensor surfaces of the skin and 
appears in early or mid-adult life, with a slight male preponderance (3:2); it is not commonly seen in 
children (Lionel, 2002). Furthermore, CD and DH are conditions that share pathogenesis and clinical 
features. They may well be parts of the same disease spectrum, as up to 10% of patients with CD have 
latent DH (Feldman et al., 2015). Skin lesions respond to Dapsone and a prolonged GFD may help to 
reduce the relapse rate of DH (Mansikka et al., 2018). Additionally, DH has an increased association 



















Diagnosis and management of Coeliac Disease 
 
The symptoms and signs of CD are not always present, and when present are non-specific, as other 
malabsorption disorders share similar symptom combinations; this may lead to a diagnostic delay of up 
to 3 years (Paez et al., 2017). In all instances, when clinical suspicion arises, BSG suggests that 
serological tests are employed first (Ludvigsson et al., 2014b), namely IgA assays of anti-endomysial 
antibody (EMA) and tTG antibodies that target transglutaminase in tissue. These tests are cost-effective, 
widely available and have high sensitivity and specificity (Rostom et al., 2004). Many laboratories will 
measure total IgA, to avoid error in interpreting serological tests that may produce false negatives in IgA 
deficiency, in which case IgG-based tests may be offered (Korponay-Szabo et al., 2003) .  
Upper Gastro Intestinal Endoscopy (UGIE) is the standard test to collect tissue samples for 
histopathological analysis, where duodenal scalloping may be noted as a gross mucosal feature of CD 
(Brocchi et al., 2002). Although small bowel biopsy is not a gold standard and may not be needed in the 
diagnosis of all cases of CD (Gülseren et al., 2018) because of complexity of levels of diagnosis in CD 
(Catassi & Fasano, 2010),  it does add significant weight to the diagnosis (Caruso et al., 2014, McCarty 
et al., 2018) and is recommended by the BSG (Ludvigsson et al., 2014b). The BSG further states that  
small bowel biopsies are only useful if interpreted carefully within the clinical context, as VA is also seen 
in other pathologies (Ludvigsson et al., 2014b); isolated VA without any supportive serology, or even 
clinical symptoms, is a difficult clinical entity (DeGaetani et al., 2013) and HLA tests are indicated.  
Although serological tests serve as diagnostic  and prognostic tools,  their diagnostic utility is interpreted 
in light of the clinical index of suspicion: in a patient with a low index the negative predictive value 
increases and vice versa. Because of the strong relationship between CD and HLA DQ2 or DQ8, genetic 
tests are undertaken when a patient has negative serology but has VA (DeGaetani et al., 2013) and a 
negative test excludes CD with great certainty in all age groups (Hadithi et al., 2007).  
 
Micronutrients and malabsorption in CD 
 
Severe malnutrition is rarely seen in current medical practice, but malabsorption of various 
micronutrients such as iron, calcium and vitamins is common in patients with CD (Haines et al., 2008, 
N. Kumar et al., 2004, Wierdsma et al., 2013). The reasons for malabsorption are complex: reduced 
surface area coupled with reduced secretion of intestinal cholecystokinin (Nousia-Arvanitakis et al., 
1999) leads to impaired secretion of pancreatic enzymes, resulting in reduced absorption of fat-soluble 
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vitamins. The most clinically significant deficiencies are those of calcium and vitamin D (Bischoff-Ferrari 
et al., 2006), which lead to metabolic bone diseases ranging from osteopenia to osteoporosis (Di Stefano 
et al., 2000, Mahadev et al., 2018) and  fracture (Olmos et al., 2008). In reported literature, 64% of men 
and 71% of women with CD exhibited vitamin D deficiency according to a study investigating bone 
mineral density (Kemppainen et al., 1999a) and hypocalcaemia was reported in 40% of patients in 
another study (Zanchi et al., 2008). Additionally, iron deficiency leading to anaemia is seen in 3% to 
12% of patients with CD (Grisolano et al., 2004). Similarly, magnesium deficiency was noted in 19% of 
treated and 21 % of untreated CD patients (Rujner et al., 2004). Deficiencies of various other vitamins 
including B12, folate and vitamin K are occasionally observed (Kinsey et al., 2007, Qiu et al., 2006). 
Also recognised in association with CD are deficiencies of zinc, selenium, copper, vitamin E and vitamin 
B6, but these are rarely encountered in day to day practice (Haines et al., 2008, N. Kumar et al., 2004, 
Wierdsma et al., 2013, Högberg et al., 2009). 
Management of CD 
 
The only recognised treatment for CD is avoidance of dietary gluten (Rubio-Tapia et al., 2010). The term 
‘gluten free’ (GF) means absolute elimination of all sources of gluten, which is found in wheat and related 
products (Rubio-Tapia et al., 2013), although it is accepted that food items containing gluten up to 20 
ppm or less are considered as gluten free for standardisation purposes (Food and Drug Administration, 
HHS, 2013). Strict adherence to a GFD is the cornerstone of CD treatment (Rubio-Tapia et al., 2013) 
and this should be prescribed for all subgroups of CD, including symptom-free latent CD (Kurppa et al., 
2014).  
 
Food labelling and hidden gluten 
 
Apart from products derived from wheat, barley and rye such as: bread, pasta, biscuits, cakes and 
pastries, gluten is also found in many other products including soups, takeaway meals, repackaged 
ready-to-eat meals and sausages (Denery-Papini et al., 1999), and even lipsticks and toiletries (Verma 
et al., 2018). The Food Standards Agency (FSA), in their most recent guidelines, define ‘gluten free’ 
food as one that has a gluten concentration of up to 20 parts per million (ppm) (FSA, 2012). More 
recently, in the United States, the Food and Drug Agency (FDA) has given a similar ruling on Gluten 
Free Foods (GFF) (FDA, 2013) and foodstuffs that remain below 100 ppm can now be labelled as low 
in gluten. In India, there is a statutory body of food regulation called the “Food Safety and Standards 
28 
 
Authority of India” and it requires a gluten level of less than 20 ppm for an item to be labelled GF (Dudeja 
et al., 2016). This threshold stands at 80 ppm in Australia, although an Australian study analysing the 
gluten contents of 127 commercial products found that up to 9% of food items in Melbourne may still 
contain high levels of gluten, despite being labelled GF (Halmos et al., 2018). A US based study also 
reported that 41% of samples were contaminated with gluten, despite being labelled GF (Thompson et 
al., 2010).  Another study examined 74 samples from different sources and analysed them by using a 
gliadin competitive enzyme-linked immunosorbent assay and found that up to 60% of supposedly GF 
products were contaminated with gluten (Lee et al., 2014). Regardless of the cause(s) of contamination, 
this is a serious issue, as trace gluten may potentially cause inflammation of the small bowel mucosa 
and delay clinical recovery (Hollon et al., 2013). A recent systematic review examining selected studies 
(n=23) questioned the reliability of food items labelled as GF and suggested further research in this area 
(Falcomer et al., 2018).  
A complete list of all GFF is difficult to present here, as it is being updated endlessly; nonetheless, the 
Coeliac Society UK publishes a directory of drinks, foods and other consumed products for members 
that contain gluten, along with a list of GF foods (Coeliac UK, 2018). The literature is renewed every 
month and sister organisations in other countries also have similar arrangements for their members 
(ACS, 2016, CA, 2015). Furthermore, patient-friendly mobile phone apps are available to guide patients 
in relation to a GFD (CSUK, 2016). The table below shows the list of typical GFF (Table No 3).  
Table 3: A list of typical Gluten Free Foods (www.fitneass.com). 
Produce Meat (organic hormone 
free) 
Nuts and Seeds Baking/ Flour 
Apple, avocado, baby 
tomatoes, banana, bell 
peppers, blueberries, broccoli, 
brussel sprouts, beets, carrots, 
cauliflower, celery, cucumber, 
ginger root, green onion, kale, 
lemon, mushrooms, 
pomegranate,  red and yellow 
onion, turmeric root, small 
sweet peppers, spinach, 
strawberries and sweet 
potatoes.  
Egg, chicken breast, ground turkey 
meat, shellfish, fish and bacon. 
Almond, cashew nuts, 
walnuts, chia and sunflower 
seeds.  
Coconut, arrow root, 
brown rice, almond, 
stevia, corn starch, 
baking soda, cream of 
tartar and tapioca 
starch. 
Oils Dairy 
Extra virgin olive oil, coconut oil, palm 
oil and avocado oil.  
Almond milk, dairy produce 
and coconut milk.  
Misc. 
Dill, garlic, dates, 
lentils, nut butters, 
parsley, thyme, black 





Aims of Treatment 
 
The aims of treatment, as per The National Institute for Health and Care Excellence (NICE), include: 
relieving symptoms, replenishing micronutrients and reducing long-term complications (Downey et al., 
2015). In addition to the established dietary recommendations for the treatment of CD, research is 
ongoing to genetically modify grain into a nontoxic grain (Bakshi et al., 2012). Furthermore, IL-15 
blockers are also being investigated to determine whether it is possible to reduce the inflammatory 
cascade to reduce the mucosal inflammation (Maiuri et al., 2003). It is accepted that glucocorticoids 
have no role in the management of CD (Lara et al., 2003), although there is some room for their use in 
relation to refractory and acute life-threatening coeliac crisis (Dennis & Case, 2004). The salient features 
of management of CD are best presented as the mnemonic COELIAC, as explained in the table below 
(Table No 4).  
 
Table 4: Basic steps in the management of CD. Modified from NIH Consensus Development Conference (June 28-30, 
2004, Bethesda, Maryland, USA) on Coeliac Disease (James, 2005). 
 COELIAC 
1 Consultation with a skilled dietitian 
2 Education about the disease 
3 Lifelong adherence to a gluten-free diet 
4 Identification and treatment of nutritional deficiencies 
5 Access to an advocacy group 
6 Continuous long-term follow-up by a multidisciplinary team 
  
Patient education is pivotal in the management of CD and repeated reinforcement is required by both a 
well-informed physician and a qualified dietitian, working together as a multidisciplinary team (MDT). In 
addition to advice to consume a GFD and possible major complications, the MDT should be vigilant for 
micronutrient deficiencies as well, such as: vitamin D, B12, folic acid, iron, zinc, magnesium and calcium, 
as suggested by a systematic review examining 22 out of 281 studies (Vici et al., 2016). However the 
exact clinical significance of this finding is not clear, especially in light of the long term deleterious effects 




Refractory CD and complications of CD 
 
CD that does not respond to treatment after excluding all possible exposure to gluten for a period of 
between 6 to 12 months (1-2%) is termed refractory CD (Malamut et al., 2012). This category has been 
further divided into two types and may well serve as a precursor for ulcerative jejunoileitis (UJ) (Biagi et 
al., 2000) and/or EATL (Cellier et al., 2000a). It is thus inferred that CD, refractory CD, UJ and EATL 
are all within a spectrum of diverse but pathologically-related conditions, stemming from the same clones 
of T cells (Ashton-Key et al., 1997). A detailed discussion on the pathophysiology of this condition is 
beyond the scope of this work; nevertheless, other complications of CD have been referred to earlier 
and include anaemia, osteopenia and osteoporosis.  
In the past, CD was reported to be very closely related to the development of malignancies (Holmes et 
al., 1989), but subsequent studies have produced conflicting results. This may be explained by: the 
evolving definition of CD over time, patient selection, methodology adopted, years of follow up and age 
of the cohort studies. For example, CD was found to be associated with increased mortality in one 
Swedish study (n=29000); however, the methodology was retrospective and included older  patients, 
who are generally prone to increased mortality secondary to cardiovascular and malignant causes 
(Ludvigsson et al., 2009). Likewise, studies have identified an increased risk of cancers in patients with 
CD, such as small intestinal adenocarcinoma, oesophageal cancer, melanoma and non-Hodgkin's 
lymphoma (Green et al., 2003). However, the study was retrospective and low powered (n=41), although 
a UK-based study reported similar findings (West et al., 2004). A later prospective study by Holmes et 
al., (2004) with 24 years of follow up and high power (n=5684) refuted these findings and no clear 
association with cancers was noted with CD. Indeed, there are conflicting reports in this area and further 
research is needed to determine the precise answer. Table below summarises the salient features of 










Table 5: CD in a nutshell. Modified from Krupa-Kozak (2014). 
Coeliac Disease in Summary 
Prevalence  General population 0.5%–1.26%; children 0.31%–0.9% 
Female:male ratio Between 2:1 and 3:1 
Trigger Gluten (gliadins and glutenins, hordeins, secalins) 
Causation Genetic predisposition (HLA/non-HLA genes); environmental factors (infant-feeding practice, 
infections, drugs, socioeconomic factors) 
Diagnosis Positive histological testing (hyperplastic villous atrophy); positive serological testing (EMA, TGA 
antibodies); clinical remission on a strict GFD 
Clinical presentation Silent–asymptomatic, positive EMA or TGA antibodies; minor–unrelated symptoms or isolated 
symptoms of autoimmune diseases; positive EMA or TGA antibodies; major–frank malabsorption 
symptoms 
Complications RCD types I and II EATL 
Associated disease Type 1 diabetes mellitus; autoimmune thyroiditis; autoimmune myocarditis; Sjögren’s syndrome; 
autoimmune hepatitis; primary biliary cirrhosis; selective IgA deficiency; Addison’s disease; Down 
syndrome; alopecia areata; sarcoidosis; neurologic abnormalities; asthma and atopy; IBD; systemic 
and cutaneous vasculitis; psoriasis; inflammatory arthritis; vitiligo 
Treatment GFD; supplementation of identified deficiencies 
Terms: EATL, enteropathy-associated T-cell lymphoma; EMA, endomysium; GFD, gluten-free diet; IBD, inflammatory 










Dietary adherence in CD 
 
The World Health Organization (WHO) defines adherence as ‘the extent to which a person’s behaviour 
– taking medication, following a diet, and/or executing lifestyle changes, corresponds with agreed 
recommendations from a health care provider’ (Sabaté, 2003). 
Attached to this concept is the word compliance, which is used in literature and to some extent 
interchangeably with adherence. Although both words are derived from Latin and entered the English 
language through old French, the word ‘compliance’ (Latin: complier) means to fill up (and hence to 
complete an action or process), whereas adherence (Latin: adhaerere) means to cling to, keep close or 
remain constant. Hence, when a patient is compliant with a GFD he follows it passively and does not 
necessarily own the process.  On the other hand, when a patient is adherent, he actively gets involved 
or takes responsibility (Aronson, 2007) and the prescriber respects his right to choose (Cohen, 2009). 
In this text, the word “adherence” is given preference over “compliance” for this reason and this is also 
an established trend in the literature (Osterberg & Blaschke, 2005, Seng et al., 2015, Zschocke et al., 
2014, Murage et al., 2018, Tovoli et al., 2018, Muhammad et al., 2019).  
Non adherence with therapeutic dietary recommendations has been a major obstacle in achieving 
optimum control of disease activity in general. This applies particularly to non-GI areas such as 
cardiovascular, diabetes and metabolic medicine, where dietary adherence has emerged as a major 
factor affecting morbidity and mortality (Metz et al., 1997). An extensive meta-analysis of 569 studies 
(spanning over 50 years) investigating adherence to therapies, was conducted by DiMatteo (2004), who 
reported that the average non-adherence rate to medical therapies was 24.8%. Additionally, there are 
reported variations in adherence according to gender (Chung et al., 2006) and ethnicity (Natarajan et 
al., 2009).  It is, however, accepted that studies done in this area are of variable durations, refer to 
different standards when measuring adherence and have diverse methodologies e.g. prospective, 
retrospective and interview based research (Desroches et al., 2010).    
In CD, there are two aspects to the issue of adherence to a GFD: issues faced by the patients in adhering 
to this diet and also the difficulty for the treating dietitian in ascertaining whether a particular patient is 
adherent or not. In CD, strict adherence to a GFD is particularly important as there is no pharmacological 
treatment, in contrast to e.g. diabetes, where pharmacological agents (i.e. insulin and oral 
hypoglycaemics) are available. Additionally, it is an accepted notion that self-management by the 
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individual is of paramount importance. The role of the health team revolves around empowering 
individuals to self-manage the condition, as could be said for any chronic disease where active 
involvement by the patient is needed (Redman, 2005). In the case of CD, it remains relatively difficult to 
achieve success in these three areas: strict dietary adherence, patient autonomy and the ability of 
physicians to measure adherence objectively.  
 
Advantages of adherence to a GFD 
 
Symptomatic patients usually derive health benefits soon after starting a GFD (Murray et al., 2004) and 
this phenomenon was noted in an earlier research study, which demonstrated that, for the 70% of 
patients with classical symptoms, a GFD leads to symptomatic improvement (Pink & Creamer, 1967). 
More latterly, a research study (n=3031) also determined that the improvement is not limited to classical 
CD but also atypical-type disease (Kurppa et al., 2014). Furthermore, over the years research has 
shown that following a GFD: reverses the duodenal pathology, improves quality of life and reduces 
complications in patients with CD (Bernardo & Pena, 2012, Hall et al., 2013).  
  
Histological recovery and a GFD 
Histological improvement is the indirect reflection of reversal of malabsorption status related to CD. This 
is reflected in the clinical observation that iron deficiency anaemia improves following a GFD, suggesting 
increased iron absorption (Annibale et al., 2001). In addition, improvement in the duodenal histology is 
objective, as seen in one study (n=284) comparing Index and at least one subsequent biopsy of CD 
patients (Hutchinson et al., 2010), but the improvement is not necessarily complete, as suggested by 
another study (n=39) (Lee et al., 2003). This suggests that, for malabsorption to improve, complete 
histological recovery is not essential.  
Annibale et al., (2001) in their prospective study (n=190) also noted that the recovery of villi was 
dependant on various factors such as: time between the biopsy and starting a GFD, severity of 
histopathological changes at diagnosis and age of the patients. A later study (n=65) with longer follow 
up reported this recovery to be 66% (Galli et al., 2014), which is two times higher than Lee et al. (2003) 
and this disparity may be explained by a difference in power, patient selection and the instruments used 
to measure adherence to a GFD. A recent study (n=65) by Belei and colleagues (2018), noticed that 
complete histological recovery (n=105) may take longer than a year after commencing a GFD. In 
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contrast, Lanzini et al., (Lanzini et al., 2009) in their prospective study (n=429), suggested that complete 
mucosal recovery was rarely (8%) possible. It is thus concluded that, although histological recovery 
takes a long time to progress (Hære et al., 2016), it improves beyond a critical point and malabsorption 
of nutrients is reversed.     
Prevention of complications of CD and a GFD 
CD has a set of complications related to malabsorption (such as anaemia), its effects on bone 
metabolism and yet another set of complications in relation to chronic inflammation in the SBM, driven 
by exposure to gluten; a brief overview will be given. Among the malabsorption group, calcium 
metabolism and related bone health is one important aspect that is affected in 50% of patients with CD 
(Zanchetta et al., 2016) and it ranges from osteopenia (Choudhary et al., 2017) to  bone fractures 
(Heikkilä, Pearce et al., 2015, Olmos et al., 2008). Although earlier studies (Mora et al., 1999, 
Kemppainen et al., 1999b) denoted that initiation of a GFD improves bone health, a later study refuted 
these results (Pazianas et al., 2005), reporting significant issues with Bone Mineral Density (BMD) even 
after 4 years of a GFD. Additionally, another study reported that, although bone health is improved with 
a GFD, it is not restored fully as previously suggested (Szymczak et al., 2012).  
This discrepancy may be explained by the selection bias (Pazianas and colleagues), where the 
population group (n=24) was entirely female and bone health is relatively poor as compared to males 
(Pietschmann et al., 2009). But despite that, recovery of bone health is dependent on histological 
recovery as reported by Larussa et al., (2017) and age of the patients, as patients diagnosed in later life 
have lower BMD (Paez et al., 2017). Although detailed discussion of bone health in CD is beyond the 
scope of this literature review, it is however accepted that a definitive answer regarding improved bone 
health has not been found, as two well-designed studies have indicated an improved outcome in relation 
to bone health for patients on a GFD (McGough & Cummings, 2005, Passananti et al., 2012), yet equally 
there is evidence that points at delayed bony improvement (Kaukinen et al., 2007, Larussa et al., 2017). 
It is, however, unclear whether this is clinically important, hence more research is needed in this area 
to look at the clinical outcomes such as bone fractures.    
CD is found in up to 6% of patients with Iron deficiency Anaemia (IDA) (Karnam et al., 2004) and the 
reverse is also true, as IDA affects 10 to 41% of patients with CD (Harper et al., 2007, Dahele & Ghosh, 
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2001, Rampertab et al., 2006). A GFD leads to a 55.5% reversal of IDA, as suggested by a study (n=194) 
examining anaemic patients with CD who were started on a GFD, but it is time dependant and may take 
up to 12 months for complete recovery (Annibale et al., 2001). Fatigue, one of the principle symptoms 
of IDA, improves on initiation of a GFD in patients with CD, although this improvement is age selective, 
with more symptomatic improvement in the paediatric age group as compared with adults, as suggested 
by a study (n=737) examining a retrospective cohort (Jericho et al., 2017). Prospective studies are 
needed to determine the recovery pattern and time taken in recovery from IDA in CD.  
CD is known to have other complications such as UJ (Biagi et al., 2000) and EATL, which develop in a 
subset of the CD population (Chander et al., 2018). Nevertheless, there is a paucity of research on the 
effect of a GFD on the reduction of these complications and this is partly due to their inherent rare nature 
and the requirement for longer follow up. Earlier research in this area was dogmatic about the protective 
nature of a GFD against cancers in DH (Lewis et al., 1996) as well as CD patients (Holmes et al., 1989); 
however, these were observational studies and not all the cancers referred to (Corrao et al., 2001, Green 
et al., 2003) had any significant association with CD.  
EATL is a recognised complication of CD and Silano et al. (2008) followed up 1,757 CD patients (31,801 
person-years) to examine the protective effect of a GFD. They reported that only nine patients developed 
EATL and concluded that a GFD is protective against EATL. The quality of evidence is weak: partly 
because of the power of the study, but also by reason of its observational nature. It is thus concluded 
that no strong evidence is available to determine whether a GFD is protective against any of the 
malignant or pre-malignant lesions of the small bowel in CD, and this is due to low incidence and 
variability in the quality of the studies (Ondrejka & Jagadeesh, 2016).  
Based on the available evidence, a GFD may prevent these complications and patients should be 
advised about the protective effect of a GFD. Additionally, it is postulated that increased adherence with 
a GFD, by improving physical and psychological health for patients, may improve employability rates 
and also reduce health-related expenditure in the NHS, which was estimated by a cohort study (n=3646) 




Health-related quality of life (HRQoL) and a GFD 
HRQoL in CD depends upon the symptoms and the issues related to adherence to a GFD (Gray & 
Papanicolas, 2010). Adherence to a GFD may improve symptoms and may also improve HRQoL in 
patients (Kurppa et al., 2014), yet the tolerability of a GFD may also become an issue (Wolf et al., 2018). 
Combining these two concepts, it is inferred that a GFD has a variable effect on HRQoL in CD. 
Improvement of symptoms, for example in symptomatic patients after starting a GFD, also improved 
their HRQoL, as shown by a prospective study (n=132) using the 36 item short form survey (SF-36) and 
the Gastrointestinal Symptoms Rating Scale (GSRS) in newly diagnosed CD cases (Nachman et al., 
2009). Additionally, a prospective multi-centre study using the Morisky scale and with relatively high 
power (n=366), subsequently confirmed these results (Casellas et al., 2015). It has likewise been shown 
that such an improvement in HRQoL is better in patients who are being followed up in a healthcare 
setting (Hughey et al., 2017). However, in contrast to this, a UK based case-control postal survey  
(n=573) indicated that 80% of adults with a mean duration of 8 years post-diagnosis did not report a 
significant difference in HRQoL and they found it difficult to follow a GFD (Barratt et al., 2011).   
Burger et al., (2017) conducted a systematic review and meta-analysis (18 studies) and concluded that, 
although a GFD significantly improves HRQoL, it does not normalise it in CD. Studies included had used 
both generic and disease specific questionnaires, such as: the SF-356 Mental Component Score (MCS), 
the SF-36 Physical Component Score (PCS) and the psychological general well-being (PGWB) 
questionnaire; there was variability in the reported improvement depending upon which questionnaire 






Table 6: A brief outline of the studies investigating HRQoL in CD. 
Main Author N Country Description of Questionnaire  Characteristics of study/ comments 
(Deepak et al., 2018) 60 India (SF-12) and specific (CD-QOL) questionnaires Reduced HR-QOL in adult CD patients, improves significantly on GFD 
(Zysk et al., 2018) 251 Poland Health-Related Quality of Life Questionnaire (HRQOL) Females patients, economic scores inversely related low HRQoL 
(Pratesi et al., 2018) 450 Brazil  Coeliac disease quality of life (CD-QoL) Higher education related to better HRQoL 
(Crocker et al., 2018b) 64 UK Coeliac Disease Assessment Questionnaire (CDAQ) Five stigmata of HRQoL defined: social, dietary, symptoms, social and worries 
(Wolf et al., 2018) 80 USA CD-specific measures assessment of HRQoL Teenage, potential negative consequences of strict gluten-free diet 
(Halmos, Deng et al., 2018) 5310 Australia CDAT and quality of life data gathered Dietary adherence was associated with better quality of life 
(Oppenheimer et al., 2018) 273 Israel  Generic Disease Questionnaire (CODI) and the 
DISABKIDS Chronic Generic Measure (DCGM-37) 
Paediatric study. Coping with low HRQoL in CD 
(Mager et al., 2018) 243 Canada HRQOL (Peds TM/KINDL and Celiac Disease DUX) HRQOL in a multi-ethnic population with CD is comparable to healthy reference 
(Lee & Clarke, 2017) 124 USA CD-QOL questionnaire No significant association between HR-QOL and laboratory parameters 
(Skjerning et al., 2017) 422 Ireland Coeliac Disease Quality of Life questionnaire (CDQL) The CDQL comprehensively measures HRQoL 
(Haas et al., 2017) 61 Canada Patient-Reported Outcomes Measurement Information 
System (PROMIS) and global Short Form measure of 
QOL 
HRQoL improved with text messages  
(Borghini et al., 2016) 201 Belgium  Psychological General Well-Being Index (PGWBI) and 
Beck Depression Inventory (BDI) questionnaires 
GFD induces an improvement of well-being (HRQoL) 
(Rodríguez Almagro et al., 2017) 1097 Spain Coeliac Disease Quality of Life questionnaire (CDQL) There was a high level of congruence between quantitative scores and narratives 




Several studies have included cross sectional analysis (Deepak et al., 2018, Zysk et al., 2018, C. Pratesi 
et al., 2018, Wolf et al., 2018, Halmos, Deng et al., 2018) or an intervention (Haas et al., 2017). Others 
have attempted to look at the role of different aspects of CD such as: better adherence to a GFD 
(Halmos, Deng et al., 2018, Haas et al., 2017, Deepak et al., 2018), education level  (Pratesi et al., 
2018), effect of a strict GFD (Wolf et al., 2018), economic aspects  (Zysk et al., 2018), psychological 
wellbeing (Borghini et al., 2016) and HRQoL. Another has attempted to test the congruence between 
quantitative scores and narratives in mixed method research (Rodríguez et al., 2017). An earlier study 
reported that delay in diagnosis may also affect quality of life, which improves after a GFD (Norström et 
al., 2011). Also, if symptoms fail to improve, the quality of life remains low, as suggested by a German 
study examining 446 patients (Hauser et al., 2006).  
The quality of these studies is nonetheless questionable, as the results may have been affected by the 
way HRQoL was measured, patient selection, power of the study and the duration of follow up. Yet, 
notwithstanding these factors, it is acknowledged that improvement in both psychological and physical 
symptoms improves HRQoL in a parallel fashion, but shows variable improvement, as suggested by the 
meta-analysis (Burger et al., 2017). The instruments used in these studies (such as: SF-36, EQ-5D and 
GSRS) were not disease specific and have their limitations when it comes to the specific aspects of CD.  
A Norwegian study (n=422) found that there are differences in HRQoL in CD based on age and gender 
of the patients (Skjerning et al., 2017). The Oxford Working Group (Crocker et al., 2013) created a 
disease specific questionnaire, the Coeliac Disease Assessment Questionnaire (CDAQ), developed 
through in-depth qualitative interviews (Crocker et al., 2018b). The CDAQ is composed of five domains: 
social stigma, dietary burden, symptoms, social isolation and concerns related to CD. This reliable and 
valid coeliac-specific measure scrutinises all aspects of quality of life important to adults with CD 
(Crocker et al., 2018a). It is thus accepted that HRQoL is multifactorial and a detailed systematic review 
and meta-analysis of all available studies is needed.  
HRQoL suffers decrements as well when a GFD is started and this is especially important in adolescent 
patients, who feel stigmatised and isolated when initiated on to a GFD (Olsson et al., 2008, Olsson et 
al., 2009). Similarly, in relation to comorbidities, initiating a GFD in patients with T1DM has a negative 
impact, as suggested by a study (n=73), although the questionnaire used in this study was nonspecific 
(Bakker et al., 2013). A Canadian study (n=3408) reported a further general negative impact of a GFD 
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on HRQoL, namely difficulty in obtaining a GFD, avoiding eating out and socialising, as well as event 
and travelling avoidance (Zarkadas et al., 2013). Additionally, a GFD is expensive to manage and that 
too can affect quality of life in economic terms (Zivin & Green, 2007a).  
Evidently, total abstinence from gluten-containing products is not easy for patients to achieve and then 
maintain (Samasca et al., 2014). A GFD restricts several aspects of lifestyle and also has a negative 
effect on the way patients enjoy their food. Whitaker et al., (2009) in a UK based study (n=177) reported 
a variety of problems faced by CD patients using a questionnaire. Apart from the direct effect on the 
flavour of food, 54% referred to indirect effects and an additional economic decrement for buying GFF.  
In general, a GFD does take away certain freedoms in life in relation to eating and drinking, which does 
have indirect effects on factors such as where to eat and who to eat with. A Finnish study (Ukkola et al., 
2012) identified the same trend as noted earlier by Whitaker et al., (2009), that asymptomatic patients 
had more negative views about the diagnosis of CD. What is more, there is gender variation in reported 
HRQoL and females tend to score lower on such questionnaires (Jacobsson et al., 2012). Interview-
based research (n=16), which studied the effect of a GFD on women, similarly reported that affected 
female patients expressed a sense of loneliness and invisibility, especially when socialising with others 
(Roos et al., 2013). The reasons for such findings are not clear, however it should be noted that the 
studies have low power and may have suffered selection bias. It may therefore be concluded that studies 
to assess the negative effect on quality of life need more robust methodology: namely control groups, 
high power, validated instruments and qualitative methods to explore this area.    
 
Cost attached to a GFD 
By comparing the unit cost of gluten-free products (GFP) to gluten-containing products (GCP), the 
former were found to be relatively more expensive in a US based study (Stevens & Rashid, 2008a). This 
is despite the recent increased availability due to the demand for GF food items among consumers with 
Non-Celiac Gluten Sensitivity (NCGS) and as a fad diet (Reilly, 2016). A market based study by Mintel’s 
Group (2015) has suggested that the GF industry has seen a growth of 136% from 2013 to 2015. The 
finding of increased cost of GFP was further analysed quantitatively and GFP were found to be 240% 
more expensive in one study and twice as expensive in another US based study (Zivin & Green, 2007a). 
In the UK the situation is similar and the prices are higher for GFP (Fry et al., 2018). In quantitative 
terms, a UK based study established this figure to be 76-518% (Singh & Whelan, 2011) and a recent 
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study has suggested this increase affects 91% of the GFF categories, which were 400% more expensive 
than their gluten containing counterparts (Jeanes & Hanci, 2018). The situation may well be similar in 
the rest of Europe, as suggested by a study from Greece, in which the cost difference was estimated to 
be 22–334% (Panagiotou & Kontogianni, 2017). This had a negative effect on HRQoL as suggested by 
a Canadian study (n=5912) exploring the day to day issues of patients with CD (Zarkadas et al., 2013).  
The reported disparity may be explained by the methodological differences, but based on the above 
studies, a GFD is not an economically inexpensive option for patients. The practical point here is the 
effect of unaffordability of GFP on an economically deprived fraction of society and its effect on 
adherence to a GFD, especially when GFP are not available on prescription, or at best in insufficient 
quantities.  A recent systematic review examining the economic burden of CD (49 studies) reported that 
initiation of a GFD leads to reduced visits to the GP and fewer missed working days (Mearns et al., 
2018). More quantitative research is needed to explore this area by involving both patient groups and 












Instruments used to measure adherence to a gluten free diet 
 
Several instruments have been used in research studies and clinical practice to measure adherence to 
a GFD. The table below enumerates the methods used and detailed discussion of the evidence will be 
presented thereafter (Table No 7).  
 
Table 7: Different methods used to measure adherence to a GFD. 
Method   Description  
Clinical    
 Symptomatic enquiry Persistence of symptoms may indicate non-adherence (Sainsbury et al., 
2013) but there exist asymptomatic patents as well (Kurppa et al., 2014, 
Sharkey et al., 2013). 
 Serology Persistently elevated anti-tTG denotes non-adherence with a GFD (Dipper 
et al., 2009) and the reverse is true (Leffler et al., 2007), but the evidence 
is not conclusive (Vahedi et al., 2003). 
 Dietitian’s assessment Currently considered as gold standard (Pietzak, 2005) but subjective and 
patient dependant elements exist.  
 Duodenal histology Contrasting results suggested by (Biagi et al., 2014) and considered 
unnecessary by Pekki et al., (2017).  
 Self-reporting  Clinician or dietitian enquiry  
Research   
 Questionnaire  Abundant methods with variable results (Hall and colleagues, 2009), but 
comparable results to serology according to others (Leffler, 2009). 
 Interview Used in conjunction with questionnaire: variable results. 
 Faecal/ urine test Gluten immunogenic peptides in experimental stage (Comino et al., 2012, 
Moreno et al., 2017). 
 
Clinical interviews and symptomatic enquiry 
 
Clinical follow up is routinely used for assessment of symptoms and may be coupled with examination 
of indirect haematological markers in selected cases, such as: blood count, folate, B12, iron studies and 
liver biochemistry (Rubio-Tapia et al., 2013). Assessment of symptoms may be used in research, as 
suggested by a meta-analysis analysing seven studies (n=3383) where persistence of symptoms 
(especially abdominal) indicated decreased adherence with a GFD (Sainsbury et al., 2013). This 
strategy as a research instrument, however, has its own issues, as not all patients with CD have 
symptoms (Kurppa et al., 2014, Sharkey et al., 2013). Secondly, and more importantly according to Brar 
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and colleagues (2007), there is no correlation between mode of presentation of CD and degree of VA, 
as suggested by a study (n=499) examining duodenal histology.  
Accordingly, there is a subset of the population with no symptoms at all, but with significant VA 
(Lähdeaho et al., 2011) and this may be explained by the patchy nature of CD and the requirement of 
loss of a critical absorptive area of the duodenum to cause symptoms. It is thus accepted that 
symptomatic improvement may not provide an accurate picture of adherence with a GFD in patients 
with CD. A Finnish study (n= 856) also described gastrointestinal symptoms persisting in a minority (6%) 
of patients despite strict adherence to a GFD for many years (Laurikka et al., 2016).  
 
Duodenal histology  
 
Traditionally, duodenal biopsies are obtained for the diagnosis of CD, although the clinical applicability 
of this practice has been questioned (Cammarota et al., 2006, Efthymakis et al., 2017). Biopsy 
assessment offers objective classification of the severity of CD based on research-established criteria 
(Ensari, 2016, Villanacci, 2015). A study (n=317) has highlighted the role of biopsy for follow-up, as (with 
an average 12 months follow-up) a proportion (8%) of patients who improved on serology, but not on 
histology, would have been deemed healed without duodenal histology (Biagi et al., 2014). In contrast, 
Pekki et al., (2017) in a nationwide follow-up study (n=760), did not find any significant advantage of 
performing repeat duodenal biopsies for GFD adherence in relation to: long-term adherence, symptoms, 
sero-positivity, questionnaire scores, frequency of fractures or malignancies. There is evidence to 
suggest that VA is not complete on follow-up biopsies as Lebwohl and colleagues (2014a), who 
identified 7,648 follow-up biopsies, reported  that 31% of patients had persistent VA; but this was a 
retrospective study and it is not clear if the patients were adherent to a GFD or not.  This area is 
controversial and contrasting studies with different methodologies exists for (Biagi et al., 2014, Elli et al., 
2015) and against (Pekki et al., 2017) follow-up biopsies.  
In addition, immunohistochemistry and flow cytometric analysis may be performed on the samples 
obtained for objectivity in diagnosis (Sanchez-Munoz et al., 2008, Patey‐Mariaud De Serre et al., 2000).     
Despite the fact that duodenal biopsies are considered the gold standard research and clinical tool for 
adherence with a GFD, biopsies are invasive, expensive and time-consuming. Furthermore, this strategy 
may not be available everywhere and even with availability may not be suitable or even practical for 
every patient. It is therefore concluded that biopsy on its own is not a practical strategy for measuring 
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adherence in CD, but since differences of practice exist in this context, more research is needed in the 
form of a randomised study, which not only involves a pathologist but a trained dietitian who could 
assess adherence to a GFD.  
 
Serological tests to measure adherence with a GFD 
 
Several serological tests with high sensitivity and specificity are available for the diagnosis of CD in 
clinical practice and have been mentioned above. Their use for the purpose of measuring adherence 
with a GFD is also established in clinical practice (Rubio-Tapia et al., 2013). Among the serologies, anti-
tTG has been used extensively in clinical practice for GFD-related adherence. It has been suggested 
that persistently elevated anti-tTG denotes non-adherence with a GFD, according to a study (n=182) 
with a 54 month follow-up period (Dipper et al., 2009). The reverse was indicated in another study 
(n=154), which reported that falling tTG was associated with adherence on questionnaire based 
assessment (Leffler et al., 2007).  
Various studies have also examined the reliability of anti-tTG for this purpose: results show that there is 
a discrepancy between serological improvement and mucosal recovery. A study (n=95) examining the 
dietitian assessment and serology suggested that anti-tTG was not a reliable marker for occasional 
dietary transgressions (Vahedi et al., 2003). Moreover, a controlled cross-sectional study (n=87) 
examining this issue, reported persistence of VA despite the fact that serology was negative (Kaukinen 
et al., 2002b) and a later prospective study also confirmed these findings (Hopper et al., 2008). More 
latterly, Sharkey et al., (2013) also reported that serology is not an optimum surrogate marker of mucosal 
recovery, as the sensitivity of anti-tTG was 43.6% in detecting persistent VA when comparing the levels 
of anti-tTG and histological presence of VA. Although it was a high-powered study (n=595), as compared 
with previous studies, their methodology was retrospective. It is thus concluded that it is not currently 
clear how reliable serology is in assessing adherence to a GFD and more research is needed by 
establishing baseline adherence by an expert dietitian and then following patients up with periodic 
serology and dietitian assessment.  
Other serological markers, such as EMA, have used a serological diagnostic adjuvant to test anti-tTG; 
they are nearly 100% specific, but they are less sensitive and their only other use is in the diagnosis of 
latent CD (Kurppa et al., 2009). Similar to anti-tTG, EMA also has issues with reliability in relation to 
measuring adherence with a GFD (Dickey et al., 2000). Likewise, antibodies against deamidated gliadin 
peptides (anti-DGP) have also been used in measuring adherence with a GFD, and their persistence in 
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the serum indicates non-adherence (Spatola et al., 2014). What is more, they are superior to anti-tTG 
for this purpose (Monzani et al., 2011, Volta et al., 2008). The American College of Gastroenterology 
has suggested that any of the above may be used as serological markers for assessing adherence to a 
GFD (Rubio-Tapia et al., 2013). 
One particularly promising advance is the development of tests to measure GIP. These peptides are 
involved in the immunogenic reaction of CD and anti-α-gliadin G12 antibody (G12) may be detected in 
bodily fluids such as faeces and urine (Comino et al., 2012, Moreno et al., 2017); this has been used in 
monitoring adherence with a GFD in a research setting (Comino et al., 2016). 
Novel Experimental Biomarkers of GFD adherence  
 
Several other experimental markers are being developed, namely: citrulline (Blasco Alonso et al., 2011), 
intestinal fatty acid-binding proteins (Oldenburger et al., 2018), autoantibodies against pancreatic 
secretory-granule membrane glycoprotein 2 (GP2) (Laass et al., 2015), REG Iα (Planas et al., 2011) 
and plasma total alkylresorcinols (Lind et al., 2016). It is thus inferred that both EMA and anti-tTG are 
not reliable markers of histological recovery, but their base-line levels are important as they remain 
elevated with persistent transgression.  
 
Use of questionnaires to measure adherence to a GFD 
 
Questionnaire-based methodology has been used in CD to measure adherence with a GFD in multiple 
studies (Butterworth et al., 2004, Biagi et al., 2009, Leffler et al., 2009, Schilling et al., 2018, Ramirez-
Cervantes et al., 2016, Espino et al., 2011) with slightly different methodological and questionnaire 
designs. Such a mode of delivery is considered economical when compared with other modes of delivery 
(Sinclair et al., 2012). (Edwards et al., 2009). A brief outline of the questionnaire-based studies is given 







Table 8: A brief outline of the studies investigating adherence to a GFD using a questionnaire (Q’r).  
Main Author n Country Description of Questionnaire  Characteristics of study/ comments 
Rodrigues (2018) 35 Brazil 34 Item Q’r, assessing adherence and nutritional status  Paediatric/ adolescent cross sectional, 20% non-adherence 
Schilling (2018) 64 Chile  Q’r by (Biagi et al., 2012) was used Paediatric, cross sectional, 70% non-adherence, serology tested 
Ramirez-Cervantes (2016) 56 Mexico 20 items with sub-items long Q’r. Adherence  Paediatric, cross sectional, 39% non-adherence, CD and non CD cohort 
Fueyo-Diaz (2016) 306 Spain CDAT (Leffler et al., 2009), 7 items, adherence  Adult, two-stage observational transversal study, 30% non-adherence 
Rajpoot  (2015) 146 India Celiac symptom index (CSI), and SF-36. 36 points Adult, Prospective randomised two groups, 35 to 47%  non-adherence 
Silvester (2016) 222 USA 20 Q’s, complex, tables, adherence & knowledge Adult, GFD Knowledge and effect on adherence, 21%  non-adherence 
Villafuerte.G  (2015) 709 USA CDAT (Leffler et al., 2009), 7 items Adult, cross sectional, study knowledge and cost GFD, 25% non-adherence 
Casellas (2015) 366 Spain Modified Morisky et al., (1986) questionnaire Adult, 23% non-adherence, Prospective, Quality of life and adherence  
Bannister (2014) 150 USA Biagi Questionnaire used Paediatric, questionnaire, 12% non-adherence 
Hall (2013) 287 UK Mixed Q’r open and closed ended Adult, Prospective, 40% non-adherence 
Sainsbury (2013b) 189 Australia CDAT (Leffler et al., 2009), 7 items, adherence Adult, Prospective randomised intervention, 55% non-adherence 
Charalampopoulos (2013) 90 Greece 3 section, Likert scale, simple Q’r Paediatric/ adolescent cross sectional, 56% non-adherence   
Biagi (2012) 141 Italy Biagi Q’r developed. Five items, short  Adult, Biagi questionnaire was developed in this study, 20% non-adherence 
Barratt (2011) 573 UK Sf-36, Hospital anxiety scale and adherence Adult, questionnaires used are generic, 34%% non-adherence 
Espino (2011) 1,212 Chile  Interview and an online questionnaire, long Adult, interviews and questionnaire, 8% non-adherence 
Hopman (2009) 53 Netherlands SF-36 and Food frequency Q’r. Adult Adult, cross-sectional, questionnaires nonspecific, 34% non-adherence 
Leffler (2009) 200 USA CDAT was developed, 7 items Q’r. Adult Adult, interviews and questionnaire, 8% non-adherence 
Butterworth (2004) 130 UK 20 Items Q’r, non-adherence and causes. Adult Adult, South Asians and White,  52 to 73%  non-adherence 
Journal articles published (in English) since 2014.  
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It is evident that several studies have examined adherence using a questionnaire and the number of 
participants in such studies range from under thirty by Högberg et al., (2003) to 1212 by Espino et al., 
(2011). Although several studies extracted data from questionnaires (Taghdir et al., 2016, Barratt et al., 
2011, MacCulloch & Rashid, 2014, Dowd et al., 2014, Högberg et al., 2003, Garg & Gupta, 2014, Hall 
et al., 2013), there was no definitive description or template of the questionnaire available in the studies. 
Certain questionnaires were long (Butterworth et al., 2004, Rodrigues et al., 2018) and complex with 
sub-sections and appeared complex visually (Rodrigues et al., 2018, Silvester et al., 2016), whereas 
others were simple and short (Biagi et al., 2012, Leffler et al., 2009, Leffler et al., 2007). A few studies 
used questionnaires validated and developed by other investigators (Villafuerte‐Galvez et al., 2015, 
Fueyo-Diaz et al., 2016, Schilling et al., 2018, Sainsbury, Mullan & Sharpe, 2013b).  
The CDAT questionnaire by Leffler and colleagues (2009) is user-friendly, short (seven items), precise 
and designed to measure adherence with a GFD. It was developed by a panel in collaboration with 
different stake holders such as: gastroenterologists, dietitians, patients with CD and a psychologist, who 
assembled together to discuss factors related to CD with particular reference to their ability to affect 
adherence to a GFD. These factors were divided into five domains namely: symptoms, self-efficacy, 
motivation to observe a GFD, knowledge about GFD and perceived adherence to the GFD. A total of 
85 statements were agreed upon, which were later reduced to seven statements. A lower score on 
CDAT denotes better adherence and the authors have suggested a CDAT score of 13 or more as the 
cut-off value for non-adherence to a GFD. The instrument was evaluated to have a 73.7% sensitivity, 
with a specificity of 76.7%. Its usefulness in a clinical setting has not been reported, despite the fact that 
it has the ability to evaluate non adherence and is better than anti t-TG in terms of sensitivity. A recent 
publication has also asserted that CDAT, in combination with the Biagi questionnaire, significantly 
outperformed IgA-TTG (p=0.01) in detecting VA (Lau et al., 2018). CDAT has been applied in several 
studies since its publication (Villafuerte‐Galvez et al., 2015, Sainsbury, Mullan & Sharpe, 2013b, Fueyo-
Diaz et al., 2016, Hære et al., 2016, Nazareth et al., 2015) and has proved to be a reliable instrument 
(Leffler et al., 2009, Fueyo-Diaz et al., 2016). It may be argued that CDAT as an instrument to measure 
adherence to a GFD is less biased, as the results are reliable and consistently similar in the above cited 
studies despite differences in the methodologies.    
Biagi and colleagues (2012) also developed an easy and short questionnaire. Their study examined CD 
patients (n=141) on a GFD, and the sensitivity of the questionnaire for detecting non-adherence was 
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compared to serology and histology; lower scores were significantly associated with persistent VA. All 
patients in the study were well instructed about the GFD and the study endorsed the validity of the 
questionnaire in detecting non-adherence to a GFD. The questionnaire is simple to follow as it is 
depicted as a visual chart rather than questions. In comparison to CDAT, which has a holistic approach 
covering social and symptomatic aspects of CD, this questionnaire concentrates more on gluten 
ingestion. This questionnaire was subsequently used in two studies (Schilling et al., 2018, Bannister et 
al., 2014). The questionnaire, although simple, needs validation in high powered prospective studies.  
Hopman at al., (2009) assessed adherence by using a food frequency questionnaire and this idea was 
subsequently transformed to develop a gluten-specific food frequency questionnaire (FQ-gluten4) by 
the same author (Hopman et al., 2012). Parents (n=74) filled 2 days’ worth of food diaries for children 
aged between 1-2 years and these were compared with the FQ-gluten4. The mean amount of gluten 
intake based on the FQ-gluten4 was comparable to the food diary and it was concluded that the easy-
to-use FQ-gluten4 may be a useful instrument in assessing gluten intake.  
A Greek team of researchers designed a questionnaire of moderate length (15 items) to measure 
adherence rate (Charalampopoulos et al., 2013) and more recently an Iranian study team also measured 
adherence with a GFD by questionnaire, but the details available are limited (Taghdir et al., 2016). 
Among longer questionnaires, a Birmingham-based study evaluated adherence to a GFD in a 20-item 
questionnaire that holistically approached adherence employing clinical, social and economic terms 
(Butterworth et al., 2004). This instrument was used in the author’s MSc Project (Muhammad et al., 
2013) but it is, however, a long questionnaire as compared to the CDAT and Biagi questionnaires. 
Although research has indicated that detailed interview by an experienced dietitian coupled with 
serological tests is the optimal method to assess adherence to a GFD in day-to-day practice (Simpson 
& Thompson, 2012, Mehta et al., 2018), questionnaires such as the ones developed by Leffler and Biagi 
may have comparable sensitivity and specificity. This area, however, needs more research as the use 







Adherence and non-adherence to a GFD 
 
An assessment of GF dietary adherence by a dietitian is considered highly effective and is inclusive of 
assessing knowledge, behaviour while dining out and intent to adhere (Kurien et al., 2016, Mehta et al., 
2018). Indeed it is considered a gold standard by some authors (Leffler et al., 2009, Sainsbury et al., 
2015). Leffler et al., (2009) suggest that, although serological tests have very high sensitivities and 
specificities for the diagnosis of CD, they cannot replace dietitian evaluation in the assessment of GFD 
adherence.  
Absolute non-adherence means ingestion of any amount of gluten (Muhammad, 2013). It is nonetheless 
acknowledged that patients with absolute adherence will ingest gluten, albeit inadvertently, and also 
some gluten (<20 ppm) is in GF labelled food (Bascunan et al., 2017). Hall et al., (2009) conducted a 
systematic review and noticed variability in the definition of adherence to a GFD, based on the 
methodology adopted by the authors. Some studies using interview or questionnaire techniques have 
defined adherence to a GFD as discretely variable and plotted on a scale (i.e. strict, partially or fairly 
strict and non-adherent) (Hall et al., 2009). These categories emerged from a prescriptive definition of 
an individual study based on the number of dietary transgressions over a defined time.  
Variability has also been noted in reported adherence to a GFD. Hall and colleagues reported adherence 
ranging from 42% to 91% (Hall et al., 2009). The authors selected 38 adult studies by excluding papers 
involving combined data on children and adults, or if CD was not the primary illness under study. Since 
Hall and colleagues (2009), numerous studies have measured adherence applying different 
methodologies and found scores ranging from 53-76% (Leffler et al., 2009, Whitaker et al., 2009, Barratt 
et al., 2011, Holmes & Moor, 2012, Hall et al., 2013, Villafuerte‐Galvez et al., 2015, Casellas et al., 2015, 
Rajpoot et al., 2015, Silvester et al., 2016, Sainsbury et al., 2018, Leffler et al., 2008).  
Questionnaire-based studies that rely on self-reported adherence rates typically show higher adherence 
rates (Ciacci et al., 2003a), as do studies involving children (MacCulloch & Rashid, 2014). These studies 
have certain characteristics e.g. a clear majority of them had used CDAT (n=8) as their instrument to 
measure non-adherence to a GFD (Joelson et al., 2018b, Fueyo-Diaz et al., 2016, Sainsbury et al., 
2018, Sainsbury, Mullan & Sharpe, 2013b). In this context, Villafuerte and colleagues (2015) determined 
that a CDAT score of 13 or above reflected non-adherence. Whilst the seminal study on CDAT (Leffler 
et al., 2009) suggested its validity for measuring non-adherence, Sainsbury and colleagues utilised 
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CDAT to assess the effectiveness of an intervention to increase adherence to a GFD (2016). The 
adherence measured by studies using CDAT ranges from 52% to 87% and there are differences such 
as power, recruitment, methodology and age of the patients, which may explain this wide variation. The 
table below shows an overview of these studies (Table No 9).  
Table 9: Studies investigating adherence to a GFD using a variety of methods, after Hall et al., 2009.  
Main Author n Country Method Description, Adherence (Ad), factors affecting it. 
Leffler (2009) 200 USA CDAT Adult. CDAT was found to be valid.  
Biagi (2009) 168 Italy Biagi Q’r Adult. Details limited.  
Barratt (2011) 573 UK Sf-36 Adult. Ad: 70%. GFD improves symptoms.  
Holmes (2012)  1,305 UK D’tn assessment Adult. Ad: 88-92%. Audit.  
Biagi (2012) 141 Italy Biagi Q’r, serology Adult. Ad: 74%. Discrepancy of histology & serology. 
Charalampopoulos (2013) 90 Greece Likert scale Paeds. Ad: 44.4%, Child’s age, parental knowledge. 
Hall (2013) 287 UK Q’r Adult. Ad: 82%. Intentional > non-intentional. 
Sainsbury (2013b) 189 Australia CDAT Adult. Ad: 62%. Intervention improves adherence. 
Galli (2014) 65 Italy Biopsy, serology Adult. Ad: 81%. Histology take time to normalise. 
Garg (2014) 134 India Interview Paeds. Ad: 65.5%. Age, mother’s education, family. 
MacCulloch (2014) 253 UK Q’r Paeds. Ad: Good.social events, camping out.  
Rajpoot  (2015) 146 India CSI Adult. Ad: 53.3%. FU increases it significantly.  
Villafuerte.G  (2015) 709 USA CDAT, serology Adult. Ad: 75.5%. CDAT score > non-adherent. 
Webb (2015)  13,279 Sweden Q’r, Serology Paeds. Ad: 75%. All patients were 12 years old. 
Casellas (2015) 366 Spain Morisky Adult. Ad 74.5%. Adherence improves symptoms. 
Silvester (2016) 222 USA Food Q’r Adult. Ad: 82%. Lack of GFD knowledge.  
Fueyo-Diaz (2016) 306 Spain CDAT Adult. Ad: 72%. CDAT highly valid for adherence. 
Ramirez-Cervantes (2016) 56 Mexico Q’r Adult. Ad: 46%. Intentional consumption.  
Taghdir (2016)  65 Iran Q’r Adults. Ad: 53.8%. Availability, cost, taste. 
Sainsbury (2018) 7,393 Australia CDAT Adult. Ad: 60.5%.  
Schilling (2018) 65 Spain Biagi Q’r, serology Paeds. Ad: 44% and 30%. Age, social events. 
Halmos (2018) 7,393 Australia CDAT Adult. Ad: 61%. Age, male, knowledge, symptoms. 
Joelson (2018b) 519 USA CDAT Adult. Ad: 87%. Mood may affect adherence. 






Other than CDAT, studies have used the Biagi Questionnaire (Biagi et al., 2009, Schilling et al., 2018) 
for measuring adherence and reported a range of 30-74%. The low adherence reported may be 
explained by the adolescent age of the patients assessed by Schilling and colleagues (2018). The 
remaining studies have used their own questionnaires coupled with serology and interviews and have 


















Factors affecting the rate of adherence to a GFD 
  
Research has indicated that causes of adherence and non-adherence to a GFD are numerous and 
multifactorial (Abu-Janb, 2018)and these include: socio-demographics, age at diagnosis, whether 
symptoms are present with gluten ingestion, practical difficulties associated with the GFD, and 
membership of advocacy groups (Hall et al., 2009, Leffler et al., 2008). Correspondingly, research has 
also indicated factors that may increase adherence to a GFD; a study conducted by Butterworth et al., 
(2004) who cited different reasons for poor adherence such as: understanding food labelling, 
affordability of GF products, obtaining GF products on prescription, obtaining sufficient GF products on 
prescription, and detailed explanation of CD in clinics. On the other hand, better adherence was 
identified as being related to membership of the Coeliac Society as well as regular dietetic follow-up. 
Later, Pietzak (2005) also reported factors affecting adherence and pointed to poor palatability of GF 
foods, confusing food-labelling practices, and common comorbidity and psychological burdens such as 
anxiety and depression in relation to poor adherence to a GFD. A systemic review by Hall and colleagues 
(2009) has ultimately identified and summarised many factors that affect adherence to a GFD including: 
socio-demographics, age at diagnosis and membership of advocacy groups. This area was further 
researched after the systematic review and several studies examined the factors responsible for poor 
adherence.  
Among the socio-demographic factors, age is significantly associated with adherence to a GFD and 
shows variability in the adherence rate as suggested by the systematic review by Hall and colleagues 
(2009). In childhood, for example, adherence scores are better (Czaja-Bulsa & Bulsa, 2018, Jadrešin et 
al., 2008), as minors are fed by their parents; however adolescents do have issues with adherence as 
suggested by several studies (Levran et al., 2018, Schilling et al., 2018, Arnone & Fitzsimons, 2012, 
Olsson et al., 2008, Olsson et al., 2009, Errichiello et al., 2010). Schilling and colleagues (2018) 
examined 65 adolescent patients and assessed their adherence both serologically as well as through 
an adherence questionnaire; they found adherence to be low. The serology (tTG, EMA) suggested that 
the adherence was around 44% and the questionnaire reported it to be 33.1%. However a Swedish 
study (n=240) reported a high adherence rate (75%) among adolescents who were screen detected 
(Webb et al., 2015). An earlier review reported lower adherence but no figures were given (Arnone & 
Fitzsimons, 2012). Another study, using focus groups of parents and adolescent patients (n=45), 
reported that a GFD was a challenge for the adolescent and this was multifactorial (S. Meyer & 
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Rosenblum, 2018).  This area needs more research as low adherence in this age group is multifactorial 
and detailed review of this age group is beyond the scope of this literature review. The table below 
shows the main factors affecting adherence to a GFD (Table No 10).  
 
Table 10: Summary of factors affecting adherence to a GFD in patients with CD. 
Factors Description of main studies and finding  
  Social Hall and colleagues (2009) suggested this to be a significant factor e.g.  Social events and dining out. Following 
that, MacCulloch (2014), Rodrigues (2018) and Schilling (2018). Studies are questionnaire based ranging from 
35 to 253 participants. Camping out and participation in social events have variable effects noted. Significant 
especially in the adolescent group. Adherence is better at home and school but worse when attending social 
events. Hall et al., (2009) also identified dining out as one of the factor affecting the adherence to a GFD. 
      Peer pressure 
      Social event, Camping out     
  Demographic Hall and colleagues (2009) suggested a role for advancing age to be associated with better adherence, but no 
significant relationship was noted for ethnicity or gender. Age at diagnosis also has significant positive 
correlation with adherence (Vilppula et al., 2011, Casella et al., 2012). Adolescents tend to have low adherence 
(Arnone & Fitzsimons, 2012). Males may be more compliant with a GFD (Halmos, Deng et al., 2018).   
       Age,  
       Gender, Ethnicity   
   Psychological Hall and colleagues (2009) reported increased levels of anxiety and depression in CD and no significant 
correlation with non-adherence. Later, (van Hees et al., 2013, Halmos, Deng et al., 2018) also reported 
increased prevalence of depression and a systematic review by (K. Sainsbury & Marques, 2017) suggested a 
negative effect of depression on adherence. Psychological traits may also affect adherence to a GFD.  
      Depression 
      Anxiety 
  GFD related Hall and colleagues (2009) did not establish a consistent relationship with cost and availability, but later studies 
were able to show that adherence is associated with high cost and low adherence. Availability was low in local 
Asian stores and it may affect adherence; understanding of food labelling is associated with adherence 
(Butterworth et al., 2004, J. Singh & Whelan, 2011, Zarkadas et al., 2006). Taste of GFF may affect adherence 
as suggested by Taghdir et al., (2016). 
      Cost, Availability 
       Label understanding, taste   
  Family Parental education about a GFD and CD plays a positive role (Charalampopoulos (2013). Similarly Garg 
(2014) and Khurana et al., (2015) reported the positive role of maternal education and the role of the nuclear 
family in increasing adherence in India.          Mother’s education 
       Family support 
Advocacy group & clinical      
follow up and symptoms     
Hall and colleagues (2009) reported increased levels of adherence in members of such groups and later 
studies confirmed this (Leffler et al., 2008, Muhammad et al., 2017, Muhammad, 2013, Rajpoot et al., 2015). 
Clinical follow-up plays a significant role. Asymptomatic patients tend to transgress (Halmos, Deng et al., 2018).   
 Education  Positive correlation found with education (Leffler et al., 2008, Sainsbury et al.,, 2013b, Villafuerte‐Galvez et 
al., 2015). 
     
 
Patients diagnosed later in life had relatively good adherence (Vilppula et al., 2011, Casella et al., 2012). 
Vipul and colleagues (2011) reported conducting a study (n=54) of patients above 54 years of age and 
reported adherence of 85% 18 months after starting a GFD. Casella and colleagues (2012) examined 
clinical, serological and histological characteristics of patients above the age of 65 years (n=59) and 
reported even higher adherence (90%) in this age group. The consistency in these studies with longer 
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duration suggests higher adherence in this age group but, equally, there might well be other confounding 
variables which may not have been taken into account. Although it is accepted that extremes of age are 
associated with better adherence and adolescent age has relatively poor adherence, more prospective 
research is needed to tailor dietary advice for these age groups.  
Research has indicated that the number of diagnosed females with CD is more than for males (Leffler 
et al., 2008), but there is no clear evidence to suggest that there are gender differences in relation to 
adherence to a GFD. Hall et al., (2009) in a systematic review, did not report any significant difference 
between genders in relation to adherence to a GFD. However, the studies selected (Dubé et al., 2005, 
Leffler et al., 2008, Ciacci et al., 1998a, Ciacci et al., 2002, Ciacci et al., 2003b) were not specifically 
designed to assess differences in the adherence between genders. In my MSc thesis (n=185) 
(Muhammad, 2013), no significant difference in adherence to a GFD was reported and a series of later 
studies also reported no difference in adherence between genders (Ramirez-Cervantes et al., 2016, 
MacCulloch & Rashid, 2014, Errichiello et al., 2010, Hall et al., 2013). It may be argued that there is a 
lack of consistent association between gender and adherence to a GFD.  
Several studies have reported adherence in SA patients (Rajpoot et al., 2015, Chauhan et al., 2010, 
Yachha et al., 2006, Sachdev et al., 2002, Abbas et al., 2018, Khurana et al., 2015, Garg & Gupta, 2014, 
Masood & Shaikh, 2014b), but none has specifically compared the effect of ethnicity on adherence to a 
GFD. Additionally, it has been postulated that a separate set of dietary and cultural issues might affect 
adherence to a GFD among this ethnic group, such as: food habits, affordability and availability of GFF 
and composition of family structure (Rajpoot & Makharia, 2013, Garg & Gupta, 2014, Khurana et al., 
2015). These inferences, however, are opinion based and more research is needed.  
The first study to compare adherence between SA patients and White Caucasians reported that SA 
patients were comparatively less adherent to a GFD (Butterworth et al., 2004), but the study was 
relatively low powered (n=130). This study was replicated, using the same questionnaire, in my MSc 
thesis and no significant difference in adherence was reported (Muhammad et al., 2013). This is a 
contrasting result, despite the similar methodologies and cohort.  It is clear that good quality and high-




A GFD does have associated financial costs (Singh & Whelan, 2011, Hanci & Jeanes, 2018) and details 
are explained in the relevant section above; but in relation to adherence this may have a negative effect, 
as suggested by studies (Pourhoseingholi et al., 2017, Villafuerte‐Galvez et al., 2015, Estévez et al., 
2016, Leffler et al., 2008, Zivin & Green, 2007b). Pourhoseingholi et al. (2017) conducted a 
questionnaire based study (n=213) and evaluated the detailed cost implications of CD on patients. Their 
cost analysis included visits to doctors, costs of tests (such as blood tests and endoscopy) and cost of 
GFF and suggested that the economic burden attached to CD may affect adherence to a GFD. Similarly, 
Lee et al., (2007) suggested that higher cost may be associated with reduced adherence to a GFD. 
Villafuerte‐Galvez et al., (2015) surveyed 709 patients and 60% of the patients responded that cost may 
affect their adherence to a GFD to some degree. Estévez et al., (2016) examined the affordability of a 
GFD in the underprivileged quarters of Santiago, Chile and suggested that the higher costs of a GFD 
may well be an obstacle to achieving full adherence to a GFD. The studies above have suggested a 
relationship between higher cost and low adherence to a GFD, but there exist a lack of prospective 
studies to evaluate this area. One research suggestion would be to identify a group of non-adherent 
patients who had issues with affordability of GFF and then provide them with free GFF for a certain 
period, in order to assess the effect of correcting the cost factor. This is because adherence is a 
multifactorial issue (Hall et al., 2009, Leffler et al., 2008) and evaluation of a single factor (e.g. cost) and 
its effect on adherence needs a robust study design. 
This suggestion was also included in an earlier UK-based study (Burden et al., 2015). At the time of 
writing, major changes are happening across all commissioning groups in the UK, with regards to the 
availability of GFP on prescription. Further research is needed to re-measure adherence within the 
population in general, especially among those who are from the lower socio-economic strata and those 
who were previously adherent.  
Availability of GFF on prescription may also be associated with GFD adherence, as GFP is relatively 
expensive (Singh & Whelan, 2011). One study, using retrospective evaluation of GPs’ electronic medical 
records, found that GFF are under-prescribed in the UK (Martin & Mercer, 2014). Moreover, provision 
of GFP on prescription might change, as suggested by a consultation exercise by the Nottinghamshire 
Health Authority (NSHA, 2016). Similar suggestions have also been put forward by the Oxfordshire 
Health Authority, in order to save £350,000 per year from local health budgets (OSHA, 2012). In August 
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2018, the Department of Health and Social Care (DHSC) initiated a consultation exercise on the 
prescription of GFP involving different stakeholders i.e. patients, charities, NHS organisations, members 
of the public and health professionals, to give guidance on reclassifying available GFP on NHS 
prescription (Department of Health and Social Care, 2018). This means that GFF (other than GF bread 
and GF mixes) may not continue to be prescribed in primary care in all areas of England. Concerns 
were expressed regarding the drop in adherence to a GFD as a result of these proposed changes, which 
came into force in December 2018. Stakeholders also pointed out that leaving this decision with the 
clinical commissioning groups (CCGs) may lead to variable practice and patients’ access to GFF on 
prescription may well be a post code lottery. It is suggested that prospective studies are designed to 
see the effects of these changes on long term adherence to a GFD.   
The pattern of clinical presentation (sub-clinical vs. clinical) has no significant effect on adherence 
(Viljamaa et al., 2005, S. D. Johnston et al., 2004). Screen detected (asymptomatic) patients have 
similar adherence to symptomatic patients, as suggested by a study involving 19 screen detected and 
21 symptomatic patients (Mustalahti et al., 2002). A later study (n=97) with 14 years follow up also 
agreed and reported a rather higher adherence to a GFD among screen detected patients (Viljamaa et 
al., 2005). Yet another study (n=466) arrived at similar conclusions and reported similar adherence to a 
GFD in both groups (Paavola et al., 2012). A recent study reported that patients who are asymptomatic 
tend to transgress (Halmos et al., 2018). There is variability in the methodology of the studies cited and 
detailed review of this area is beyond the scope of this PhD, but needs more exploration with prospective 
questionnaire based studies which measures adherence objectively, for example via urinary GIP 
(Moreno et al., 2017).  
Butterworth and colleagues (2004) in a questionnaire based study (n=130) reported a positive 
association of dietetic advice on adherence to a GFD. Hall and colleagues (2009) also arrived at the 
same conclusion in their systematic review. Barratt and colleagues (2011) in a case control study 
(n=573) implied that dietitian follow up is linked with better adherence to a GFD. Similarly, a study 
(n=617) from Quebec reported that only 44% of patients received dietitian advice and adherence to a 
GFD was positively associated with that advice (Lamontagne et al., 2001). Later, the role of follow up 
was also specifically evaluated in a prospective intervention study and it was found that repeated 
counselling at follow up has a positive impact on adherence to a GFD (Rajpoot et al., 2015). Despite 
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differences in the methodologies of the studies, it may be inferred that dietitians have an important role 
in adherence to a GFD, although prospective research with high power studies is required.  
Other factors such as social interaction with others (dining out, frequenting meetings) may also have 
negative effects on adherence, as suggested by Black & Orfila (2011). The participants (n=146) in this 
study came from Coeliac UK and had 96% baseline adherence, but reported transgressions in situations 
where they had to interact socially. This phenomenon was previously noted by Hall and colleagues 
(2009) and has been confirmed in two similar studies (MacCulloch & Rashid, 2014, Schilling et al., 
2018). Zarkadas and colleagues (2006) reported universal issues of adherence to a GFD while travelling 
and dining at friends’ houses, where patients with CD were found to avoid travelling (38%) because of 
their illness.  This is because a GFD imposes restriction on QoL (Rose & Howard, 2014) and it may not 
be possible to adhere to a GFD in all situations.  
Hall and colleagues (2009) reported increased levels of adherence in members of coeliac advocacy 
groups such as Coeliac UK and later studies confirmed this (Leffler et al., 2008, Muhammad, 2013, 
Rajpoot et al., 2015). It is however not clear what causes this increased adherence i.e. do naturally 
adherent patients join the advocacy groups or is it the education and motivation from the advocacy 
groups which increases adherence? The first theory is difficult to test, but the latter may be verified by 
reviewing the literature of all the advocacy groups and looking for common themes and then comparing 
their adherence rates. Such themes may then be included in an educational intervention programme 
which may be given to non-adherent and control groups to ascertain its effectiveness.   
Depression is common among patients with CD (van Hees et al., 2013) and may have a negative effect 
on adherence, as suggested by a systematic review (Sainsbury & Marques, 2017). However, the quality 
of the systematic review is questionable – as admitted by the authors – because the number of studies 
included was very limited and they had strict/limited inclusion criteria. Improvement in depression 
symptoms was not shown to be a significant factor in increasing or maintaining  adherence with a GFD, 
as shown in earlier studies (Ciacci et al., 1998b, Fera et al., 2003), although a later study (Abenavoli et 
al., 2006) showed opposite results; but there is a paucity of research in this area and more studies are 
needed.  
Among other factors, an important but potentially modifiable cause of low adherence is lack of 
awareness about gluten-containing foods (Silvester et al., 2016) and studies have reported the effect of 
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knowledge on adherence to a GFD (Leffler et al., 2008, Lamontagne et al., 2001, Casellas et al., 2006, 
Zabolotsky et al., 2017). Similarly, the taste of GFF may also decrease adherence to a GFD (Taghdir et 
al., 2016). It is however accepted that studies in this area are methodologically flawed, with low power 
and un-validated questionnaires. It is felt that this area needs interview based research to evaluate these 
causes further. Clinical follow-up plays a significant role.  
In summary, causes of low adherence are diverse and affected by many factors, and may even be 
different for particular ethnic groups. The evidence for different causes, as suggested by studies, is 
limited by the methodologies utilised and because the studies have used different instruments. A 
comprehensive meta-analysis may be conducted to identify the factors from different studies and 
classify them into modifiable (e.g. knowledge, GFF availability and membership of advocacy groups) 
and non-modifiable factors (e.g. age, sex and ethnicity) and the intervention programmes that are 
designed to rectify the modifiable factors in order to improve the adherence to a GFD.   
 
There is a very limited body of literature about the adherence to a GFD of SA with CD, and it is important 
to understand adherence among SA based on their specific ethnic characteristics. Several factors may 
differentiate a typical Indian patient from their European counterpart. A typical Indian family is a nuclear 
family (Garg & Gupta, 2014); fresh food is cooked and consumed on a daily basis (Counihan & Van 
Esterik, 2012) and eaten at home, whereas this may not be true for a typical European family, as 
suggested by a study examining the consumption of food outside the home in ten European countries 
(Orfanos et al., 2007). Eating at home among SA families is a known cultural trend (Aloia et al., 2013, 
Goyal & Singh, 2007), but this trend is changing towards a westernised diet, as suggested by research  
(Holmboe-Ottesen & Wandel, 2012, Wandel et al., 2008, Namvarasl & Chakravarty, 2018). Moreover, 
a typical Hindu family may be vegetarian (Namvarasl & Chakravarty, 2018) and consume cereals, 
pulses, spices and vegetables, whereas a Muslim family may consume meat, fish, poultry and 
vegetables depending upon availability and affordability (Bhatti et al., 2007). Wheat and rice are staples 
of the diets and, again depending on affordability, dairy products and seasonal fruits are also consumed.  
In order to evaluate adherence rates and barriers to adherence in the Indian population, one well-
designed Indian study (n=146) recruited both treatment-naïve participants (n=54) and those on a GFD 
(n=92) and found the main cause of non-adherence was reported to be non-availability of a GFD, 
although they did not specify which component of the diet was not available (Rajpoot et al., 2015). 
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However the results may well have been affected by selection bias, as patients were drawn from 
specialised CD clinics, which tend to be attended by motivated patients.  
There exists a paucity of food labelling in India, with the exception of the main cities, and knowledge 
about a particular food item is often anecdotal (See & Murray, 2006, Saturni et al., 2010). Additionally, 
certain practices in grinding mills may encourage cross-contamination of GF products with gluten, and 
such flour could reach the UK and be sold in Asian shops. This area needs research by designing a 
study to measure the gluten content of rice flour available in the UK, for example, from randomly 
collected samples. It has also been observed that newlywed young women face adherence issues while 
living among her husband’s family members, whose knowledge of CD is non-existent or negligible, and 
she may be required to prepare food for the whole family (Rajpoot & Makharia, 2013). This area again 
is based on anecdotal observations or opinions in reviews and needs further interview based research.  
The first analysis of SA immigrants with CD was undertaken in a Birmingham-based study which 
specifically looked into the question of adherence with a GFD in SA (n=40) as opposed to Western 
Caucasians (n=90) (Butterworth et al., 2004). The SA were reported to be dissatisfied with the services 
offered and often missed follow-up appointments in comparison to Western Caucasian patients. Indeed, 
the questionnaire return rate was low, as observed previously (personal communication with Professor 















Interventions to improve adherence to a GFD 
 
Following a GFD is not just a matter of changing the diet, but involves the patient changing their entire 
lifestyle; further research is needed for the development of an easy to understand, cost-effective and 
patient-friendly intervention to improve adherence to a GFD. To date, only nine intervention programmes 
have been reported with reference to GFD adherence in the literature and three particularly target 
improving adherence to a GFD. The studies have approached the issue (increasing adherence to a 
GFD) from different angles and the majority of them lack general applicability and are not clinically 
relevant for day to day practice. Computer based interventions, for example, are technology dependant 
and may only be able to target a proportion of patients affected by CD. Similarly, studies which have 
either included only White Caucasians or SA may not be fully interchangeable, as there are dietary and 
cultural differences in both communities; although the dietary ingredient in question (wheat) is the same, 
the products produced from it vary between different cultures. Likewise, studies which have either 
targeted patients with psychological issues and CD or diabetes with CD may also lack generalisation for 
the vast majority of patients whole present only with CD. Lastly, but importantly, there exists variability 
in health delivery models in different countries and this too may have an effect on the delivery of a 
particular intervention, when for example it is developed in one country but applied elsewhere.  
It is however accepted that the issue (i.e. low adherence to a GFD) has been recognised and some 
efforts have been made in the form of interventions to increase adherence. These studies have been 
grouped according to the approach they have used to increase adherence to a GFD. A detailed critical 
review of each study will be given, followed by the conclusion drawn from it. Salient features of these 










Table 11: Interventions to improve adherence to a GFD in CD. 
Study  N Method of assessing  adherence to a GFD Key Findings Strength/ weakness 
Addolorato et al., 2004. Rome, Italy. 
To evaluate the use of psychological support 
counselling to improve affective disorders 
and gluten‐free diet adherence in CD. 
 
66 Instruments: State-Trait Anxiety Inventory 
test Y-1 and modified Zung Depression scale. 
Intervention: Psychological support  
2-6 weeks; FU for 6 months. Non randomised 
and lack of ethnic population. 
Significant improvement in adherence in 
intervention group as compared to non-
intervention (39.4% vs. 9.1%; P=0.02). 
Lack of general applicability. Depression was not 
defined in relation to lack of adherence and 
methodology to measure adherence was not objective. 
Mixed patients with anxiety and depression hence no 
clear distinction about the mechanism of improvement 
of adherence.  
Meyer et al., 2004 Leipzig, Germany. 
Comparative analysis of conventional 
training and the computer-based interactive 
training program (CBITP).  
64 Instrument: Knowledge questionnaire. 
Indirect inference of adherence. Intervention  
CBITP vs conventional training groups; 
FU 3 weeks. 
Both intervention and control groups 
increased knowledge about CD. 
However, the intervention group 
performed significantly better.  
Randomised study but adherence was not measured 
directly and clinical value is uncertain. Short follow up (3 
weeks) and dependant on technology and computer 
literacy.  
Ring Jacobsson et al., 2012, Linköping, 
Sweden. Effects of patient education on the 
psychological well‐being of women with CD 
in remission. 
106 Instrument: Psychological wellbeing test and 
validated questionnaire. Intervention 
Two groups randomised. 10 sessions. 
Wellbeing checked at 10 and 25 weeks. 
Omnigender (female). 
Significant improvement in psychological 
well‐being at 10weeks, whereas the 
controls given usual care reported a 
worsening in psychological well‐being. 
Randomised study but adherence was not measured. 
Clinical value of the study is questionable as 
psychological wellbeing was not correlated with 
adherence. Generalisation is questionable. 
Sainsbury et al., 2013b and 2015 
Sydney, Australia. To test the effectiveness 
of an interactive online intervention to 
improve GFD adherence in adults with CD. 
189 Instrument: CDAT. Intervention 
Online intervention “Bread and Butter.” 
Intervention group (n=101) and control 
(n=88). 3 month follow up. 
Significantly improved GFD adherence, 
and GFD knowledge following the 
treatment period compared to control 
group (p=<0.001). 
Randomised study, comprehensive and direct 
assessment. Selection bias as patients recruited from 
Coeliac Society and no ethnic population. 
Technology dependant and limited clinical value. 
Assor et al., 2015 Ottawa, Canada. 
To evaluate the safety and efficacy of a GFD 
in patients with CD and to assess adherence 
and facilitate evaluation of a GFD. 
NK* Instrument: Dietary interview (visits), CDAT, 
Serology Intervention Dietary curriculum; 
2, 3 and 4 months visits. 
The study did not publish the results so it 
is not clear what the outcome of the 
intervention was.   
Randomised study, comprehensive assessment, 
only asymptomatic CD, generalisation and clinical value 
questionable. Longer follow up but results never 
published. 
Rajpoot et al., 2015. Delhi, India. To assess 
the level and barriers to adherence and role 
of clinical follow-up in adherence. 
172 Instrument: Coeliac symptoms index and 
adherence questionnaire. Intervention 
Repeated counselling given; FU 6 months. 
Significant improvement in adherence 
from 35% to 92% at 6 months.  
Randomised, medium (6 months) FU. Has clinical value 
but only Asian patients. Lacks counselling details.  
 
Pekki et al.,2017. Temper, Finland. To 
evaluate predictors and significance of long-
term follow-up i.e. adherence. 
677 Instrument: Serology and validated 
questionnaire. Intervention: Followed up 
groups observed. 
No significant difference between the FU 
and NFU groups. 
Non randomised and retrospective. Selection bias in 
survey recruitment. Longer follow up but generalisation 
questionable. May have clinical value if repeated with 
better methodology. 
Haas et al., 2017 California, USA. To 
determine the impact of the Text Message 
on adherence.  
64 Instrument: CDAT serology. Intervention 
Text Message Educational Automated 
Adherence Help. 3, 6 and 12 months FU.  
There was no statistically significant 
difference in patient-reported or 
objectively measured GFD adherence. 
Randomised, medium (6 months) FU. Has clinical 
value. Cost effective.  
Wolf et al., 2019 New York, USA. To 
determine the impact of gluten sensing 
device (Nima) on adherence 
30 Instrument: Gluten sensing device  Prevented users for consuming gluten in 
food items thought to be gluten free. 
Randomised, three months FU but low powered. The 
testing was time consuming.  




Role of Follow-up in increasing adherence to a GFD 
Two studies have assessed the role of follow-up (FU) by health professionals and its effect on adherence 
to a GFD and come up with contrasting results. A study from Finland (n=667) by Pekki and colleagues 
(2017) evaluated predictors and the significance of long-term FU in relation to adherence. They reported 
that there was no significant difference between the groups (regular FU 6.3% (n=94) vs. no FU 15.1% 
(n=527), respectively, p = 0.343; n = 95). Although not explained, patients without FU reported more 
symptoms (16% vs. 26%). There was no major difference between the ages, adherence to a GFD or sero-
positivity of the groups. It is not clear if they took into consideration all reported confounding variable 
such as: membership of a coeliac advocacy group, accidental intake of gluten and level of knowledge 
about different GF and GCP.  
Rajpoot and colleagues (2015) prospectively followed CD patients (n=146) who were both treatment 
naïve (n=54) and already on a GFD (n=92) for the preceding six months and reported that FU and 
counselling lead to a decrease in celiac symptom index (CSI) score, suggesting better adherence. 
Additionally, improvements in haemoglobin and albumen levels were also noted. Both groups in the 
study showed improvement from the baseline; the FU group showed a significant increase in adherence 
(from 53.3% to 92.4%) to a GFD in comparison to the treatment naïve group (64.8 % to 96.3%).  Note 
that these findings are very different from the results reported by Pekki and colleagues (2017). 
There are methodological differences between the two studies which may explain the conflicting results. 
The study by Pekki and colleagues (2017) was mainly a retrospective observational study and did not 
administer any intervention, but compared the adherence in FU and non-FU groups, whereas the study 
by Rajpoot and colleagues (2015) was prospective; it also compared availability and affordability of GFP 
in both groups, which was same. The role of FU in relation to better adherence has previously been 
reported (Wylie et al., 2005, Butterworth et al., 2004) and BSG (Ludvigsson et al., 2014b) as well as 
ACG (Rubio-Tapia et al., 2013) also assert this. The possible benefits of FU need more research by 
conducting prospective studies and comparing groups in terms of validated instruments for adherence 
to a GFD. Duodenal biopsies and serology may also be used to objectively evaluate the role of FU in 







Role of gluten detecting device to increase adherence to a GFD 
The principle of this study (Wolf et al., 2019) was based on assumption that increasing the knowledge 
motivated people about gluten in a food item, thought to be gluten free, will deter them from eating gluten 
hence, increasing their adherence to a GFD. The group recruited 30 participants and the device was 
charged with disposable capsule by the participants each time the food item was tested. This would help 
in identification of the gluten contents (set at > 20ppm) of the food item. The researcher found 
subjectively reported increase in adherence to a GFD by the participants.  Although, attractive in theory, 
the device (Nima) was found to be time consuming and increased anxiety among the participants. 
Moreover, the study was low powered may have selection bias. Additionally, the device only targets 
motivated patients and helps to avoid only accidental intake of gluten. Furthermore, it is concurred that 
the device will have attached cost to it and its exact role in the long term control of adherence is not 
clear at this stage.  
Role of computer based education in increasing adherence to a GFD 
Two studies have assessed the role of computer based literacy programmes as an intervention to 
increase adherence to a GFD and reported similar results. Meyer and colleagues (2004) utilised a 
computer-based interactive training program (CBITP) combined with interactive exercises to see their 
effect on improvement in knowledge about CD and not adherence. Patients (n=64) were randomised 
into two groups and one received CBITP whereas the other only received written instruction. Although 
both groups were noted to have increased in knowledge, the CBITP group showed significantly better 
improvement in knowledge than the control group. Notwithstanding the fact that randomisation had been 
included in the study design, several issues were identified that diminished the applicability of this study. 
Most notably, increased knowledge was assumed to be a surrogate for increased adherence, although 
it is accepted (even by the author) that adherence to a GFD is a complex interplay of multiple factors 
(Hall et al., 2009); the clinical value of this study is therefore questionable. In addition, the way that the 
cumulative score was measured gives no clear information about individual key areas of CD knowledge. 
For example, a patient may score highly in multiple areas about the GFD, but may score poorly on their 
knowledge about a GFD in a restaurant, and thereby still ingest gluten. This study, like the previous one, 





These issues were addressed in a later study (Sainsbury & Mullan, 2013b): a well-structured, goal-
directed and objective RCT to improve the adherence rate for GFD in CD patients (n=189) who were 
divided into intervention (n=101) and control (n=88) groups. Of the 101 intervention participants, 50 
(49.5%) completed the intervention and the remainder were either lost to FU (n=31) or partly participated in 
the study (n=21). They devised a web-based intervention, called ‘bread and butter’ and the primary 
outcome was to improve GFD adherence. Three months’ FU was arranged for the patients. CDAT was 
used to measure GFD adherence, which showed improvement in the intervention group (p<0.001) and 
remained unchanged in the control group (p=0.67). In addition, they noted an increase in knowledge 
about CD in the intervention group. The comparative adherence scores, both pre and post intervention, 
are shown in the Figure below (Fig No 6). 
 
 
Figure 6: Baseline, post-intervention, and three-month follow-up adherence scores. Note: Fixed line (all) refers to 
analyses conducted on the sample of intervention group participants (n=101) who completed the intervention and 
responded to the 3-month FU survey (n = 46); baseline vs. follow-up: t 46 = 3.63, P < 0.001; post versus follow-up: t 46 = 
0.53, P = 0.600. Dashed line (inadequate only) refers to analyses conducted on the subsample of intervention participants 
who had inadequate adherence at baseline and completed the intervention and 3-month follow-up survey (n = 18); 
baseline vs. follow-up: t 18 = 4.50, P < 0.001; post vs. follow-up: t 18 = 0.70, P = 0.497; GFD adherence scores range = 7 
– 35; higher scores indicate poorer adherence; inadequate adherence defined as a score of 13 or higher; * * * P < 0.001. 





Sainsbury and colleagues (2013) selected patients from the Coeliac Disease Society (CDS) and social 
media which may thus introduce selection bias, as patients from such a society have better adherence 
to a GFD as suggested by research into this area (Leffler et al., 2008, Muhammad, 2013, Rajpoot et al., 
2015, Hall et al., 2009). Furthermore, both studies employed web-based methodology and hence 
computer literacy might well be an issue in an elderly group that forms a significant proportion of the 
adult UK population with CD (West et al., 2014). Regardless of this, the latter study provides both a 
theoretical as well as a practical baseline for future design and execution of studies in this context. Using 
the same cohort, Sainsbury and colleagues (2015) also reported in a follow up publication, that baseline 
intention and GFD adherence were strongly associated with FU intention and adherence to a GFD. 
Role of text messages in increasing adherence to a GFD 
Following the same line, Haas and colleagues (Haas et al., 2017) evaluated the role of text messages 
in relation to increasing adherence to a GFD (n=64). The text message group received 45 unique text 
messages over a 3-month study period, while the control group received standard care.  Adherence 
was measured with serum anti-tTG (IgA) and deamidated gliadin peptide (IgA) levels and no significant 
difference was noted between the groups. The study, however, could be criticised for the short duration 
of FU (3 months) and over-reliance on serology to confirm adherence. The role of serology to detect 
non-adherence has been questioned (Vahedi et al., 2003, Kaukinen et al., 2002b, Hopper et al., 2008, 
Sharkey et al., 2013). Additionally, patients’ ages ranged from 12 to 24 years: a demographic which has 
low adherence generally (White et al., 2016, Schilling et al., 2018) and which may weaken the general 
applicability of this study.  
Role of improving psychological wellbeing in increasing adherence to a GFD 
Two further studies concentrated on improving the psychological condition of CD patients and measured 
the indirect outcome i.e. improved adherence to a GFD. In the first study (n=66), newly diagnosed CD 
patients with anxiety and depression were divided into two equal groups and followed up for 6 months 
(Addolorato et al., 2004). The intervention arm received psychological support, whereas the control 
group was only followed up in the clinic.  At six months, the intervention group was reported to show 
better adherence with a GFD as compared to the non-intervention group (39.4% vs. 9.1%; P=0.02). 
However, there are many flaws to this study, which bring into doubt the general applicability of such 
psychological support. Adherence to a GFD, for example, was not measured objectively e.g. by a 




subgroup of patients with CD was selected, which was not representative of the whole group in terms 
of behaviour, attitude or even knowledge about adherence to a GFD. Furthermore, the mechanism 
through which improvement in depression is related to an increase in adherence was not explored. This 
raises questions about the clinical value of this study.  
The second study (n=106), a randomised controlled trial, recruited only women with CD, all ≥ 20 years 
old and on a GFD for more than 5 years (Ring Jacobsson et al., 2012). The aim of the study was to 
assess the effects of an active method of patient education on the psychological well-being of women 
with CD in remission. The indirect aim was to assess the role of such an intervention on adherence to a 
GFD. They were divided into two groups: those who received a dedicated 'Coeliac School' intervention 
(n=54) and those who received information in relation to CD at home (n=52). The intervention group 
underwent a 10-session educational programme. The primary outcome was psychological general well-
being measured with a validated questionnaire. The intervention group showed psychological well-being 
at 10 weeks and that remained sustained after 3 months FU. Although a very thorough and time-
consuming study, this intervention also is not applicable to all patients. In addition to that, the cohort is 
gender-biased and it is not clear how adherence to a GFD was measured. Furthermore, the clinical 
value of this intervention is questionable.  
 
Role of improving education in increasing adherence to a GFD 
In a US based study (n=75) Zabolotsky and colleagues (2017) assessed the role of an educational 
programme on CDAT and CDQoL and reported improvement in score post education but this was a 
short conference presentation and apart from passing mention about information on: the GFD, lifestyle 
changes, counselling for family members, and other associated conditions, details about the educational 
instruction and contents of the educational strategy were not available. In addition to that, CDAT was 
measured in non-conventional way i.e. increasing CDAT was linked with improved adherence. The 
information about this study are sparse and, although worth mentioning, cannot be considered a 







Finally, there is also a report of an incomplete study, CD-DIET, which focused only on patients with CD 
and T1DM (Assor et al., 2015). The aim of the study was to evaluate the safety and efficacy of a GFD 
in patients with asymptomatic CD and T1DM with regards to diabetic control. However, one of the 
indirect aims was to develop rigorous guidelines to assess adherence and facilitate evaluation of a GFD 
on: metabolic control, bone health and patient quality of life in patients with CD and diabetes. The results 
of this study were not published.  
 
Aims of the Research 
 
This PhD aims to report factors influencing GFD adherence and whether there are any factors specific 
to people of SA origin with CD. From the information gathered, a subsequent study aims to improve 
GFD adherence in patients with CD through an intervention. The literature review above indicates that 
there remains a paucity of data on ethnic minority CD patients in the UK and the potential difficulties 
faced by this subset of the population in adhering to a GFD. Additionally, of substantial clinical 
importance, there is limited research on interventions to increase adherence to a GFD which are cost 
effective, acceptable to patients and above all not significantly technology dependant.  
 
The PhD is divided in to three studies. Study I of this PhD thesis aims to establish the factors influencing 
GFD adherence in a cohort of Caucasians and SA residing in the UK. Study II, an interview based 
research study, aims to understand the factors influencing GFD adherence in Caucasian and SA 
patients residing in the UK who are not presently adhering to a GFD, and suggest interventions to help 
their adherence improve. Study III aims to improve GFD adherence in patients with CD currently not 
adhering to a GFD through an intervention, with a 6 month follow up (FU) period. The details of each of 
the three studies will be provided in the relevant chapters to avoid duplication of information. A summary 










Table 12: Brief overview of the studies and their aims in relation to the PhD. 
Study No/ Hypothesis          Aims 
Study I:  
Adherence to a GFD may be measured through a 
combination of validated questionnaires 
 To measure adherence to a GFD in relation to age, gender and 
ethnic background 
 Explore symptomatology in relation to activity of disease 
 Factors associated with adherence to a GFD 
Study II:  
Adherence to a GFD is multifactorial and can be 
determined by questionnaires combined with 
telephonic interview 
 To investigate reasons behind non-adherence to a GFD 
 To design an intervention for increasing adherence to a GFD 
Study III:  
Interventions based on patients’ input can increase 
adherence to a GFD 
 To increase adherence to a GFD by an intervention 



























Research has shown that adherence to a GFD, which is challenging for a significant number of patients 
(Zarkadas et al., 2013), has multifactorial causes (Hall et al., 2009). A variety of methods including 
interviews and questionnaires has been used to determine the adherence and causes, but this area is 
still under researched. Improvement in adherence can not only reduce symptoms but may also reduce 
the long term complications of CD. 
There is limited research in the area of GFD adherence in ethnic populations, especially in the UK. Most 
of the studies in this area are observational and cross sectional. This could be improved by including 
information from medical notes, clinical letters and computerised health records. This current study is a 
follow-up study of a pilot MSc project (LEVANT) (Muhammad, 2013) which studied 320 patients (67% 
female). The return rate was 57.6% (n=180) and the absolute adherence was 65% (116). There were 
no significant differences in adherence based on ethnicity, gender or age. The pilot study (Muhammad, 
2013) proposed that a high power study should be conducted using the same database supplemented 
by medical notes. Additionally, linguistic support should be available to the ethnic minority patients in 




The study aims to measure adherence to a GFD in relation to age, gender and ethnic background and 
explore symptomatology in relation to activity of disease along with factors associated with adherence 
to a GFD.  
 
Method 
This was a questionnaire based survey using validated instruments to evaluate basic demographics of 




the University Hospitals of Leicester NHS Trust (UHL). The identified participants were approached via 
letter and sent a research pack through first class post. Return rate (RR) is defined as the number of 
completed units divided by the number of eligible units in the sample (Fan & Yan, 2010). Completed 
questionnaires were received, codified, entered and subsequently analysed. In addition, the medical 
records of the patients were screened for supplementary information. Informed consent was obtained 
from the patients who completed the questionnaire and returned it (Appendix 1.1c). The methodology 
was adapted from previously published studies (Butterworth et al., 2004, Leffler et al., 2007) and the 
MSc by the author (Muhammad, 2013).   
Because of the potential volume of notes required and the difficulty associated with tracking them down, 
it was decided to use just the last 3 clinical letters from the computerised record, along with laboratory 
test results accessed using ILAB® or APEX®. Where it was felt necessary, if there was ambiguity in the 
clinical letters, notes were accessed for supplementary data. First of all the data was checked for 
associated comorbidity. 
Design 
The design of this observational study was cross sectional, as data was collected from a subset of the 
population at one specific point in time, using validated instruments i.e. two questionnaires and one food 
diary. In population based studies, cross sectional analysis is used to describe some feature of the 
population (Levin, 2006) and in this particular case it was used to collect information about: adherence 
to a GFD, causes behind low adherence and related issues (which are described below in the 
appropriate section).  
Participants 
The participants in this study came from the UHL pathology department database. The data had been 
coded by the computerised record system known as the Systematized Nomenclature of Medicine® 
(SNOMED). SNOMED uses a collection of medical terms (diseases in this context) and provides a 
reliable and consistent way to index, store and retrieve medical data in commonly used interfaces (in 
this case MS Excel® spreadsheets) (Cote & Robboy, 1980). Local approval to extract the data was 
obtained from the consultant pathologist, after approval of the ethics committee had been received. The 




the study in order to avoid any selection bias. Only adult patients diagnosed between 2004 and 2014 
were selected for this study and they had to meet the diagnostic criteria of CD on pathological grounds 
as explained below. The geographic location of all the participants was Leicestershire, which is an 
English county in the Midlands.  Demographic records were checked using the Trust’s computerised 
diagnostic software, ILAB® (2nd Edition, 2010).  
Inclusion criteria 
All adult patients (18 years and above) diagnosed with CD on confirmed histological grounds between 
2004 and 2014 in the SNOMED database of the department of pathology at UHL were selected for this 
study. In addition, for standardisation of diagnosis, only patients who were diagnosed by UHL 
pathologists were included. Moreover, for consistency in treatment and dietary advice received, only 
patients who were under the FU of UHL consultant gastroenterologists and dietitians were included in 
this study.  Patient selection involved only those diagnosed with CD between 2004 and 2014.  
Exclusion criteria 
All patients below the age of 18 were excluded. In addition, all those who were not under UHL FU were 
excluded for ethical reasons, as the local Research and Development office approval was only 
applicable to UHL related patients and standardisation. Furthermore, patients with learning difficulties, 
those living outside Leicestershire and those who were diagnosed by non UHL pathologists were 
excluded from the study. Patients diagnosed with CD before 2004 were also excluded.  
Materials/ instruments used 
A total of three instruments were used to collect the data. In previous similar research (Muhammad, 
2013) the questionnaire by Butterworth et al., (2004) was used and this time it was supplemented with 
a validated dietary adherence questionnaire (Leffler et al., 2009). The former questionnaire gathered 
epidemiological data and the latter only focused on adherence. Furthermore, a food diary (WCRF, 2013) 
was sent out to collect information about food and nutrient intake from the patients.  
A postal invitation in the form of a research pack was then sent to all eligible patients. The research 
pack included an invitation letter (Appendix 1.1b), patient information sheet (Appendix 1.1a), study 




questionnaires and a stamped addressed envelope. Demographic data was collected from the CD 
database at UHL; dietary adherence and quality of life related responses were extracted from the 
questionnaires.  
Data analysis 
Data was entered and analysed using SPSS V 24 (IBM SPSS Inc., Chicago, IL). Data was initially 
evaluated for characterization of the recruitment cohort in terms of: age range, gender distribution, ethnic 
variation and evidence for the diagnosis. To assess skewness, continuous variables e.g. age, were 
screened for normal distribution by using the Kolmogorov-Smirnov test and transformed if considered 
necessary. In addition to that, nonparametric tests such as χ2 test Mann-Whitney (MW) and Kruskal-
Wallis tests were used to compare percentages. 2X2 contingency tables were used to compare nominal 
data in cross tabulation and the Odds Ratio (OR) was calculated. The Student’s t-test or equivalent non 
parametric tests i.e. MWU test were used to analyse differences between the mean age and length of 
FU since diagnosis of the returnees and non-returnees of the questionnaire among the Caucasian and 
SA patients.  
Binary Logistic Regression was used to find associations between certain parameters (membership of 
the Coeliac Society (CS), understanding food labels etc.) and adherence to a GFD. Logistic regression 
analysis provided a P value and an OR with a 95% confidence interval. For the purpose of this test and 












Description of questionnaires used 
The cognitive process to respond to a questionnaire involves four steps, namely: comprehension, recall, 
linking the retrieved information and communicating the response (Bowling, 2005). It is important that 
this process is facilitated by the design of the questionnaire and must have traits to reduce bias in this 
process. The questionnaires selected for this purpose, therefore, had general characteristics including: 
relevance to the area of interest (e.g. adherence in this case), reliability and validity (Roberts & Priest, 
2006). The instruments selected had these properties and are described below. 
A: Comprehension: 
This is related to the respondents’ ability to understand the question and be able to respond by following 
instructions (Lietz, 2010). It was noted that the questionnaire by Butterworth et al., (2004) did not have 
instructions for filling in the questionnaire and these were therefore added. All instruments had 
vocabulary which was appropriate for the target population (Brace, 2008) and the sentence structure 
was simple, without ambiguity or vagueness (Saris & Gallhofer, 2007, Aday & Cornelius, 2006). 
Furthermore, the questions were presented in a logical, sequential, tabulated and easy to follow manner, 
which aided visual comprehension of the document (Brace, 2008) .   
B: Recall from Memory: 
Significant sections of the instruments were concerned with recall, and that is the area which can be 
affected by recall bias (Brusco & Watts, 2015). Special care was therefore taken to screen the selected 
questionnaires for reducing recall bias (Eisenhower et al., 2004). For example, information about specific 
events (such as age of diagnosis) was cross checked with the medical record held in the hospital. It was 
noted that, instead of asking for a specific date, a temporal range was asked for, as that is easier to 
recall. Similarly, for better recall, patient selection involved only those diagnosed with CD in the past 10 
years.  
C: Response reporting: 
It is generally accepted that information provided by the respondent is truthful, but care was taken not 
to make the questions too difficult, embarrassing or long; otherwise they may be difficult to answer and 
introduce social desirability bias (Holbrook & Krosnick, 2010). The questionnaires selected were 




Butterworth et al., (2004) questionnaire 
This questionnaire was selected because the population on which it had originally been used had similar 
geographical, social, ethnic and linguistic characteristics to our population (Butterworth et al., 2004).  
This questionnaire was originally used to survey Birmingham and the surrounding area of the Midlands; 
the population for this PhD was recruited from Leicestershire (East Midlands), where there is a large 
ethnic population with a similar demographic. For example, the ethnic populations of Birmingham and 
Leicester may be compared on the basis of their origin from South East Asia including: India, Pakistan, 
the Middle East, Bangladesh, Sri Lanka and Afghanistan (Birmingham City Council, 2018, Leicester City 
Council, 2018). Their languages include: Hindi, Urdu, Pashto, Punjabi, Persian, Dari and Arabic and the 
author can speak all of them (Appendix 1.1G). In addition to that, the questionnaire was focused on 
GFD adherence in Asian and Caucasian people, which is the area of interest for this study.  
The questionnaire contained 20 questions and permission to use this questionnaire was obtained from 
the author of the study (Appendix 3.1). The questionnaire was designed to gather a variety of information 
including: symptoms before diagnosis, information given to the patients after diagnosis (by both 
physician and dietitian) and difficulties faced by them in following a GFD.   
Clear instructions were added at the beginning of the questionnaire, in order to help the participants 
complete it. They were advised not to leave any part blank and instead write “Don’t know” or simply 
“DK.” Participants were also advised to use extra sheets if they felt it was necessary to add comments 
or extra information. The questionnaire was divided into several sections, with basic demographics such 
as age and gender included along with ethnicity details at the very start of the questionnaire. The next 
section included questions about dietary habits (vegetarian/ non-vegetarian) and information about their 
age at diagnosis. Following this, the time taken to arrive at a diagnosis was asked, to ascertain the gap 
between first contact with healthcare and diagnosis of CD. Thereafter, in the next section, all commonly 
known associated symptoms of CD were listed and patients were asked to tick those applicable to them. 
Symptoms in this section were related both to GI tract symptoms (like diarrhoea, abdominal pain, 
bloating and oral ulceration) and extra-intestinal symptoms (like rash, weight loss, hair loss and 
generalised fatigue). There was also an area where participants could state if they were in fact 
asymptomatic (and had been diagnosed due to a positive family history for CD). Information given to 




information they had received about the disease and disease process, any FU plan and instructions 
about a GFD and its importance. Patients were also asked about their satisfaction with the information 
given to them, by both physicians and dietitians and they were encouraged to write down the reasons if 
they were not satisfied. One question specifically asked about the role of dietitians in the management 
of CD.  
The next few questions investigated the difficulties faced by the patients in following a GFD. This 
included their baseline understanding and perception of a GFD and if they were symptomatic after 
dietary transgressions. The economic aspects related to following a GFD were also explored and they 
was asked if they were aware that some GFP are available on prescription. Relevant to this question at 
the time of this research, health commissioners in many NHS English CCGs were restricting the 
dispensing of GFP on prescription. In the East Leicestershire and Rutland CCG, these changes have 
now been implemented and only eight items are allowed on prescription, with a plan to review the items 
in 12 months (East Leicestershire and Rutland CCG, 2016).The last few questions were about Coeliac 
UK (CUK) and participants were asked if they were members of CUK; reasons behind non-membership 
were explored.  The participants were also asked if they would be happy to be contacted in the future 
for similar studies.  
Leffler et al., (2009) questionnaire 
This validated questionnaire was selected for its ability to indicate dietary adherence to a GFD. It had 
also been used in recent similar studies (Nazareth et al., 2015, Sainsbury et al., 2013b, Villafuerte‐
Galvez et al., 2015, Mahadev et al., 2013). The seven item questionnaire was considered appropriate 
to minimise participant burden and promote a good response rate (Iglesias & Torgerson, 2000). 
Permission to use this questionnaire was obtained from the author of the study (Appendix 3.2). 
The questionnaire utilised a five point Likert scale (Likert, 1932) and explored general symptoms 
associated with low adherence, such as headache and low energy. This was followed by two questions 
asking about personality traits such as self-discipline (by exploring participants’ ability to follow a GFD 
in non-familiar environments such as restaurants) and a cautious nature (when considering 
consequences of actions). Next a specific question was asked about self-assessment and patients’ 




gluten ingestion, including if there had been no ingestion in the past four weeks. The questionnaire had 
the added advantage of being easily translated into different languages and could be administered over 
the telephone because of its simple structure. Last but not least, the questionnaire generated continuous 
data which was easy to code and analyse in statistical operations.  
WCRF food diary 
Food diary analysis was completed by CD patients adhering to a GFD to assess their nutritional status 
(Shepherd & Gibson, 2013), but reliable adult studies with good power in non-adherent patients are 
lacking. This study utilised a 3 days World Cancer Research Fund (WCRF) food diary to explore 
unintentional gluten ingestion (WCRF, 2013). This was a short and easily understandable diary with one 
page per day (Appendix 1.1F).  
Ethics 
 
Integrated Research Application System (IRAS) was used to apply for ethical approval for the study 
(IRAS ID: 159160). The study was first approved by the University of Roehampton Ethics Committee 
(LCS 14/112). Thereafter, ethical approval was applied for through the central Research and Ethics 
Committee (REC) and permission was granted from the REC NHS London – Queen Square (Ref: 
14/LO/2128). The local NHS research and development department at UHL was involved through a site 
specific application form linked to IRAS (UHL Ref: 11418). The ethical approval letters from the relevant 
bodies for this study are attached in the appendix section (Appendices 2.1A-C).   
 
Procedure 
Each participant was given a unique trial number, which was assigned by the principal investigator to 
preserve the confidentiality of the patients. This was stamped on every document using a COLOP® 
mini-folio (S126) prefilled number generating stamp. Assurance regarding the confidentiality was clearly 
stated in the invitation letter and patients were encouraged to clarify any concerns (if they had any) by 
either writing to the researchers or telephoning them at a particular time (Wednesday afternoon). 




During the recruitment phase of the study, extreme care was taken to preserve the confidentiality of the 
patients by constructing a comprehensive password protected database. The database was received 
from the pathology laboratory using the UHL email and only Trust specified memory sticks were used. 
Data was accessed on a need to know basis only. The researcher analysed the diagnostic database 
and only relevant details like: age, sex, and ethnicity, basic information given at the first meeting with a 
dietitian and histological confirmation were entered into the database. Only then were the questionnaires 
sent out.  
The first phase of the study was the postal recruitment, where patients were identified by their pre-
allocated number. The suitably identified patients were carefully re-evaluated prior to sending the 
research pack out, as a precautionary measure to comply with the exclusion criteria and prevent sending 
out the research pack to unintended recipients (e.g. minors, learning disabled or deceased patients). 
Additional information gained from the CD database like age, ethnicity and gender was also entered 
onto the research database.  
The returned questionnaire was kept in a separate file in the research room at UHL and all identifiable 
data was kept linked only to trial numbers to protect confidentiality. Each response on the questionnaire 
was coded from 0 to 12.  
Conduct of the study 
No adverse incidents were reported. Patients were provided with contact information for the Head of 
Department, in case they had any issues, queries or questions. One patient had an issue regarding the 
way she was approached for the study i.e. how did we obtain her contact details? This was duly 
discussed with the university and academic supervisors. Full explanation was given about the ethical 
procedure, methodology of patient contact and patient comments were invited; she was satisfied with 
the explanation. Thereafter, no further contact was received from the patient.  
A separate leaflet in seven ethnic languages accompanied the invitation letter to invite questions from 
anybody who had difficulty understanding the purpose or conduct of the study, even if English was not 
their first language (Appendix. 1.1G).  The researcher received a total of 13 calls from different patients, 
all enquiring about different aspects of the study. The calls could be broadly grouped into 4 themes. 




our adherence to confidentiality guidelines during collection, storage and safe disposal of identifiable 
data before, during and after the study. All of those who enquired were satisfied with the explanation 
given. Secondly, 3 callers had specific questions about the purpose of the research. They were given 
full explanations about the aims and purpose of the research. Thirdly, 3 callers pointed out mistakes in 
the questionnaires, especially question number 2, where ethnicity was confused with religion; the 
researcher apologized. Finally there was a caller who asked for different questions to be explained to 
them in their language, which was done.   
Data entry: 
In the first stage, the entered data was checked for any errors and missing data. The researcher found 
cases (n=4) where typographical errors were detected and a further two cases where data was missing. 
Missing data was cross checked with the paper based data and the missing values were rectified. 
Following this, in the second stage, coding of the data was cross verified, and no coding errors were 
identified. All entries in the software were done by the researcher (author) and 20% of the data was 
double checked for accuracy by an audit committee in 2 steps. The committee suggested changes to a 
few entries and, after rectifying the data errors, data was statistically analysed. No omission in the data 
was left blank. Ambiguous phrases such as ‘not available’ were avoided. No patients withdrew from the 
study, although it was clarified with the patients that they were allowed to withdraw from the study at 














A total of 1,248 patients were identified from the CD database at UHL. The pathology database 
(SNOMED®) has extensive records for CD patients (over 2000); only those patients who were 
diagnosed between January 1st 2004 and December 1st 2014 were selected (11 years). Data was broken 
down into diagnosis of CD per year and the average number of patients diagnosed per year was 111. 
Additionally there was a trend of increasing numbers of CD cases being diagnosed over the years. The 
number of diagnosed cases of CD per year is shown in the bar chart below (Figure No 7). 
 
Figure 7: The diagnoses of CD per year at UHL 
The selected population had objectively confirmed histological changes in their duodenum consistent 
with CD.  
Diagnosis of CD in the study population 
Data was extracted using SNOMED®, a coding system devised by the College of American Pathologists 
as explained above. Pathological reports of those who responded to the questionnaire were manually 




















Furthermore, for correct diagnosis, it was ensured that all those with histo-pathological appearances of 
CD had corresponding supportive positive serology (either anti-tTG or endomysial anti-bodies) at some 
stage during their diagnosis or FU. Thus the diagnoses were established by a combination of 
pathological and serological features.  
Study population 
SNOMED® data generated 1,248 patients and, after applying the exclusion criteria, 972 were selected 
for the postal questionnaire. Out of the excluded patients, 170 were minors and 33 were duplications of 
data. A further 73 patients were excluded after applying exclusion criteria such as: patients moved out 
of geographic region (n=47), doubtful diagnosis (n=11), death of patients (n=4), no address available 
(n=4) and learning difficulty (n=2). The final excluded category (n=5) had no active FU with the 
department and no GP details were available, so it was assumed that they were either lost to FU or they 
were not on a GFD. Another possibility is that they were from outside the Leicestershire area and were 
only diagnosed at UHL and were not receiving FU there. It is also possible that a few of them did have 
active CD and needed a GFD, but were diagnosed by non GI physicians and were awaiting 
gastroenterologist input in their management or they had been referred for a second opinion from 
outside the Leicestershire region. 
Age, gender and ethnicity of the study population 
The mean age for the population (n=972) ranged from 18 to 85 years (Mdn = 50, IQR = 35-65) and it 
was not distributed normally (p<0.01), with skewness of -.02 (SE = .07) and kurtosis of -1.03 (SE = .15). 
The most prevalent group was the age ranging between 34 to 50 years followed by 51 to 60 years. The 
sample was predominantly female (67.7%), compared to 32.3% males; the females had a slightly lower 
mean age. Female age ranged from 18 to 83 years (Mdn = 50, IQR = 34-65) and was not distributed 
normally (p<0.01), with skewness of .01 (SE = .09) and kurtosis of -1.06 (SE = .19).  The age for males 
ranged from 18 to 85 years (Mdn = 51, IQR = 38-66) and was also not distributed normally (p=0.03), 
with skewness of -.08 (SE = .13) and kurtosis of -.93 (SE = .27). There was no significant difference 
between the ages of males and females; the Mann-Whitney U (MWU) test was used: males (Mdn = 
51.5, n = 314) and females (Mdn = 49.5, n = 658), U = 98029, z = -1.28, p = .197, r = -.04 (Appendix 
4.1Ac). Ethnic analysis showed that there were 829 (85.3%) Caucasians and the remaining 143 (14.7%) 




gender, the Caucasian population could be further divided into 573 (64%) females and 256 (28.6%) 
males. Similarly, there were 85 (59.4%) females and 58 (40.5%) males in the SA group. Out of the SA 
population, 64 (44.7%) identified themselves as Hindu, 42 (30.6%) as Sikh and 37 (25.8%) as Muslim. 
The table below shows the breakdown of the entire study population from the database (Table No 13)  
 
Table 13: Characteristics of the entire study population from the CD database. 
 Gender P Value 
 Total (n=972)         Male   (n=314)                            Female (n=658)  
Median Age (IQR) 50.0 (35-65) 51 (38-66) 50 (34-65) 0.19** 
Age Groups    0.05*** 
   < 20 years 38 (3.9%) 11 (3.5%) 27 (4.1%)  
   21-30 years 138 (14.2%) 39 (12.4%) 99 (15%)  
   31-40 years 131 (13.5%) 40 (12.7%) 91 (13.8%)  
   41-50 years 183 (18.8%) 62 (19.7%) 121 (18.4%)  
    51-60 years 181 (18.6%) 62 (19.7%) 119 (18.1%)  
    61-70 years 155 (15.9%) 49 (15.6%) 106 (16.1%)  
     > 70 years 146 (15%) 51 (16.2%) 95 (14.4%)  
Ethnicity    0.02*** 
     White Caucasians 829 (85.3%) 256 (81.5%) 573 (87.7%)  
      South Asians  43 (14.7%) 58 (18.5%) 85 (12.9%)  
Ethnic groups    <0.01*** 
              Sikh 42 (4.3%) 24 (7.6%) 18 (2.7%)  
              Muslim 37 (3.8%) 13 (4.1%) 24 (3.6%)  
              Hindu 64 (6.6%) 21 (6.7%) 43 (6.5%)  
*IQR Interquartile range **MWU test ***Chi Square test 
The Table above shows that there were significant differences between genders in terms of ethnicity 
and age groups, but there was no significant difference between the median ages of males and females 
(Appendices 4.1Aa-f).  
Return rate of questionnaire 
A total of 375 completed questionnaires were received, which gives a RR of 38.6%. None of the 
questionnaires was left blank and the information was legible. Out of 375 completed questionnaires, 63 




sections. For simplicity, the entire population was divided into questionnaire responders (n=375), who 
will make up the study population, and non-responders (n=597).   
Age of the study population 
The mean age for those who returned the questionnaire (n=375) ranged from 18 to 85 years (Mdn = 50, 
IQR= 33-60) and was not distributed normally (p<0.01), with skewness of .01 (SE = .12) and kurtosis of 
-.91 (SE = .25). The age of non-responders (n=597) ranged from 18 to 83 years (Mdn = 51, IQR= 37-
67) and was not distributed normally (p<0.01), with skewness of -.04 (SE = .10) and kurtosis of -1.10 
(SE = .20). The most prevalent responder age group was 41 to 50 years of age (19%), whereas among 
non-responders this was 51 to 61 years (24%).  There was a significant difference between the ages of 
responders (Mdn = 50, n = 375) and non-responders (Mdn = 51, n = 597), U = 100469, z = -2.69, p<0.01, 
r = -.17 (Appendix 4.1Bc). This result suggests that advancing age was linked to a lower RR for the 
questionnaire (Table 2).  
Ethnic diversity of the study population  
In the responder group (n=375), White Caucasian was the dominant ethnicity: 337 (90%) of the patients 
were White Caucasians and 38 (10%) were SA. Equally, in the non-responder group (n=597), White 
Caucasian was the dominant ethnicity: 492 (82.4%) of the patients were Caucasians and the remaining 
105 (17.6%) were SA. The SA population in the responder group (n=38) had two (5%) Sikh males and 
18 (47%) Sikh females. Similarly, the number of Muslim males was three (7%) and 6 (14%) were 
females. Additionally, the number of Hindu males was 5 (13%) and females was 4 (10.5%). The SA in 
the non-responders group were further divided into sub-groups and it showed that 20 (52.6%) identified 
themselves as Sikh, 9 (23.6%) as Hindu and 9 (23.6%) as Muslim. Chi-square for independence 
indicated that there was a significant association between ethnicity and questionnaire RR, χ2 (1, n=972) 
= 10.201, p<0.01, phi = -.102 (Appendix 4.1Be). The data revealed that White ethnic patients (40.7%) 
had a higher completion rate than patients of South Asian ethnicity (26.6%). 
Gender of the study population 
Out of 375 responders, 267 (71.2%) were females and the remaining 108 (28.8%) were male. From an 
ethnic point of view, of the 337 Caucasians who responded, 239 (70.9%) were female and 98 (29.1%) 




males (26.3%). The completion rate for the female group was 40.5% and that of the male group was 
34.3% (a trend towards a significant association p=0.06; Table No 14). (Appendices. 4.1Ba-f). 
Table 14: Characteristics of the study population from the CD database. 
 Response status  
Variables N (Total) Responders  Non-responders  P 
Value 
 972 375 (38.6%) 597 (61.4%)  
Median Age (IQR) 50 (35-65) 50 (33-60) 51 (37-67) <0.01* 
Age Groups    <0.01** 
 < 20 years 38 (3.9%) 24 (6.4%) 14 (2.3%)  
 21-30 years 138 (14.2%) 59 (15.7%) 79 (13.2%)  
 30-40 years 131 (13.5%) 42 (11.2%) 89 (14.9%)  
 41-50 years 183 (18.8%) 69 (18.4%) 114 (18.4%)  
 51-60 years 181 (18.6%) 91 (24.3%) 90 (15.1%)  
 61-70 years 155 (15.9%) 48 (12.8%) 107 (17.9%)  
> 70 years 146 (15%) 42 (11.2%) 104 (17.4%)  
Gender    0.06** 
  Male 314 (32.2%) 108 (28.8%) 206 (34.5%)  
  Female 658 (67.7%) 267 (71.2) 391 (65.5%)  
Ethnicity    <0.01** 
  White Caucasians 829 (85.3%) 337 (89.9%) 492 (82.4%)  
  South Asians 143 (14.7%) 38 (10.1%) 105 (17.6%)  
Ethnic groups     
   Sikh 42 (4.3%) 20 (5.3%) 22 (3.7%)  
   Muslim 37 (3.8%) 9 (2.4%) 28 (4.7%)  
   Hindu 64 (6.6%) 9 (2.4%) 55 (9.2%)  
*MWU test **Chi Square test 
 
Dietary preferences, health problems in childhood and age at diagnosis: 
Of the 375 participants who returned the questionnaire, 15 (4%) were vegetarian and the rest were non-
vegetarian. There was a dominance of Asians patients in the vegetarian category 11/15 (73%); seven 
were Hindus and four were Sikhs. Only four Caucasians reported being vegetarian. None of the Muslim 




related health problem and the majority of them (66.6%) were female, however a χ2 analysis revealed 
no difference between males and females (1, n=375) = 1.035, p=.30, phi = -.053) (Appendix 4.1Cb). 
Similarly, age at diagnosis was explored and the majority of patients (26%) were diagnosed between 
ages 18 -30 and there was a female predominance (79%) in this group. Additionally, a second peak is 
observed between ages 51-60 with a male majority (30.6%). (Appendices 4.1Ca-c) 
Symptoms at diagnosis and types of coelaic disease 
The most common symptom at diagnosis was fatigue (61.6%), followed by stomach pain (55.5%), 
bloating (38.8%) and diarrhoea (35%). The symptoms are shown in the Table below (Figure No 8).  
 
Figure 8: Symptoms of CD reported at diagnosis.  
Fatigue, bloating and diarrhoea were the most common symptoms in females; among males the most 
common symptoms were fatigue and weight loss. Stomach pain, hair loss and fatigue were the most 
common symptoms among Asians. Symptoms were further analysed according to the gender and the 
difference was significant between male and females when reporting fatigue (1, n=375) = 6.09, p=.014, 
phi = -.12) (Appendix 4.1CD1) and nausea (1, n=375) = 5.42, p=.02, phi = -.12) (Appendix 4.1Cd8). This 



































Table 15: Number of participants reporting CD symptoms at diagnosis split by ethnicity and gender (% of total (n=375) count).  
                    Ethnicity                         Gender 
Category  White (n=337) Asian (n=38) p  Male (n=108) Female (n=267) p 
Childhood symptoms 73 (19.5%) 8 (2.1%) 0.931  27 (7.2%) 54 (14.4%) 0.30 
Fatigue 211 (56.3%) 20 (5.3%) 0.23  
56 (14.9%) 175 (46.7%) 0.01 
Hair loss 24 (6.4%) 0 (-- %) 0.08  
6 (1.6%) 18 (4.8%) 0.65 
Stomach pain 157 (41.9%) 10 (2.7%) 0.01  
45 (12%) 122 (32.5%) 0.47 
Bloating 128 (34.1%) 18 (4.8%) 0.26  
38 (10%) 108(29%) 0.34 
Skin rash 24 (6.4%) 3 (0.8%) 0.86  
6 (1.6%) 21 (5.6%) 0.43 
Poor appetite 22 (5.9%) 2 (0.5%) 0.76  
7 (1.9%) 17 (4.5%) 0.96 
Diarrhoea 119 (31.7%) 9 (2.4%) 0.15  
32 (8.5%) 96 (25.6%) 0.24 
Nausea 44 (11.7%) 4 (1%) 0.65  
7 (1.9%) 141 (11%) 0.02 
Vomiting 15 (4%) 5 (1.3%) 0.02  
4 (1%) 16 (4.3%) 0.37 
Aphthous ulcers 15 (4%) 2 (0.5%) 0.82  
4 (1%) 13 (3.5%) 0.62 
Weight loss 92 (24%) 6 (1.6%) 0.12  
26 (6.9%) 72 (19.2%) 0.56 
Family history 16 (4.3%) 2 (0.5%) 0.88  
5 (1.3%) 13 (3.5%) 0.92 
Joint pain 16 (4.3%) 2 (0.5%) 0.88  4 (1%) 14 (3.7%) 0.52 
Difficulty walking 15 (4%) 1 (0.3%) 0.59  
3 (0.8%) 13 (3.5%) 0.36 
 
The largest group of patients (28.5%) was diagnosed between 6 to 12 months after the appearance of 
symptoms. A minority of the patients (3.4%) never had any symptoms and were placed in the “No 
symptom” group. A Pearson chi-square for independence indicated no significant association between 
gender and time taken to diagnose, χ2 (1, n=375) =.718, p=.94, phi = -.044 (Appendix 4.1Cf). Nor was 




phi = .143 (Appendix 4.1Cf). It is thus concluded that time taken to diagnose CD was not biased by 
either gender or ethnicity.  
The presentation of CD was further categorised based on the presence of typical classical, non-classical 
or atypical symptomatology; patients were divided into three groups, termed as: “Classical”, “Non-
Classical” and “Subclinical” disease respectively. There was female predominance in all groups. Sixty 
percent of participants in the Non-Classical group were female, 35% in the Classical and 4.5% in the 

















Appointment with hospital physician and dietitian 
 
Clinical appointment with hospital doctor 
Among the responders (n=375) a clear majority (80% (n=303)) of the patients reported having received 
information about the diagnosis. Similarly, 335 (89%) reported that they were advised to follow a GFD 
and 345 (92%) of them were referred to a dietitian. Eighty five patients (23%) wrote comments in the 
“other” section and these responses had 4 main themes. Firstly, 40 out of 85 (47%) were praising the 
clinical service. Secondly, 16 (19%) were referring to appointment delay, cancellation and waiting time 
in the hospital. Thirdly, 20 patients (34%) commented regarding access to the clinic such as: hospital 
parking, lack of directions to the clinic and lack of flexibility for clinical appointments. Nine participants 
made miscellaneous comments which were not relevant to the question. Overall dissatisfaction with 
clinician service was 4% (n=18). Multiple reasons were given by Caucasians to account for 
dissatisfaction and there was no main theme. They included: poor explanation by the doctor (7), no 
chance was given for questions at the end of the clinical session (7), the session was rushed (10), use 
of medical jargon (3), poor eye contact (7) and doctor was writing and ignored my questions (6). Asian 
patients on the other hand reported no dissatisfaction with the service at all (Appendices 4.1Da-g). 
Clinical appointment with hospital dietitian 
All patients answered the question related to the information given by the dietitian. The majority agreed 
that an information pack containing a diet sheet, food list and starter pack was provided. Satisfaction 
with the dietitian was 92% (n=345) and all of those who were dissatisfied were Caucasian. Only 15 
participants entered comments and there were 2 main themes. 6 patients wanted another session with 
the dietitian and 3 pointed out that a local website from the hospital could help to resolve their issue. 
158 patients (87%) recognized the role of the dietitian in the management of CD. The table below 








Table 16: Comparison of appointments with dietitian and doctor. 
 Gender  Ethnicity  
 Male  n=108  Female n=267  P  White n=337  Asian n=38  P  
Clinical appointment with Clinician       
       Explained what CD was 93 (86%) 210 (78%) 0.09 269 (80%) 34 (89%) 0.15 
      Told me to follow a GFD 99 (92%) 236 (88%) 0.35 302 (87%) 33 (87%) 0.60 
      Referred me to a dietitian 103 (95%) 242 (91%) 0.35 309 (92%) 36 (95%) 0.51 
      Arranged a follow up 90 (83%) 222 (83%) 0.96 227 (88%) 35 (92%) 0.12 
      Gave me information about CD   94 (87%) 224 (84%) 0.44 286 (85%) 32 (84%) 0.91 
       Satisfaction with the information 105 (97%) 252 (94%) 0.24 320 (95%) 37 (97%) 0.50 
Appointment with dietitian       
      Explained the diagnosis and GFD 103 (95%) 242 (91%) 0.12 309 (92%) 36 (93%) 0.51 
      Discussed GFD 100 (93%) 250 (94%) 0.71 312 (93%) 38 (100%) 0.08 
      Discussed Coeliac Society UK 102 (94%) 250 (94%) 0.76 314 (93%) 38 (100%) 0.09 
      Information pack provided 101 (93%) 255 (95%) 0.42 318 (94%) 38 (100%) 0.13 
      Discussed prescription of GFP 98 (91%) 243 (91%) 0.93 303 (89%) 38 (100%) 0.04 
      Arranged a follow up 94 (87%) 232 (86%) 0.97 288 (85%) 38 (100%) 0.01 
      Contact number given 91 (84%) 221 (83%) 0.72 275 (82%) 37 (97%) 0.01 
      Does dietitian have a role in CD   98 (91%) 229 (86%) 0.49 289 (85%) 38 (100%) 0.01 
      Satisfaction with the information 101 (93%) 244 (91%) 0.19 307 (89%) 38 (100%) 0.05 
Data displayed here are returners who answered yes to the questions 
 
Significant differences were noted in the perceptions of Asians and Caucasians in relation to the dietitian 
appointment. For example, Asians were more informed in relation to: prescriptions, arrangement of FU, 







CD from the patient’s perspective and adherence to a GFD 
All patients who returned the questionnaire (n=375) provided information about adherence to a GFD. 
They were divided into two groups: adherent and non-adherent. In the adherent group, which showed 
complete abstinence from gluten, there were 228 (60.8%) patients and the remaining 39.2% were non 
adherent based on the frequency of ingestion of gluten (monthly, weekly or daily) in their diet. They were 
further divided into 3 main categories: mild non-adherence, moderate and severe non-adherence groups 
who ingested gluten: once a month, once a week and daily respectively. The relative frequencies of 
each group are shown below in the bar chart (Figure No 9).  
 
 
In the adherent group (n=228) there were 63 males (27%) and 165 females (73%). Similarly, the non-
adherent group contained 45 males (30%) and 102 females (70%). A Pearson chi-square for 
independence indicated no significant association between gender and dietary adherence, χ2 (1, n=375) 
=.387, p=.53, phi = -.032. It is noteworthy that all those in the severely non-adherent group were female 
(n=8) (Appendix 4.1Ea). Based on ethnicity, in the absolutely adherent group (n=228) there were 206 
(90%) Caucasians and 22 (10%) SA and a Pearson chi-square for independence indicated no significant 
association between ethnicity and dietary adherence, χ2 (1, n=375) =.150, p=.69, phi = -.020 (Appendix 
 




4.1Eb). The ages of patients who were absolutely adherent to a GFD (n=228) ranged from 18 to 82 
years; data was not distributed normally (p<0.01), with skewness of -.03 (SE = .12) and kurtosis of -.96 
(SE = .32).  In both the adherent (23.8%) and non-adherent groups (24%) the most prevalent age-group 
was between 51 and 60 years of age.  The ages of the adherent group (Mdn = 51, n = 228) were not 
significantly greater than those of the non-adherent group (Mdn = 51, n = 147), as indicated by the MWU 
test, U = 15911, z = -.827, p = .40, r = -.04 patients. The results of the demographics have been 
summarised in the Table below (Table No 17) (Appendix 4.1Ec1). 
 
Table 17: Table 6: Comparison of adherent (absolute) and non-adherent groups. 
 Adherence to a GFD  
Variables N (Total) Adherent  Non-adherent  P Value 
 375 228 (60.8%) 147 (39.2%)  
Median Age (IQR) 50  (33-60) 51  (33-61) 48  (33-59) 0.40* 
Age Groups     
 < 20 years 24 (6.4%) 12 (5.3%) 12 (8.2%)  
 21-30 years 59 (15.7%) 37 (16.2%) 22 (15%)  
 30-40 years 42 (11.2%) 25 (11%) 17 (11.6%)  
 41-50 years 69 (18.4%) 39 (17.14%) 30 (20.4%)  
 51-60 years 91 (24.3%) 56 (24.6%) 35 (23.8%)  
 61-70 years 48 (12.8%) 34 (14.9%) 14 (9.5%)  
> 70 years 42 (11.2%) 25 (11%) 17 (11.6%)  
Gender    0.53** 
  Male 314 (32.2%) 108 (28.8%) 45 (30.6%)  
  Female 658 (67.7%) 267 (71.2%) 102 (69.4%)  
Ethnicity    0.69** 
  White Caucasians 337 (89.9%) 206 (90.4%) 131 (89.1%)  
  South Asians 38 (10.1%) 22 (9.6%) 16 (10.9%)  
   Sikh 20 (5.3%) 11 (4.8%) 9 (6.1%)  
   Muslim 9 (2.4%) 6 (2.6%) 3 (2%)  
   Hindu 9 (2.4%) 5 (2.2%) 4 (2.7%)  





In summary, the adherence rate to a GFD is 60.8% and it is not affected by advancing age, ethnicity or 
gender.  
Difficulties faced in following a GFD and symptoms post gluten ingestion 
Patients experienced difficulty in adhering to a GFD. For example, 301 (80%) agreed with the statement 
‘gluten free products (GFP) were expensive’ and 284 (76%) were not happy with the amount of GFF 
their GP was prescribing for them.  Of the 278 (74%) patients who were able to get GFP on prescription, 
only 218 (58%) agreed that they were getting sufficient. Additionally, several statements in the 
questioannire were analysed in relation to adherence to a GFD. Prescription of gluten free product on 
prescription was associated significantly with adherence to a GFD: χ2 (1, n=375) =16.8, p <0.01, phi = 
.21 (Appendix 4.1Fa). Additionally, understanding of gluten free food (χ2 (1, n=375) =6.49, p =0.01, phi 
= -.13 (Appendix 4.1Fa), amount of GFP on prescription (χ2 (1, n=375) =5.69, p <0.01, phi = -.12 
(Appendix 4.1Fc) and understanding of food labelling (χ2 (1, n=375) =20.29, p <0.01, phi = -.23 
(Appendix 4.1Fe) were also associated with adherence to a GFD. It means that those who were 
receiving either no or less GFP from the GP, those who were not able to understand food labelling and 
those who did not know which food to eat were significantly less adherent to a GFD (Appendices 4.1Fa-
g). These statements were also analysed according to gender and ethnicity and the results are displayed 




Table 18: Difficulties reported by patients not adhering to the gluten free diet (n=147) comparing ethnicity and gender  














Yes No Yes No P* Yes No Yes No P*  Yes No Yes No P* 
1 186 (82%) 42 (18%) 92 (63%)   55 (37%) <0.01 82 (76%) 26 (24%) 196 (73%) 71 (27%) 0.64  34 (89%) 4 (11%) 244 (72%) 93 (28%) 0.02 
2 19 (9%) 209 (91%) 25 (17%) 122 (83%) 0.01 9 (8%) 99 (92%) 35 (13%) 232 (87%) 0.19  29 (76%) 9 (24%) 15 (4%) 322 (96%) <0.01 
3 14 (6%) 214 (94%) 12(8%) 135 (92%) 0.45 4 (4%) 104 (96%) 22 (8%) 245 (92%) 0.11  1 (3%) 37(97%) 25 (7%) 312(93%) 0.27 
4 163 (71%) 65 (29%) 121 (82%) 26 (18%) 0.01 83 (77%) 25 (23%) 201 (75%) 66 (25%) 0.74  36 (95%) 2 (5%) 248 (74%) 89 (26%) 0.04 
5 8 (4%) 220 (96%) 26 (17%) 122 (83%) <0.01 12 (11%) 96 (89%) 21 (8%) 246 (92%) 0.31  20(53%) 18 (47%) 13 (9%) 324 (91%) <0.01 
6 189 (83%) 39(17%) 112 (76%) 35 (24%) 0.11 82 (76%) 26 (24%) 219 (82%) 48 (18%) 0.17  37(97%) 1 (3%) 264 (78%) 73 (22%) 0.05 
7 130 (57%) 98 (43%) 93 (63%) 54 (37%) 0.22 63 (58%) 45 (42%) 160 (60%) 107 (40%) 0.77  31 (82%) 7 (18%) 192(57%) 145 (43%) 0.03 
*Chi Square test. Numbers on the left represent statements: Statement 1: Do you get GF food on prescription, Statement 2: I don’t understand what to eat, Statement 3; I don’t have time to prepare meal, 
Statement 4: My GP does not prescribe enough GFP Statement 5:  I don’t understand food labelling Statement 6: GF diet is expensive Statement 7: GF diet is unpleasant 
 




It is clear from the table above that there are significant differences between South Asians and white 
Caucasians in response to all statements except “I don’t have time to prepare meals”.   Symptoms post 
gluten ingestion were explored next and out of the 147 non-adherent patients, only 87 reported 
symptoms on introducing gluten. Abdominal pain was reported by 72 (19%), fatigue by 73 (19%) and 
diarrhoea by 42 (14.4%). (Appendix 4.1I) 
Membership of the Coeliac Society and availability of GFP on prescription 
The question about the CS was completed by all participants. Although 352 (93%) responded that they 
were told about the CS in their consultation with the dietitian, only 202 (53) joined the CS (186 
Caucasians and 16 Asians; Chi Square test p= 0.125). Those who were not members of the CS (n=173) 
had variable reasons. Eighty three participants (48%) reported they did not feel it was important to be a 
member of the CS, whereas 53 patients (38.6%) cited other reasons such as: expense related to 
membership, confidentiality issues, fear that their address might be used for junk mail and others stated 
that they would think about it. Membership of Coelaic UK was strongly associated with better adherence 
to a GFD (χ2 (1, n=375) =15.4, p <0.01, phi = .20 (Appendix 4.1Ih).   
Adherence was further analysed by entering it into Binary Logistic regression. Presence (1) or absence 
(0) of adherence was entered for different variables such as:  membership of the CS, understanding of 
food labelling, affordability of GFP, obtaining GFP on prescription and obtaining enough GFP on 
prescription. This generated an OR and p values for individual factors. Results are summarised in Table 











Table 19: Combined results of the 2X2 Contingency table and χ2 test in comparison of different factors.   
 Responders (n=375)     
Different factors/ Statements which may be 
related to non-adherence to a GFD  
Adherent %      Non-adherent %     
Yes No Yes No  OR 95% CI p Value 
Are you a member of the Coeliac Society 32 28.8 12.5 26.7  2.09 1.33 - 3.7 <0.01 
GFD is unpleasant  34.4 26.1 24.8 14.4  0.92 0.5 - 1.4  0.74 
GFD is expensive   50.4 10.4 29.9 9.3  1.74 0.9 – 3.0 0.05 
I don’t understand what I can eat  5.1 55.7 6.7 32.5  0.77 0.3 - 1.6 0.50 
I don’t understand food labelling 2.1 58.7 6.7 32.5  0.22 0.9 - .56  <0.01 
Dietitian gave me information pack 57.3 3.5 37.6 1.6  1.04 0.2 – 3.6 0.94 
Contact telephone given by dietitian 48.3 12.5 34.9 4.3  0.37 0.1 – 0.8 0.02 
OR: Odds ratio, CI: Confidence Interval 
 
Factors achieving significance were: membership of the CS (p<0.01), understanding what to eat 
(p=0.05), affordability of GFP (p=0.05), contact information given to the patient (p=0.02) and 










GFD adherence as assessed by CDAT questionnaire  
CDAT scores from all 375 participants were calculated from the cumulative scores of individual 
components; based on that, patients were divided into two groups namely: adherent to GFD (CDAT 
<13) and non-adherent to GFD (CDAT>13). CDAT scores for the entire population (n=375) ranged from 
7 to 30 (Med= 13, IQR= 10-19) and were not distributed normally (p<0.01), with skewness of .65 (SE = 
.21) and kurtosis of -.32 (SE = .25). There was no significant relationship of increasing score with gender 
and ethnicity (Appendix 4.1Kc&d).  
The most prevalent score was 9 (n=35), followed by 12 and 7 (n=32). Wilcoxon Signed rank test showed 
that there was a significant relationship between CDAT score and increasing age; (n=375), z=-16.6, 
p<0.01, r= -.8 (Appendix 4.1Ke). Individual scores against the number of patients are presented in the 













Table 20 : CDAT score of the population (n=375). Line shows the cut-off point of the 
adherent (to the left CDAT score <13) and the non-adherent groups. IQR=Interquartile 
range. 
 




Males and females had similar CDAT scores (Mdn=13, n = 108 and Mdn=13, = 267 respectively); MWU, 
U = 14293.5, z = -.131, p = .896, r=-.00. Similarly, there was no relationship between ethnicity and 
increasing CDAT score (Appendix 4.1Kc&d). The adherent and non-adherent groups are further 
compared according to CDAT scores in the table below (Table No 21).  
Table 21: Comparison of adherent and non-adherent patients based on CDAT score. 
 CDAT Score  
Variables Total CDAT <13 CDAT >13  P Value 
 375 n=171 (45.6%) n=204 (54.4%)  
Median Age (IQR) 50 (33-60) 53 (33-63) 47 (32-58) 0.04* 
Age Groups    0.08** 
 < 20 years 24 (6.4%) 10 (5.8%) 14 (6.9%)  
 21-30 years 59 (15.7%) 26 (15.2%) 33 (16.2%)  
 30-40 years 42 (11.2%) 14 (8.2%) 29 (13.7%)  
 41-50 years 69 (18.4%) 27 (15.8%) 42 (2.6%)  
 51-60 years 91 (24.3%) 43 (25.1%) 48 (23.5%)  
 61-70 years 48 (12.8%) 31 (18.1%) 17 (8.3%)  
> 70 years 42 (11.2%) 20 (117%) 22(10.8%)  
Gender    0.45** 
  Male 108 (28.8%) 46 (27%) 62 (30.4%)  
  Female 267 (71.2%) 125 (73%) 142 (69.6%)  
Ethnicity    0.25** 
  White Caucasians 337 (89.9%) 157 (92%) 180 (88%)  
  South Asians 38 (10.1%) 14 (8%) 24 (12%)  
   Sikh 20 (5.3%) 6 (3.5%) 14 (6.9%)  
   Muslim 9 (2.4%) 4 (2.3%) 5 (2.5%)  
   Hindu 9 (2.4%) 4 (2.3%) 5 (2.5%)  
*WRS test **Chi Square test, IQR= Interquartile range 
 
It is evident from the table above that gender and ethnicity are not significantly associated with 
adherence based on CDAT score dichotomised at CDAT score of 13, whereas age is associated with 
better adherence; CDAT<13 (Mdn=53, n = 171) and CDAT>13 (Mdn=47 , n=204), U = 15328, z = -2.02, 
p = .04, r=-.10 (Appendix 4.1Lc-e).   




Several factors were analysed between adherent (CDAT<13) and non-adherent (CDAT<13) groups and 
among them “Do you get GF food  on prescription”, “I don’t understand what to eat”, “I don’t understand 
food labelling”, “GF diet is unpleasant” and “Membership of Coeliac UK”  were significantly associated 
with CDAT score  of  less than 13. The results are displayed in the Table below (Table No 22) 
(Appendices 4.1Ma-h) 
 
Table 22: Factors associated with low CDAT scores. 
Variables CDAT <13 (n=204) CDAT >13 (n=171)     
 Yes No  Yes No  χ2 Phi  P* Value 
Do you get GF food on prescription 139 (81%) 32 (19%)  139 (32%) 65 (68%)  8.8 .15 <0.01 
I don’t understand what to eat 157 (92%) 14 (8%)  174 (85%) 30 (15%)  3.81 -.10 0.05 
I don’t have time to prepare a meal 162 (95%) 9 (5%)  187 (92%) 17 (8%)  1.35 -.06 0.24 
My GP does not prescribe enough 
GFP  
165 (96%) 6 (4%)  177 (87%) 27 (13%)  .71 -.04 0.39 
I don’t understand food labelling   165 (96%) 6 (4%)  177 (87%) 27 (13%)  10.96 -.17 <0.01 
GF diet is expensive 136 (80%) 35 (20%)  165 (81%) 39 (19%)  .10 -.01 0.74 
GF diet is unpleasant 90 (53%) 81 (47%)  133 (65%) 71 (35%)  6.09 -.12 0.01 
Membership of Coeliac UK 89 (52%) 82 (48%)  126 (62%) 78 (38%)  7.18 .13 <0.01 
*Chi Square test 
It may be noted that these results are in agreement with the results generated from the binary logistic 
regression for the Butterworth questionnaire (Table No 19, page 93) in relation to membership of Coeliac 
UK and “I don’t understand food labelling.”   
CDAT score was a combination of several statements categorised as: symptoms, social, psychological 
and gluten exposure. The most prevalent answer was low energy (70%), followed by reports of 
difficulties while dining out (69%). Similarly the mean score for low energy was the highest (1.9) followed 
by difficulties dining out. The mean score for those who ate gluten on purpose was 0.1 and this was the 
lowest. The results of median scores of individual components of CDAT are shown in the Table below 
(Table No 23).   




Table 23: Comparing CDAT sub score of the responders (n=375) based on gender and ethnicity. 
  Gender  Ethnicity  
 Total Male Female  White Asians  
 375 108 (32.2%) 267 (67.8%)  337 (89.9%) 38 (10.1%)  
Statements in CDAT Score Mdn (IQR) Mdn (IQR) Mdn (IQR) p Mdn (IQR) Mdn (IQR) P* 
Symptoms of CD        
    Low energy? 2 (1-3) 2 (1-3) 2 (1-4) 0.02 2 (1-3) 2 (1-3) 0.91 
    Headache 2 (1-3) 1 (1-3) 2 (1-3) 0.01 2 (1-3) 2 (1-3) 0.75 
Social Issue        
    Follow GFD while dining out? 2 (1-4) 2 (1-4) 2 (1-3) 0.32 2 (1-4) 2 (1-4) 0.80 
Psychological        
    Consider the consequences 2 (1-2) 2 (1-3) 2 (1-2) 0.30 2 (1-2) 2 (1-2) 0.16 
    Don’t consider myself a failure 1 (1-2) 1 (1-3) 1 (1-2) 0.53 1 (1-2) 1 (1-3) 0.41 
Gluten Exposure        
   Accidental gluten exposure? 1 (1-3) 2 (1-3) 1 (1-3) 0.34 1 (1-2) 2 (1-4) 0.00 
    Eaten gluten on purpose? 1 (1-2) 1 (1-2) 1 (1-2) 0.72 1 (1-2) 1 (1-2) 0.77 
Overall CDAT score 13 (10-19) 13 (9-19) 13 (10-18) 0.89 13 (10-18) 13 (10-19) 0.28 
*MWU test, IQR= Interquartile range, Mdn= Median value 
It is evident in the table above that there is no difference in total CDAT score based on ethnicity and 
gender, but sub-group females were significantly more symptomatic as compared to males. Further 
analysis of the individual statements showed SA reported significantly more accidental ingestion as 
compared to White Caucasians (Appendix 4.1N a & b).   
The individual domains (symptomatic, social, psychological and gluten exposure) were compared and 
the non-adherent group had universally increased mean scores. This is displayed in the Table below 
(Table No 24) (Appendix 1.4O)   
 
 




Table 24: Comparison of adherent and non-adherent patients based on CDAT score. 
 CDAT Score  
Variables N (Total) CDAT <13 CDAT >13  P Value* 
 375 171 (45.6%) 204 (54.4%)  
 Median (IQR) Median (IQR) Median (IQR)  
Symptoms of CD     
    Low energy? 2 (1-3) 2 (1-2) 3 (2-4) 0.00 
    Headache 2 (1-3) 1 (1-2) 3 (2-4) 0.00 
Social Issue     
    Follow GFD while dining out? 2 (1-4) 1 (1-2) 3 (2-4) 0.00 
Psychological     
    Consider the consequences 2 (1-2) 1 (1-2) 2 (1-3) 0.00 
    Don’t consider myself a failure 1 (1-2) 1 (1-1) 2 (1-3) 0.00 
Gluten Exposure     
   Accidental gluten exposures? 1 (1-3) 1 (1-1) 2 (1-3) 0.00 
    Eaten gluten on purpose? 1 (1-2) 1 (1-1) 2 (1-3) 0.00 
Overall CDAT score 13 (10-19) 9  (8-11) 18 (15-21) 0.00 
*MWU test, IQR= Interquartile range, Mdn= Median value 
 
Comparing adherence based on the CDAT and Butterworth criteria 
The questionnaires described above use different criteria to categorise a patient as adherent or non-
adherent. Butterworth and colleagues (2004) for example use ingestion of gluten (any amount), whereas 
Leffler and colleagues (2009) use CDAT score of >13 as non-adherent to a GFD. Although the Leffler 
questionnaire also has one statement about ingestion of gluten, it relies on several other categories in 
addition to that. The two questionnaires will now be compared, to evaluate their sensitivity for detecting 
non adherent patients. Using the strict Butterworth criterion, 147 (39.2%) were non-adherent; in contrast, 
using the Leffler criterion, 204 (54%) were non-adherent out of 375 responders. This means that the 
Leffler questionnaire detected an extra 57 (14.8%) patients who were non-adherent to a GFD. When 
this was further compared it was evident that 11 patients who were non-adherent according to 
Butterworth were adherent according to Leffler. Similarly, 68 patients who were adherent according to 
Butterworth were non-adherent according to Leffler. This is presented in the comparative graph below 
(Fig No 10)  














Next the sensitivity and specificity of the Butterworth questionnaire were calculated and are shown in 
the Table below (Table No 25). 
 Table 25: Diagnostic accuracy of the Butterworth questionnaire 
 Value 95% CI 
Parameters   
Sensitivity 93.96% 89.44% to 96.94% 
Specificity 75% 69.41% to 80.03% 
Positive Likelihood Ratio 3.76 3.05 to 4.63 
Negative Likelihood Ratio 0.08 0.05 to 0.14 
Positive predictive value  71.55% 67.11% to 75.61% 
Negative predictive value  94.88% 91.24% to 97.06% 
Accuracy  82.6% 78.79% to 85.97% 
 
Figure 10: Comparing Butterworth and Leffler adherence questionnaires. 
 




This shows that the Butterworth questionnaire is 6% less sensitive than the Leffler questionnaire for the 
purpose of detecting adherence rates in a given population. The sub-categories of the Butterworth 
method were further analysed according to Leffler adherence. The whisker chart below shows that all 
those who were non-adherent in the moderate (20.8%) and severe (4.5%) categories on the Butterworth 
criteria, were also non-adherent on Leffler score. The mild category had 84 (47.2%) patients and 8.6% 
(n=17) were adherent on the Leffler method. This is evident from the wide range of Leffler scores in this 





whisker chart above shows that the average total Leffler score increases as the severity of the non-
adherence increases. Furthermore, in the moderate and severe non-adherence groups, the Butterworth 
questionnaire has comparable sensitivity to the Leffler questionnaire, as all those who are non-adherent 
in the latter are non-adherent in the former; but in the mild group the data is not consistent between the 
questionnaires.  
 
Figure 11: Comparing  individual Butterworth categories and CDAT score 




Themes from participants’ comments 
Additional comments were received from 63 patients (16.8%), ranging from short phrases to descriptions 
related to different sections; they fell into five themes.  The predominant theme was related to 
inadvertent ingestion of gluten by 48 patients in different settings including: dining out in restaurants 
(n=40) or friends’ houses (n=20), or even accidentally buying GCP (n=6). Patients’ comments in relation 
to a GFD included: 
“Sometimes you find out late, too late, someone has fed you with a gluten containing stuff”, 
“Rarely, though, I may take gluten without any intention”, “…by mistake I do take gluten now and then” 
and “accidental ingestion, very rare though.” 
The second most common theme was change of address (n=11) or contact details (n=3), followed by 
the third most common theme: weight gain on a GFD (n=7).  
“Hate it!!! I have gained weight on gluten free stuff”, “I was so slim, on gluten free diet I have 
gained weight”, “well weight gain is a new issue with this gluten free diet” and “slight weight gain while 
on gluten free diet.” 
The fourth most common theme was related to the difficulty in obtaining GFF from Asian shops and 
takeaways, as the owners lacked awareness of GFP (n=6).  
“No gluten free diet in local stores”, “Sorry but cannot get gluten free diet from local stores, not sure if 
they even know what gluten free means!!” and “ Asian stores have no gluten free food items” 
The final category contained miscellaneous/unclassifiable comments (n=5) such as: difficulty following 
a GFD during a period of depression, redundancy related to CD symptoms, inability to find a priority 
toilet for diarrhoea related to CD and issues with the hospital menu during admission.  
 
 




Clinical correlation  
 
Clinical letters and computerised record analysis 
All 375 patients gave permission for their health records to be accessed. IDA was present at some stage 
in 216 (57.5%) patients. Autoimmune diseases were the next most commonly associated conditions, 
affecting 50 patients (13.3%), followed by depression which affected 47 patients (12%). The relative 
frequencies are displayed in the car chart below (Fig No 12) 
 
Figure 12: Disease frequency among CD patients. IDA=Iron deficiency anaemia, DH=dermatitis herpetiformis, CKD=Chronic 
kidney disease, IBD= iInflammatory bowel disease, IHD= Ischaemic heart disease.  
 
The diagnosis of depression was made on the basis of an assessment by a qualified psychiatrist; being 
on anti-depressants prescribed by the GP was not considered adequate for diagnosis. Frequencies of 
common health conditions are shown in the bar chart above. Since these records were extracted from 
patients’ clinical data and none of these tests was done as part of this study, only those parameters for 
which a full record was available were selected. The clinical conditions were compared for significance 
(χ2 test) in relation to adherence to a GFD, as determined by CDAT scores, and no significance 





















Table 26: Conditions in relation to GFD adherence as measured by CDAT in CD patients. 
Blood Parameter raised No of Patients χ2 Phi P Value 
Ischaemic heart disease 10 .00 -.001 .989 
Diabetes Type 1 5 .24 -.025 .623 
Diabetes Type 2 11 .06 -.013 .80 
Chronic Kidney Disease 4 .99 .051 .319 
Depression 24 .27 -.027 .597 
Inflammatory Bowel  5 .018 .007 .89 
Osteoporosis 25 1.239 .057 .538 
Autoimmune diseases 23 .050 .012 .823 
 
Haematological and biochemical parameters 
Analysis of laboratory values showed that certain haematological parameters were found to be raised.  
Among these, the liver function test Alanine Transferase (ALT) was raised in 10 patients (2.7%), Alkaline 
Phosphatase was raised in 20 patients (5.3%), whereas Bilirubin was raised in 24 (6.4%) patients. The 
Table below (Table No 27) shows the frequency of elevated blood test results amongst the patients 
(Appendix 41.Q) 
Table 27: Laboratory values in relation to CD patients (n=375). 
Blood Parameter raised No of Patients Percentage 
Alanine Transaminases (ALT) 10 2.7 
Bilirubin 24 6.4 
Alkaline Phosphatase 20 5.3 
White cell count (WCC) 9 2.4 
Mean Corpuscular Volume (MCV) 6 1.6 
C reactive proteins 34 9.1 
Platelets 59 15.7 




Next the clinical conditions were compared for significance (χ2 test) in relation to GFD adherence of the 
patients: no significant difference was found, as shown in the Table below (Table No 28).  
Table 28: Laboratory values in relation to CD patients.   
Blood Parameter  No of Patients χ2 Phi P Value 
Bilirubin 7 3.44 .096 .063 
Phosphate  6 1.36 -.060 .243 
Calcium  17 1.107 -.054 .293 
Magnesium 14 1.326 .059 .515 
White Cell Count 3 1.446 .062 .485 
MCV 120 1.232 .057 .540 
Neutrophil  8 1.336 .060 .513 
CRP  17 .096 -.016 .756 
Iron Deficiency  106 .528 -.038 .468 




















The “No Triticeae” study explored the demographics of CD in a Leicestershire population and specifically 
attempted to determine the adherence rate to a GFD by two different instruments, namely the 
questionnaires by Leffler and colleagues (2009) and Butterworth and colleagues (2004). Additionally, 
the study looked into the causes of non-adherence to a GFD and views on CD from patients’ 
perspectives, involving both Caucasians and SA patients. The study was a follow up to the MSc project 
by the author (Muhammad, 2013), with significantly larger power and additional collected data. In 
relation to the Index study by Butterworth et al., (2004) which used the same questionnaire, it was 
evident that the adherence to a GFD in this study (60.8%) was not significantly different from 
Butterworth’s finding (62%). There were, nonetheless, differences in the power, as we finally received 
375 completed questionnaires as compared to 87 questionnaires in Butterworth’s study (2004).  
 
Choice of methodology 
 
The study used a postal questionnaire survey to assess adherence to a GFD and aspects of quality of 
life in patients diagnosed with CD who were theoretically on a GFD. Such a study design offers several 
advantages such as: data related to all variables is collected simultaneously, it is time efficient, it offers 
analysis of multiple outcomes and exposures and may aid in measurement of prevalence. Moreover, 
there is no risk of “loss to follow-up” with such a methodology. The main drawbacks of such an approach, 
however, include: its dependence on RR, difficulty in making causal inferences and susceptibility to 
recall bias (Bland, 2015). Two questionnaires, using the postal service, were used to gather data in this 
study. Questionnaires are routinely used in social research (Brace, 2008) and it is a special kind of 
conversation where patients are engaged to collect information; it is also a common tool used by 
physicians (Kumar & Phrommathed, 2005) for this purpose.  The method itself demands structured 
methodology (Richardson, 2004) and ethical considerations (Evans et al., 2002) and these issues were 
addressed while conducting this study. Both of the questionnaires had been used in previous studies 
(Butterworth et al., 2004, Leffler et al., 2009) and the questionnaire by Leffler et al., (2009) had also 
been validated previously. Similarly, questionnaires have been used in CD research in relation to 
adherence to a GFD in many studies (Biagi et al., 2009, Butterworth et al., 2004, Rosen et al., 2011, 
Pietzak, 2005, Sainsbury et al., 2013b, Villafuerte‐Galvez et al., 2015, Rajpoot et al., 2015) with slightly 




different designs and questionnaire contents. Furthermore, such a mode of delivery was considered 
economical when analysed in comparison with other modes of delivery in a study (Sinclair et al., 2012). 
An on-line questionnaire was another available option, but access to individual email addresses was not 
available and, more importantly, the computer literacy of the population approached has not been 
studied, hence we decided against it. Additionally, a previous Leicestershire based study (n=466) did 
not find any significant difference in the non-response rate between online and paper based 
questionnaires (Denscombe, 2009), although it is accepted that the study population was different from 
that in our study. It is therefore felt that this study derived maximum advantage using the postal 
questionnaire approach, in terms of accessing a widely scattered population. 
Diagnoses of CD per year 
 
It is evident from this study that the number of patients diagnosed per year (from 2004 to 2014) increased 
over time. This may reflect an increasing trend of CD diagnosis at UHL. However, this must be 
interpreted with caution, as this apparent rise in the number of diagnoses of CD per year does not equate 
to the true incidence of CD, as it was not calculated for the whole population of Leicestershire (because 
of un-availability of data and not being an aim of this study). This finding, however, gives an indirect 
impression that there is an increasing incidence (hence prevalence) of CD in the Leicestershire area, 
which follows the previously defined trend of increasing epidemiological parameters for CD worldwide 
(Rewers, 2005, Murray et al., 2003b, Altobelli et al., 2014, Riddle et al., 2012, Rubio-Tapia et al., 2009, 
Lohi et al., 2007). Several reasons for this increased incidence have been cited in the literature, such 
as increased availability of sensitive serological tests and increased awareness among physicians to 
use these tests (Ludvigsson et al., 2013a), yet an environmental factor cannot be excluded (Riddle et 
al., 2012, Welander et al., 2010, Stene et al., 2006).  
The rate of diagnosis of CD at UHL will vary, depending on multiple factors. Firstly, not all patients had 
the diagnostic indication for D2 biopsies, as a proportion of them would have been diagnosed before 
2004 (the starting year of data collection) and will be having follow up biopsies. Secondly, the diagnosis 
of CD in a given population per year is dependent on the number of endoscopies performed in that 
period. This means that a falsely high number of CD cases may be diagnosed, if more endoscopies 
were performed in that particular year. Thirdly, pathologist related factors such as staff sickness and 
mandatory leave may also affect the numbers of slides reviewed per year in order to diagnose CD. 




Fourthly, the number of referrals made by General Practitioners (GP’s) per year will also affect the 
figures.  
It is thus suggested that these figures must be audited prospectively by taking into consideration all the 
factors to arrive at correct figures. This may be achieved by first collecting all available data and then 
analysing it to ascertain the cause; future projection of the number of patients with CD should be 
determined, so that healthcare budget allocation can be assigned judiciously. 
Study population and return rate  
 
The study population was all inclusive except for the paediatric age group (which was outside the scope 
of this research) and those who had learning difficulties. The SNOMED® database at UHL has 
information on over 2000 patients, but we only selected patients diagnosed between 2004 and 2014. 
Based on the MSc pilot study (Muhammad et al., 2013) and published data, this power (n=972) was 
considered sufficient to meet the study aims. The number of CD patients evaluated with questionnaires 
in other studies has been diverse depending on the research question (Leffler et al., 2007, Chauhan et 
al., 2010). Our index study reported data from 130 adults with CD (Butterworth et al., 2004).  
The combination of histological diagnosis of CD coupled with positive serology was chosen for increased 
sensitivity and specificity (Donaldson et al., 2008). This method has the disadvantage of missing that 
small number of patients who never had biopsy to diagnose CD, as they either had a contraindication 
for an endoscopic procedure or biopsy, or their diagnosis was established on clinical grounds coupled 
with serology (which has sensitivity and specificity of over 95% (Hill, 2005)). In addition to that, patients 
who were diagnosed with capsule endoscopy, which is an alternative (Rondonotti et al., 2007), although 
less sensitive (Rokkas & Niv, 2012) way of diagnosing CD, may also have been missed. The study thus 
approached the diagnosis from a very objective standpoint and in a way that provided the power needed 
to reach meaningful conclusions.  
 
Gender distribution of the sample and female predominance 
 
There was a female predominance in our study population, which reflected the previous trend of CD 
presentation in the general population (Murray et al., 2003a, Green et al., 2001). The ratio of female to 
male was 2:1 in this study and this figure is close to that in previous published research (Megiorni et al., 
2008). A recent US based study (n=982) reported an even higher ratio of 5.5:1 (Joelson et al., 2018a), 




but the diagnostic criteria in this study did not base the diagnosis entirely on duodenal biopsies. 
Historically, several studies have reported the ratio and it depends on the sample size and methodology, 
although it is accepted that all have reported female predominance in the samples and the cause for 
this finding remains obscure.  
Green et al (2001) reported a higher ratio of 2.9:1 for females based on a large sample (n=1,612) where 
75% had biopsy proven CD. However, the sample in this study came from a coeliac advocacy group 
which had a female predominance to begin with. Furthermore, the higher rate may well represent 
response bias, where females might have responded to the questionnaire more than males (Smith, 
2008, Rübsamen et al., 2017), thus leading to a higher ratio than our sample. Similarly Murray (2003b) 
analysed data between 1950 and 2001 in a US based study and reported a ratio of 2.4:1, which is close 
to our study and the strength of Murray’s study lies in its access to detailed data from the Rochester 
Epidemiology Project (REP, 2018) spanning over 50 years. Collin and colleagues (1994) reported a 
lower ratio of 0.34:1, but the sample selected came from symptomatic patients and there is a possibility 
that it had selection bias. There is therefore variability in the reports of female predominance in samples. 
Our study therefore follows the trend of the previous reports of increased numbers of females being 
diagnosed, but since studies done to ascertain the ratio between males and females are diverse in terms 
of methodology, sample selection, period of diagnosis and availability of diagnostic criteria, it is difficult 
to know if our study is reporting the true ratio. Despite these methodological differences, the question of 
whether this discrepancy in gender ratio is real is difficult to ascertain. There is also a suggestion that 
such a ratio disappears with advancing age (Fasano et al., 2003), although this study only used 
screening methods in the population in contrast to other holistic methodologies such as patients’ 
records, histological data and questionnaires.  
One may argue that there are gender differences in health related help-seeking behaviour (Oliver et al., 
2005) and there is evidence to suggest that females attend their GP more often  (Vedsted & Christensen, 
2005, Corney, 1990) than their male counterparts (Galdas et al., 2005) and this might have led to more 
female cases being identified, but the evidence presented in support of this argument is weak and based 
on low powered and possibly biased studies. Another possible explanation might well be the exclusive 
female consultations in relation to fertility, obstetric and gynaecological issues, which have a clear 
association with CD (Stazi & Mantovani, 2000). Linked to this concept is anaemia which again is a 
presenting sign of CD (Harper et al., 2007), is common in pregnancy (Goonewardene et al., 2012) and 




necessitates CD testing, thus skewing the diagnosed case burden in favour of one gender. Osteoporosis 
is another condition which is associated with CD (McFarlane et al., 1995) and is more common in the 
female gender ( O'neill et al., 1996); this may also increase the number of females in the sample. It is 
thus concluded that our sample is close to a representative ratio of 2:1.   
 
Response rate of the questionnaire 
 
The RR for this study was 38.6%, whereas the reported average RR with a questionnaire is 52% (Baruch 
& Holtom, 2008); RR will vary depending upon the target audience and distribution method (Ekhtiari et 
al., 2017). The variability in absolute RR ranges from 14% to 91% as assessed by a study (Cummings 
et al., 2001) and this is multifactorial (Richards, 2007, Edwards et al., 2009). 
Although it is not clear what is a minimally acceptable rate (Richardson, 2005), it has been suggested 
that rates above 80% are generally good, but rates between 40-80% are acceptable, as suggested by 
Gehlbach (Gehlbach, 1993). Similarly, Cummings and colleagues (2001) analysed studies looking into 
the RR to physician postal questionnaires spanning more than four decades. They inferred that, with 
passage of time, the RR has increased gradually and has reached a plateau. They concluded that, on 
average, RR was generally 62% for small to medium studies, but 52% for larger studies. Similarly, our 
index study (Butterworth et al., 2004), which used the same questionnaire, had a RR of 66.9%. Our MSc 
pilot project, using the same but contracted cohort, had a RR of 57.8% and, looking at the RR of this 
study, one can argue that it is close to the lower range of acceptability.  
The survey was mailed and took on board suggestions by Edwards and colleagues (2009) to increase 
the RR, however a decrease in the survey response was noted as compared to the MSc project 
(Muhammad et al., 2013). This may be explained by the length of the questionnaire, as this study in 
comparison to the MSc project was 60% longer. This question was examined by a study which 
concluded that longer questionnaires (more than seven pages) had RR closer to 40.5% (Iglesias & 
Torgerson, 2000) and this description matches our study in terms of length of questionnaire and the 
related RR of 38.5%.    
In addition to that, the MSc project (Muhammad, 2013) questionnaire could be finished in one sitting by 
patients, whereas this survey required the participants to provide a prospective diary of food intake for 
three consecutive days. This factor is important, as the diary RR was 15% in comparison to the 




questionnaire RR of 38.6%. It is thus inferred that length of questionnaire affects the RR as previously 
shown (Kalantar & Talley, 1999, Galesic & Bosnjak, 2009, Dillman et al., 1993). 
This study reports a low RR for patients of SA ethnicity and this finding was significant. This is in contrast 
to published literature about ethnicity affecting RR, as one systematic review did not find any difference 
(Sykes et al., 2010) in the RR for all non-white minorities and the results of this may not be generalised 
to SA communities in the UK. Sheldon and colleagues (2007) on the other hand found that RR was low 
for black and ethnic minorities, but this was in a report to NHS authorities and was poorly referenced. 
Similarly a Danish study reported the RR in such a population to be low (24%) in a recent study 
(Bodewes & Kunst, 2016). A UK based study (n=9,100), involving SA, reported a recruitment rate of 8% 
in a questionnaire based study (Malavige et al., 2015) which is very low. However the results need to 
be interpreted with caution, as the survey was related to sexual health and this is considered a social 
taboo, naturally leading to a reduced response. Previous observation by Professor John F Mayberry 
(personal communication) has shown that Asian populations tend to have lower RR, for which possible 
explanations were cultural or literacy related. Additionally, the sensitive nature of the questionnaire may 
reduce RR in SA. Importantly, this issue is significant from the point of view of future CD related research 
among minority communities which have the same CD prevalence as White Caucasians. High-powered 
interview based research involving only Asian patients should be organised to explore the causes behind 
poor RR.  
On the contrary, there was no significant difference in returners and non-returners when analysed 
according to gender. This area has been examined previously and conflicting results have emerged; 
there is weak evidence to suggest that females respond better than males (Smith, 2008). In our index 
study and other research into CD related questionnaires this effect was not observed and there was no 
difference between the RR of different genders (Butterworth et al., 2004, Leffler et al., 2009). It may be 
argued that the study by Smith (2008) was targeting a selective group of university faculty students and 
clinical studies like ours have a different set of patients, so the apparent departure of Smith (2008) may 
be explained by selection bias.  
Our study reports that increasing age is significantly related to poor RR. This area too has conflicting 
results and one study, for example, has reported that younger age has been noticed to affect the survey 
response positively (Kaplowitz et al., 2004), but the methodology involved the internet as well as postal 
routes. In addition to that, the study recruited university students with age ranges between 24 and 30 




years and 80% of them were 24 years or younger, suggesting sample bias; the study itself does not 
claim to have reached the conclusion. Similarly another recent well organised study from the US Army 
found that RR was low in younger personnel (Miller & Aharoni, 2015), but again this study had a 
contracted age range.  In addition to that, an earlier but comprehensive systematic review did not find 
any evidence of age or gender affecting survey RR, agreeing with our findings (Asch et al., 1997).   
 
Health problems in childhood and age at diagnosis 
 
Our study reports health related problems in childhood in around 30% of the patients. This area is difficult 
to present as objective evidence, as it is affected by recall bias, although it is accepted that a significant 
number of patients are undiagnosed in childhood (Bingley et al., 2004, Cosnes et al., 2002). Other 
studies in this area have relied on serological diagnosis hence cannot be compared with our findings.  It 
is suggested that true figures may only be possible by prospective studies and may be objectively 
researched by exploring childhood health records rather than relying on recall based data. Age at 
diagnosis in our study shows two peaks: firstly between the ages of 18 and 30 and then between 51 
and 60 years of age; this late peak was reported in previous research (Vilppula et al., 2011, Vilppula et 
al., 2009). 
Symptoms of CD  
 
Fatigue was the most common symptom in those who responded to the questionnaire. It is interesting 
to note that fatigue has gradually taken over from the symptom of diarrhoea in the past decade or so 
(Feldman et al., 2015).  Fatigue is commonly found as the presenting feature in CD, as suggested by a 
study which explored the role of fatigue in 71 untreated CD patients (Siniscalchi et al., 2005a) and our 
results follow this trend. Of interest is the generalised nature of fatigue and its relationship with 
depression (which again is related to CD) and it is thus possible that some in our cohort had associated 
depression leading to fatigue (Chaudhuri & Behan, 2004). It has been suggested that in future studies 
the Depression Anxiety Stress Scales (DASS) should also be measured when evaluating CD and its 
symptomatology (Crawford & Henry, 2003). Similarly, it was noted that 51% of our patients reported 
diarrhoea alone or in combination with other symptoms. This is in accordance with previous reports that 
half of the patients present with chronic diarrhoea (Green & Cellier, 2007).  
66% of our patients presented with symptoms suggestive of vague abdominal pain and bloating and this 
has been reported to range from 46% to 70% (Corazza et al., 1996, van der Wouden et al., 2007, Zipser 




et al., 2003). Additionally, these are also principle symptoms of IBS (Drossman et al., 2009), a functional 
disorder of the GI tract, which overlaps in symptomatology with CD (Ford et al., 2009). Our study thus 
follows the previously reported trend. Comparing the effect of gender on presentation, our study reports 
that symptoms of fatigue and nausea were significantly more common in females than in males. 
Previous research had suggested that there were no gender differences in the mode of presentation of 
CD (Bai et al., 2005), although the authors accepted that males tended to have greater malabsorption. 
Although we report this for the first time, our report needs further verification by in-depth interview for a 
more holistic picture.   
Comparing the symptomatology on ethnic grounds, it is clear that Asians tend to report more stomach 
pain and vomiting. Previous research using a similar cohort reported that SA with CD are less likely to 
present with ‘irritable bowel syndrome’ symptoms, but more likely to have features of vitamin D 
deficiency, iron deficiency and have a higher alkaline phosphatase than White Caucasians (Butterworth 
et al., 2005). Although we did not analyse the results in terms of irritable bowel syndrome, abdominal 
pain and vomiting may be partly related to irritable bowel syndrome (Sanders et al., 2003), thus, 
reporting contrary results to this study. Our study (n=38) is comparable in power to the study by 
Butterworth and colleagues (2005) where there were 40 patients, but the methodology is different, as 
our study used questionnaire based data and their study used retrospective clinical notes based data; 
both approaches have their pros and cons. It is thus suggested that an audit should be designed which 
examines this issue more holistically e.g. a prospective study, in newly recruited patients over a number 
of years, within the outpatient department, in the form of a history taking audit.    
The symptomatology of CD is changing and thus this issue needs exploration, as GPs need to be aware 
of the emerging symptomatology of CD and not looking for classical symptoms before testing for it. 
Research in this area will hopefully increase case detection as previously suggested (Sanders et al., 
2003), as it is low in the general population (Kolho et al., 1998). Additionally, based on the presenting 
symptoms and classification of CD, the most prevalent group was non-classical CD and this is the group 
which has dominated the clinical picture of CD in reported studies (Dewar & Ciclitira, 2005, van Heel & 
West, 2006, M. Bardella et al., 2007). Finally, when clinical presentations were analysed according to 
gender of the patients, there was no significant difference between males and females and this is in 
accordance with previously reported research (Nachman et al., 2009). 




Diagnostic delay in CD 
 
In relation to the first presentation of symptoms and the final histological diagnosis, the average gap in 
this study was 6 to 12 months. Delay in diagnosis is a recognised phenomenon and, although it is 
multifactorial, it is argued that it is the clinician who fails to recognise the disease, rather than the patient 
failing to seek medical care, as suggested by Green and Jabri (2003) in a review. Other authors have 
suggested that a delay in diagnosis has a negative effect on HRQoL (Norström et al., 2011) and on 
cancer in CD (Silano et al., 2007). The time interval in our study, in comparison to previous research, is 
contracted (Corazza et al., 1996, Green et al., 2001). 
Although there is no robust data examining the delay in diagnosis, this discrepancy may well be 
explained by the methodology of our study. A previous Canadian study (n= 5,240) has reported a mean 
delay of 11 years (Cranney et al., 2007). Similarly, a questionnaire based study (n=2,000) from the UK, 
similar in return rate to our study (40%), reports the delay to be 13 years (Gray & Papanicolas, 2010).  
The possibility of such a swift diagnosis in this centre is explained by many factors, but important among 
them is the way the survey question was posed i.e. “How long had you been experiencing symptoms 
before you were diagnosed?” The question was followed by a choice of four answers and also unified 
two concepts (the symptoms and diagnosis) which may mean different things to different patients. It is 
possible, for example, that patients may infer from the word diagnosis: “first explanation by the GP”, 
“referral to the hospital consultant and his explanation”, “blood test and results” or “endoscopy and 
biopsy results”. All these concepts are on a time line and, depending upon the interpretation of the 
survey question, may be answered differently by different patients depending on their understanding. 
This phenomenon has been discussed by well-established authors in this field (Schuman & Presser, 
1996) and has implications for our study.  
Another reason which may explain this phenomenon is recall bias (Coughlin, 1990), as patients tend to 
recall things close to important events, which in this case was the diagnosis of CD and perhaps 
symptomatic improvement with a GFD. Additionally, our cohort was based on histological diagnosis,  
whereas other surveys had different methodologies such as postal invitations to members of the CS 
(Gray & Papanicolas, 2010) or the Canadian Celiac Association (Cranney et al., 2007), where the 
sample clearly has high power (n=2,000 and 5,240 respectively). The sample which is identical in 
demographic characteristics to  the index study (Butterworth et al., 2004) reports this delay to be 9.4 




and 5.3 years for Caucasians and Asians respectively; these figures were obtained either from clinical 
notes or interview, as the questionnaire does not have the ability to measure this value with such 
accuracy. A limitation of our study was the question technique and it is suggested that future survey 
should have open ended question without giving multiple choice options and preferably with the addition 
of another question about the date of gastroscopy and biopsy sample.    
Consultation with physician and dietitian 
 
Our study reports high satisfaction rates (> 90%) with both physician and dietitian and this suggests 
almost equal involvement of physician and dietitian in the management of CD. This is in accordance 
with Bebb et al., (2006), who examined a cohort of 126 CD patients (80% adherent to a GFD) and they 
were asked about different options in FU i.e. clinician, dietitian, clinician and dietitian, general practitioner 
or no FU.  Patients, in this questionnaire based study, preferred a combined clinician and dietitian clinic, 
although a latter study reported a clear preference for a dietitian only clinic (Ryan et al., 2016). 
Furthermore, the satisfaction rate in our study shows improvement when compared to our index study 
(Butterworth et al., 2004) and other similar research (Rubin et al., 1993, Faye et al., 2018). Patient 
satisfaction, however, is multifactorial and depends on age, receiving an explanation of the symptoms, 
cause, likely duration and lack of unmet expectations (Jackson et al., 2001). Possible causes for 
improvement might include improved communication with patients or a response bias in the opinion of 
the responders (Mazor et al., 2002). Both of the consultations in this study, however, were fulfilling the 
purpose of the appointment. The important part was the comments left by the patients, who pointed 
towards certain common issues faced by the patients related to the communication e.g. use of medical 
jargon, not paying attention to patients’ concerns and (above all) poor eye contact. For SA patients, the 
linguistic barrier was the main issue and previous research recommends the use of the patient’s own 
language (Singh, 2011), although it might not be possible for a variety of training, economic and logistic 
reasons.  
No difference was noted in the dissatisfaction rates of either the Caucasian or SA populations. This 
again is in contrast to the index study, where SA had more dissatisfaction compared to Caucasians, a 
finding echoed by another later study (Lyratzopoulos et al., 2012). Additionally, in a slightly different set-
up, but with extensive power and robust methodology, a relatively recent study also reported less 
satisfaction of SA patients with GP consultations (Brodie et al., 2016) and one of the reasons was the 
linguistic barrier. It may be argued that in our study language support was available, so the result may 




have been affected. It is hoped that a clear answer can be found if a large numbers of participants, with 
modification in the design of the questionnaire, are employed to answer this question i.e. use the ethnic 
languages for future studies. Additionally, interpretation of patient satisfaction should be adjusted for 

























Adherence to a GFD 
 
Our study reported self-reported adherence to a GFD by two methods: absolute adherence to a GFD 
based on ingestion of any amount of gluten (60.8%) and based on CDAT questionnaire (54.4%). 
Although absolute adherence is one of the criteria used by the CDAT questionnaire, a validated 
instrument as compared to Butterworth et al., (2004), it takes into consideration several other social, 
psychological and symptomatic issues when calculating adherence to a GFD (Leffler et al., 2009). 
Hence, for the purpose of this PhD, CDAT is the preferred method of estimating adherence to a GFD.   
A detailed systematic review by Hall et al., (2009) has reported a wide range of adherence rates and it 
is affected by the power of the study, age of the patients (Fabiani et al., 2000, Hauser et al., 2006), 
educational level of the patients (Leffler et al., 2008, Sainsbury et al., 2013b, Villafuerte‐Galvez et al., 
2015), knowledge (J. Silvester et al., 2016)  and methodology of the reported studies. It is, thus, difficult 
to compare our adherence rate with these studies, keeping in view the multi factorial nature of the 
studies. An average adherence rate of 58% (range 41% to 91%) reported by Hall and colleagues (2009) 
is close to our finding.  
Studies after Hall et al., (2009) have also reported variable adherence rates.  Rajpoot et al., (2015) in a 
prospective, single-centre, observational study in India (n=172) reported an adherence rate of 53.3%, 
which is close to our value. The same year, Villafuerte-Galvez et al., (2015) in a US based study (n=709) 
reported an adherence rate of 75.5% and this is a higher value than in our study. This may be explained 
by the observation that the participants in this study had been on a GFD for over 10 years and FU had 
been cited as one of the reasons for better adherence (Rajpoot et al., 2015, Hall et al., 2009, Barratt et 
al., 2013). The participants in Rajpoot et al., (2015), although all native Indians, were both new and FU 
patients, which is similar to our cohort. Similarly, Silvester et al., (2016), in a US based study (n=82), 
reported an adherence rate of 55% which is similar to our value. Although lower powered than our study, 
this was an adult study with patients under dietitian FU, just as in our cohort. In contrast to this, a higher 
adherence rate (93%) was reported by a Mexican study (n=1,238) and although an adult study, the 
striking difference of this study was the increased number of males (45%) and presence of both CD and 
non-celiac gluten sensitivity patients (Ontiveros et al., 2015), in whom the adherence rate is generally 
reported to be higher (DiGiacomo et al., 2013). In conclusion, considering our methodology, which was 




questionnaire based, our CDAT based adherence value of 54.4% follows previously reported studies to 
some extent. 
Our absolute adherence (60%) as defined by no gluten (except inadvertent intake), is close to the 
reported value (62%) by Butterworth and colleagues (2004), who used a cohort of mixed ethnicity such 
as ours. Additionally, it is noteworthy that Butterworth’s data was collected a decade earlier than our 
data and management of CD has changed over those years in the NHS. The nearly static adherence 
rate, a decade apart with comparatively similar demographics, in two geographically adjacent cities 
cannot be explained simply by the power difference. One could argue that this may represent a plateau 
in adherence rate to a GFD, but more research is needed.  
The non-adherence group was divided into three groups: mild, moderate and severely non-adherent. 
Comparing the results, severe non-adherence was noted in 2% of our cohort, as opposed to 18% in the 
index study (Butterworth et al., 2004). Since the questionnaire, methodology of administration and cohort 
are comparable, it may be argued that adherence in this group has improved in the past 10 years, 
although there are differences from the Butterworth study in terms of power and length of FU. Our study 
presents a comparative picture in a relatively similar cohort and using the same questionnaire.  
Things have moved on since 2004 and one may argue that people are now more aware of CD as a 
disease entity and there has been an increase in the provision of GFP  in the shops and online (Burden 
et al., 2015). It is however possible that the reason behind this improved adherence might be non-
response bias, as our sample was comparatively large and the RR was low. It is thus possible that those 
who responded to the questionnaire were motivated and already more adherent to a GFD. This however 
needs to be confirmed by performing an audit to measure adherence retrospectively in the dietetics 
department and comparing the results in order to assess the reliability of our findings.  
There was no significant difference between genders when analysed according to adherence rates, 
although interestingly we noted that all severely non-adherent participants were female. This might 
simply reflect sample bias, due to the female predominance in the sample (as in any CD sample) 
(Ivarsson et al., 2000), or this might represent a true trend. Previous studies have referred to the 
difficulties for women in following a GFD as compared to men (Ciacci et al., 2003, Hallert et al., 2003, 
Lee & Newman, 2003, Zarkadas et al., 2013), but it is not clear if these difficulties may be translated 
into severe non-adherence in females. It is thus suggested that a fairly large sample (n>200) of severely 




non-adherent patients with histologically proven CD should be surveyed in an attempt to answer this 
question. 
The study did not detect any significant difference based on ethnicity when comparing the non-adherent 
patients and although this follows the trend as suggested by Hall et al., (2009), the index study 
(Butterworth et al., 2004) reported opposite results. As previously described, the adherence rate itself 
has improved and it is possible that the same factor which led to improvement in the adherence rate 
may also have closed the ethnic gap. In contrast to our findings, a recent UK based study (n=146) 
reported a significantly low adherence among South Asians to a GFD in comparison to Caucasians 
(Adam et al., 2019). There are several methodological differences when this study is compared to our 
study, for example; the study is retrospective, lacks demographic characteristics (age and sex), lack of 
information about Coeliac UK membership and lack of information about the availability of gluten on 
prescription. In addition, the study used a non-validated method of classifying patients into three 
categories; fully adherent, partly adherent (accidental intake) and non-adherent as opposed to our study 
where CDAT was used, a fully validated and fit for purpose questionnaire. It is thus argued that 
methodological differences may explain the discrepancy in related results.  
It is thought that this question needs further exploration by a combination of research and audits. 
Similarly, the study did not detect any significant difference based on age of patients when comparing 
the non-adherent patients and this is in accordance with the conclusion drawn by Hall et al., (2009) from 
their well-planned systematic review.  
 
Difficulties faced in following a GFD and symptoms post gluten ingestion 
 
The majority of the patients in our study (80%) had concerns about the cost of a GFD, which is indeed 
expensive. This follows recent research where data was collected from 50 stores and 10 online retailers: 
it was reported that, although availability of GFP had increased, it was comparatively more expensive 
than the GCP (Hanci & Jeanes, 2018). Previously, a market based study (Zivin & Green, 2007b) 
compared similar items (wheat and GF) and found that all 56 GF items were more expensive than their 
wheat-based counterparts. A relatively more extensive study suggested that GFP were 242% more 
expensive as compared to gluten-containing equivalents (Stevens & Rashid, 2008b), suggesting the 
need for GFP to stay on prescription. Our study suggests that the price of GFP, among others, is one 
factor which significantly affects adherence to a GFD (0.3-1.0. 95% CI, p=0.05).  




Although CD patients are not the only consumers of GFP, they were available on prescription on the 
NHS in England. However, following extensive consultation with different stakeholders, health 
commissioners across England have implemented changes to restrict access to GFP on prescription to 
GF breads and flour mixes only (NHS, 2018b), despite an internet based campaign to oppose these 
changes (Campaign, 2016).  
Our study suggests that patients had difficulty understanding GF labelling and this factor was associated 
significantly with non-adherence. Although understanding of food labelling being a factor for non-
adherence was identified in our index study (Butterworth et al., 2004), this trend continues in recent 
studies as well (Verrill et al., 2013, Sharp et al., 2014). It was not possible to determine exactly how lack 
of understanding of the labelling was an issue for the patients, but it was clear that this factor was 
significantly associated with SA, suggesting linguistic or technical barriers. A qualitative research study 
is needed to explore this point in detail, along with other factors which may affect adherence to a GFD. 
Additionally, it is suggested that, if the GF food industry included messages on products in major ethnic 
languages, that might increase understanding and in fact may improve adherence to a GFD. This 
concept is also linked to restaurant foods being labelled GF whilst actually containing gluten, as 
suggested by an Irish study which found that 10% of “gluten free” meals in fact contained gluten 
(McIntosh et al., 2011). Such alarmingly high gluten contents may have multiple causes, but one of them 
is restaurant chefs’ knowledge about CD. This was examined in a UK based study and it was found to 
be lower than the general public level of knowledge (Karajeh et al., 2005). However the same group 
conducted a FU study after a decade (Aziz et al., 2014) and found that GFF food related knowledge had 
increased significantly in both aforementioned groups; this may well relieve some patients’ concerns 
around eating out in restaurants. It is suggested that a broad based approach, such as educating both 
consumers and providers in this industry at all levels, may help this inadvertent ingestion of gluten.   
Membership of the CS was one important factor which was significantly associated with increased 
adherence and this is in accordance with the previously mentioned systematic review (Hall et al., 2009). 
The CS in the UK (Coeliac UK, 2016c) and other sister organisations or advocacy groups across the 
globe, provide up-to-date knowledge in patient friendly ways on all major aspects of life as a consumer 
of a GFD, along with support in following such a diet. How exactly this leads to increased adherence is 
elusive, although one reason might well be their guidance on GFD (Coeliac UK, 2018), eating out 
(Coeliac UK, 2016a), food labels (Coeliac UK, 2016b) and gluten sensitivity (Coeliac UK, 2015). It is 




also possible to argue that those who are more adherent to a GFD join the CS or an equivalent 
organisation. If this indeed is the case, then research which inducts patients from such societies 
(Sainsbury et al., 2013) has selection bias and the results cannot be generalised. One way to examine 
this issue is to conduct extensive interview based research on members of the CS, both adherent and 
non-adherent, and explore this area.    
Other factors, such as poor palatability of GFP, were reported by our patients and this issue has long 
been recognised (Thompson, 2009). This factor, which is important from a quality of life point of view as 
reported earlier (Hall et al., 2009, Olsson et al., 2008), had a significant effect on adherence to a GFD 
in our study (Table no 9, page 49). Research such as: detoxification of wheat via genetic alteration 
(Stenman et al., 2009), gluten enzyme degradation (Mitea et al., 2008), volume enhancement with 
chickpea flour (Bird et al., 2017) and texture enhancement with legumes (Huang et al., 2018) has 
produced relatively palatable GFP, but this area is evolving and more research is needed. 
Another significant factor related to non-adherence in this study was lack of symptoms before the 
diagnosis. Similarly, factors related to patients’ symptoms post gluten ingestion were also significantly 
related to non-adherence.  Although research has shown that there are benefits for both asymptomatic 
and symptomatic patients from a GFD (Kurppa et al., 2014), it is not exactly clear why non symptomatic 
patients have reduced adherence, but the answer may be partly explained by the disproportionate drop 
in quality of life. This was demonstrated in a questionnaire based study, where among asymptomatic 
patients (n=23), perception of health worsened and concerns about health increased whilst they were 
on the diet (Ukkola et al., 2011).  
Although neither dietitian nor clinician information was associated with adherence to a GFD, being given 
a contact telephone number by the dietitian was significantly associated with improved adherence in our 
study. The positive role of a similar strategy has been previously observed in relation to outpatient 
appointments (Hardy et al., 2001) and obsessive‐compulsive disorder (Kenwright et al., 2005), but this 
was the first time that a study has reported on the positive role of giving telephone contact information 
to patients and its effect on adherence. Additionally, non-prescription of GFP by the GP was found to 
be associated with low adherence (Table No 18, page 91). This is especially important in view of the 
current climate of austerity which has affected GFP prescribing as referred to earlier. 
  




CDAT score and adherence to a GFD and comparison of instruments 
 
Our study has used two methods of assessment for adherence to a GFD (Butterworth and CDAT) and 
our method of preference is CDAT. There was a significant correlation between increasing CDAT score 
and non-adherence as measured by Butterworth (p=0.00) and that confirms the previous reported 
findings (Leffler et al., 2009, Villafuerte‐Galvez et al., 2015). This method of measuring adherence is 
reliable and validated and has been used in multiple recent studies in assessing adherence to a GFD 
(Villafuerte‐Galvez et al., 2015, Mahadev et al., 2013, Nazareth et al., 2015, Haas et al., 2017). Gender 
and ethnicity of patients had no significant relationship with the adherence as measured by CDAT score, 
which follows the trend (Butterworth et al., 2004).  
Comparing non-adherence, using both Butterworth and Leffler scores, it is clear that Butterworth non-
adherence had higher scores, but also that Leffler scores identified more non-adherent patients (54%) 
as compared to Butterworth (39%); this difference is significant. It is not clear exactly why the Leffler 
questionnaire is detecting more non-adherent patients, but perhaps it may be explained in terms of 
questionnaire design. Firstly, the length of a questionnaire may affect the response of individuals 
(Galesic & Bosnjak, 2009) and in this case may well have affected the quality of data in the Butterworth 
questionnaire. Secondly, the CDAT score is plotted as continuous variables, ranging from 7 to 35 and 
giving rise to a compliant (CDAT <13) group and a non-compliant group, whereas the Butterworth score 
is nominal data and divides the groups into 3 types of non-adherence depending on the interval of gluten 
ingestion. Although the final question in the Leffler questionnaire also enquires about the adherence of 
individuals, it generates 4 categories of non-adherent patients, thus giving more choice. Finally, when 
the data is analysed by two categories in the Leffler questionnaire, the adherence rate is markedly 
different from the Butterworth questionnaire, but when analysed according to the last question, the 
adherence rate is comparable in terms of percentage to the Butterworth adherence. This approach may 
be criticised for the fact that the same cohort was used to compare these questionnaires, which may 
compel the responder to answer both the questions in the same way and thus affect the quality of the 
data.  
The way to resolve this issue is to administer these questionnaires to different groups who have had a 
dietitian assessment as a benchmark of their adherence and then draw inference from the 
questionnaires’ ability to measure adherence in these groups. Similarly, membership of the CUK was 
associated with adherence; this has been explained above in relation to Butterworth adherence. On the 




balance of probabilities, it may be argued that the CDAT is more sensitive than the Butterworth 
questionnaire in detecting non-adherence to a GFD.  
This is the first time such a comparison has been reported, by comparing previously used instruments 
of non-adherence using the same population. The questionnaire design has been discussed in the 
method section, but it may be relevant to add here that the LQ is shorter, less complex and easier to 
comprehend. In addition, it has questions about personality traits and draws its validity from multiple 
recent studies as mentioned above. It is thought that the development of the Leffler was more methodical 
and took into account the holistic nature of gluten ingestion and not just intake as recalled by the patient. 
Plus it was developed by a committee of gastroenterologists, dietitians, psychologists and individuals 
with CD with a validity pilot project and confirmed by blood markers. We thus feel that for future research 





















Strengths of the study 
 
This study selected a population of CD patients who were diagnosed on objective, highly sensitive and 
specific grounds i.e. a combination of both serological and histopathological criteria was used. The 
diagnosis of CD was made by the same pathologists and using the same standards, thus reducing 
chronology bias.  In addition to that, the diagnosis of CD was supplemented from clinical notes, thus the 
diagnostic sensitivity and specificity was close to 100%.  Furthermore, the demographics of the 
population were compared in terms of age, ethnicity and gender, with a previously reported population 
in a similar survey targeting patients with CD (Butterworth et al., 2004)  
Data reliability 
 
This was a well-designed observational study and data in this study went through a rigorous process of 
cross checking via an audit, which improved the standard of data for final analysis. Additionally, data 
was obtained from clinical notes and computerised records which improved the quality, reliability and 
validity of the data, thus addressing some aspects of data related issues such as recall bias.  
Implications of study findings 
 
The findings of this study were published in the journal Nutrients at a time (Muhammad et al.,2017) 
when public consultation in relation to GFP was at a preliminary stage and our study was cited as one 
of the strongest pieces of evidence (by NHS England) for a link between prescribing and adherence in 
their recent document (NHS, 2018a). As a result, this may affect access to GFP for certain patient 
groups and this may also affect adherence to a GFD, but larger studies are needed to explore this point 
of immense practical importance.  
This study evaluated a single English NHS Trust and found no major differences in the patient perceived 
management of CD in White and SA populations. Our Index study painted a different picture, where SA 
patients were being treated sub-optimally. The Index study, however, was published in 2004 and the 
data therein is at least 14 years old. It is possible that their findings were isolated, but it is also possible 
that the suggestions made in the study have changed attitudes towards Asian minorities and thus 
improved health care for that group. If treated as a FU study, this study shows that patient education 




has improved in relation to CD patients.  However, SA are still not receiving adequate information to 
enable them to understand food labels -which is key to adherence. 
The ultimate aim of measuring adherence to a GFD is to find ways to increase adherence in the future, 
which will help to prevent long-term complications of CD. A team effort from physicians and dietitians is 
needed and, although it might appear difficult to improve patient adherence, it is not unachievable. This 
study may help to alleviate the difficulties associated with following a GFD by increasing awareness in 
both patients and physicians.  
 Limitations of the research 
 
There were several limitations which might have affected the quality of this research. Firstly, the choice 
of a questionnaire (Bowling, 2005) and additionally sampling may be selective (Andrews et al., 2003). 
Data quality is a relative construct and depends on multiple factors, but it is accepted that sampling may 
be biased in questionnaire based studies. However it should be noted that Andrew and colleagues 
conducted their research in relation to an internet based survey, which differs from mail surveys in terms 
of its penetration and access to the experimental cohort (Kaplowitz et al., 2004).  
Secondly, the survey may be affected by RR and that is why every effort was made to increase the RR 
in the light of research (Richards, 2007, Edwards et al., 2009, Root & Blismas, 2003), although it is 
accepted that RR is on the decline in mail based surveys (Galea & Tracy, 2007). This study achieved a 
RR of 38.5% and, although there are no good or bad RRs (Richardson, 2005), this rate is on the lower 
end of acceptability (Gehlbach, 2006). As a result, it may be argued that the collected data may have 
been affected by non-response bias (Hill et al., 1997), although rates as low as 20% may still be valid 
and accurate in relation to data quality as suggested by (Visser et al., 1996), or in other words low RR 
is not synonymous with non-accurate results, as suggested by a few authors (Holbrook et al., 2007, 
Keeter et al., 2006, Curtin et al., 2000). The notion of dissociating quality of research from the RR is 
further supported by a study comparing relative risk estimation from two studies with different RRs yet 
comparable and consistent results (Mealing et al., 2010). Also, a meta-analysis has suggested that 
detailed description of methodology and the way data was collected is more predictable in determining 
quality of data than RR (Cook et al., 2000). Additionally, despite the low adherence rates, there may be 
some selection bias, since the participants who responded may be more motivated and perhaps 
therefore more likely to adhere to a GFD.  




Thirdly, it is accepted that the questionnaire method of survey excludes certain groups such as blind 
and visually impaired people, as special arrangements were not in place (such as the tactile reading 
system, Braille (Kaczmarski & Wolff, 2007) or audio supported questionnaires (Kirchner & Schmeidler, 
2001)). However there are no clear reports on the prevalence of visually impaired patients with CD, 
apart from scattered case reports and secondary references in articles (Millington et al., 2015, Lea et 
al., 1995, Pfaender et al., 2004). Another group which might have been excluded would be those with 
literacy problems and elderly patients who may have health and/or computer literacy issues. Although 
support in 7 ethnic languages was available from the author, it is possible that patients of languages 
outside the list provided might have been excluded. 
Fourthly, questionnaire based methodology is static and does not carry lateral or longitudinal depth of 
exploration (Coughlan et al., 2009). However it must be noted that the purpose of this piece of research 
was not an in-depth enquiry into CD; rather it was a valid questionnaire designed for collecting pre-
determined data.   
Fifthly, the questionnaire RR was 38.5% which, whilst low, compares well with other similar published 
studies. Also, all the questionnaires were completed and the entries were legible. Furthermore, separate 
themes were extracted from the added comments and that gave an extra dimension to the issues raised 
by the patients. Finally, although adherence was measured through a questionnaire based 
methodology, there was no external verification such as histology (Ensari, 2016, Villanacci, 2015) or a 
combination of serology with histology. Additionally, by the time this research was being conducted, 
novel methods of ascertaining adherence were in development, such as urinary markers (Comino et al., 
2012, Moreno et al., 2017) for CD. It is suggested that in future, if measurement of adherence is being 
researched, especially in relation to an intervention, it may be supplemented with laboratory data to 
increase the validity of the study findings.  
Conclusion & future research 
 
The CD database provides a unique opportunity to evaluate: the adherence rate to a GFD, causes 
behind low adherence to a GFD and reliable incidence and prevalence rates of CD in the Leicestershire 
area. Keeping the aforementioned limitations in view, this study has certainly established that adherence 
to GFD is related to food labelling, membership of the CS and cost and texture of GFF. This study, 
however, found no major difference in adherence to a GFD between the Caucasian and SA populations; 




this is contrary to the index study (Butterworth et al; 2005), where Asians were reported to be less 
adherent. This may be because of increased awareness about GFD among Asian patients, but a large 
scale interview based research study could confirm this finding.  
Extending this study would be feasible with more participants, employing mixed methods of delivery, 
additional questionnaires and supplementing information provided by the patients with clinical letters 
and computerised data. The study findings must be interpreted with caution and must be taken in 
context. The author also recommends that current literature and local trends must be taken into 
consideration before applying the findings of this study to similar groups or set-ups. It should thus be 
treated as a baseline study for the purpose of providing ideas about adherence rates and basic 
demographics of CD.  
The main lesson from this study is perhaps that adherence rates in the Leicestershire area are very 
close to the national average and there are definitive reasons behind that including: cost of GFF, taste 
of GFP and reading food labels correctly. Addressing these reasons will include educating patients about 
food labelling, encouraging joining the CS and, last but not least, providing them with support when 
needed to bring the daily transgressors to absolute adherence, by repeated counselling in dedicated 
CD clinics.  
Another related and important finding is the correlation between adherence with membership of the CS 
or other advocacy groups. This theme has been reported in several studies (Butterworth et al., 2004, 
Hall et al., 2009, Charalampopoulos et al., 2013, Sdepanian et al., 2001) and in my MSc pilot study 
(Muhammad et al 2013). It is not clear what exactly leads to increased adherence, but possible 
explanations might well be: group therapy, increased education about CD, timely advice about diet, 
regular leaflets and emails. However, more questionnaire or interview based research is needed to fully 











Study 2 (PhD): Patients’ Views on Improving Adherence to a Gluten Free Diet in 






Non adherence to a GFD ranges from 53 to 76%  (Hall et al., 2013, Villafuerte‐Galvez et al., 2015, 
Casellas et al., 2015, Rajpoot et al., 2015, Sainsbury et al., 2018), which may cause persistent 
symptoms (Dewar et al., 2012). Behavioural change is a key factor in improving the implementation of 
evidence based interventions to increase adherence to a GFD (Sainsbury, Mullan & Sharpe, 2013b). It 
may be defined as “coordinated sets of activities designed to change specified behaviour patterns” 
(Michie et al., 2011) and in the case of adherence to a GFD, it means reduced or no intake of gluten.  
Research has indicated that non-adherence to a GFD is multifactorial (Hall et al., 2009) and improved 
adherence to a GFD has beneficial effects on the activity and associated complications of CD (Whitaker 
et al., 2009, Siniscalchi et al., 2005b, Kotze, 2004). Different instruments have been used to measure 
gluten intake and these have been reviewed in chapter 1. There exists a gap in knowledge in relation to 
factors influencing dietary adherence in South Asian people. There are quantitative studies with variable 
methodologies (reviewed earlier page No 53) which has explored this area but to date there are no in 
depth qualitative studies. The reason for this seems multifactorial including; cultural and linguistic 
barriers and interview based research are needed to explore this area.  
 
Study Aims:  
1. Explore reasons for non-adherence 
2. Explore options for interventions to promote adherence to GF diet 
Method: 
 
This was a short semi-structured telephonic interview, conducted in two phases, which on average 
lasted for 20 to 30 minutes and for which guidance was drawn from different sources (Carr & Worth, 
2001, Valenzuela & Shrivastava, 2002, Britten, 1995, DiCicco‐Bloom & Crabtree, 2006, Turner III, 2010, 
Burke & Miller, 2001).  




It was fit for purpose in exploring patients’ views about the design of an intervention to promote GF 
dietary adherence (Harvey, 1988) and causes for non-adherence. The interview was conducted 
according to a topic guide (Appendix 1.3E) which served as a formal structure for conducting the 
interview, although it is acknowledged that a topic guide does not provide a rigid structure; such 
interviews are flexible and open to accepting respondents’ spontaneous descriptions and narratives 
(Brinkmann, 2014). The completed interviews were recorded, transcribed and then codified using 




The participants in the study came from a subset of the CD database held within the UHL pathology 
department and they were the responders in Study 1 (Chapter 2). Only those who were diagnosed 
between 2004 and 2014 were eligible state diagnostic bits. Demographic records were checked using 




Patients who responded to the questionnaire in study one were eligible for inclusion in this study. All 
patients were 18 years or above and had histologically confirmed CD. As per study one, only patients 




All patients who had not responded to study one were excluded. In addition to that, all those patients 
who were not under UHL follow up were excluded, as the local Research and Development office 
approval was only applicable to current UHL patients. Those who were finally selected were divided into 
2 groups: adherent and non-adherent, based on the findings of study one.  
 
Questions in Telephonic Interview 
 
Each interview question was designed to clearly address a single topic and guidance was drawn from 
previous research and suggestions (Babbie, 1989, DiCicco‐Bloom & Crabtree, 2006, Turner III, 2010). 
In addition, an evidence based approach was adopted when designing the questions to ensure 
objectivity. This included: literature search, in-depth reading of the topic being researched, opinions of 
experts in the field and avoiding difficult and unanswerable questions or questions which had already 




been answered (Robson, 2002, DiCicco‐Bloom & Crabtree, 2006). The interview opened with a formal 
introduction, where the patient was identified by simple questions and the purpose of the interview was 
reiterated. Similarly the first couple of minutes were utilised to build rapport with the patient (Price et al., 
2012), followed by specific questions. Different types of questions used in the interview are given in the 
table below ( Table No 29).  
 
Table 29: Themes and question types in the interview  
Themes  Question type 
Exploring issues   Main issues preventing following a GFD 
Exploring obstacles  Specific obstacles preventing following a GFD  
Exploring specific problems   Specific problems in following a GFD 
Exploring factors   Specific factors preventing following a GFD 
Exploring reasons  Reasons which prevent following a GFD 
     
 
 
The above questions generated factors responsible for difficulties following a GFD and the patients were 
then asked about the possible modifiable factors which could be improved and lead to adherence to a 
GFD. This was mainly a listening area, where patients came up with their own methodologies for dealing 
with modifiable factors. Thereafter, the researcher was involved actively and asked a series of follow up 
questions to clear up any ambiguities, as suggested by previous research (Sturges & Hanrahan, 2004), 
such as probing (Rubin & Rubin, 2011) and specific question (Legard et al., 2003). Subsequently, a 
series of direct and indirect questions were asked to further probe the specific area and they are given 









Table 30: Types of questions in the interview 
Direct Questions Indirect Questions 
Is adherence to a GFD important for you?  What is your opinion on following a GFD? 
Is it possible to improve adherence to a GFD?  Should people follow a GFD or it is an option? 
Any plans to improve adherence to a GFD?  Is a GFD important for asymptomatic CD patients? 
Are you ready to improve adherence?   What is your opinion on GFD transgression? 
Have you already started working on it?  What is the possible solution to following a GFD? 
Do you need any help in this regard?  Can you follow a GFD on your own? 
How many times a month might you take gluten?  Is a GFD absolute or a relatively optional diet? 
     
 
Interview questions generated further spontaneous themes and as new themes came to surface 
questioning techniques and strategies were changed accordingly until the point that theme saturation 
was reached (Francis et al., 2010, Tong et al., 2007, Walker, 2012). The interviews were recorded using 
the call recorder® app and the Record app of the IPhone 5. The data obtained was directly entered into 
interview transcripts.  
Procedure: 
 
Each participant was given a unique trial number, which was assigned by the principle investigator to 
preserve confidentiality of the patients. This was stamped on every document using a COLOP® mini-
folio (S126) prefilled number generating stamp. The research pack (contained in a C5 envelope) 
included an invitation letter, patient information sheet, consent form and patient’s availability calendar, 
along with a stamped addressed envelope (Appendices 1.2 A-D). Using an online randomising interface 
for researchers, randomisation was conducted to select patients (Randomiser, 2016). The details of this 
process is given in the result section below (Section II, Pages No 136-38).  
 
Conduct of the Study: 
 
As a first step, participants (n=15) were randomly selected from the responder group and pilot interviews 
(n=13) were conducted. All the patients in this phase were adherent to a GFD and the details of the 
demographics are given in the result section. This was done to gather data to refine the topic guide for 
actual interviews. None of the data generated in these initial interviews was used for the final analysis. 
Patients were informed that their data would not be used in the analysis, but would aid the research 




tremendously by helping to improve the topic guide which would standardise the research. This 
approach guided the author towards rapport and wording issues and also helped with the timing of the 
interview. Although, care was taken to conduct these pilot interviews by including participants who were 
demographically similar to the rest of the cohort, it was not possible in all respects. A thorough process 
of reflection was then allowed after each interview to refine questioning technique and rapport building; 
necessary changes were made to the topic guide accordingly.  
A separate leaflet in seven ethnic languages accompanied the invitation letter, welcoming questions 
from anybody who had difficulty understanding the purpose or conduct of the study..  The researcher 
received a total of 20 calls from different patients and a clear majority (n=15) were referring to a mistake 
in the timings on the patient calendar. They were given guidance and no further calls were received in 
this regard. The remaining calls were about general aspects of research such as the purpose of the 
research, and one patient updated her new address. All of those who made enquiries were satisfied 
with the explanations given.    
Ethics: 
 
Integrated Research Application System (IRAS) was used to apply for ethical approval for the study 
(IRAS ID: 177503). The study was first approved by the procedures of the University of Roehampton 
Ethics Committee (LCS 15/130). Ethical approval was then applied for through the central NHS 
Research and Ethics Committee (REC) and permission was granted from the REC Yorkshire & The 
Humber-Sheffield (Ref: 15/YH/0289). The local NHS research and development department at UHL was 
involved through a site specific application form linked to IRAS (UHL 11418). The details of ethical 




Several software programmes are available to analyse qualitative data, such as: Aquad, CLAN, NVivo, 
ATLAS-ti and others; all have their merits and demerits. For this project, data was analysed in NVIVO® 
version 11, which is Windows® based qualitative data analysis software (Bazeley & Jackson, 2013) and 
its use is well established in qualitative analysis (Bringer et al., 2004, Walsh, 2003). There are several 
advantages of NVIVO® including: it may be used in both qualitative and mixed methods research and 
designed to organise, analyse and find insights in unstructured or qualitative data. In addition to that, it 
also helps index segments of text to particular themes; link research notes to coding; carry out complex 




search and retrieve operations and aid the researcher in examining possible relationships between 
themes (King et al., 2004). 
Quantitative data generated from this study was analysed using SPSS® version 24. Descriptive 
statistics were computed for mean, mode, standard deviation (SD) and associated kurtosis and 
skewness. Normality of the data was assessed by Kolmogorov–Smirnov test (K–S test). Ethnicity and 
gender were compared with Chi-Square test (χ2 test) in 2X2 contingency tables. For the analysis of 
continuous variables such as age or CDAT Score, Student’s t-test was employed or Mann–Whitney U 
test if parametric assumptions were not met. In all instances a statistical value of P = 0.05 or lower was 
considered significant.  
Theme analysis: 
 
The sources of the data were interview transcripts and field notes. The transcribed scripts were 
approached in a systematic way and themes and issues addressed in the interviews were linked to each 
other via a category system. A constant comparative method of analysis (Boeije, 2002) was used where 
different segments such as line, paragraph and sentences were codified in the light of field notes. First 
of all, notes were made after each interview to supplement the recording and they were the spontaneous 
thoughts of the author after each interview, with guidance from previous works (Maxwell, 2012, Strauss 
& Corbin, 1990). Following this, all transcripts were skimmed to ‘’sense’’ the data in terms of volume and 
diversity and then a systematic reading was given to identify different aspects of the contents (Morse & 
Field, 1995). Following this, based on theory or available data, “open coding” was done as per guidance 
from previous research (Flick, 2009) and as shown in Figure below (Fig No 13). 






Figure 13: Interview process to refine the nodes and themes 
 
The codes were divided into different categories by asking questions in relation to nodes. Questions 
such as: “what is this?”, “why is this interesting?” and “is this relevant to the research question?” 
generated descriptive, thematic and analytic categories of nodes respectively (Bazeley & Jackson, 













Figure 14: Data organisation. Adapted NVivo® 11 Essentials by Edhlund & McDougall, 2016 
 




Help was also obtained from the auto coding feature of the NVIVO®. Subsequently higher orders were 
identified in the open codes and the aim here was to condense the data to avoid unnecessary repetition.  
Then the data was reviewed in order to identify similarities between themes, generalisation trends, inter-
code relationships and differences, to generate a set of conclusions which would help to develop 
theories or test hypotheses. Codes were subjected to queries and annotation using NVIVO® to extract 
meaningful directions from the data analysed (Bazeley & Jackson, 2013). The suggested structural 















Patients were asked specific questions during the interview to compare: cost effectiveness, usefulness, 
behaviour modification potential, knowledge potential and over effectiveness of different techniques. A 
simple Likert scale (Likert, 1932) was used to record their opinions. The table below shows the pattern 






Figure 15:  structural hierarchy of the analysis 




Table 31: Question types  in interview  
Direct Questions Indirect Questions  
Cost incurred to mode of intervention  1--2--3--4-5--6--7--8--9--10  
Usefulness of mode of intervention  
1--2--3--4-5--6--7--8--9--10 
 
Effect on knowledge of mode of intervention  
1--2--3--4-5--6--7--8--9--10 
 
Behavioural modification potential of mode of intervention  
1--2--3--4-5--6--7--8--9--10 
 
Overall effectivity of mode of intervention  1--2--3--4-5--6--7--8--9--10 
 
Next, patients were asked about the type of incentive they would prefer to help them remain adherent 
to a GFD. This included categories such as: holidays, monetary incentives, GF food hampers, gift 
vouchers or something else. It was however specified that incentives which had monetary value or were 
expensive maybe available in limited numbers, but GF food hampers might well be available in high 























Participant selection process 
 
Thirty seven patients were selected through a process of randomisation and selection which had several 
phases and none of the patients found the interview objectionable or found any aspect of it sensitive 
enough to cut the interview short (Mealer & Jones, 2014). In the first phase, the responder group (n=375) 
of Study 1 of the PhD (“No Triticeae”) was selected. In addition, an extra 21 patients were also available 
who had replied late and seven of them were non-adherent. Only the non-adherent (n=7) from this group 
were added to the 375 for final possible participation in the study and this made available a total of 382 
participants.  The age of the population ranged from 18 to 85 years (Mdn = 49, IQR = 33-60). This was 
a White Caucasian and female predominant group and had 343 (89.8%) White Caucasians and 267 
(70.7%) females whereas the age of the female sub-group was significantly higher than the male 
counterparts: U = 11508, z = -3.88, p <0.01, r = -.19. CDAT Scores ranged from 7 to 30 (Mdn = 13, 
IQR=13-19). (Appendix 4.2Aa-d). 
 
In the next phase, 255 patients were selected randomly from the above cohort (n=382); they were 
divided into adherent and non-adherent groups. The ages of the population ranged from 18 to 85 years 
(Mdn = 48, IQR=32-59). The population was predominantly white females (59.6%), the randomisation 
increased the number of males from 30% to 32% and reduced the females from 70% to 68% (NS). Total 
CDAT Scores for the population (n=255) ranged from 7 to 30 (Mdn = 16, IQR=11-20). There were 82 
patients whose CDAT score was above 13 and non-adherent according to Leffler’s questionnaire and 
there was no significant difference between male and female participants in relation to adherence to 
GFD (Leffler et al., 2009) (Appendices 4.2Ba-e).  
 
Postal invitations were sent to 255 pts and 135 of the invitations were accepted, giving a return rate of 
53%. All patients filled the patient calendar with clear information about possible dates and timings for 
the interview, along with a contact number. 53.5% of the 155 non-adherent patients responded and 
accepted the invitation; 52% of the 100 adherent patients responded.   
 




The ages of the population (n=135) ranged from 18 to 82 years (Mdn = 44, IQR=31-57) and CDAT 
Scores for the population ranged from 7 to 30 (Mdn = 16, IQR=12-20). There were 40 (29.6%) patients 
whose score was above 13 and non-adherent according to Leffler’s questionnaire. At all levels of 
selection and randomisation, there were no significant differences in age, gender and ethnicity (table 








Table 32: Different phases towards final selection of patients for interview  




















Mdn CDAT (IQR) 13 (10-19) 16 (11-20) 10 (8-13)  16 (11-20) 11 (9-13) 19 (16-22)  16 (12-20) 12 (9-13) 20 (16-22)  
Mdn Age (IQR) 49 (33-60) 48 (32-59) 51 (33-62) .32* 48 (32-59) 51 (32-60) 46 (33-59) .55* 44 (31-57) 45 (31-59) 43 (31-56) .43*** 
Males 115 (30.1%) 82 (21.5%) 33 (8.6%) .21** 82 (32.2%) 29 (11.4%) 53 (20.8%) .38** 45 (33.3%) 15 (11.1%) 30 (22.2%) .38** 
Females 267 (70.7%) 173 (45.3%) 94 (24.6%) 173 (67.8%) 71 (27.8%) 102 (40.0%) 90 (66.7%) 37 (27.4%) 53 (39.3%) 
White Caucasians 343 (89.8%) 227 (84.4%) 116 (30.4%) .48** 227 (89.0%) 89 (34.9%) 138 (54.1%) .99** 116 (85.9%) 44 (32.6%) 72 (53.3%) .72** 
 South Asians  39 (10.2%) 28 (15.2%) 11 (2.9%) 28 (11.0%) 11 (4.3%) 17 (6.7%) 19 (14.1%) 8 (5.9%) 11 (8.1%) 
*Mann Whitney U test, **Chi Square test, ***Independent sample t test 




Selection of the patients to interview: 
 
Since the number of responders (n=135) exceeded the number of intended interviews (n=52), 80 
participants were randomly selected (described below) from the responders, by first dividing them into 
adherent (n=52) and non-adherent groups (n=83) and then separately randomising them. It was 
estimated that 20 interviews would be sufficient from the former group, so by random selection 20 
participants were selected (Guest et al., 2006a). Similarly, 60 participants were randomly selected from 
the non-adherent group. A total of 52 interviews were planned to be conducted based on theme 
saturation, 15 were for the pilot study and 37 were included within the analysis. 
Those who were not included in the interview were individually called to thank them for their help with 
the research; the author apologised for not conducting their interviews, explaining that the required 
number of interviews had already been conducted. The figure below shows the staged approach 
towards final selection of individual participants for the interviews (Fig No 16).  
 
 
Figure 16: Bar chart showing the selected and interviewed populations. 
 
Demographics of the pilot interview group: 
 
As explained earlier 15 adherent participants were randomly selected from those patients who accepted 
the interview invitation (n=135) for pilot interview and out of them 13 were interviewed to refine the topic 
guide. The age of the population (n=13) ranged from 32 to 68 years (Mdn =53, IQR= 43-59) and it was 




normally distributed. There were nine females in this interviewed group. Additionally, there were two 
South Asians in the group and the remaining were White Caucasians. Furthermore, there were 10 
patients who were adherent to GFD in this group. The CDAT score of this group ranged from 10 to 16 
and it was not distributed normally (Mdn=13, IQR= 10-16). Six interviews were conducted in international 
languages (3 Hindi/Urdu and 3 in Punjabi) and the remaining were conducted in English.    
 
Demographics of the finally interviewed group: 
 
The age of the study population (n=37) ranged from 19 to 77 years (M = 43, SD = 15.2). The gender 
and ethnic distributions of the populations of pre and post randomised samples were compared and are 
shown in the Table below (Table No 33).  
 
Table 33: Characteristics of the adherent and non-adherent groups. 
 Adherence to a GFD  
Variables Total Adherent Non-adherent  P Value 
 n=37  9 (39.2 %) 28 (60.8%)  
Mean Age ± SD 43± 15.2 43.4 ± 17.3 42.8 ± 14.8 .61* 
Age Groups     
 <  20 years 1 (2.7%) -- (--%) 1 (2.7%)  
 21 -30 years 9 (24.3%) 3 (8.1%) 6 (16.2%)  
 30-40 years 5 (13.5%) 1 (2.7%) 4 (10.8%)  
 41-50 years 12 (32.4%) 2 (5.4%) 10 (27.0%)  
 51-6- years 4 (10.8%) 2 (5.4%) 2 (5.4%)  
 61-70 years 4 (10.8%) -- (--%) 4 (10.8%)  
>  70 years 2 (5.4%) 1 (2.7%) 1 (2.7%)  
Gender    .056** 
  Male 8 (21.6%) 4 (10.8%) 4 (10.8%)  
  Female 29 (78.4%) 5 (13.5%) 24 (64.9%)  
Ethnicity    .86** 
  White Caucasians 28 (75.7%) 7 (18.9%) 21 (56.8%)  
  South Asians 9 (24.3%) 2 (5.4%) 7 (18.9%)  
*Independent sample T test, **Chi Square test 
 




The table above shows there was no significant difference between the ages of adherent (M=43.4, 
SD=17.3) and non-adherent (M42.8, SD=14.8) patients, Conditions; t (35) =-.099, p=.92. Likewise there 
were no significant differences between the genders, χ2 (1, n=37) =3.65, p=.056, phi = -.31 or ethnicities, 
χ2 (1, n=37) = .029, p=.86, phi = -.02 (Appendices 4.2Da-d)   
The number of absolute non-adherent patients, who were ingesting gluten on a daily basis in this group 
was 7 (5.5 %), followed by 25.1% who were ingesting gluten on a weekly basis. The table below shows 
the self-reported gluten ingestion of the population (Table No 34). 
 
Table 34 : Ingestion of gluten in the study population. 
 Ingestion of Gluten   
 Adherent (n=9)  Non Adherent (n=28)   
Frequency Frequency Percentage  Frequency Percentage 
 Total  
Never 9 100%  0 0.0% 
 9 (24.3%) 
Daily 0 0  1 3.6% 
 1 (2.7%) 
Once a week 0 0  8 28.6% 
 8(21.6%) 
Once a month 0 0  18 64.3% 
 18 (48.6%) 
rarely 0 0  1 3.6% 
 1 (2.7%) 
Total 9 24.4%  28 75.6% 
 37 
 
Total CDAT Scores for the population (n=37) ranged from 9 to 29 (M = 18.3, SD = 5.8). The scores were 
distributed normally (p=0.00), with skewness of .28 (SE = .38) and kurtosis of -.91 (SE = .75). The 










































A total of 37 participants were interviewed, as at this point themes were saturated and no further 
interviews were conducted thereafter (Guest et al., 2006b). It was a predominantly White Caucasian 
sample with a female predominance. The number of Caucasians was 28 (76%) and there were 29 (78%) 
females in the interviewed group. Interviews lasted for up to 30 minutes. All non-adherent participants 
wanted to increase their adherence, which meant that they were not on the initial phase of the trans-
theoretical model of behaviour change (Prochaska et al., 2008), where people have not thought about 
changing their behaviour as yet. 
Theme analysis: 
 
The most common words in the interviews were first detected through a word query and the most 
common word was “Researcher” followed by the word “Patient”. This was used in the generation of 
nodes for further analysis. The word cloud of all the transcripts is shown in the figure below (Fig No 18). 
 
Figure 18: Word Cloud of all transcripts in the study. 
 
Following this, main nodes were generated by going through each transcript; they were classified into 
main themes from A to S based on relevance to the theme and research question. This step generated 
19 main nodes, where the most common theme was CD clinics, which had 37 sources and 324 




references. The word “adherence” had 28 sources and 188 references. Main nodes and their relative 
frequencies are displayed in the table below (Table No 35). 
Table 35: Classification of nodes in the main stem. 
 
Node Type Sources References   Classification 
     
Adherence  28 188  Thematic, Analytic 
Belief and GFD 12 33  Thematic, Analytic 
CD Clinics 37 324  Thematic, Analytic 
CD Diagnosis 7 7  Descriptive 
Complication of CD 12 25  Descriptive, Analytic 
Cost and GFD 1 2  Descriptive, Analytic  
Demographics 0 0  Descriptive  
Hospital and CD 0 0  Thematic, Analytic 
Cultural Perceptions 3 3  Thematic 
Dietitian Appointment 12 12  Thematic, Analytic 
CD Knowledge 10 11  Descriptive, Analytic 
Gluten Free Diet 37 37  Descriptive, Analytic, Thematic 
Mode of Intervention 3 6  Descriptive, Analytic, Thematic 
GFD on Prescription 8 9  Descriptive, Analytic 
Problem following GFD 2 3  Thematic, Analytic 
Restaurant and GFD 5 7  Thematic, Analytic 
Rewards and Adherence  0 0  Descriptive 
Shopping and GFD 8 9  Descriptive 
Miscellaneous  0 0  Descriptive, Analytic, Thematic 
 
Adherence to a GFD: 
 
This appeared in 28 nodes and 188 references; several sub themes were identified among the nodes 
and references. The figure below gives details of this and related nodes (Fig No 19). 
 
 


















One of the principle sub themes was if adherence was possible at all and 26 out of 28 responded yes. 
Similarly 22 out of 28 were of the opinion that a GFD could be adapted. 
 
Several factors (Nodes=41) were identified which could possibly lead to low adherence in the population. 
These were broadly classified into lack of knowledge (Nodes=13, References=36), finding themselves 
in situations leading to low adherence (Nodes=2, References=2), unacceptable taste (Nodes=2, 
References=2) and lack of variety in GF products (Nodes=1, References=36). Additionally, availability 
of GF products, either on prescription or in local stores, was related to the main theme of adherence to 
a GFD. Furthermore there were special situations e.g. travelling or dining at a friend’s house, which lead 
to non-adherence to a GFD.  
 
Knowledge about a GFD was based on belief about the necessity of adherence to a GFD (Nodes=37, 
References=108) and beliefs about a GFD itself (Nodes=12, References=33). In the former category, 
theme analysis revealed that 16 participants (57%) from the non-adherent group did not consider it 
important or necessary to adopt an absolute GFD. Generally, being symptom free was one factor in 
non-adherence to a GFD, as suggested by a patient: 
 
“…. but you see, I don’t think it is an important element in controlling the disease activity 
especially if I haven’t got any issue with that….” (CD2/001, F, 21 years) 
 
The latter category included beliefs about the cultural and nutritional importance of gluten i.e. bread and 
it was given a central role in the diet as suggested by a patient: 
 
 “I ate rice for a few weeks but then you cannot eat rice all your life, can you? (CD2, 013, F, age 
34) and “wheat is an essential part of our culture.. Something we have been doing for centuries.. How 
can that be an issue when our forefathers have done something for years and now it suddenly became 
an issue (CD2, 011, F, age 23).   
One patient refused that he would ever be able to adapt his diet based on his culture and the other 
referred to religious issues;  




“The diet does not fit in our cultural aspect.” (CD2, 010, F, age 49), “…it is a matter of religion 
after all… what to eat and what not to eat…(CD2, 012, M, age 42). 
A dominant majority (22/28) were able to consider adapting strict adherence provided they had 
information about this subject. Linked to this concept, knowledge about a GFD was related to CD 
knowledge (Nodes=37, References=368) and that had many sources including: hospital dietitians, 
family and friends, patients with CD, social media and clinicians. This was further related to knowledge 
about complications of CD (Nodes=12, References= 25). Knowledge about complications of CD was 
one area where patients lacked a degree of insight and this was gathered under a single node 
(Nodes=12, References= 25). There were sub nodes such as: bone health complications, complications 
of CD in relation to cancer and haematological complications of CD. Theme analysis showed that 23/28 
patients lacked knowledge about these complications. The overall theme analysis showed that 
improving knowledge may lead to improvement in adherence to a GFD. The figure below shows the 
interrelation of these nodes and possible related effects of low adherence to a GFD (Fig No 20). 
 
 








The taste of GF products was featured in nodes (n=2) and sub nodes (n=2) i.e. adherence to a GFD, 
cultural perceptions about a GFD, issues with a GFD and the restrictive nature of a GFD. A total of 16/28 
participants had issues with the taste of GF products.  
 
“Gluten free products have no taste (CD02/001, F, Age 21), “…and has no taste…” (CD02/010, 
F, Age 49), “tastes bad and smells.. Don’t want to say .. But I don’t like it. (CD02/018, M, Age 56), “it is 
not a palatable a diet you see… I like my bread..” (CD02/020, M, Age 29), and “taste is not good either” 
(CD02/023, F, Age 42).  
 
Furthermore, several nodes (n=5) were related to availability of GF products: Shopping and GFD, 
Prescription and GFD, Problems following a GFD, Restaurant and GFD. Local stores in Asian quarters 
were not selling GF products as acknowledged by all of the Asian patients. In contrast GF foods were 
available in major supermarkets. Theme analysis showed that, lack of availability of GFD (n=11)  had 
negative impact on the adherence to GFD. Finally, there were two important situations (travelling and 
visiting a friend’s house) which posed special issues with following a GFD. Patients commented that it 
was difficult to obtain GF products (n=11), they felt embarrassed when asking for GF products (n=5), or 
found it impossible to prepare and carry GF products when travelling (n=7).  
 
I do my grocery from XXXX (Asian shop).. they don’t have anything for gluten.. (CD2, 010, F, 
age 49), “…no gluten products are available in our local store, (CD2, 011, F, age 23), “..Well sir it is 
restrictive when you go out, you cannot eat what other would like to eat…”  (CD2, 015, F, age 53), 
Problem in following a GFD: 
 
Patients in the non-adherent group (28) were asked specifically for problems faced in following a GFD; 
the multifactorial nature of the issue was evident. The bar chart below (Fig No 21) shows the reasons 
for poor adherence in the South Asian group (n=7).   





Figure 21: Problems in following a GFD reported by pts not adhering to a GF diet 
 
GFD was reported by patients to be associated with high cost 
 
“….gluten free product, it does not come cheap you see…”(CD02/002, F, Age 30), “..it does not 
come cheap… (CD02/004, F, Age 45), “..very pleasant a diet,  very cheap!! (being sarcastic)”.. 
(CD02/007, F, Age 49), and ” is restrictive in travelling.. dining out and not a cheap diet..” (CD02/023, F, 
Age 42). 
 
A GFD was considered restrictive by patients:  
  
“well it is restrictive because what you can eat, where you eat and who you eat with is dependent 
on if you will eat gluten or not.. did I make it too complicated? (laughing) (CD02/004, F, Age 45), “it is 
difficult and it takes away my control .. so a bit restrictive” (CD02/024, F, Age 46), “gluten (free) diet is 
… restrictive, one, and secondly it is restrictive in travelling.. dining out” (CD02/023, F, Age 42), “well 
you either have to go on this diet or socialise.. it is a restrictive diet.. one cannot follow it all the time, 
that is why it is not possible” (CD02/019, F, Age 51), and “well sir it is restrictive when you go out, you 
cannot eat what others would like to eat … that makes the choice of restaurants very limited for me..” 
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Cross contamination is another issue which was a major intentional and unintentional barrier to GFD 
adherence. It was a non-modifiable factor to some extent as well. In the patients’ words: 
 
 “…secondly the spices we bring from Pakistan, might well have contamination from the supplier 
or producer as we saw on the tele..” (CD02/017, F, Age 36) and “again to avoid gluten…not to eat wheat, 
to avoid contamination while cooking but these are practical issues, easier said than done.. (CD02/018, 
F, Age 56). 
 
Reward for GFD adherence: 
 
All patients were given the option to select one out of five rewards, as an incentive for following a GFD. 
12 patients selected monetary incentives, followed by the option of a holiday abroad. The breakdown of 
the results is given in the bar chart below (Fig No 22).   
 




There were several non-classifiable nodes (n=13) which were grouped under the miscellaneous 
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Table 36: Classification of Nodes in the main stem. 
 
Node Type Sources References   Classification 
     
Dietary Issues 16 20  Thematic, Analytic 
Ready for GFD 29 77  Thematic, Analytic 
Sarcasm about GFD 4 6  Thematic, Analytic 
Specific issues  30 74  Descriptive 
Religious issues 2 2  Descriptive 
Food labelling GFD  2 4  Thematic, Analytic 
Ideas about CD 33 111  Thematic, Analytic 
Inadvertent gluten intake 1 1  Descriptive 
Priorities GFD  28 29  Descriptive 
Programme 28 35  Descriptive 
 
Patients referred to religious issues (being vegetarian) in the context of a GFD:  
 
“GP and these gluten free company what do you call them.. yes XXXX they only do English 
meals .. there are few vegetarian meal.. but you never know what they mix in it.. it is a matter of religion 
after all..” (CD02/012, F, Age 42), “I cannot get my head around what is gluten free and what is not 
gluten free to be honest.. I ate rice for few weeks but then you cannot eat rice all your life, can you? 
(CD02/013, F, Age 34) and “well the labelling now shows the ingredients to a much greater extent than 
it used to do and usually it highlights the things that people are likely to be allergic to on the label itself..” 
(CD02/032, M, Age 54) 
 
Choice of Intervention: 
 
 
A principal aim of the study was to ascertain the best mode of intervention based on patient views, to 
increase adherence to a GFD; approximately half of the interview time was spent probing this issue. 











Table 37: Classification of Nodes in the main stem. 
 
Node Type Sources References   Classification 
     
CD Day conference 32 289  Descriptive, Thematic 
Planning to improve 18 19  Descriptive, Thematic, Analytic 
Possible to be adherent  29 48  Descriptive, Analytic 
Telephonic contact  29 64  Descriptive, Thematic, Analytic 
Text messages 1 1  Descriptive, Thematic,  
Website   6 10  Descriptive,  
Ready to improve adherence  18 20  Descriptive, Thematic, Analytic 
Emails and adherence   28 270  Descriptive, Thematic,  
Face to face interview 1 1  Descriptive, Thematic, Analytic 
Group interaction  0 0  Descriptive, Thematic, Analytic 
Home visit 34 312  Descriptive,  
Leaflets  10 16  Descriptive,  
Method 29 30  Descriptive, Thematic, Analytic 
Motivation 8 13  Descriptive, Thematic, Analytic 
 
These options were grouped and weightage was assigned to different individual options based on 
participants’ weightage, negative comments and thematic analysis; the idea is represented in the figure 
below (Fig No 23).  
 





Figure 23: Intervention methods based on importance and frequency of nodes.  
 
Standard clinic and dietitian appointment: 
 
This theme was liked by 37 participants. All patients had seen a dietitian and clinician at some stage of 
their diagnosis.  The theme was difficult to node under one heading, as it was partly shared by three 
main themes i.e. Hospital and CD, CD Clinics and Costs and CD. Although it was available as both 
clinician and dietitian appointments, the most favourable option was a combined clinic with dietitian and 
clinician and this was sourced from 12 sources and 12 references.  Interestingly all adherent patients 
liked the concept and they had only positive comments about it. All patients liked the way dietitians 
explained CD and patient-related literature to them. Moreover, the way in which the clinician described 
the disease to them was well liked by all patients. In general terms, clinics were friendly (n=28), full of 
information (n=33) and useful (n=15), but a few patients found them difficult: 
 
“Clinical appointments .. I have an issue with them, I have to take time off, arrange transport 
and a lot more….” (CD02/002, F, Age 30), “…don’t like the appointments.. and then arranging time off.. 
so possibly it is difficult for me.. (CD02/024, F, Age 46), and I would love to see them again for a longer 
appointment you see.. if at all…(CD02/001, F, Age 21), 
 




Car parking was the main negative issue with regards to hospital appointments. Parking was considered 
unpredictable (n=23), difficult to get (n=20), expensive (36). Additionally, it was difficult to get into the 
car park and to exit the main barrier (n=7). Patients also highlighted negative aspects about the inability 
to pay through debit nor credit card (n=10) and that the parking payment machines would only accept 
coins and would not give change (n=11). Also, the parking payment machines were designed so that 
one had to pay for a pre-determined amount of time, which meant that there was potential for 
overpayment, as asserted by the patients: 
 
“…think the hospital car park is a serious main issue .. costly and always eager to charge more.. 
that is the real issue …with clinical appointments. ..charges are on the mount and people pay a fine 
because they are late to collect their cars (CD02/015, F, Age 53), “…many issues such as parking which 
is not cheap these days.. used to be reasonable a few years ago.. but now it is all about money you 
see.. (CD02/005, F, Age 74), and “..Parking is another issue, very strange issue not sure how to describe 
it..” (CD02/007, F, Age 49), 
 
Other issues with clinics were: repeated cancellations and changes in time of attendance (n=10) and 
prolong waiting times; these were further aggravated by the over parking issues and related anxiety. 
Privacy in clinic was another issue raised by the participants (n=23):   
 
“…you are seen by many people in the same clinical area where other people are sitting. They 
might know you.. privacy is non-existent in the NHS.. people shouting your name.. Mr this and that.. Mrs 
this and that.. honestly ..(sounding frustrated)” (CD02/003, M, Age 42), Serious issues with the privacy.. 
no way I am going to discuss my personal problems there” (CD02/014, F, Age 61), I have heard people 
talking aloud and even in the clinical room you can hear what the other person is saying, no privacy at 





A telephonic clinic idea was liked by both adherent and non-adherent participants. This was based on 
the seriousness of individual interview responses and node frequency. It had 29 associated nodes and 




64 references and was liked by a clear majority of the participants (n=33); this was then sub divided into 
four sub nodes as detailed in the table below (Table No 38). 
Table 38: Classification of Nodes and telephonic clinic. 
 
Node Type Sources References   Classification 
     
Telephonic clinic 10 19  Descriptive, Thematic, Analytic 
Telephone pros and cons 37 65  Descriptive, Thematic, Analytic 
Telephonic contact method  33 46  Descriptive, Thematic, Analytic 
Telephonic interaction   31 271  Descriptive, Thematic, Analytic 
 
Telephonic interaction was considered easy (n=33), flexible (n=29) and convenient (n=19) for the 
patients.  Theme analysis showed that patients approved of it as a practical intervention based on their 
experience of using the telephone in both personal and professional life. It was considered important for 
privacy (n=27) and ease of communication (n=18). In addition to that, the telephonic clinic gave control 
to the patients to stop the conversation when they wanted to (n=20). This theme was further explored 
and, based on patients’ experience (n=8), they could hang up without giving any specific reason to the 
interviewer.  
The themes were analysed for pros and cons of a telephonic interview. A clear majority of participants 
considered this method friendly (n=25), convenient and deliverable in the ease of their home 
environment. This has the added advantage of privacy and being cost effective to the patients (n=28). 
Furthermore, this was eco-friendly (n=27) as it avoids driving to hospital or another face to face contact, 
thus avoiding adding to the carbon footprint. .   
Telephonic teaching in conjunction with a supplement leaflet was favoured by 31 patients. The figure 
below shows the theme as perceived by the participants in the study. There were however concerns 
such as lack of face-to-face contact for the participants, which may lead to an uncomfortable situation, 
as body language may not be read by either the health care professional or the participant. The 
telephonic clinic was predominantly considered acceptable and practical to the patients based on ease, 
cost, flexibility and privacy and this is represented in the figure below (Fig No 24).  
 







Figure 24: Telephonic clinic pros and cons. 
 
CD day conference: 
 
A CD day conference was featured in 289 references and from 32 sources. A clear majority of patients 
(n=24) liked the idea and it was opposed by six patients; the remaining patients had a neutral opinion 
about it. The breakdown of sub themes is given in the table below (table No 39). 
Table 39: Classification of Nodes and CD day conference. 
Node Type Sources References   Classification 
     
Information lecture 6 8  Descriptive, Thematic, Analytic 
Course  8 9  Descriptive, Thematic, Analytic 
Negative comments  1 1  Descriptive, Thematic, Analytic 
Positive comments 1 1  Descriptive, Thematic, Analytic 
CD talk  37 126  Descriptive, Thematic, Analytic 
 
The perceived usefulness of a conference was related to the focused nature of the educational material 
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presenters (n=4), providing detailed views from experts in the field. Moreover, group activity was valued 
highly among several patients (n=18), mainly Caucasian, due to the advantages of socialising (n=10) 
and associated group support (n=10). Thematic analysis showed that lecture based talks were also 
acceptable to patients (n=6), as they found this traditional teaching method equally effective. Lectures 
were thought to be an effective source of background information (Nodes=6, References=8) and these 
ideas could subsequently be developed through private study.  
Several participants (n=9) thought it was a good idea if the lectures were part of a course over a few 
weeks (Nodes=8, References=9). Three participants thought that lectures were passive activity and 
there was only a  limited role for lecture based education in changing attitudes and behaviour; this was 
partly related to an inability to attend such events, as suggested by patients: 
  
“…not sure if that is going to be useful though .. but will give it a go” (CD02/008, M, Age 65), 
“…possibly difficult for me at this stage, I am too busy to attend group discussions..” (CD02/002, F, Age 
30), “…no issue at all… but it might not be possible to come to the course.. depends..” (CD19/002, F, 
Age 51), “….that will be good, and I will; agree with this.. not sure I will be able to come for the whole 
day.. arranging a day off for a coeliac disease type day.. may not be possible.. I have a manager you 
see.” (CD02/001, F, Age 21).  
The figure below shows the theme as perceived by the participants (Fig No 25). 
 
 
Figure 25: Coeliac disease day and related themes. 
 




Cost was an issue for a majority of patients (n=33) in particular travel (n=17) and parking (n=12) related 
costs; this was one of the deterring factors as suggested by patients: 
 
“…and then parking is a very difficult issue you see..” (CD02/001, F, Age 21), “but car parking, 
waiting for the appointment is an issue” (CD02/017, F, Age 36), “many issues such as parking which is 
not cheap these days.. used to be reasonable few years ago” (CD02/005, F, Age 74), “parking in the 
hospital you see that is another issue.. (CD02/002, F, Age 30), and car parking in the hospital is also an 
issue.. .. (CD02/025, F, Age 19) and “ …honestly .. and car parking.. don’t even go there” (CD02/003, 
F, Age 42). 
 
Other deterring factors were: privacy related issues (n=7), clashes with job commitments (n=13), and 
availability of time for a day’s conference (n=4). It is thus inferred that lecture based teaching was well 
liked by participants but was at a cost to them and considerable time commitment. 
 
Web based teaching: 
 
This was sourced from 6 sources and 10 references. Web based teaching received 13 “yes” comments 
from participants, mainly females (n=11). All of those who approved this methodology insisted on related 
video links being included, as “dry slides” were considered boring.  The table below shows the 
breakdown of sub nodes for this intervention (Table No 40). 
 
Table 40: Classification of Nodes and web based teaching. 
 
Node Type Sources References   Classification 
     
Computer based teaching 19 20  Descriptive  
Internet based programme 29 40  Descriptive, Thematic 
Negative comments  3 5  Descriptive, Thematic, Analytic 
Role of social media 2 2  Descriptive, Thematic, Analytic 
Web based approach  20 26  Descriptive, Thematic, Analytic 
 
There were mixed views from the patients about web based teaching and in the patients’ words: 
 




“hmmm.. may be a good idea.. maybe.. internet..” (CD02/022, F, Age 50), “not sure.. not a very 
attractive idea.. for me at least internet” (CD02/023, F, Age 42), This will work for me yes especially with 
videos in it.. Explaining the concepts” (CD02/002, F, Age 30),  and “I think this will engage me but think 
of other people who might not be internet learned for a variety of reasons. Not sure one can generalize 
this idea .. ” (CD02/005, F, Age 74).  
 
Theme analysis revealed that such a methodology was practical only if patients had the chance to 
interact with an instructor. The main issues attached to web based teaching were: computer literacy, 
dependence on technology, internet access and attached costs to the patients. The figure below shows 


















This was sourced from 34 sources and 312 references. 35 patients opposed home visits as a possible 
intervention, based on a variety of issues including: being intrusive (n=8), breach of private life (n=9), 




Figure 26: Web based teaching and theme analysis. 




“..home might be difficult..” (CD02/024, F, Age 46), “..not a feasible option..” (CD02/003, M, Age 
42), At home? No.. I think it is difficult.. not sure about that.” (CD02/002, M, Age 42), “See .. well .. not 
sure.. I think no…” (CD02/020, F, Age 29) and “home.. no way.. do you think it is a good idea to go to .. 
well (laughing) (CD02/028, F, Age 30).  
Since this was a sensitive issue, and not liked by the majority of participants it was not explored in further 
detail.  
Other themes and adjuvant measures: 
 
Compact discs, DVDs or books were only favoured by two of the participants. A YouTube® link was 
favoured (n=20), but only in relation to web based teaching. Intervention through Skype® was favoured 
by nine patients and group calls were rejected by 35 patients.  Although email was accepted by 25 
patients but text messages were not favoured (n=28). Email related teaching was not considered 
productive by 31 participants.  
“I get so many email and .. Well I might not get through them you see..” (CD02/01, F, Age 21). “Emails 
have their own issues.. I mean spam etc.. (CD02/02, F, Age 31). “Emails, hmm.. good.. will give it a try, 
not sure it will affect me a lot.. (CD02/04, M, Age 45). 
The figure below summarises the main issues in Miscellaneous or adjuvant themes (Fig No 27).  
 
 
Figure 27: Patients’ views on printed and web based material. 
 






All participants were asked to assign a number from 1 to 10 to each mode of intervention against certain 
parameters. CD day conference and telephonic clinic achieved the highest overall value (8), followed 
by standard clinic. Telephonic clinic, home visit and Skype were the least expensive options. The trend 
was similar for both adherent (n=9) as well as non-adherent patents (n=28). The results of the 
comparative analysis for cost and usefulness of the methods of interventions are given in the bar chart 
below (Fig No 28). 
 
 
Figure 28: Mean values form Likert scale (n=37). Comparative analysis of all available methods of intervention. High 
cost is a detriment to patient and vice versa. High usefulness is a benefit and promotes the choice of methodology. Y 
Axis shows Likert scale.    
 
Based on the above bar chart, as suggested by the participants, it can be inferred that the telephonic 
clinic is considered the most cost effective method and convenient for the patient as it has low cost 
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Comparison of knowledge, adherence to a gluten free diet and difficulties faced by 
Asians and Caucasians in relation to coeliac disease 
 
There were 21 White Caucasians (75%) and 7 South Asians (25%) interviewed who were not adhering 
to the GF diet. All South Asians were born outside the UK but has spent more than 10 years in the UK. 
Fifteen (53.6%) patients were members of the Coeliac Society of the UK. The ages ranged from 19 to 
74 years (M = 42.8, SD = 14.8). The table below shows their demographics (Table No 41).  
 
Table 41: Characteristics of population according to gender 
 
Ethnicity  
Variables Total White Caucasian South Asian P Value 
 n=28  21 (75 %) 7 (25%)  
Mean Age ± SD 42.8± 14.8 44.8 ± 15.9 37 ± 9.3 .23* 
Gender    1.0** 
  Male 4 (14.3%) 3(10.7%) 1 (3.6%)  
  Female 24 (85.7%) 18 (64.3%) 6 (21.4%)  
*Independent sample T test, **Chi Square test 
 
The sample was mainly White Caucasian and the dominant gender was female, but there was no 
significant difference between the ages of the White Caucasians (M=44.8, SD=15.9) and South Asians 
(M=37, SD=9.3), Conditions; t (26) =-1.21, p=.23. Likewise there was no significant difference between 
the genders, χ2 (1, n=28) =.00, p= 1, phi = .00 (Appendices 4.2Ea-c). The patient CDAT scores ranged 
from 10 to 29 (M = 20, SD = 5.4). CDAT scores for White Caucasians ranged from 11 to 28 (M = 19.2, 
SD = 4.8) similarly, CDAT scores for the South Asian population ranged from 10 to 29 (M = 22.2, SD = 
6.7) and there was no significant difference between these scores (Appendix 4.2Ed) 
 
Knowledge about CD: 
 
Knowledge about CD was classified in 10 nodes and it was derived from 11 references and multiple 
field notes (n=17). All participants commented about this issue. There were three sub nodes which were 




further classified into 15 nodes. Sub nodes were further classified into daughter nodes. Theme analysis 
was related to other nodes such as: complications of CD, miscellaneous, symptoms of CD and food 
label reading. The main theme was source of knowledge, which was mainly from dietitians and patients 
showed satisfaction with the information provided, as shown in the table below (Table No 42). 
 
Table 42: Classification of Nodes in the main stem. 
 
Node Type Sources References   Classification 
1 Knowledge about CD 10 11  Descriptive 
1.1 Information CD 37 368  Descriptive, Thematic, Analytic 
  1.11 Coeliac 13 14  Descriptive, Thematic, Analytic 
     1.111 CD health 3 3  Descriptive, Thematic 
  1.12 Coeliac day to day 3 3  Descriptive, Thematic, Analytic 
2 Knowledge other 6 20  Descriptive, Thematic, Analytic 
 1.1 CD Related 5 6  Descriptive, Thematic, Analytic 
 1.2 Bone health 13 29  Descriptive, Thematic, Analytic 
 1.3 CD Social 1 1  Descriptive, Thematic, Analytic 
 1.4 CD Complication a 4 9  Descriptive, Thematic, Analytic 
 1.5 CD Complication b 1 1  Descriptive, Thematic 
 1.6 CD and GUT 9 17  Descriptive, Thematic, Analytic 
 1.7 CD Causes 1 1  Descriptive, Thematic, Analytic 
   1.71 Complication 1 1  Descriptive 
   1.72 Symptoms 2 3  Descriptive 
 1.8 CD understanding 27 63  Descriptive, Thematic, Analytic 
 1.9 GFD usefulness  1 1  Descriptive, Thematic, Analytic 
 1.10 Wheat 22 17  Descriptive, Thematic, Analytic 
3 Source of information   37 126  Descriptive, Thematic, Analytic 
 3.1 Dietitian and clinician 3 3  Descriptive, Thematic 
 3.2 Internet 4 5  Descriptive, Thematic 
 3.3 Others 1 1  Descriptive, Thematic 
 
The majority of patients (n=26) correctly linked wheat to CD, but the information was patchy about the 
exact relationship with wheat. Four patients thought that CD would cause cancer at some stage in their 
lives, while others (n=11) thought that consuming a small amount of wheat was not harmful. Additionally, 
knowledge about a GFD was not uniform and 13 patients thought a GFD was for weight loss in CD. 
Similarly, another six patients thought a GFD meant only avoiding wheat. Interestingly, three Asians 
patients thought only wheat in Chapattis was harmful in CD. Following on from this, different areas were 
explored in a quantitative manner and the table below shows the results of a series of questions that 
patients were asked in order to explore these aspects (Table No 43) 




Table 43: Comparison of  White Caucasians and South Asians in following a gluten free diet  
 Total (n=28) White Caucasian (n=21, 75%)  South Asians (N=7, 25%)  
Variables M±SD Mdn (IQR) Min-Max M±SD Mdn (IQR) Min-Max M±SD Mdn (IQR) Min-Max P 
  Age  42.8± 14.8 42 (30-50) 19-74 44.8 ± 15.9 45 (31-58) 19-74 37 ± 9.3 36 (29-46) 23-49 .23* 
  CDAT Score 20.04±5.4 19 (15-26) 10-19 19.2±4.8 19 (15-230 11-28 22.2±6.7 25 (18-28) 10-29 .21* 
  Sufficiency of information Gluten 70.3±26.4 80 (60-90) 0-100 74.7±20.4 80 (70-90) 30-100 57.1±38.6 60 (10-90) 0-100 .34** 
  Sufficiency of information GFD 68.2±23.7 80 (50-80) 0-100 72.8±19.2 80 (65-80) 30-100 57.1±33.0 50 (40-80) 0-100 .29** 
  Confidence about GFD 68.2±21.2 70 (60-80) 10-100 71.9±16.6 70 (65-80) 30-100 57.1±30.3 70 (30-80) 10-90 .43** 
  Eating home cooked meal per week 72.5±18.5 80 (60-87) 30-100 66.1±16.8 70 (55-80) 30-90 91.4±8.9 90 (80-100) 80-100 .00* 
  Order cooked meal / eat out per week 38.1±23.3 40 (30-50) 0-90 44.5±21.6 40 (30-57) 10-90 20.0±19.1 30 (0-40) 0-40 <0.01* 
  Confidence in person preparing meal  39.5±26.5 40 (10-50) 0-90 45.2±23.6 50 (3-60) 10-90 12.5±25.0 0 (0-37.5) 0-50 .02* 
  Difficulty following GFD eating out 84.8±21 90 (90-100) 0-100 81.9±22.7 90 (70-100) 0-100 95.0±8.3 100 (87-100) 80-100 .12** 
  Difficulty following GFD in friend’s house 93.9±8.7 100 (90-100) 70-100 91.9±9.2 90 (85-100)  70-100 100.0± -- 100 (100-100) 100-100 .04** 
  Difficulty following GFD travelling 90.3±11.0 90 (80-100) 70-100 88.1±11.23 90 (80-100) 70-100 97.1±7.5 100 (100-100) 80-100 .04** 
  Sufficiency of GFD on prescription  45.1±18.0 50 (30-60) 10-70 50.0±15.2 50 (32-60) 20-70 31.4±19.5 30 (10-50) 10-60 .03** 
  Difficulty buying GFD 78.1±21.1 80 (70-90) 0-100 80±15.2 80 (70-90) 40-100 72.8±34.0 90 (70-90) 0-100 .97** 
  Availability of GFD in store 70.3±44.0 100 (10-100) 0-100 88.5±28.3 100 (90-100) 0-100 15.7±37.3 0 (0-10) 0-100 <0.01** 
  Problem with taste of GFD 30.3±18.7 30 (20-40) 0-80 27.6±14.8 30 (20-40) 0-50 38.5±27.3 30 (10-70) 10-80 .18* 
  Improvement on GFD 34.2±24.4 30 (20-47) 0-90 28.1±19.3 30 (10-400 0-70 52.86±29.8 40 (30-90) 20-90 .01* 
  Symptoms after gluten ingestion  31.07±20.0 30 (12-40) 0-90 24.7±14.0 30 (10-400 0-50 50±24.4 50 (30-80) 20-80 .02** 
*Independent sample t test, **MWU test 






The table above shows that there exists significant differences in relation to eating food at home and 
ordering precooked meals. In addition to that, there is also a significant difference in confidence in the 
person who serves the meal ( in restaurants),  difficulty following a GFD in a friend’s house, sufficiency 
of GFD on prescription, availability of GFD in (local) stores, improvement on GFD and post gluten 
symptoms (Appendices 4.2F a-f) 
 
Node analysis suggested that this area was directly or indirectly affected by several nodes i.e. 
knowledge about CD, eating out, restaurant, shopping and CD, sources of knowledge about CD and 
hospital and dietitian appointment. There was lack of understanding in terms of long term beneficial 
effect of GFD on health. Additionally, unavailability of GFD in local stores (Asian) was another issue 
which may affect confidence of the patients in adherence to a GFD.  
 
This area could not be explore in depth and will need in depth interview based research but It is may be 
inferred that, although the confidence level was reasonable among patients and there was no difference 
between the ethnicities. In terms of node analysis, this area was widespread and was covered by: 
cooking at home, restaurant, travelling, dining at friends’ and costs related to a GFD. The breakdown of 

















Table 44: Classification of Nodes in the main stem. 
 
Node Type Sources References   Classification 
1 Problems following GFD 2 3  Descriptive 
1.1 Problems with GFD 23 34  Descriptive, Thematic, Analytic 
1.2 Symptoms post GFD 3 4  Descriptive, Thematic, Analytic 
2 Restaurant and CD 5 7  Descriptive, Thematic, Analytic 
 2.1 Restaurant 8 11  Descriptive, Thematic, Analytic 
 2.2 Restaurant Knowledge 1 1  Descriptive, Thematic, Analytic 
 2.3 Restaurant Issues 6 8  Descriptive, Thematic, Analytic 
3 Prescription and GFD 8 9  Descriptive 
 3.1 Negative  4 4  Descriptive, Thematic, Analytic 
4 GFD 37 37  Descriptive 
 4.1 GFD not available 6 7  Descriptive, Thematic, Analytic 
 4.2 GFD restrictive 10 14  Descriptive, Thematic, Analytic 
 4.3 GFD Supermarket 6 8  Descriptive, Thematic 
 4.4 GFD Taste and issues 7 8  Descriptive, Thematic, Analytic 
 4.4 GFD difficulties    Descriptive, Thematic, Analytic 
5 Misc. Issues       
 5.1 Inadvertent Gluten intake 1 1  Descriptive, Thematic, Analytic 
 5.2 GFD priority  28 29  Descriptive, Thematic 
 5.3 Others 30 75  Descriptive, Thematic 
 
 
Several problems were encountered in following a GFD and there was a distinct difference in themes 
when comparing the two ethnicities. The majority of Asians (90%) cooked at home and for the whole 
family, which posed a special issue of demarcation of a GF area in the kitchen. There was frequent 
cross contamination (n=6) from family members and guests when invited. This was linked to associated 
frustration and anxiety amongst Asian patients (n=3).  
 
“I have to cook for the family and not possible to avoid complete separation from gluten world.. 
I do knead dough myself..(CD02/011, F, Age 23), “I have the responsibility to cook for the whole family 
and we eat wheat all the time as bread.. difficult to control oneself..” (CD02/016, F, Age 46) and 




“….causes are slightly beyond my control.. none of my family understands the importance of gluten free 
diet.. and I cannot make separate food for myself…I have to eat what all eat..” (CD02/017, F, Age 36), 
 
Those White Caucasians who did not cook at home (n=14) tended to have concerns about whether their 
ordered meal was gluten free or not. Theme analysis showed that this area was difficult to probe as it 
was multifactorial (n=26).  
 
Buying Gluten Free products (GFP) again posed two specific issues: cost and availability. Cost related 
issues have been explained above. Considering the availability, South Asian participants reported 
virtually no Asian supermarkets had any idea about GFP and they did not sell any GFP, whereas all 
major western supermarkets e.g. TESCO, Sainsbury and ASDA had clearly demarcated GF areas. This 
led to difficulty in obtaining GFP for the Asian patients in their local area and they resorted to the main 
supermarket, which was an inconveniences and source of poor quality of life. Theme analysis again 
showed that this area was difficult to probe as it was multifactorial (n=26). Patients’ comments included: 
: 
“I do my grocery from XXXX ( Asian Shop).. they don’t have anything for gluten like Tesco has 
and that is too expensive” (CD02/010, F, Age 49), “…no gluten products are available in our local 
store…” (CD02/011, F, Age 23), and “….issue is non availability of gluten free products in local shops 
and we have to go to XXX or …..since I don’t drive I am dependent on my son to bring that for me” 
(CD02/017, F, Age 36) and “…we have issues as it is difficult to find local stores who sell gluten free 
products..” (CD02/013, F, Age 34).  
 
It was particularly difficult for frequent restaurant-eaters to find a reliable restaurant where GF food was 
served, although it was felt by patients (n=4) that awareness about a GFD was increasing among 
restaurants. This clearly had an impact on quality of life (n=10). Since the majority of the South Asians 
(n=6) were not eating outside on frequent basis, is likely to only have a minor (if any) role in their quality 
of life. 
 
These concepts were then assessed in a quantitative manner. Firstly the patients were asked about the 
number of times they ate a cooked meal at home. Ninety two percent of Asians eat a cooked meal at 
home, whereas only 65% of Caucasians ate a home cooked meal  every day. Similarly, when they were 
asked about the number of times they ordered a meal out, only 15% of Asians said yes, in contrast to 




46% of Caucasians.  When asked how confident they were that the person serving the meal was aware 
of their GFD requirements, only 15% of the Asians showed confidence; in contrast 44% of Caucasians 
showed confidence in the restaurant staff (Table No 27).  
There was a significant difference between White Caucasians (Mdn = 70, IQR = 55-80) and South 
Asians (Mdn =90, IQR = 80-100) in relation to eating at home, U = 12, z = -3.31, p = <0.01, r = -.63. 
Similarly there was also a significant difference between White Caucasians (Mdn = 70, IQR = 55-80) 
and South Asians (Mdn =90, IQR = 80-100) in relation to eating out, U = 28, z = -2.3, p = 0.01, r = -.1. 
The results are displayed in the figure below (Fig No 29) (Appendices 4.2 Fa-c). 
 
 
Figure 29: Significance of dinning habits in relation to White (Mdn = 70, IQR = 55-80) and Asian (Mdn =90, IQR = 80-100) 
ethnicity. (MW U test).  
 
The results suggests that the White Caucasian population tend to eat out more when compared to the 
South Asians; conversely South Asians tend to eat more home cooked food than their White Caucasian 
counterparts. Similarly, in relation to the issue of preparing GF meals at home, 53% of patients had 
issues, but this was not significantly different when analysed according to the ethnicity; χ2 (1, n=28) = 
1.19, p=.27, phi = -.20.  
 




Next, the level of difficulty in following a GFD in three special situations was assessed: eating out, dining 
at a friend’s house and travelling. A clear majority of patients (around 90%) had issues in these special 
situations. The results are displayed in the bar chart below (Fig No 30). 
 
 
Figure 30: Comparing ethnicities and special situations in relation to a GFD (MW U test) 
 
It is clear that, although there was no significant difference in the difficulties faced when eating out 
(between the ethnicities), there were a significance differences when eating at a friend’s house: Asians 
(Mdn 100, n = 7) and Caucasians (Mdn=90 , n = 21), U = 36, z = -2.33, p = .04, r = -.44 or travelling: 
Asians (Mdn 100, n = 7) and Caucasians (Mdn=90, n = 21), U = 36, z = -2.09, p = .04, r = -.40.This 
suggests that South Asians had significantly more issues in both travelling and dining at a friend’s house. 
(Appendices 4.2G a-f) 
 
Both groups were then asked to comment on certain statements in relation a GFD. The participants 










Table 45: Ethnic differences in relation a GFD  
Statements Total White Caucasian South Asian  
Do you/ do you have /have you/ what is….. Yes 
(%) 
No (%) Yes (%) No (%) Yes (%) No (%) P 
  Issues with preparing GF meal? 15 (54) 13 (46) 10 (36) 11(39) 5(18) 2 (7) .27*** 
  Read food labels 24 (86) 4 (14) 20 (71) 1 (4) 4 (14) 3 (11) .01*** 
  Understand food labels 21 (75) 7 (25) 20 (71) 1 (4) 1 (4) 6 (21) <0.01*** 
  Know about gluten in cosmetics etc? 3 (11) 25 (89) 2 (7) 19 (68) 1 (4) 6 (21) .72*** 
  Heard anything negative about GFD 13 (46) 15 (54) 11 (39) 10 (36) 2 (7) 5 (18) .27*** 
  Membership of Coeliac UK 13 (46) 15 (54) 12 (43) 9 (32) 1 (4) 6 (21) .04*** 
***Chi square 
 
Table above shows that there exists significant differences between both ethnicities in relation to reading 
and understanding food labels and membership of coeliac UK. (Appendices 4.2G a-f) 
 
Sufficiency of information and confidence level about a GFD:  
 
Sufficiency of information about gluten containing food (GCF) ranged from 0 to 100 (Mdn = 80.3, 
SIQR=60-90) and was non-normally distributed (p=0.00), with skewness of -1.33 (SE = .44) and kurtosis 
of 1.06 (SE = .85). Sufficiency of information about a GFD ranged from 0 to 100 (Mdn = 80, IQR = 50-
80) and was non-normally distributed (p=0.00), with skewness of -1.1 (SE = .44) and kurtosis of 1.22 
(SE = .85) but there was no significant difference on ethnic analysis. The results are displayed in the 
figure below (Fig No 31) 
 





Figure 31: Comparing ethnicities and special situations in relation to a GFD (MW U test) 
 
The confidence level post counselling about a GFD and related education ranged from 10 to 100 (M = 
68.2, SD = 21.2) and was non-normally distributed (p=0.03), with skewness of -.99 (SE = .44) and 
kurtosis of 1.03 (SE = .85). When analysed according to ethnicity there was no significant difference 
between South Asians (Mdn 70, n = 7) and White Caucasians (Mdn 70, n = 21), U = 58.5, z = -.81, p = 
.41. r = -.15. Similarly, in relation to confidence they had in pre-ordered or restaurant food being gluten 
free, only 23 participants answered this question and only 15% of the South Asians showed confidence 
in restaurant staff, in contrast to 44% of White Caucasians. This result was significant (p=.02), 
suggesting that South Asians had less confidence in restaurant staff when compared with White 
Caucasians. (Appendices 4.2G a-f) 
 
Finally, questions were posed to evaluate the level of help received from GPs and 27 patients replied to 
these questions. Theme analysis suggested that GPs were under prescribing GFP as suggested by the 
patients: 
 
“….marginal if any help from GP, used to be quite good though” (CD02/005, F, Age 74), “ (GP Helps) to 
some extent though” (CD02/008, M, Age 65),“….marginal help and they give me English food like pizza.. 
pasta.. we don’t eat that..” (CD02/011, F, Age 23) and “…nothing.. no help..” (CD02/016, F, Age 46) 
 




The MWU test was used to compare sufficiency of GFP from the GP and it showed significant difference 
between Asians (Mdn 30, n = 7) and Caucasians (Mdn 50, n = 20), U = 31.5, z = -2.17, p = .03, r = -.41. 
This suggests that South Asians were getting comparatively fewer GFP on prescription from their GPs   
 
Availability of GFP was an issue in local Asian stores and not in supermarkets, as suggested by all 
patients. Scores ranged from 0 to 100 (M = 70, SD = 44) and was non-normally distributed (p=0.00), 
with skewness of -.97 (SE = .44) and kurtosis of -1.06 (SE = .85). A MWU test indicated there was a 
significant difference between the availability of GFP in local stores reported by Asians (Mdn 0, n = 7) 
and Caucasians (Mdn 100, n = 21), U = 17, z = -3.3, p = .00, r = -.62. Moreover, there was a significant 
difference between White Caucasians (M = 80, SD = 15.2) and South Asians (M =73, SD = 34.0) 
conditions; t (25) =.76, p = .45 in terms of difficulty buying GFP but there was no significant difference 
in the difficulty experienced when buying GFP, White Caucasians (M = 80, SD = 15.2) and South Asians 
(M =73, SD = 34.0) conditions; t (25) =.76, p = .45. These results suggests that it was significantly more 
difficult for South Asians to obtain GFP from local Asian stores, but that there was no difference in buying 
power of GFP between both ethnicities. (Appendices 4.2F a-f) 
 
Miscellaneous issues in relation to a GFD: 
 
Several miscellaneous issues were also explored, among them food labelling. The results showed that 
24 patients (85.7%) read labels before buying food and 71% of White Caucasians would read food 
labels in comparison to 14.3% of South Asians; a chi-square for independence showed a significant 
difference between ethnicity and reading of food labels, χ2 (1, n=28) = 6.22, p=.01, phi = -.47.. Similarly, 
the comprehension of food labels was acknowledged by 21 (75%) of the participants, predominantly in 
White Caucasians (75%) as compared to South Asians (3.6%); a chi-square for independence  showed 
a significant difference between the ethnicities in relation to the comprehension of food labelling; χ2 (1, 
n=28) = 18.3, p=.00, phi = -.81. This means that South Asians were significantly less often reading the 
food labels and had significantly less comprehension of them..  
Gluten is found in minute quantities in cosmetics etc. and the results showed that only 3 (11%) of the 
participants knew about that; among the non-informed there was no significant difference based on 
ethnicity χ2 (1, n=28) = .124, p=.72, phi = .06. A question was also posed about negative press in relation 
to a  GFD.13 (46%) had heard about this, mostly on the internet (39%) and from other sources (32%) 




i.e. social media, friends and relatives, but there was no significant difference between the ethnicities: 
χ2 (1, n=28) = 1.83, p=.40, phi = .25. Similarly, the results showed that the taste of GFP was an issue 
ranging from 0 (no issue at all) to 90 (severely disliked), but no significant difference was found between 
White Caucasians (M 27.6=, SD = 14.8) and South Asians (M =38.5, SD = 27.3) conditions; t (26) =-
.135, p = .18. (Appendices 4.2G a-f) 
 
In relation to a GFD, information about improvement on the diet was also explored and it ranged from 
20 to 90 (M=52.8, SD=29.8); this was significantly different between White Caucasians (M 28.1=, SD = 
19.3) and South Asians (M =52.8, SD = 29.8) conditions; t (26) =-2.55, p = .01. This means that South 
Asians drew more symptomatic benefits from a GFD. Equally, when they were asked if they developed 
symptoms after the ingestion of gluten, a significant difference was found between Asians (Mdn 50, n = 
7) and Caucasians (Mdn 30, n = 21), U = 30, z = -2.3, p = .02, r = -.44. This means that South Asians 
experience significantly more symptoms after ingestion of a gluten containing food items. Finally, 
membership of the advocacy group (Coeliac Society UK) was also explored and 13 (46.4%) were current 
members of the Coeliac Society. Among them, 12 (43%) were White Caucasians and 1 was South 





















A clear majority of the patients in this semi-structured, mixed methods interview opted for telephonic 
clinic as an option for intervention to increase adherence to GFD in CD. Additionally, leaflet was 
considered an adjuvant of telephonic clinic but not a standalone method of intervention. The interview 
was well received by the participants and this trend has previously been observed in relation to 
telephonic interviews (Stone & Rowles, 2007). However, no claims are made to assert the definitive 
superior role of telephonic interviews in extracting qualitative data and it is accepted that this area is 
under-researched, as suggested by Cachia and Millward (2011). 
This may be a selection bias caused by participants’ willingness to be interviewed and it may be possible 
that only those participants who were motivated to change responded to the interview invitation. 
Furthermore, there exists a wide variation in behaviour among patients in regards to adherence to 
medicinal recommendations (DiMatteo, 2004). Ideally the study would also include those who are not 
motivated and although research has indicated ways to increase participation in surveys (Edwards et 
al., 2009), there is no credible research to show how participation in telephonic interviews may be 
increased in a completely unbiased way.  
 
It has previously been observed, in a systematic review, that patient involvement may contribute to a 
range of healthcare strategies (Crawford et al., 2002) and a telephonic interactive voice response 
system has recently been used in relation to paediatric CD (Lionetti et al., 2017) but our study is a 
seminal study where patients have been directly involved in the design of CD related research through 
a telephonic interview.  
  
Choice of methodology: 
 
The choice of a semi structured telephonic interview is well known to qualitative research including in 
CD (Ivarsson et al., 1999, Murray et al., 2004, Catassi et al., 2007, Da Silva et al., 2014). However this 
is the first time that a semi structured telephonic interview has been used in the design of an intervention 
for CD (Sainsbury et al., 2013b). None of the participants mentioned any adverse difficulty in telephone 
over face to face interaction, as felt by the author, hence, “facial anonymity” did not appear to affect the 




quality of our data extraction (Hofisi et al., 2014), but this is an anecdotal observation and equally our 
research was related to a specific topic and was not researching in depth and/or over several broad 
areas.  
 
The pilot interview phase (Paterson & Bramadat, 1992) in this research provided significant help in the 
smooth conduct of the research, such as with wording issues, and also with the timing of the subsequent 
interviews (Burke & Miller, 2001, Turner III, 2010). The initial phase guided the interviewer towards the 
possible intervention strategies, as the first phase used grounded theory of social research ( Martin & 
Turner, 1986) and once the direction was fine-tuned the remaining interviews were conducted according 




This study included only patients who were diagnosed on both serological as well as histological criteria. 
This is a clear strength of this study in terms of diagnostic objectivity, as suggested by earlier research 
(Watson, 2005, Green et al., 2005, Zevit & Shamir, 2014, Husby et al., 2012). It certainly reduces the 
pitfalls in the diagnosis of CD caused by the variable sensitivities and specificities of all individual 
methods of diagnosis (Dieterich et al., 1998, Brown et al., 2006, Robert, 2005).   
Study population: 
 
Guidance on the number of participants was drawn from previous studies (Biagi et al., 2009, Corrao et 
al., 2001, Ascher et al., 1997). The finally selected 80 patients (and interviewed 37 patients) compare 
well with published studies (Catassi et al., 2007, Sverker et al., 2005, Olsson et al., 2008) where 
interviewed population sizes ranged between 42 and 47. This, however, is not an absolute number as 
another study administered telephonic interviews to 215 patients (Murray et al., 2004), in our study we 
interviewed participants until no more new themes were emerging 
 
There was a female predominance in the study population, which reflected the trend of CD in the general 
population, where the male to female ratio is 1:1.8 (Megiorni et al., 2008). This point has been explained 
in detail in relation to study I (Pages No 107-09). Another strength of our research is the inclusion of 
ethnicity data, which is novel in the sense that the author is not aware of any CD intervention that has 
included views from British Asians during the study design process, especially in such a robust manner. 
Themes analysis has clearly brought to the surface special issues in relation to diet, socialising and the 




cooking environment, on the background of joint family systems and this has been detailed in a separate 
section below. Our study has started an in-depth exploration into the lives of British Asians, further 
comprehensive interviews would be of clinical interest. Whilst this area has previously been researched 
by questionnaires (Butterworth et al., 2005, Butterworth et al., 2004), these studies are now more than 
a decade old. The structure of the NHS has evolved significantly, and the affordability of CD treatment 
(a GFD) has been affected by NHS rationing. This may well affect the adherence level in all strata of 
patients.  
Responders and return rate:  
 
The return rate (53%) in this study is higher than that in study one, although the basis for this is 
multifactorial (Fan & Yan, 2010), it may be partly related to the length of documents/questionnaires the 
patients had to complete, which were clearly shorter in the latter and longer in the former and also the 
fact that they had volunteered to take part in study I. Additionally, one   participant was given 50 GBP 
through a prize draw in study II. The impact of questionnaire length has been observed previously 
(Dillman et al., 1993, Edwards et al., 2004). Although monetary incentives in the form of a prize draw 
have a variable effect (VanGeest et al., 2001), we believe this may have played some role in the 
improved return rate in this study. There was no age, gender or ethnicity had any effect on return rate 




The technique of extracting themes through nodes using NVIVO® is an established method in qualitative 
research (Bazeley & Jackson, 2013). For this purpose, source documents (i.e. transcripts and field 
notes) were used (Patton, 2005). It is accepted that not all interviews were in English or completely in 
English, hence standardisation of data may be questionable, as a translator may infer different meanings 
leading to translation bias or dilemma (Temple & Young, 2004). But since the author speaks the relevant 
ethnic languages and translated the interviews himself into English, this effect is minimal. 
It is also clear from the themes analysis that patients needed improvement in their education about CD 
as well as motivation to achieve adherence with a GFD. Both these areas were previously explored and 
later tried as an intervention in the previously explained study (Sainsbury et al., 2013b). However, it is 
noteworthy that web based training has a static approach and does not provide a patient centred 









The majority of the participants declared telephonic clinics their intervention of choice and they were 
considered socially desirable. The telephonic clinics, according to the participants, are easily 
administered and this phenomenon was previously suggested by another study (Walker et al., 2011). 
They are, however, not without issues e.g. interruptions from family members and the inability to give 
visual prompts (Sturges & Hanrahan, 2004). The study relets in terms of choice of a telephonic clinic as 
a mode of intervention may be biased by the observation that since this data was gathered through a 
telephonic interview, hence patients may have opted for telephonic choice. It, however, is noteworthy 
that the participants in study II were selected from responder of study I through a process of 
randomisation to minimise this bias.  
Although lack of non-verbal clues may affect telephonic interviews, the interviewer, however, was able 
to gather non-verbal clues during the interview process (e.g. sarcasm, tone of voice, interest level of the 
patient in the process) and manner of answering a particular question (e.g. seriousness, boredom or a 
feeling of urgency on the patient’s part). High social desirability for telephonic clinics however must be 
interpreted with caution, as data gathered by telephonic survey has reported response bias, as 
suggested by previous research in this area (Chang & Krosnick, 2009, Holbrook et al., 2003, Kreuter et 
al., 2008). Chang & Krisnik (2009) reported that data gathered through telephonic means had 
comparatively more quantitative errors, satisfaction rate and relatively more social desirability response 
was recorded in comparison to online survey. Similarly, in comparison to face to face interviews 
Holbrook and colleagues (2003) reported that telephonic interviews gather more socially desirable 
responses. Similar observations were also reported by Kreuter and colleagues (2008). These biases 
were reduced by posing open ended questions and guidance was drawn from (DiCicco‐Bloom & 
Crabtree (2006) and Qu & Dumay (2011) 
The interview was regarded as private by the participants and that too has been suggested by a previous 
study (Mannino et al., 2007), but a later high powered study (n=465) suggested that a clear majority of 
patients (81%) had concerns about privacy during a telephonic consultation (Bahrani et al., 2017). This 
may be explained by the low power of our study population and more research is advised to explore this 
area. Privacy, was an important issue for patients in our research, as going to a sign-posted CD clinic 




and sitting in an open waiting area gives rise to privacy issues. Privacy is a patient’s fundamental right 
as per article 8 of the Human Rights Act (HRA) 1998. This issue was explored previously in the NHS by 
an interview based research and lack of awareness of the HRA was found amongst health care 
professionals (Woogara, 2005).  
Privacy is of paramount importance to patients when it comes to personal and intimate health related 
issues, as suggested by an earlier study (Bull et al., 2001). Although it is accepted that CD is not a social 
stigma e.g. when compared to HIV (Kumarasamy et al., 2005) and other diseases, this area needs more 
research and patients’ choices should be given preference in how they want to attend a clinic. This is 
only possible if more choices are available, such as telephonic clinics which offer relatively more privacy 
as compared to face-to-face clinics. It is acknowledged that telephonic clinics are not a valid alternative 
to face-to-face clinics in all clinical or research situations.   
Patients considered telephone clinics to be pro-environment and this has been reported recently as well 
(Bahrani et al., 2017). Patients in our study showed environmental awareness and the impact of driving 
to clinic was not regarded as environmentally friendly. Although environmental awareness is not a novel 
concept, perhaps its awareness among CD patients may reflect the growing awareness among the 
general public in the past decade or so (Bohdanowicz, 2006), further consideration when designing 
patient services is warranted.  
 
The traditional belief that, approaches other than face-to-face interactions lack the human touch (Ilieva 
et al., 2002) was not reported by the majority of participants in this study, apart from two who mentioned 
it in passing comments. Studies specifically designed to holistically investigate the differences between 
face-to-face or telephone clinic in patients with CD may bring some objectivity to these claims and may 
well remove this stigma from telephonic interactions between researchers and participants (Wasson et 
al., 1992). 
 
The costs associated with of telephonic clinics are relatively small,  this factor has previously been 
explored by Marcus and Crane (1986), where telephonic interviews were found to reduce cost by 75% 
which is (although low) still higher than our reported price. This is a decade old research and the cost 
of making a telephone call has reduced tremendously. Additionally, the role of telephonic clinic in 
qualitative research is not well established and it is less practiced as compared to face to face interviews 
(Opdenakker, 2006, Sturges & Hanrahan, 2004). Cost related to the telephonic clinic is an issue and 




many studies have tried to quantify this in different settings, but no clear guidance can be drawn from 
the research as the issues dealt with were diverse. In relation to an osteoarthritis related telephonic 
service, no major difference was found with cost and the annual costs were $70.86 and $31.00 per unit 
improvement in physical functioning and pain, as suggested by a US based study (Weinberger et al., 
1993). Similarly a later study involving telephonic support for heart failure patients found this method to 
be cost effective (Clark et al., 2007). Likewise, nurse operated telephonic triage lead to a saving ranging 
from €22.2 to €70.2 (Marklund et al., 2007). Detailed economic analysis of a telephone clinic service 
would be warranted.  
 
Coeliac disease day conference: 
 
The idea of a CD day conference was accepted universally by the White Caucasian participants. 
Although patient education is a regular event and conferences are arranged for this purpose by patient 
advocacy groups such as the Coeliac UK, there have been no specific studies looking into the 
effectiveness of these conferences, especially in ethnic populations. We report low interest in such group 
teaching from our South Asian community, but this area may be looked into by ascertaining causes of 
low interest. Conferences do however carry educational value, as suggested by an HIV conference 
which seemed to improve patients’ adherence to anti-retroviral therapy (Rueda et al., 2006), but the 
seriousness of HIV is evident to patients and physicians and this effect cannot be generalised to CD. It 
is not entirely clear why the majority of Asian patients were opposed to the idea of attending a CD 
conference day, but this area needs in depth interview based research. Other issues raised by the 
patients were travel related and participation anxiety. On the positive side, group meetings were within 
the experience of the majority of the White Caucasian population.  
Attendance at such meetings is high only for motivated patients and previous research has identified 
characteristics which define poor attendance, such as: lower social class, unmarried patients and the 
amount of time taken to reach the event (McClure et al., 1996). One of the issues however demands 
special attention and that was parking, which appeared as a recurrent theme in this study. Previous 
research has also indicated that availability of parking is a key issue for patients in attending an event 
(Avis et al., 1995, Penneys & Glaser, 1999, Ackerman et al., 2013) and reimbursement for parking or 
arranging transport seems to improve attendance (Ackerman et al., 2013). It is thus inferred that, in 
order to improve attendance, parking is a key factor to be kept in mind.  
 




Standard extended clinic and dietitian appointment: 
 
This option was liked by the majority of the non-adherent patients and such clinics, when offered in 
conjunction with a dietitian, improve adherence to a GFD, as suggested by previous research (Hall et 
al., 2009, Addolorato et al., 2004). However, it is not clear if increasing the length of time per patient 
from 20 minutes to 60 minutes would have any effect. This issue was previously noted to have no 
significant effect (Eide et al., 2003), but the clinical setting was an oncology clinic and the finding cannot 
be easily generalised to CD; specific research must be conducted. Another well designed study (n=99) 
and detected an improvement in adherence to GFD while under dietitian follow up (Wylie et al., 2005) 
and although our power (n=37) is less as compared to this study, the inference is the same. A year later 
Bebb et al., (2006) arrived at the same conclusion but another study (n=413) reported no significant 
relationship between dietitian follow up and adherence to a GFD (Mahadev et al., 2013). The latter study 
however had a significant proportion of patients (39%) who had seen the dietitian only once, hence, 
were not followed up by the dietitian. Our study is not conclusive in this area partly because we did not 
explore this area as an aim of this study but our results do follow the well-designed studies and it may 
be inferred that dietitian lead clinical follow up do inprove the adherence to a GFD especially in view of 
a intervention study by Rajpoot et al., (2015).         
The issues of parking and privacy raised by the patients have been explained above, but special issues 
were raised about car parking machines and the punitive nature of the Trust for over-parking. This is an 
interesting area and may well be linked to patients’ inability to attend to other clinics. Survey and 
interview based research needs to be conducted to explore this area further. Similarly, waiting time was 
one issue that patients did not like about CD outpatient clinics and research has shown that this indeed 
is one major factor for patients’ dissatisfaction about clinics (Huang, 1994, McCarthy et al., 2000) and 
correcting this actor may improve satisfaction (from 50% to 74%) among patients (Eilers, 2004). Outside 
the NHS, in a private setting, this is not a major issue, as there is a smaller gap between referral to the 
physician and the appointment (Roll et al., 2012). It may thus be argued that, provided there are no cost 
implications, a longer clinic duration with preferably a shorter waiting time, would not only improve 
adherence to a GFD but also patient satisfaction.    
 
 




Web based teaching: 
 
The approval rate for web based intervention was 31% as patients were not clear about the way in which 
a web based methodology would work. They also insisted on videos rather than “dry slides.” This is 
understandable, as this is a technology dependant intervention and necessitates internet access. The 
Australian based web intervention (Sainsbury e al., 2013b) showed significant improvement in 
adherence scores to a GFD, the study was conducted on a cohort selected from the Coeliac Society, 
which tend to show better adherence as shown by study one and an earlier systematic review (Hall et 
al., 2009). Additionally, the ethnicity of participants was not reported and the programme was only 
available in English. It is recommended that the applicability of “Bread and Butter” (Sainsbury et al., 
2013b) should be confirmed in a multi-ethnic population who are diagnosed on objective criteria with 
input from patients in the design of the course. Web has also been used to deliver a Webinar (Loucka, 
2018, Case, 2013), a seminar conducted through internet but the acceptability of Webinar has not yet 
been assessed in well-designed research studies apart from a study (n=7) where five patients 
considered this to be an acceptable method of patient related education is end stage lung disease. More 




Home visits were not liked by the patients and only few patients were happy to accept that. The main 
issues were patient availability and privacy. One previous study confirmed the effectiveness of home 
education in improving self-care in cardiac patients post discharge (Jaarsma et al., 1999), but the study 
also used in-patient care and education, so it is not clear how big a part the home visit played in 
improving the outcome. A similar study with much improved methodology was conducted a few years 
later and home visits were found to be effective in improving outcome in heart failure patients (Krumholz 
et al., 2002). The author reported that this issue was sensitive for a few patients and it was not explored 
in detail, but the exact role of home visit in CD needs further research.  
Email was favoured as an intervention by very few patients and its effectiveness in patient care has 
been questioned in the past by a randomised trial, which concluded that email was an ineffective 
strategy (Katz et al., 2003). Similarly, Haas et al., (Haas et al., 2017) evaluated text messages as an 
intervention strategy and found it in effective in increasing adherence to a GFD.  




It may thus be concluded that email on its own is ineffective and not favoured by the patients, but may 
well have a role along with other modes of intervention. Similarly, none of the patients favoured an 
information booklet on its own as a mode of intervention. The impact of booklets has not been 
researched in CD, but their role in pre-operative anxiety was not found to be significantly useful (Gillies 
& Baldwin, 2001), although several other studies have found them useful (Frederikson & Bull, 1995, 
Giraudet-Le Quintrec et al., 2003, Gold & McClung, 2006, Deakin et al., 2006). Interestingly, almost all 
of the participants liked the idea of an information booklet as a supportive material. It is thus concluded 
that patient leaflets should be an adjuvant to other interventions.   
Only three patients were interested in watching DVDs although previous research has indicated the 
usefulness of DVDs (Meilleur & Littleton‐Kearney, 2009), it is argued that trends are changing and 
patients are more interested in watching YouTube® rather than DVDs (Stellefson et al., 2014, Gabarron 
et al., 2013, Fat et al., 2011). In conclusion, themed analysis of this study supports the use of a well-
structured telephonic clinic with supplementary leaflets. This intervention would appear to be the most 




A comparison of the eight suggested models of delivery shows that the CD day conference and 
telephonic clinic were particularly favoured by the participants, followed by standard clinical appointment 
and dietitian clinics and this may be based on several factors. Firstly, cost to patients was assessed in 
relation to the different models and patients found the costs of telephonic clinic, home visit, text message 
and leaflets negligible. The CD day conference was assessed to be the most expensive choice, followed 
by standard clinics. Although the causes behind this were not explored, a combination of parking costs, 
travel expenses and possible conference costs might have been in the patients’ minds. This is an 
interesting area in terms of patient centred care and needs further exploration.  
Secondly, the usefulness of the mode of intervention was assessed using the same technique and the 
CD day conference was considered most useful by the patients. This brings to the surface a discrepancy 
between the CD day conference was not liked by all patients, whilst the majority recognised its 
importance in terms of usefulness, hence this may be related to a group effect (Johnston & White, 2003, 
Barsade, 2002). This area also needs more research, as if the cost implications could be met, then this 
might well turn out to be the best choice. Other useful models in this context were: telephonic clinic, 




leaflets and standard clinic; the least useful was considered by patients to be the home visit. This is 
interesting as leaflets on their own were not favoured as a mode of intervention, but were considered 
useful by the patients. It may thus be argued that leaflets could be part of an intervention. Home visits 
were considered the least useful and although research has shown benefits of home visits in heart 
failure (as stated above), our sample reported concerns with home visits, which may be particular to 
patients with CD and not represent the views of patients in general. This is also an important area to be 
researched, as any future intervention may or may not have to exclude home visits altogether in relation 
to CD.  
Thirdly, potential of the mode of delivery to lead to sustained change in behaviour was explored and all 
but home visits, text messages and multimedia were seen favourably by the patients. None of the modes 
of delivery had more than 50% approval, which either reflects pessimistic viewpoints on the patients’ 
part, a common finding in chronic or incurable disease (Wildman et al., 2007, Schulz et al., 1996), or 
this area may be truly multi-factorial and training and education may only play a part in sustained 
behaviour improvement. Fourthly, in terms of knowledge, again the CD day conference was ranked 
highest, followed by the telephonic clinic. This area again will need high powered in-depth interview 
based research to ascertain the true ranking of these modes of deliveries. It may also be inferred that 
probably one type intervention may not be suitable for all patients and it has to be tailored according to 
age, ethnic background, level of education and personal preferences of the patients. .  
Finally, it is quite clear from the overall ranking and subsequent quantitative data, that most of the 
participants would prefer a course which has reduced costs to them, but at the same time has the 
advantage of improving knowledge and the potential for behaviour change.  
In conclusion, this study has reached an opinion that the best design for this set of patients is a 
telephonic clinic to increase the knowledge of non-compliant patients and to motivate them to improve 
their adherence to a GFD. This was accomplished in the next phase of the PhD.  
 
Comparison of White Caucasian and South Asian ethnicities: 
 
CD is a global disease and affects both White Caucasians and South Asians. Two seminal studies 
addressing this issue (which used questionnaires in a slightly different fashion) are more than a decade 
old (Butterworth et al., 2004, Butterworth et al., 2005). Our study was unique in examining a group of 
patients who were non adherent to a GFD, through a mixed methodology. Additionally, it is also 




accepted that the catchment population of our hospital is just as ethnically diverse as those in the above 
studies, although the power of our study (n=7) is lower as qualitative interviews were undertaken to 
saturation of themes.  
Knowledge about CD: 
 
Several aspects of knowledge about CD came to the surface, including: understanding information given 
by the dietitian and clinician, sufficiency of information, comprehension of information and uniformity of 
information about CD. There was variability in the responses from both ethnicities, but since this 
multifactorial area needs deeper exploration with focused questions before conclusions may be drawn.  
The sufficiency in terms of the level of knowledge about CD was similar between the South Asians and 
White Caucasians in this study. It is, however, accepted that our questions were measuring the 
horizontal knowledge as compared to the vertical and in-depth knowledge about clinically important 
aspect of CD. This is important, as knowledge about CD is an independent factor for adherence to a 
GFD (Halmos et al., 2018). However, the construct “knowledge” covers a wide spectrum and may mean 
different things to different patients, ranging from the pathophysiology of CD to the identification of GFP. 
Several questionnaires have been developed, but a particularly effective one was created by Silvester 
and colleagues (2016). Their questionnaire directly tests patients’ knowledge about the presence or 
absence of gluten, by getting them to label items as permissible or non-permissible. This questionnaire 
is used in study 3 of the PhD.  
 
Problems in following a GFD: 
 
Certain issues were common to both ethnic groups, such as the availability of GFP and the cost attached 
to them. Additionally, the taste of GFP and lack of motivation to follow a GFD,, lead to decreased 
adherence to a GFD. These views are supported by published studies (Hall et al., 2009, Errichiello et 
al., 2010). Socio-cultural dietary differences between Caucasians and other ethnicities have been 
researched previously (Mumford et al., 1991, Kelemen et al., 2003, Counihan & Van Esterik, 2012, 
Simmons & Williams, 1997) and our study also reported differences between these two groups. 
However, this is a separate and evolving research area, as South Asian populations integrate into 
western society and westernised food habits are adopted, such as increased fat and meat intake 
(Wandel et al., 2008, Aloia et al., 2013). Among Asian patients, interestingly, there are unique issues 
that might be related to the way food is prepared and served in the Asian household, this has been 
previously described (Counihan & Van Esterik, 2012). All Asian patients (n=9) from our study were 




served warm meals cooked at home from fresh ingredients on a daily basis and consumed ensemble 
on most weekdays. This is in contrast to the previously reported research where increasingly 
westernised food consumption was noted amongst South Asians (Holmboe-Ottesen & Wandel, 2012, 
Wandel et al., 2008).  
The majority of South Asians reported to eat at home and this is a known cultural trend (Aloia et al., 
2013) which also follows the previously reported trend (Goyal & Singh, 2007) and the reasons are 
multifactorial, as previously researched in relation to type 2 diabetes (Lawton et al., 2008, Stone et al., 
2005). Our study is unique in reporting this trend in relation to CD in a similar fashion. It does highlight 
the practical importance of dietitians who are advising South Asians keeping in mind these cultural 
trends when explaining GFD.  
Our study included mostly with first generation South Asian people (based on the fact that they were 
born outside the UK) and the previously reported trend may well be affected by the age of participants. 
It is postulated that younger and second generation South Asians are more integrated, hence 
westernised to consume high energy and high fat food  (Holmboe-Ottesen & Wandel, 2012, Wandel et 
al., 2008, Namvarasl & Chakravarty, 2018). It is accepted that this area is complex, multifactorial and 
shrouded in cultural and social layers.  
White Caucasian participants reported reasonable confidence in restaurants to serve GFP, but South 
Asians did not show comparable confidence. Although food served in restaurants may well be GF, this 
issue again has a cultural specific. South Asians have less confidence in the restaurant staff and this is 
related to perceptions of South Asians about restaurant food. This issue was previously researched by 
Aloia and colleagues (2013) and they suggested that the reasons were multifactorial such as 
convenience, price, social enjoyment and quality of meals. Interestingly, the perception of the South 
Asians can be supported, as there is some evidence to show that restaurant chefs have less knowledge 
about CD than patients with CD (Karajeh et al., 2005).  It is felt that awareness of CD might well have 
changed and more qualitative and qualitative research is needed in this area to explore the reasons 
behind this issue. This again will influence how we advise patients with CD about eating out at 
restaurants; at present they consume restaurant food less frequently as compared to home cooked 
meals (Zarkadas et al., 2013, Zarkadas et al., 2006).   
Our study reported universal issues of poor adherence to a GFD while travelling and at a friend’s house. 
This trend has previously been reported by Zarkadas and colleagues (2006), where patients with CD 




were found to avoid travelling (38%) because of their illness. We, for the first time, have reported that 
significantly more South Asians avoid travel as compared to White Caucasian patients with CD. It is felt 
that this area again is multi-factorial and possible issues may include availability of GFP and / or 
preparation of GF meals pre travel and more research is needed for effective dietary advice for CD 
patients while travelling.  
Our study reported very low availability of GFP in local Asian stores and that was reported to be poorer 
compared with the main supermarkets. Although a general trend of poor availability (41%) of GFP was 
reported by Singh and colleagues (2011), since then general awareness has increased and so has the 
availability, as reported by a later study (Burden et al., 2015). Recently, another UK based study has 
reported good availability of GFP (Hanci & Jeanes, 2018), However, in all the studies there was limited 
availability in local convenience stores but the differences may be explained by the methodologies i.e. 
interviews and questionnaire based studies.  That is perhaps why our study reported good availably 
(88%) of GFP.  
We have reported sparse availability of GFP in Asian stores. One reason behind this might well be the 
cost, as a GFD is four times more expensive than a normal diet (Burden et al., 2015). However, lack of 
knowledge about CD among store owners and low numbers of regular customers with CD, might be 
other factors which deter Asian store owners from stocking GFP.  It is felt that again this area needs a 
well-designed study including all stores ethnic groups purchase their food from. 
Limitations of the research: 
 
Firstly, the manner in which the data was collected (through telephonic interviews) and the inevitable 
lack of face-to-face interaction but, it is acknowledged that perhaps Skype® based interviews might 
solve this issue to some extent and it is thus recommended it is offered to patients if similar research is 
being conducted, a visual medium could be considered, as access to the internet is improving in the UK 
and worldwide (Poushter, 2016) and Skype® is increasingly being used in qualitative research 
interviews (Hanna, 2012, Janghorban et al., 2014).  
Secondly, the analysis of qualitative data in social science is equivalent to “impression analysis” in 
forensic science, where trace evidence leads to reconstruction of the scene and inference may differ 
depending on how that is arrived at (Welsh, 2002). This area has been debated for both reliability and 
validity in relation to such analysis (Kelle & Bird, 1995), but outside this discussion there are well 
documented research studies using qualitative methods.   




Thirdly, the interviews were conducted in 20 to 30 minutes, which might be considered  insufficient time 
to obtain data about choice of intervention, but it is clear from the methodology that the initial 13 pre-
interviews gave sufficient guidance to the authors about the questioning strategy and obtaining 
maximum information in a limited time (Burke & Miller, 2001). Time is an essential element and 
information obtained is directly proportional to interview length. Although it is acknowledged that high 
power may bring diversity, the purpose of this research was to gather a reasonable amount of 
information from patients, in order to design an intervention which was both cost effective and time-
efficient. It was not our purpose to explore every possible and rare way an intervention could be designed 
and, keeping in view the previous research, this sample size was sufficient for qualitative research of 
this type (Marshall et al., 2013, Francis et al., 2010). Additional time before the interview for patients to 
consider the pros and cons may have helped to gather more informed decisions from participants. 
Fifthly, our study focused on adults and thus the preferences for paediatric age group were not explored 
(Maki et al., 2003). Their choices may be different from those of the adult population and finally it may 
also be inferred that using telephone as a medium to data about choices of intervention which also 
includes telephonic intervention is a potential bias.   
Despite limitations, as explained above, “Your View” has given a unique view of a multi-ethnic population 
to inform the design an intervention aimed at increasing adherence to a GFD. Whilst acknowledging its 
limitations, this study has strengthened the view point that patients are valuable assets in all aspects of 
the treatment and management of chronic diseases, including the design of interventions/ service 
development. In conclusion, telephonic clinic informed by published studies and the qualitative 
















Study 3: Intervention to Increase Adherence to a Gluten Free Diet (REST-Gluten) 
 
Introduction 
To date there are only eight intervention programmes reported in the literature stating an intervention to 
improve adherence in relation to a GFD and only three of them report direct data on improving 
adherence to a GFD. Studies have either targeted behavioural aspects (Addolorato et al., 2004, Ring 
Jacobsson et al., 2012) to indirectly improve adherence to a GFD, or have used follow up models (Pekki 
et al., 2018, Rajpoot et al., 2015) to assess the role of follow up in clinics in maintaining or improving 
adherence to a GFD; recently a well-designed study examined the role of text messages in 12 to 24 
year olds to improve adherence to a GFD (Haas et al., 2017). Sainsbury and colleagues (2015, 2013b) 
used a web based intervention to improve adherence to a GFD in a study population derived from social 
media and Australian Coeliac Society members. A recent study (n=118) examining the role of a smart 
phone app in the management of CD has been reported, but it is not directly related to increasing 
adherence to a GFD, hence excluded (Dowd et al., 2018).  
Detailed critical review of the aforementioned studies can be found within Chapter One and suggests 
that there are methodological deficiencies in these studies as, for example, increased adherence is 
associated with membership of coeliac advocacy groups (Hall et al., 2009, Muhammad, 2013), thus 
introducing selection bias in the latter study (Sainsbury et al.,2013b). Additionally, web based 
methodology is dependent upon computer literacy and additional associated costs might well be an 
issue in an elderly group which forms a significant proportion of the adult UK CD population (West et al., 
2004). Furthermore, intervention studies in this area (Sainsbury et al., 2013b, Haas et al., 2017) have 
predominantly used a cohort with CDAT score below 13, thus already adhering to a GFD. Despite these 
shortcomings, the study provides both a theoretical as well as a practical baseline for future design and 
execution of studies in this under researched area. 
It is quite clear from the literature review in Chapter One that intervention to increase adherence to a 
GFD is a minimally explored area and there is a need to design an intervention which is: not substantially 




dependant on technology, cost effective for patients as well as health care providers, easy to administer 
and not geographically bound; above all is designed with direct input from patients. One way of 
conducting this research would be to recruit patients from a hospital data base, diagnosed on histological 
grounds to minimise selection bias, with a proportion of them being from ethnic minorities so that the 
intervention designed is generalizable and clinically relevant. It is evident that no intervention to date 
has been reported in the UK population, which compared to Australia has a different demographic.  
The PhD will be using a telephonic clinic as an intervention and it is one of the accepted and well 
established ways of interacting with patients to gather quantitative data (Aday & Cornelius, 2006, 
Barriball et al., 1996, Carr & Worth, 2001); additionally, it is used extensively in social research (Bernard, 
2011). Perhaps as a cultural trend, face to face contact is preferred over telephonic conversation 
(Garbett & Mccormack, 2001, Marcus & Crane, 1986). In addition to that, Telephonic interview can also 
affect survey outcomes such as data quality, as reported by one study (Aquilino, 1994). Although no 
extensive comparison with face to face interviews has been conducted to assert the superiority of one 
mode of practice over another, there is a suggestion that face to face interviews may improve the quality 
of data, as shown by a later study (Moum, 1998). It should be pointed out that data quality in qualitative 
interviews is multifactorial (Bryman, 2003) and is affected by both interviewee and interviewer related 
factors (Patton, 2005).  
Telephonic interview is an economical alternative (McHorney et al., 1994, Chapple, 1999), as it cuts 
down costs of travel and increases access to wide geographical areas (Sturges & Hanrahan, 2004). 
Although loss of non-verbal and contextual data is a potential issue (Burnard, 1994), telephonic interview 
for this piece of research was selected according to participants preference. More importantly, no 
significant evidence exists to suggest that the loss of non-verbal and contextual data will affect the 
quality of data gathered, especially in this type of research. The table below (Table no 11) compares 
telephonic and face to face interviews to clarify the reasons why telephonic interview was selected for 
this study. The table below summarises and compares the characteristics of both modes of interview 




Table 46: Comparison of two modes of interview: telephonic vs face to face. 




Characteristics Telephonic Face to Face 
 Positives Negatives  Positives Negatives  
Related Cost  
Less -- -- More 
Access to patients 
Wide geographic  -- -- Restricted 
Privacy 
Reasonable -- -- Reasonable 
Flexibility 
More  -- -- Less 
Body language  
-- Absent Present  -- 
Human touch 
-- Lost Present -- 
 
   
 
 
This PhD aims to recruit patients directly from a hospital database and our intervention will involve a 
telephonic medium which is relatively less technology- and literacy-dependant than computer based 
teaching. The ideas from a review of the literature, including of the Sainsbury and Mullen (2013) study, 
were refined by involving CD patients as detailed in Chapter Three REST-Gluten, the third study in 
series in this PhD, aims to fill the methodological gaps in the previous studies and focus on the non-
adherent patients along with a control group, to assess the efficacy of a telephonic intervention in 
increasing adherence to a GFD. Additionally, it is the first study which specifically aims to improve GFD 




To explore the role of telephonic clinics on adherence to GFD in adults with CD by conducting a semi-
structured telephonic clinic and to assess if post intervention adherence to GFD is significantly different 
than pre intervention. In addition, it is also aimed to see if delivering such an intervention will affect 
knowledge about CD in the patients as measured Silvester’s questionnaire (2016). Furthermore, this 
study aims to see the impact of a telephonic clinic as an intervention on HRQoL as measured by CDQoL 








The hypothesis for this study is non-directional (two tailed) and the null hypothesis (H0) for the study is 
that there will be no significant difference between adherence to a GFD, knowledge and quality of life in 
pre and post intervention groups. It may thus be stated that the independent variable i.e. telephonic 
clinic will have no effect on the dependant variable i.e. CDAT, Silvester and CDQoL scores.  
 
Method 
The study was conducted using a telephonic intervention in a prospective controlled manner and the 
instruments used to measure the effect were: CDAT score (Leffler et al., 2009), Silvester CD knowledge 
score (Silvester et al., 2016) and Crocker CDQoL score (Crocker et al., 2018b). One to one telephonic 
conversation was used to add a human touch to the research and make it interactive and more 
acceptable to patients based on patients’ choice of intervention.  
The suitability of this design is evident from the universal acceptability of this methodology among the 
intervention patients and as previously suggested by the study II cohort in their interviews. In clinical 
practice, due to the complex nature of human disease patterns, a particular ailment (CD in this case) 
may be pathologically similar in a group of patients, yet affects the patients very differently. Telephonic 
conversation represents an inferior level of human interaction as compared with a face to face meeting, 
but, as suggested by the patients in study II, it is acceptable, cost effective and convenient for them, 
hence accepted as a study design.  
Inclusion and Exclusion Criteria 
All adult patients (18 years and above) diagnosed with CD on confirmed histological grounds and within 
the CD database held within the dietetic department of the Dudley Group of Hospitals (DGH) were 
selected for this study. In addition, for standardisation of diagnosis, only patients who were diagnosed 
by the DGH pathologists were included in this study. Moreover, for consistency in treatment and dietary 
advice received, only patients who were under the follow up of the DGH consultant gastroenterologists 
and dietitians were included.  Similarly, all patients below the age of 18 were excluded. In addition, all 
those who were not under DGH follow up were also excluded for ethical reasons (as the local Research 
and Development office approval was only applicable to DGH related patients), plus the standardisation 
issue as explained above. Furthermore, patients with learning difficulties, problems filling in forms and 




questionnaires, living outside the geographical area of Dudley and those who were diagnosed by non 
DGH pathologists were excluded from the study.  
Participants 
 
Participants for this study came from the CD database of the dietetic department of the DGH. 
Considering the number of available patients, a convenience sampling method was used (Farrokhi & 
Mahmoudi-Hamidabad, 2012, Marshall, 1996) and all eligible CD patients were approached via postal 
invitation after applying the inclusion and exclusion criteria. 
 
Sample size: 
Research has shown a modest effect from telephonic based interventions, in promoting healthy dietary 
behaviour in participants without CD, as shown by a systematic review (Eakin et al., 2007). Therefore, 
based on two tailed hypothesis a-priori power analysis was done (d = 0.5; 80% power; α = 0.05) and it 
was shown that 128 participants will be required to detect a statistically significant difference in change 
of behaviour between the groups. A meta-analysis, examining psychotherapy on symptoms of 
depression, concluded that keeping in view the significant heterogeneity in attrition across these studies 
(Q = 32.43, p = .0006), the mean attrition rate was 7.56% (95% CI = 4.23–10.90, p < .0001) and allowing 
for this, the desired sample size was 138 (Mohr et al., 2008). Additionally, a previously conducted 
intervention by Sainsbury and colleagues (2013) reported a significant improvement in CDAT score in 
participants (n=26) who completed three months follow up. Moreover, based on the previous return rate 
of 39% (Muhammad et al., 2017), the expected available sample was 75, with 28 expected non adherent 





All patients were sent a research pack containing: CDAT (Appendix 1.1D) as an adherence instrument,  
DASS questionnaire (Appendix No 1.3H) to exclude participants if evidence of subclinical depression 
was observed, CD quality of life questionnaire (Crocker et al., 2013) to assess HRQoL (Appendix no 
1.3I) and CD knowledge questionnaire ( Silvester et al., 2016)  to assess patients’ knowledge about a 
gluten free diet (Appendix No 1.3G). Additionally, a change in circumstances form (Appendix no 1.3J) 




was also sent to ensure that the possible effect of known factors (Hall et al., 2009, Flaherty, 2014) which 




The telephonic clinic targeted both knowledge and motivation components. One hour telephonic clinics 
were administered as an intervention (explained below). A leaflet as a guide to the discussion in clinic 
was posted to all those patients who were selected for interview (Appendix No 1.3D). Selected patients 
were asked about their stage of behavioural change at the very beginning of the clinic, as per guidelines 
drawn from Prochaska and colleagues (Prochaska et al., 2008) (Appendix no 1.3K). The steps of the 
intervention are explained in the figure below (Fig No 32).  
 
 
Figure 32: Study Three process 
Groups for Intervention 
Based on a review of the literature and the PhD study II “Your View” as explained in the earlier section, 
the intervention for increasing adherence to a GFD was designed as a prospective trial using two arms. 
The first of these was the Non-Compliant Intervention Group (NCIG) with the aim of recruiting 50 patients 
who were non-compliant with a GFD. They agreed on a schedule time for the telephonic clinic 
intervention which lasted for approximately 1 hour. Three months after the telephonic clinic they were 
requested to complete CDAT, CD related quality of life, CD knowledge and a change in circumstances 
questionnaire. They were followed up at six months and requested to complete the Leffler and a change 
in circumstances questionnaire. The second group was the Adherent Non-Intervention Group (ANIG) 




with the aim of recruiting 100 patients (randomly selected from the patients’ adherent to a GFD. This 
was the adherent control group and they did not receive any intervention. Three and six months after 
the pre intervention questionnaires, they were requested to complete the Leffler, CD related quality of 
life, CD knowledge and a change in circumstances questionnaire.  
Intervention 
 
Leaflet design and contents 
 
The telephonic clinic followed the format of a leaflet which was sent to the intervention arm of the study 
in advance (Appendix 1.3D). The contents of the leaflet were based on the “Your View” study, where 
certain themes related to knowledge gaps, behavioural issues and difficulties had been highlighted by 
participants. Written information or leaflet (Raynor, 2018, Dickinson et al., 2001, Grime et al., 2007) was 
favoured by patients as a medium of education in the “Your View” study, but in combination with some 
other form of interaction e.g. telephonic interview rather than stand alone.  Although there is no evidence 
of using a leaflet in relation to adherence in CD, the leaflet for this purpose was designed based on prior 
research, as health-related leaflet design has evolved significantly since its first introduction in the UK 
in the mid-80’s (Coulter, 1998, Boundouki et al., 2004). 
  
Characteristics of the coeliac disease leaflet 
 
Research has emphasised the benefits of including pictures within leaflets, to increase readers’ attention 
to and recall of health education information (Houts et al., 2006, Mansoor & Dowse, 2003), hence our 
leaflet was mostly in pictorial form. Care was taken not to use too much technical information and at the 
same time not to make it too simple; rather a conceptual pictorial approach was used to gradually build 
up information for the topic (Collier, 2011). The majority of the pictures were coloured, as this enhances 
learning when compared with black and white pictures (Rankin et al., 2005). All pictures were selected 
from Google Image® and are in the public domain. 
 
Cultural diversity was kept in mind (Herbert, 1997) and this was supported by translating the information 
into respective different languages (Urdu, Pashto, Punjabi, Arabic, Persian, Hindi and Gujarati) with a 
view to increasing comprehension and interest in the leaflet (Dickinson et al., 2001, Kumar et al., 2004).  
Extreme care was taken to avoid any generally offensive, racially tabooed or culturally non permissible 




elements in the leaflet. The leaflet was divided into short topics and the contents of the leaflet are 
summarised in the table below (Table No 47).  
 
Table 47: leaflet for intervention 
Topic  Area targeted Contents / comments Behaviour  
Normal abdomen Knowledge  3 pictures of normal abdomen.  
Basic theme to build up discussion. 
Attitudes, perceived 
behavioural control. 
Coeliac disease Knowledge 
 
3 pictures with gradually increasing complexity about 





symptoms of CD 
Knowledge 3 pictures showing gluten containing food. They were 
kept simple and included cultural elements along with 
general information about gluten 
Attitudes, perceived 
behavioural control. 
Symptoms of CD Knowledge 4 pictures showing the most common symptoms in 
pictorial form. Care was taken not to include any 
potentially distressing pictures.   
Attitudes, perceived 
behavioural control. 
Complications of CD Knowledge 
behaviour 
3 pictures of the most common complications.  Attitudes, perceived 
behavioural control. 
subjective norms 
Gluten free food  Knowledge 1 picture. General over view of gluten free diet Attitudes, perceived 
behavioural control. 
Barrier to adherence Behaviour Educate about behaviour modification, working on 





symptoms, coping  
 
Specific issues Misc. Two pictures; cross contamination of gluten and how to 
avoid, tips on preparing meals. Issues with eating out. 

















Contents and delivery of the telephonic clinic 
 
The clinic followed a similar format to that of a normal face to face clinic in an outpatient department.  
For the purpose of standardisation, a specific format was followed and this was rehearsed before the 
actual interaction with the patients. The components of the telephonic clinic were as follows: 
 
Introduction and clinical rapport 
 
Each clinic started with a telephone call on a number provided by the patient and at the time agreed 
(Appendix No 1.3L). Clear introduction of the researcher and the related professional role was followed 
by an explanation of the purpose of the clinic; guidance in this regard was drawn from previous studies 
(Dang et al., 2017, Ali & Elzubair, 2016). Patients were encouraged to speak early in the course of 
clinical conversation and any anxiety detected was addressed at that point by providing reassurance. 
Patients were specifically encouraged to ask questions, even if that meant interrupting the conversation 
at any point during the clinic. Patients were asked (in very simple and non-judgemental language) about 
their diagnosis and if they understood their test results when first told the diagnosis of CD. Patients were 
then asked about their treatment goals and expectations from the telephonic clinic; a clinical agenda 




All patients were strongly recommended to either join or maintain membership of Coeliac UK. 
Additionally they were advised to ensure they had access to GF foods and, if their local stores lacked 
such products, the best ways to approach the store manager. They were advised to stay in touch with 
the hospital dietitian and keep their physician and dietitian appointments. For events of a temporary 
nature, such as travelling or being a guest in a friend’s house, patients were advised to take, e.g.  some 
GF sandwiches with them, if unsure about access to GF foods. Furthermore, issues with the texture of 
GF foods were acknowledged to be a universal issue and patients were advised to contact the 
manufacturer of such products in order to guide them. It was however acknowledged that this was a 
difficult area, as there were ceilings in relation to costs and availability of palatable products. 
A subset of patients, who expressed cravings for gluten containing foods, were given advice about 
reducing their intake gradually i.e. from daily to weekly to monthly with an aim of stopping altogether. 
Patients were advised to keep a food diary for trigger events which may lead to dietary transgressions. 




Additionally, they were advised to read about success stories and reward themselves on maintained 
behaviour. Last but not least, a six monthly audit was advised to record the episodes of transgressions 
and to self-motivate to close the gap between theory and practice.  Participants were then invited to 
comment on specific issues that influence their adherence to a GFD, which may or may not follow 
general themes.  
Knowledge about CD 
 
The attention of the patients at this stage was drawn to the different components of the leaflet, which 
were explained using a tailored educational strategy, the guidance for which was derived from previous 
research (Deakin et al., 2006, Coulter & Ellins, 2007, Oliver et al., 2001). Although the teaching method 
by default was one to one (Harris, 1986), the method of delivery used in this section was learner centred 
(Bender, 2016) and content focused (Desimone, 2011).  
Firstly, referring to the first picture on the leaflet, a general overview of the food we eat was given, along 
with a brief outline of the anatomy and physiology of digestion. Here it was emphasized that different 
components of food are absorbed differently and wheat is one of the important components in the diet. 
Secondly, referring to the next two slides on the leaflet, a detailed outline of CD was given to the patients, 
which included the structure of the small intestinal villi and the concept of surface area available for 
absorption.  
They were then told how wheat, a harmless component of the food for others, damages the villi of the 
small intestine in patients with CD, by drawing their attention to the flat villi on the slide. At this point the 
concept of inflammation caused by the immune reaction against gluten was introduced and this was 
linked to the previous slides on normal absorption; they were further told about the effect of flat villi on 
the general absorption of food. Furthermore, inflammation leading to pain in the abdomen in some (but 
not all) patients was introduced here, as shown on slide number two on the leaflet. 
Discussion about gluten and gluten containing food continued at this stage, with a tailored explanation 
based on the patient’s GF food knowledge score (which had already been checked through the 
knowledge questionnaire) (Silvester et al., 2016). Patients were given a brief outline of GF foods 
(Gallagher, 2009) and their attention was drawn to the resources available such as Coeliac UK (Coeliac 
UK, 2015). Patients were individually advised about a GFD and were encouraged to keep a diary (or 
where applicable a smart phone based list) of commonly used gluten containing foods and how to avoid 
them (Case, 2005). 





Next, a brief sketch of the symptoms of CD was given. Looking at slide number four and linking it to the 
previous slides, it was emphasised that symptoms were not always present, despite the fact that the 
intestine was inflamed. Allied to this concept, common and less common symptoms of CD were briefly 
explained and a detailed discussion about the patient’s current or past symptoms (if any) was 
undertaken. The discussion then moved on to common complications (slide No 5) such as anaemia, 
bone fragility and related fractures, along with effects on health related quality of life such as: tiredness, 
anxiety and depression; the economic impact of CD was also discussed.  
Following this, the pace of the interview was slowed down and the patient was informed of the possible 
complications of long term inflammation in the small bowel which may result in changes to cells and 
may lead to cancer in a minority of patients. This was followed by a pause and the patient was asked to 
briefly repeat what had been said so far, to check engagement and understanding. Questions, if any, 
were answered and areas were discussed again if there was any doubt. 
Then, likening it to the previous concept of gluten containing foods, the idea of a completely GF diet was 
introduced (Slide No 6). Linked to this concept, the presence of hidden gluten was introduced and how 
to recognise it by reading food labels in a logical and methodical way (slide No 7). By virtue of its practical 
importance, this part was deliberately prolonged and the three most common international signs of GF 
food were referred to (and were printed in colour in the leaflet).  
Patients were then told where to look for nutritional information: that it is often displayed as a panel or 
grid on the back or side of packaging and usually contains information about energy and dietary contents 
such as fats, carbohydrates and proteins.  Additionally, their attention was drawn to the nutritional 
information present on the front of the packaging which comprises different food groups at a glance 
along with colour coding.  
Certain exceptions, where food has been processed and the gluten removed, were also mentioned at 
this stage (e.g. wheat starch). We also highlighted that labelling such as “may contain traces of gluten”, 
“made on a line handling wheat”, “made in a factory also handling wheat” does not necessarily mean 
that the product is contaminated with gluten. If unsure, patients were advised to contact the 
manufacturer directly if they wanted further information on the suitability of a product (Coeliac UK, 
2016b).    
 






 “Your View” identified certain issues which were barriers faced by CD patients on a daily basis and 
preventing them from following a GFD. The modifiable issues included external environmental stimuli; 
different sets of stimuli were identified for Caucasians and South Asians. Topic discussed were: eating 
out, receiving guests, anxiety about the long-term effects of a GFD, personal privacy about the 
diagnosis, the taste of GF foods and associated costs of a GFD. Before engaging patients in the 
behavioural discussion, they were asked about their position on the behavioural spectrum of the Trans-
theoretical stages of change model (Appendix 1.3J). Linked with the leaflet, they were specifically asked 





Clear information was given to the patients on individual matters and guidance was drawn from Coeliac 
UK on eating out (Coeliac UK, 2016a). They were informed that caterers must, by law, be able to provide 
you with information on any allergens, including cereals containing gluten, in all the dishes they serve 
(picture No 10). This means that if a recipe uses cereals containing gluten (such as wheat, rye, barley 
or oats), they will have provide this information. However, although caterers have to provide allergen 
information for all of the dishes they serve, they don't have to offer a GF meal, so it is best to call ahead 
or check their website to see if they offer gluten free options. Patients were advised that they could 
speak to restaurant staff and explain why they needed to avoid any foods that contained gluten. They 
could highlight what foods are naturally gluten free and suitable to eat; provide specific examples of 
what is not safe e.g. wheat flour in sauces, breadcrumbs, croutons, some stock cubes/powders and oil 
previously used to fry foods that contain gluten. If an ingredient is bought-in, such as stock cubes, 
restaurant staff, can check the ingredients list as they are covered by the same EU wide labelling laws 
as foods in the supermarket. If there is nothing suitable on the menu, patients were advised to ask if the 
chef could cook something else for them; many restaurant chefs are happy to do this once they know 
the reason for the request. 
Cross Contamination: 
To avoid cross contamination in food preparing areas, patients were advised to wipe down surfaces and 
clean pots and pans with soap and water. Standard washing up or using a dishwasher will also remove 




gluten and washing up liquids are fine to use. Standard rinsing will remove any traces, so separate 
cloths or sponges are not required, although they may want to get separate bread boards to keep GF 
and gluten-containing breads apart. Use separate toasters or toaster bags, clean oil or a separate fryer 
for frying gluten free foods. Use different butter knives and jam spoons to prevent breadcrumbs from 
getting into condiments. 
Individual modification(s) 
  
There are several ways to enhance the counselling process, but one of the most effective tools is to 
communicate in the patient’s language (Ferguson & Candib, 2002). Patients may be persuaded to keep 
“health first” or may be engaged in a dialogue where specific scenarios are reconstructed and the 
problem is broken down to identify the micro barriers and how to overcome them (for example by 
communicating in an assertive way). Patients may be asked to keep a diary of transgressions and write 
down key events leading to such transgressions and to avoid them if possible. Patients will be informed 
about SMART goals; SMART is the acronym for: Specific, Measurable, Achievable, Relevant and Time-
limited (O'Neill, 2000, Monaghan et al., 2005, Playford et al., 2009).  A detailed example of a SMART 
goal is shown below (Table No 48) 
 
Table 48. SMART goal in relation to CD 
 
SMART Goal Example 
Specific What do I want to accomplish? Why do I want to accomplish 
this? What are the requirements?  What are the constraints? 
I want to be adherent to a GFD. The requirement 
is to avoid gluten products altogether and it 
involves changing lifestyle and eating habits.   
Measurable How will I measure my progress? How will I know when the 
goal is accomplished? 
Maintain a food diary which shows that gluten 
products have not been consumed.  
Achievable  How can the goal be accomplished? What are the logical steps 
I should take? 
In order to accomplish this goal I must avoid 
situations which leads to transgressions.  
Relevant Is this a worthwhile goal? • Is this the right time? • Do I have 
the necessary resources to accomplish this goal? • Is this goal 
in line with my long term objectives? 
It is a worthwhile goal as your short and long-term 
health depends on this.  
Time bound How long will it take to accomplish this goal? When is the 
completion of this goal due? When am I going to work on this 
goal? 
It is an ongoing modification to your lifestyle to 
avoid gluten.  








The asymptomatic patients were approached very carefully and their beliefs about the activity and 
potential complications of coeliac disease were explored. After confirming that they were diagnosed on 
histological grounds, they were given a detailed illustration about the inflammatory aspect of CD 
(explained below). They were then given a detailed overview about the role of exposure to dietary 
antigens and the ongoing inflammation despite lack of symptoms. Personal privacy about the diagnosis 




Patients were followed up after 3 months with a postal questionnaire (Leffler 2009) to measure 
adherence and a CD quality of life questionnaire. A change in circumstances form (Appendix 1.3J) was 
sent at each follow up to keep in view the significant variables which may potentially affect the adherence 
CDQoL questionnaire (Crocker et al., 2013). The details of intervention and follow up are given in the 
table below (Table No 49). 
 
 Table 49 Details of questionnaires used in the intervention and the target groups 
 








CD related QoL  
CD Knowledge Q 
CDAT 
DASS 
CD related QoL  
CD Knowledge Q 
3 months post intervention  CDAT 
Change in circumstances Q 
CD related QoL  
CD Knowledge Q 
CDAT 
Change in circumstances Q 
CD related QoL 
CD Knowledge Q 
6 months post intervention  CDAT 
Change in circumstances Q 
CDAT 
Change in circumstances Q 





A postal invitation in the form of a research pack was sent to all eligible patients (Root & Blismas, 2003). 
The research pack (contained in an A5 envelope) included an invitation letter (Appendix 1), patient 
information sheet, study questionnaire, consent form and details for completing the study 
questionnaires, along with a stamped addressed envelope (Appendices 1.3 A-E). Demographic data 
was collated from the CD database of DGH; adherence and quality of life related questions were 
extracted from the questionnaire.  
Instruments used 
A detailed overview of the general aspects of questionnaire selection has been provided elsewhere 
(Study I, pages 40 to 47) and will not be repeated here. Additionally, the CDAT questionnaire, which 
was part of study I, has also been explained in the relevant section and will not be repeated here. New 
questionnaires used in this research study include: Depression Anxiety Stress Score (DASS) (Henry & 
Crawford, 2005), GFD scale by Silvester and colleagues (Silvester et al., 2016), Coeliac Disease Quality 
of Life (CDQoL) questionnaire (Crocker et al., 2018a, Crocker et al., 2018b) and Change in 
Circumstances (CIC) questionnaire; these are explained below.  
DASS-21 Questionnaire 
Each participant received the DASS-21 questionnaire: a one page short questionnaire (Lovibond & 
Lovibond, 1995) which is a purpose built instrument for the assessment of three negative emotional 
states of mental health i.e. depression, anxiety and stress. It is an abridged version of the DASS-42, a 
self-report instrument also designed to measure the above three negative emotional states. It is divided 
into three sections, each representing the above elements and each has seven questions and each 
question had four possible answers to choose from (did not apply to me at all; applied to me to some 
degree, or some of the time; applied to me to a considerable degree, or a good part of time; applied to 
me very much, or most of the time). Based on the scoring system, each element of mental health is then 
identified as normal, mild, moderate, severe or extremely severe. For depression, for example, a score 
of five and above reflects mild depression and a score of 14 and above is suggestive of severe 
depression. The table below (Table No 50) shows the scoring system from DASS-21 for different 
elements and the form is attached as appendix 1.3G.  




Table 50:  Elements of DASS-21 score and calculations of severity of individual elements 
 Elements of mental health  
 Depression Anxiety Stress 
Severity    
   Normal 0-4 0-3 0-7 
   Mild 5-6 4-5 8-9 
   Moderate 7-10 6-7 10-12 
   Severe 11-13 8-9 13-16 
   Extremely severe 14+ 10+ 17+ 
 
Silvester Gluten-Free Diet Knowledge Scale  
This GF diet knowledge questionnaire was received by participants both at baseline and then at month 
three and was divided into three kinds of food items, namely: allowed, to question and not allowed. The 
participants answered them in two ways; they identified the food item in the correct category and based 
on this were either wrong or right in their selected option. The knowledge questionnaire was, thus, 
analysed twice: once to check if they had answered the questions at base line correctly and then to see 
if they could identify the item in the correct category. This was done to simplify future analysis of 
improvement or decrement in CD knowledge. The overall GFD knowledge was the cumulative score 
from individual choices and ranged from 0-17, with 17 the most knowledgeable in relation to a GFD.  
The types of foods referred to in the questionnaire included those which could be consumed on their 
own and those which might be used in the preparation of another product. There were 17 different food 
items: seven each in the “allowed” and the “to question” categories and three in the ”not allowed” 
category. This identified two types of patients: those who were over-restricting themselves by avoiding 
allowed food items (thinking that they were not allowed) and those who were erroneously eating food 
items which were not allowed.  The details of the questionnaire are available in the appendix 1.3F.  




Change in Circumstances form 
This was a short questionnaire which explored changes in several aspects of a patient’s life which may 
affect their adherence, as shown by previous research, thus serving as a confounder (Appendix 13J). 
The most important of them was membership of Coeliac UK (Muhammad et al., 2017) and this was the 
first question, with two possible answers (“I am a member of Coeliac UK” or “I am no longer a member 
of Coeliac UK”).  This was followed by doctor or dietitian appointment to see if they had an appointment 
with a doctor/ dietitian and again this had two choices i.e. yes or no. Next, the buying capacity of GFP 
was explored and it had three choices which were: I can afford all, some or none of the GFP. Next, 
patients were asked if they had developed an allergy to GFP, as that may potentially affect adherence. 
Then their mental health was explored, as one of the exclusion criteria was a diagnosis of depression 
(which may decrease adherence to a GFD). Similarly, a diagnosis of anxiety was explored, as it was 
also one of the exclusion criteria (Appendix 1.3J).   
Coeliac Disease Quality of Life (CDQoL) Questionnaire  
The Coeliac Disease Quality of Life CDQoL is a 32 item validated instrument addressing five 
dimensions: stigma (8 items); dietary burden (8 items); symptoms (5 items); social isolation (5 items); 
worries and concerns (6 items) (Appendix No 1.3H).  The questionnaire measures Health Related 
Quality of Life (HRQoL) over the preceding four weeks. The CDQoL was developed by researchers 
within the Health Services Research Unit, part of the Nuffield Department of Population Health at the 
University of Oxford; a license was formally granted for the use of this questionnaire in the study. 
Dimension scores and an overall index score can be calculated for the CDQoL. Raw scores are 
transformed to a 0-100 scale, where 0 is the poorest quality of life and 100 is the highest quality of life. 
Details of the scoring system for the CDQoL, along with the questionnaire, are attached as appendix 












The Integrated Research Application System (IRAS) was used to apply for ethical approval for the study 
(IRAS ID: 214859). The study was first approved by Roehampton University Ethics Committee (email 
dated 19/07/2017, LCS 16/190). Thereafter, ethical approval was applied for through the central 
Research and Ethics Committee (REC) and permission was granted from the REC NHS Leicester 
Central (Ref: 17/EM/00 56). This was further approved by HRA (letter attached 21st April, 2017 Appendix 
No 2.3B); finally the local NHS research and development department at DGH was involved through a 
site specific application form linked to the IRAS form and approval was granted (email dated 12th May). 
The study applied for registration on a public data base as per the requirement of HRA and the Universal 
Trial reference Number (UTIN) for this trial is U1111-1226-9074 (Appendices No 2.3A-D)  
Procedure 
Each participant was given a unique trial number, which was assigned by the principal investigator to 
preserve the confidentiality of the patients. Assurance regarding the confidentiality was clearly stated in 
the invitation letter and patients were encouraged to clarify any concerns by either writing to the 
researchers or telephoning them on a particular day (Wednesday afternoons). Contact details for the 
acquisition of independent information were also provided. There was a separate section at the end of 
the questionnaire which the patients could sign and return to acknowledge receipt and which also gave 
them the opportunity to request not to be contacted for such studies in the future.  
During the recruitment phase of the study, extreme care was taken to preserve the confidentiality of the 
patients by constructing a comprehensive password protected database. The database was received 
from the dietitian department using the NHS Trust’s email and only Trust specified memory sticks were 
used. Data was accessed on a need only basis. The researcher analysed the diagnostic database and 
only relevant details (like age, sex, ethnicity, basic information given at the first meeting with the dietitian 
and histological confirmation) were entered into the database. Only then were the questionnaires sent 
out.  
The first phase of the study was the postal recruitment phase, where patients were identified by their 
pre-allocated number. The suitably identified patients were carefully re-evaluated prior to sending out 




the research pack. This was a precautionary measure to ensure compliance with the exclusion criteria 
and prevent any unintended recipients receiving the pack (e.g. minors or deceased patients). Additional 
information gained from the CD database (like age, ethnicity and gender) was also entered onto the 
already generated research database.  
The returned questionnaire was kept in a separate file in the research room of DGH and all identifiable 
data was kept linked only to trial number to protect confidentiality. Each response on the questionnaire 
was coded from 0 to 5. The following information was entered into the database: gender, age and 
ethnicity (1- 4). Once this round was completed, the data was analysed according to the statistics section 
below. For complex statistical analysis, including logistic regression, data with multiple factors was split 
into subsections, each with a value of 0 or 1, signifying absence or presence of the concerned factor 




In the first stage, the entered data was checked for any errors and missing data. The researcher found 
four cases where typographical errors were detected and a further two cases where the data was 
missing. Missing data was cross checked with the paper based collected data and the missing values 
were rectified. Following this, in the second stage, coding of the data was cross verified and no coding 
errors were identified. All entries in the software were done by the researcher (author) and no omission 
in the data was left. It was planned to spot missing data and to complete it with terms like ND (not done), 
NA (not applicable), NK (not known). Ambiguous phrases such as ‘not available’ were avoided. No 
patients withdrew from the study, although it was made clear to the patients that they were allowed to 
withdraw from the study at any time without being questioned about the reasons. 
Data Analysis: 
Data was entered and analysed using SPSS V 24 (IBM SPSS Inc., Chicago, IL). Data was initially 
evaluated for characterization of the recruitment cohort; age range, gender distribution, ethnic variation 
and evidence for diagnosis were also explored. To detect skewness, continuous variables e.g. age, 
were screened for normal distribution by using the Kolmogorov-Smirnov test. In addition to χ2 test other 
nonparametric tests such as Mann-Whitney U (MWU), Wilcoxon signed-rank and Kruskal-Wallis tests 




were used to compare percentages. 2X2 contingency tables were used to compare nominal data in 
cross tabulation. Odds Ratio (OR) was calculated for the table Student’s t-test or equivalent non 
parametric tests were used to analyse the difference between mean age and length of follow-up since 
diagnosis of the returnees and non-returnees of the questionnaire among the Caucasian and South 
Asian patients. Additionally, binary Logistic Regression was used to find association between certain 
parameters (membership of Coeliac Society, understanding food labels etc.) and adherence with a GFD. 
Logistic Regression analysis provided p values and an OR with 95% confidence interval. For the 





























The Dietetic department database generated 213 patients, out of which 195 were selected for the postal 
invitation and 18 patients were excluded (based on the exclusion criteria). Out of the excluded patients, 
eight patients were below the age of 18 and one was a duplication of data. A further four patients were 
excluded as they had died by the time the data was being analysed for inclusion into the study, based 
on the current information available from the mortality database of the hospital. There was no contact 
address for the five remaining excluded patients; they were assumed to have moved out of the area or 
changed their address but not updated it on the system. After the Intervention, at the time the study was 
being written, the local clinical commissioning group (in accordance with national guidelines) had also 
published new guidelines on their website regarding restricting certain gluten free products on 
prescription (CCG Dudley, 2018).  
Age, ethnicity and gender of the study population: 
The 195 patients consisted of 57 (29.2%) males and 138 (70.8%) females and there were 170 (87%) 
White Caucasians out of which 122 (62%) were females and the remaining were males. There were 16 
(8.2%) South Asian females in the sample. The ages of the population ranged from 18 to 70 years (M = 
50.6, SD = 52). Age was non-normally distributed (p=0.00), with skewness of -0.82 (SE = 1.35) and 
kurtosis of -1.14 (SE = .364). There was a significant difference between the ages of males (Mdn = 57, 
n = 57) and females (Mdn = 49, n = 138), U = 3016, z = -2.55, p = .01, r = -.18. The result thus shows 
that the sample was White Caucasian female predominant and females were significantly older than 
males. (Appendices 4.3A a-d) 
Responders and non-responders of the invitation to participate. 
Out of 195 postal invitations, 125 completed questionnaires were received, which gives a return 
(completion) rate of 64% and this was achieved in phases by sending reminders (Tai et al., 1997, Silva 
et al., 2002). In addition, four other responses were received marked “returned to sender” and no further 
attempt was made to contact them, as it was assumed that they had moved.  None of the questionnaires 




had missing data and the information was legible. The table below shows the characteristics of the 
responding and non-responding populations. (Table No 51)  
Table 51: Characteristics of responders and non-responders to invitation to participate. 
 Response status  
Variables Total Responders  Non-Responders  P Value 
 195 125 (64.1%) 70 (35.8%)  
Median Age (IQR) 52 (33-67) 51 (33-67) 53 (31-69) 0.82* 
Age Groups     
 <  20 years 7 (3.3%) 3 (2.4%) 4 (5.7%)  
 21-30 years 31 (15.9%) 19 (15.2%) 12(17.1%)  
 30-40 years 26 (13.3%) 17(13.6%) 9 (12.9%)  
 41-50 years 27 (13.8%) 20 (16%) 7 (10%)  
 51-60 years 36 (18.5%) 25 (20%) 11 (15.7%)  
 61-70 years 32 (16.4%) 20 (16%) 12 (17.1%)  
>  70 years 36 (18.5%) 21 (16.8%) 15 (21.4%)  
Gender    .24** 
  Male 57 (29.2%) 33 (26.4%) 24 (34.3%)  
  Female 138 (70.7%) 92 (73.6%) 46 (65.7 %)  
Ethnicity    .18** 
  White Caucasians 170 (87.2%) 106 (84.4%) 64 (91.4%)  
  South Asians 25 (12.8%) 19 (15.2%) 6 (8.6%)  
IQR: Inter Quartile Range, *MWUT, ** χ2 test.  
 
The ages of the responders ranged from 18 to 83 years (Mdn = 51, IQR 33-67) and were not distributed 
normally (p<0.001), with skewness of -.085 (SE = -.217) and kurtosis of -1.07 (SE = .43). The ages of 
those who did not return the questionnaire ranged from 18 to 87 years (Mdn = 53, IQR 31-69). Similarly, 
they were not distributed normally (p=.00), with skewness of -.092 (SE = .28) and kurtosis of -1.29 (SE 
= .56).  A Mann-Whitney U test did not find any significant difference in the ages of responders (Mdn = 
51, n = 125) and non-responders (Mdn = 53, n = 70), U = 4293, z = -216, p = .829, r = 0.01. 




Correspondingly, a chi-square for independence indicated no significant difference between gender and 
questionnaire return rate, χ2 (1, n=195) = 1.35, p=0.24, phi = -.083. Likewise, there was no significant 





















Depression Anxiety and Stress Score (DASS) 
Severe depression was one of the exclusion criteria and patients were asked to fill in the DASS-21 
(Henry & Crawford, 2005) questionnaire to assess their depression, anxiety and stress scores. A total 
of 87 (44.6%) completed DASS questionnaires were received, which is a sub-set of the 125 responders; 
none of the patients had severe depression, although one patient was found to have severe anxiety. 
The DASS depression scores ranged from 4 to 15 (M = 8.6, SD = 2.1) and were non-normally distributed 
(p=<0.01), with skewness of .45 (SE = .26) and kurtosis of .38 (SE = .53). Similarly, the DASS anxiety 
scores ranged from 4 to 15 (M = 8.6, SD = 2.1) and were non-normally distributed (p<0.01), with 
skewness of .45 (SE = .26) and kurtosis of .38 (SE = .53). Likewise, the DASS stress scores ranged 
from 4 to 15 (M = 8.6, SD = 2.1) and were non-normally distributed (p<0.01), with skewness of .45 (SE 
= .26) and kurtosis of .38 (SE = .53). The table below shows the relative scores of the different categories 
in comparison to the total scores (Table No 52). 
Table 52: Results of the DASS 21 questionnaire 
  Total Gender 
   Male Female  
  N= 87 N= 25 N= 62  
 Variable  Median (IQR) Median (IQR) Min Max Median (IQR) Min Max P* 
 Age 51 (33-67) 57 (43-72) 18 83 48 (32-62) 18 87 .05 
 DASS total depression score 9 (7-10) 8 (7-9) 5 13 9 (7-10) 4 15 .35 
 DASS total anxiety score 8 (6-9) 8 (6-9) 4 16 8 (6-9) 3 20 .73 
 DASS total stress score 9 (7-12) 9 (6-15) 2 21 9 (6-12) 3 21 .85 
*MWUT 
DASS questionnaire analysis showed that males (Mdn = 56, n = 25) were significantly older than females 
(Mdn = 48, n = 62), U = 569, z = -1.93, p = .05, r = .20, but there was no significant difference between 
genders in relation to depression; U = 677, z = -.93, p = .35, r = .1, anxiety U = 1064, z = -.34, p = .73, r 
= .03 or stress U = 1080, z = -.18, p = .85, r = .01, which means that neither gender was excessively 
depressed, stressed or anxious as compared to the other gender.  




Based on their DASS score, each individual was classified as depressed or not depressed; if depressed, 
they were then sub categorised as: mild, moderate, severe or extremely severe. Depression was found 
in 26 (20%) of the patients but was generally mild (n=25) and none of the patients was severely 
depressed (which was one of the exclusion criteria). The table below shows the results of the DASS 
questionnaire (Table No 53) (Appendices 4.3Ca-g). 
Table 53: Results of the DASS questionnaire   
  Gender Total   
  Male (n=25) Female (n=62) n=87 Χ2 (p) 
Depression     1.8 (.40)  
 None  20 (80%) 41 (66.1%) 61 (70.1%)  
 Mild  5 (20%) 20 (32.3%) 25 (28.7%)  
 Moderate -- 1 (1.6%) 1 (1.1%)  
 Severe -- -- --  
 Extremely severe -- -- --  
Anxiety     1.34 (.85) 
 None  10 (40%) 25 (40.3%) 35 (40.2%)  
 Mild  11 (44%) 23 (37.1%) 34 (39.1%)  
 Moderate 1 (4%) 6 (9.7%) 7 (8.0%)  
 Severe 3 (12%) 7 (11.3%) 10 (11.5%)  
 Extremely severe -- 1 (1.6%) 1 (1.1%)  
Stress     2.60 (.45) 
 None  19 (76%) 54 (87.1%) 73 (83.9%)  
 Mild  5 (20%) 6 (9.7%) 11 (12.6%)  
 Moderate 1 (4%) 1 (1.6%) 1 (1.1%)  
 Severe -- 1 (1.6%) 1 (1.1%)  
 Extremely severe -- -- --  
 




Further analysis indicated that none of the DASS components were significantly different between 
genders. It is thus concluded that, although there was some degree of depression among patients, no 























Baseline or Pre Intervention Data 
 
Leffler Questionnaire  
All patients (n=125) who returned the questionnaires completed the Leffler questionnaire and none of 
the data was left blank. CDAT score was calculated from the cumulative scores of individual components 
and based on that patients were divided into two groups: adherent to GFD (CDAT <13) and non-
adherent to GFD (CDAT>13) (Leffler et al., 2009). The adherent group will be termed the control group 
from now onwards and the non-adherent group will be called the intervention group. CDAT scores for 
the entire population (n=125) ranged from 7 to 20 (Mdn = 10, IQR= 9-12) and were not distributed 
normally (p<0.01), with skewness of 1.06 (SE = .217) and kurtosis of .41 (SE = .43). The bar chart below 




Figure 33: CDAT scores of the study population (n=125). Dotted line shows the cut-off point of 
for the adherent group (to the left CDAT score <13), with the non-adherent group to the right. 
 
 




The most prevalent scores were 9 and 10 (n=22) followed by 11 (n=18). 30 participants (24%) were 
therefore in the intervention group and the remaining (n=95) were in the control group. There were 15% 
(n=19) South Asians in the cohort and all of them had a score <13, thus indicating adherence to a GFD.   
Age, Gender and Ethnicity in relation to CDAT score (Baseline): 
There was no significant difference between the CDAT scores of both genders. CDAT scores for males 
ranged from 7 to 18 (Mdn = 10, IQR= 9-12) and were not distributed normally (p<0.01), with skewness 
of .89 (SE = .40) and kurtosis of .13 (SE = .79). Likewise, CDAT scores of female ranged from 7 to 20 
(Mdn = 10, IQR= 9-12) and were not distributed normally (p<0.01), with skewness of .897 (SE = .4) and 
kurtosis of .136 (SE = .798). A Mann-Whitney U test indicated no significant difference in the CDAT 
scores for males (Mdn = 10, n =33) and females (Mdn = 10, n = 92), U = 1458, z = -.336, p = 0.737, r = 
-0.03 (Appendix 4.3Da).  
Participants with white ethnicity had significantly higher CDAT scores compared with South Asian 
participants, suggesting lower adherence to a GFD. CDAT scores for those of white ethnicity ranged 
from 7 to 20 (Mdn = 10, IQR= 9-13) and were not distributed normally (p<0.01), with skewness of .893 
(SE = -.23) and kurtosis of -.03 (SE = .46). However, CDAT scores of South Asians ranged from 7 to 12 
(Mdn = 9, IQR= 8-10) and were distributed normally (M = 9.1, SD = 1.39)  (p=.14), with skewness of .26 
(SE = .52) and kurtosis of -.24 (SE = 1.01). A Mann-Whitney U test revealed a significant difference in 
the CDAT scores for white ethnicity (Mdn = 10, n =106) and South Asians (Mdn = 9, n = 19), U = 627, z 
= -2.63, p <0.01, r = -0.23 (Appendix 4.3Db).   
CDAT score was a combination of several statements categorised as: symptoms, social, psychological 
and gluten exposure.  The most prevalent answer was low energy (70%), followed by report of difficulties 
while dining out (69%). Similarly the mean score for low energy was the highest (1.9), followed by 
difficulties dining out. The mean score for those who ate gluten on purpose was 1 and this was the 
lowest. None of the data was distributed normally as both Kolmogrove-Smirnove (KS) and Shapiro-Wilk 
(SW) tests had significant p values (p<0.001). The results of median scores along with IQR of individual 
components of CDAT are shown in the table below (Table No 54).   




Table 54: Comparing CDAT scores of the responders at baseline based on gender and ethnicity 
 Gender  Ethnicity  
 Total (N=33) Male (N=234) Female (N=92)  White (N=106) Asians (N=19)  
 Median (IQR) Min-Max Median (IQR) Min-Max Median (IQR) Min-Max P* Median (IQR) Min-Max Median (IQR) Min-Max P* 
Statements in CDAT Score             
Symptoms of CD             
    Low energy 2 (1-3) 1-5 1 (1-3) 1-5 2 (1-3) 1-5 .84 2 (1-3) 1-5 1 (1-2) 1-4 .01 
    Headache 1 (1-2) 1-4 1 (1-2) 1-4 1 (1-2) 1-4 .06 1 (1-2) 1-4 1 (1-2) 1-2 .29 
Social Issue             
    Follow GFD while dining out 2 (1-2) 1-4 2 (1-2) 1-4 2 (1-2) 1-4 .88 2 (1-2) 1-4 1 (1-1) 1-3 .00 
Psychological             
    Consider the consequences 1 (1-2) 1-4 1 (1-2) 1-3 1 (1-2) 1-4 .35 1 (1-2) 1-4 1 (1-2) 1-3 .93 
    Don’t consider myself a failure 1 (1-2) 1-5 1 (1-2) 1-4 1 (1-2) 1-5 .99 1 (1-2) 1-5 1 (1-2) 1-2 .68 
Gluten Exposure             
   Accidental gluten exposures 1 (1-2) 1-5 1 (1-2) 1-5 1 (1-2) 1-5 .77 1 (1-2) 1-5 1 (1-2) 1-2 .19 
    Eaten gluten on purpose 1 (1-1) 1-3 1 (1-1) 1-2 1 (1-1) 1-3 .41 1 (1-1) 1-3 1 (1-1) 1-1 .12 





It is evident from the table above that South Asian participants had significantly better GF dietary 
adherence scores compared with White Caucasians, whilst there was no difference in component CDAT 
scores between the two genders. When the Leffler questionnaire was analysed for detecting adherence 
based on the frequency of knowingly ingesting gluten (statement no 7), the results showed that the GF 
dietary adherence rate was 90.4% and the majority of the patients (n=113) reported not ingesting gluten. 
The 12 (9.6%) patients who reported ingesting gluten in some form were either ingesting on a monthly 
(n=10) or weekly basis (n=2) and none of the patients reported ingesting gluten on a daily basis. This 
distinction is important in relation to the presentation of the remaining results, as non-adherence in this 
study is based on the validated CDAT score of > 13 and not on the frequency of knowingly ingesting 
gluten (Appendix 4.3Da-g). 















Demographics and CDAT scores of the study groups at base line 
The ages of those in the intervention group ranged from 18 to 87 (Mdn = 52, IQR = 34-59) and were not 
distributed normally (p<0.01), with skewness of -.082 (SE = .42) and kurtosis of -1.37 (SE = .83). The 
ages of females (n=23) in this group ranged from 21 to 73 (M = 48.5, SD = 18.5), normally distributed 
(p=.20), with skewness of .037 (SE = .48) and kurtosis of -1.56 (SE = .481). MWU test did fnot detect a 
significant difference between the ages of intervention (Mdn=53, n=30) and control (Mdn=51, n=95), U 
= 1374.5, z = -2.9, p=0.77, r = -0.24 (Appendix 4.3Eb). Furthermore, the ages of males in this group 
(n=23) ranged from 39 to 81 (M = 59.7, SD = 15.6). Similarly, they were normally distributed (p=.20), 
with skewness of -.056 (SE = .794) and kurtosis of -1.37 (SE = 1.58) and there was no significant 
difference between the ages of males (M = 59.7, SD = 15.6) and females (M = 48.5, SD = 18.5) 
conditions; t (28) =1.44, p =0.16 (Appendix 4.3Eg) 
In the control group, there were 95 (76%) patients who were adherent to a GFD and this group was 
predominantly composed of females (77%) and of white ethnicity (76%). Additionally, the ages of those 
in the control group ranged from 18 to 83 (Mdn = 51, IQR = 33-64) and were non-normally distributed 
(p<0.01), with skewness of -.088 (SE = .24) and kurtosis of -.97 (SE = .49). In addition to that, the ages 
of females (n=69) in this group ranged from 18 to 82 (Mdn = 49, IQR = 32-47) and were not distributed 
normally (p<0.01), with skewness of .065 (SE = .89) and kurtosis of -.83 (SE = .57). Furthermore, the 
ages of males in this group (n=26) ranged from 19 to 83 (Mdn = 57, IQR = 44-71) and were non-normally 
distributed (p<0.01), with skewness of -.56 (SE = .456) and kurtosis of -.72 (SE = .88). The table below 










Table 55: Characteristics of intervention and control groups 
 Study Groups  
Variables N (Total) Intervention Control Significance 
 125  30  95   
Median Age (IQR) 51 (33-67) 52 (34-69) 51 (33-64)  U =1374, P= .77 
Age Groups     Χ2.= 4.9, P=.54 
 <  20 years 3 (2.4%) 0 (0%) 3 (2.4%)  
 21-30 years 19 (15.2%) 5 (4.0%) 14 (11.2%)  
 30-40 years 17(13.6%) 6 (4.8%) 11 (8.8%)  
 41-50 years 20 (16%) 3 (2.4%) 17 (13.6%)  
 51-60 years 25 (20%) 4 (3.2%) 21 (16.8%)  
 61-70 years 20 (16%) 5 (4.0%) 15 (12.0%)  
>  70 years 21 (16.8%) 7 (5.6%) 14 (11.2%)  
Gender     Χ2= .191, P=.66 
  Male 33 (26.4%) 7 (5.6%) 26 (20.8%)  
  Female 92 (73.6%) 23 (18.4%) 69 (55.2%)  
Ethnicity     Χ2=7.07, P.00 
  White Caucasians 106 (84.8%) 30 (100%) 76 (80%)  
  South Asians 19 (15.2%) 0 (0%) 19 (20%)  
IQR: Interquartile range 
 
It is clear from the table above that there was no difference between the ages of patients in the 
intervention and control groups. Similarly, there was no difference between the age groups and gender 





CDAT scores (n=125) ranged from 7 to 20 (Mdn = 10, IQR 9-12) and were not distributed normally 
(p<0.01), with skewness of 1.06 (SE = .21) and kurtosis of -.41 (SE = .43). CDAT scores for the 
intervention group ranged from 13 to 20 (M = 15.7, SD = 2.0) and were normally distributed (p=.18), with 
skewness of .40 (SE = .42) and kurtosis of -.69 (SE = .83). In contrast the CDAT scores for the control 
group (n=95) ranged from 7 to 12 (Mdn = 9, IQR 8-10) and were not distributed normally (p<0.01), with 
skewness of -.054 (SE = .24) and kurtosis of -.90 (SE = .49).  
The intervention group had significantly higher median CDAT scores as compared to the control group; 
a Mann-Whitney U test revealed a significant difference in the CDAT scores for the intervention (Mdn = 
16, n =30) and control groups (Mdn = 9, n = 95), U = .00, z = -8.33, p = .00, r = -0.75.  The bar chart 




Figure 34: Comparison of CDAT scores of both groups. Dotted line shows the cut-off 







Different components of the CDAT scores were analysed; significance was calculated by the MWU test 
and is presented in the table below (Table No 56).  
Table 56: Comparison of CDAT scores between intervention and control groups 
 Study Groups  
Statements in CDAT Score Total (n=125) Intervention Group 
(n=30) 
Control Group (n=95)  
Symptoms of CD Mdn (IQR) Mdn (IQR) Min-Max Mdn (IQR) Min-Max P* 
    Low energy 2 (1-3) 3 (2-3) 1-5 1 (1-2) 1-5 <0.01 
    Headache 1 (1-2) 3 (2-3) 1-4 1 (1-2) 1-4 <0.01 
Social Issue       
    GFD while dining out 2 (1-2) 2 (2-3) 1-4 1 (1-2) 1-3 <0.01 
Psychological       
    Consider the consequences 1 (1-2) 1 (1-2) 1-4 1 (1-2) 1-3 .01 
    Don’t consider myself a failure 1 (1-2) 1.7 (2-3) 1-3 1 (1-2) 1-5 <0.01 
Gluten Exposure       
   Accidental gluten exposures 1 (1-2) 3 (2-4) 1-5 1 (1-1) 1-3 <0.01 
    Eaten gluten on purpose 1 (1-1) 1 (1-2) 1-3 1 (1-1) 1-2 <0.01 
Overall CDAT score 10 (9-12) 16 (14-17) 13-20 9 (8-10) 7-12 <0.01 
IQR= Interquartile range, *MWU test 
Higher median values were observed for the majority of subgroups in the intervention group compared 
with the control group. The increase in CDAT score (>13) was not limited to one component of the CDAT 








CD knowledge of the study groups at base line 
A total of 116 (92.8% of the 125) completed knowledge questionnaires (Silvester et al., 2016) were 
received at baseline. Silvester scores ranged from 10 to 17 (Mdn = 15, IQR = 14-16) and were non-
normally distributed (p<0.01), with skewness of -.54 (SE = .22) and kurtosis of .16 (SE = .44). For males 
(n=30) the scores ranged from 10 to 17 (Mdn = 14.5, IQR = 14-16) and were non-normally distributed 
(p<0.01), with skewness of -.90 (SE = .42) and kurtosis of .09 (SE = .64). Similarly, for females (n=86) 
they ranged from 10 to 17 (Mdn = 15, IQR = 13-16) and were non-normally distributed (p<0.01), with 
skewness of -.41 (SE = .26) and kurtosis of .25 (SE = .59).  A Mann-Whitney U test did not reveal a 
significant difference in the Silvester scores for males (Mdn = 14.5, n =30) and females (Mdn = 15, n = 
86), U = 1287.5, z = -.016, p = .98, r = -0.00. The results suggest that there was no significant difference 
in CD knowledge between males and females in the study population (Appendix 4.3Fe). Comparing the 
CD related knowledge between the study groups, the total score for intervention group patients ranged 
from 10 to 16 (M = 13.2, SD = 1.4) and was not distributed normally (p<0.01), with skewness of -.42 (SE 
= .42) and kurtosis of -.44 (SE = .83). Similarly, for the control group it ranged from 10 to 17 (M = 14.9, 
SD = 1.3) and was also not distributed normally (p<0.01), with skewness of -.59 (SE = .26) and kurtosis 
of .64 (SE = .51).  The bar chart below compares the scores for the groups (Fig No 35). 
 
Figure 35: Comparison of Silvester scores of the intervention and control groups at 





A Mann-Whitney U test revealed a significant difference in the knowledge scores between intervention 
(Mdn = 13.5, n =30) and control groups (Mdn = 15, n = 86), U = 545, z = -4.79, p = .00, r = -0.00. At 
base line the control group had significantly better knowledge about CD (Appendix 4.3Fj). 
Following this, individual sections of the questionnaire were analysed to see patients’ knowledge about 
specific components of the questionnaire. The majority of participants (84-97%) were able to correctly 
allocate food items to their respectively categories (“allowed”, “to question” or “not allowed”). Egg 
noodles were most often placed in the correct category (93%), followed by soy sauce (92%); whereas 
croutons were least often placed correctly (44.4%) The table below shows the frequency with which 

















Table 57: Silvester CD questionnaire  in relation to identifying category 
Food items Correct identification of category Correctly answered 






Allowed n (%) n (%) n (%) n % n %  
    Milk 97 (83.6) 10 (8.6) 3 (2.6) 76 88.4 26 86.7 .80 
    Chickpea flour 98 (84.5) 8 (6.9) 4 (3.4) 77 89.5 26 86.7 .66 
    Balsamic vinegar 94 (81.0) 12 (10.3) 4 (3.4) 77 89.5 22 73.3 .03 
    Buckwheat 100 (86.2) 7 (6.0) 3 (2.6) 79 91.9 26 86.7 .40 
    Glutinous rice 98 (83.6) 7 (6.0) 5 (4.3) 81 94.2 23 76.7 .00 
    Cocoa 98 (83.6) 6 (5.2) 6 (5.2) 81 94.2 21 70.0 .00 
    Modified corn 99 (85.3) 3 (2.6) 8 (6.9) 82 95.3 22 73.3 .00 
    Mean 97.7 (83.9) 7.5 (6.7) 4.7 (4.0)      
To question         
    Flavoured yogurt 11 (9.5) 93 (80.2) 6 (5.2) 74 86.0 25 83.3 .71 
    Sausages 9 (7.8) 100 (86.2) 1 (0.9) 82 95.3 23 76.7 .00 
    Soy sauce 7 (6) 101 (87.1) 2 (1.7) 84 97.7 23 76.7 .00 
    Oatmeal 18 (15.5) 90 (77.6) 2 (1.7) 70 81.4 24 80.0 .86 
    Rice crisps 39 (33.6) 63 (54.3) 8 (6.9) 76 88.4 21 70.0 .01 
    Seafood imitation 9 (7.8) 93 (80.2) 8 (6.9) 73 84.9 32 80.0 .53 
    Croutons 33 (28.4) 51 (44.0) 26 (22.4) 38 44.2 14 46.7 .84 
    Mean 18 (15.5) 84.4 (72.8) 7.5 (6.5)      
Not Allowed         
    Malt Vinegar 10 (8.6) 5 (4.3) 95 (81.9) 76 88.4 25 83.3 .47 
    Spelt 8 (6.9) 6 (5.2) 96 (82.8) 76 88.4 25 83.3 .47 
    Egg noodles 1 (0.9) 7 (6.0) 102 (87.9) 80 93.0 28 93.3 .95 
    Mean 6.3 (5.4) 6 (5.1) 97.6 (84.2)    





It is clear from the above table that, in the category of allowed food items, mean correct identification 
was 83.9%. In this category, buckwheat was correctly assigned by 86.2% of the participants, followed 
by modified corn (85.3%), glutinous rice (83.6%) and cocoa (83.6%). Similarly, the mean correct 
identification for the second category (food items to question) was 72.8% and in this category soy sauce 
was correctly identified by 87.1% of participants, followed by sausages (86.2%) and then flavoured 
yogurt (80.2%) and imitation sea food (80.2%). The final category (of not allowed food items) was 
correctly identified by 87.9% of the participants. It is also evident from the above table that certain food 
items were wrongly identified by either placing them wrongly into a category of consumption or 
restriction, thus inadvertently consuming or unnecessarily restricting themselves in relation to a food 
item.  The category most affected was “to question food items” where croutons, for example, were 
wrongly categorised as a consumable item by 28.4% of the participants and equally 22.4% of the 














CD Quality of life questionnaire (Baseline)   
The CD QoL questionnaire (CDQoL) was completed and returned by 116 (93%) participants, which is a 
subset of the total returners (n=125) at baseline. One questionnaire was excluded as it was incomplete, 
thus 115 CDQoL were available for analysis. The overall CDQoL scores ranged from 29 to 90 (Mdn = 
50, IQR = 46-74) and were not distributed normally (p<0.01), with skewness of .91 (SE = .22) and 
kurtosis of -.66 (SE = .44). 
Considering CD as stigma, 10% of the participants felt that they were often misunderstood by people in 
relation to CD and 33% sensed that CD was often having an impact on family and friends. Similarly, 
47% thought that they were always a nuisance to other people and 36.5% felt that they sometimes 
received unwanted attention from others. Additionally, considering GFD as dietary burden, 35% of 
patients felt that they were often disappointed with the taste and often felt frustrated having to plan 
ahead (40%) in order to find GF food (30%).  
Symptoms of CD were not a major issue and the most common symptom among CD patients was 
bloating (29%) followed by nausea and vomiting (46.1%). Patients also reported issues with social 
isolation, such as always having limitations of daily activities (7%), isolation from others because of CD 
(23.5%), avoiding social activities (10%), avoiding eating out (30%) and feeling down (35%). There were 
no major worries or concerns about general health among the patients.  
CD was not felt to be a major issue in relation to social isolation by almost half of the participants, as it: 
never affected daily activities, left patient isolated from others (54.8%) or gave them low spirits (33.9%). 
Similarly, patients reported that they never felt worried about anticipation of their own illness (50.4%), or 
illness in a family member (48.7%). Cross contamination, nonetheless, was an issue for 35.7% of the 




















 Always Often Sometimes Rarely Never 
Making a fuss around dietary requirements 5 (4.3%) 45 (39.1%) 26 (22.6%) 18 (15.7%) 21 (18.3%) 
Felt misunderstood by people  -- 10 (8.7%) 43 (37.4%) 12 (10.4%) 50 (43.5%) 
Informing people about misunderstandings  20 (17.4%) 22 (19.1%) 48 (41.7%) 6 (5.2%) 19 (16.5%) 
Received unwanted attention  29 (25.2%) 19 (16.5%) 42 (36.5%) -- 25 (21.7%) 
Impact of CD on family and friends 28 (24.3%) 39 (33.9%) 13 (11.3%) 8 (7.0%) 27(23.5%) 
Uncomfortable refusing unsuitable food  16 (13.9%) 45 (39.1%) 18 (15.7%) 14 (22.2%) 22 (19.1%) 
Nuisance to other people 55 (47.0%) 18 (15.7%) 8 (7.0%) 7 (6.1%)  27 (23.5%) 















      
Frustrated about the cost of GFP 7 (6.1%) 20 (17.4%) 20 (19.1%) 8 (7.0%) 58 (50.4%) 
Difficulty finding suitable food 7 (6.1%) 30 (26.1%) 34 (29.6%) 1 (0.9%) 43 (37.4%) 
Craved food or drinks that contain gluten 17 (14.8 %) 16 (13.9%) 33 (28.7%) 15 (13%)  34 (29.6%) 
Disappointed with taste /texture of GFP 6 (5.2%) 41 (35.7%) 40 (34.8%) 9 (7.8%) 19 (16.5%) 
Felt burdened re time taken to find GFP 9 (7.8%) 37 (32.2%) 32 (27.8%) 9 (7.8%) 28 (24.3%) 
Difficulty finding GFP when out 1 (0.9%) 6 (5.2%) 36 (31.3%) 35 (30.4%) 37 (32.2%) 
Difficulty with choices of GFP 21 (18.3%) 36 (31.3 %) 29 (25.2 %) 5 (4.3 %) 24 (20.9%) 
Frustrated by having to plan ahead 16 (13.9%) 46 (40.0%) 23 (20.0%) 7 (6.1%) 23 (20%) 













Bothered by your bowel movements 6 (5.2%)  37 (32.2%) 32 (27.8%) 12 (10.4%) 28 (24.3%) 
Bloating in your abdomen? 29 (25.2 %) 25 (21.7%) 16 (13.9%) 23 (20.1%) 22(19.1%) 
Had nausea or vomiting 1 (0.9%) 53 (46.1%) 12 (10.4%) -- 49 (42.6%) 
Had pain that you think was caused by CD -- 10 (8.7%) 11 (9.6%) 30 (26.1%) 64 (55.7%) 
Had tiredness or a lack of energy 2 (1.7%) 10 (8.7%) 21 (18.3%) 29 (25.2%) 53 (46.1%) 













Daily activities have been limited by CD 8 (7.0%) 37 (32.2%) 10 (8.7%) 4 (9.6%) 56 (54.8%) 
Felt isolated from others because of CD 27 (23.5%) 4 (3.5%) 10 (8.7%) 11 (9.6%) 63 (54.8%) 
Have you avoided social activities 10 (8.7%) 36 (31.3%) 21 (18.3%) 11 (9.6%) 37 (32.2%) 
Have you avoided going out to eat 30 (26.1%) 16 (13.9%) 31 (27%) 8 (7.0%) 30 (26.1%) 
Have you felt down or in low spirits 35 (30.4%) 6 (5.2%) 23 (20.0%) 12 (10.4%) 39 (33.9%) 

















Worried that you might become ill  20 (17.4%) 15 (13.0%) 18 (15.7%) 4 (3.5%) 54 (50.4%) 
Worried; family member may get CD 1 (0.9%) 46 (40.0%) 9 (7.8%) 3 (2.6%) 56 (48.7%) 
Concerns about health problems 1 (0.9%) 43 (37.4%) 10 (8.7%) 11 (9.6%) 50 (43.5%) 
Concerns of becoming ill when out 29 (25.2) 18 (15.7%) 35 (30.4%) 12 (10.4%) 21 (18.3%) 
Accidental consumption of gluten 6 (5.2%) 2 (1.7%) 14 (12.2%) 22 (19.1%) 71 (61.7%) 




The overall CDQoL scores for males ranged from 68 to 90 (Mdn = 48.4, IQR = 79.1-87.9) and were 
normally distributed (p=0.13), with skewness of -.77 (SE = .42) and kurtosis of .09 (SE = .83). Similarly, 
for females CDQoL scores ranged from 29 to 66 (Mdn = 47.3, IQR = 45.6-51.2) and were normally 
distributed (p=.06), with skewness of .24 (SE = .26) and kurtosis of 1.8 (SE = .51). A T test revealed a 
significant difference in the CDQoL scores between males (M = 83.3, SD =5.6) and females (M= 48.2, 
SD = 5.5) conditions; t (113) =.59, p<0.01 (Appendix 4.3Gg). The CDQoL scores of the different 
dimensions for the intervention and control groups are given in the table below (Table No 59) (Appendix 
4.3Ge).  
Table 59: CDQoL scores for the different dimensions. Values are rounded to the closest whole number.  
Dimensions Total (115) Intervention (n=30) Control (n=85)  
 *Mdn (IQR) Max Min   *Mdn (IQR) Max Min *Mdn (IQR) Max Min P** 
      Stigma 44 (34-66) 97 19 50 (37-58) 91 25 41 (31-67) 97 19 .23 
      Dietary burden 50  (41-69) 100 22 50  (41-69) 84 25 50  (41-72) 100 22 .52 
      Symptoms  60 (50-80) 100 30 50 (44-56) 90 30 70 (55-80) 100 35 <0.01 
      Social isolation 50 (40-75) 100 15 50 (40-74) 95 20 55 (45-77) 100 15 .48 
      Worries  58 (46-71) 96 21 56 (49-68) 83 21 58 (46-75) 96 25 .39 
      Overall 50 (46-74) 90 29 50 (49-59) 82 29 51 (46-78) 90 39 .22 
*Values are rounded to the nearest whole number, **MWU test, 
Among the dimensions, symptoms (of CD) was the main issue affecting quality of life in both groups, 
followed by social isolation. The only difference between the two groups which reached significance was 










Thirty patients were placed in the intervention group and received telephonic clinic as an intervention. 
The demographics of this population have been explained above. The intervention for an individual 
patient was tailored according to their needs e.g. lack of motivation, knowledge gaps or complex social 
issues in relation to the CD diagnosis or following a GFD. The mean time taken for a clinic was 49 
(SD=7.2) minutes and the duration ranged from 33 to 63 minutes. The clinic was mainly patient centred 
i.e. lead by patients and 73% (n=22) of the patients reported an “excellent” level of satisfaction. None of 
the patients was dissatisfied with the clinic and only 10% (n=3) of patients were neither satisfied nor 
dissatisfied.  
Gluten exposure was classified as either accidental or deliberate and 36.7% (n=11) of patients admitted 
to deliberate exposure to gluten. A variety of issues were discussed, but they were mainly divided into 
four sections including issues with motivation and social issues. In the former category, 70% (n=21) had 
some degree of mild motivational issues based on the patients’ perception, but none had severe issues; 
16.7% (n=5) had no self-reported issues with motivation. On the contrary, 66.7% (n=20) had no self-
reported social issues related to a GFD or the diagnosis of CD and only five had mild issues. Based on 
patient information gathered from the CDQoL, Silvester and CDAT questionnaires,  the majority of time 
(presented in bold in the table above) during the clinic was devoted to a specific targeted issue for each 
patient. However all patients were engaged in some degree of discussion about possible gluten 











Post Intervention Data at 3 Months 
At three months post intervention, 116 completed questionnaires were received from 125 patients and 
this gives a return (completion) rate of 92.8%. The responders from baseline and at three months are 
compared in the table below (Table No 60). 
Table 60: Characteristics of responder population at baseline and at three months.  
  
Responders  
 Total Baseline   Three Months*  p 
N (%) 195 125 (100%) 116 (92.8%)  
Variables     
Mean Age ±SD 50.6 ±18.9 50.5 ± 17.7 51.3 ± 17.6 1.0** 
Study Group  _    
  Intervention  -- 30 (100%) 30 (100%)  
  Control  -- 95 (100%) 86 (90.5%)  
Gender     
  Male 57 (29.2%) 33 (100%) 30 (90.9%)  
  Female 138 (70.7%) 92 (100%) 86 (93.4%)  
Ethnicity     
  White Caucasians 170 (87.2%) 106 (100%) 98 (92.4%)  
  South Asians 25 (12.8%) 19 (100%) 18 (94.7%)  
*% in this column represents in relation to baseline **Wilcox Sign Rank test 
 
It is clear from the table above that the drop in responders (n=9) was only noted in the control group, 





Assessment of change in circumstances at three months: 
A total of 116 patients completed the change in circumstances questionnaire, 30 (24%) of whom were 
in the intervention group and the remaining were in the control group. The table below shows the results 
of this analysis (Table No 61). 
Table 61: Comparison of change in circumstances between study groups at three months. 
 Study Groups  
 Intervention Group (30) Control Group (86)  
Change in circumstance Yes No Yes No  
Change in doctor appointment 1 (1%)* 29 (25%)  3 (2.6%) 83 (71.6%)  
Change in ability to buy GFP 7 (6%) ** 23 (19.8%) 14 (12.1%) ** 72 (62.1%)  
New allergy to GFP -- 30 (%)  -- 86 (74.1%)  
New diagnosis of depression -- 30 (%)  -- 86 (74.1%)  
Change in Coeliac Society membership? -- 30 (%)  -- 86 (74.1%)  
New diagnosis of anxiety or depression -- 30 (%)  -- 86 (74.1%)  
*New appointments with doctor. ** Chi Square test 
 
Change in circumstances was noted in only two criteria: appointment with doctor and ability to buy GFP.  
A Wilcoxon Signed-Ranks test indicated that the ability to buy GFP at three months (Mean Rank = 11) 
was not different from the ability to buy GFP at six months (Mean Rank = 11) Z = -3.2, p <0.01. 
Additionally, no significant difference was noted at three months (Mean Rank = 4) and six months (Mean 
Rank = 4) Z = -.37, p =.70, in relation to doctor or dietitian appointment. This suggests that neither of 
these changes was significantly different in the two groups. It is thus accepted that, among the factors 
known to influence adherence independent of the administered intervention, there was no significant 
difference between the groups to account for any subsequent change.  
Leffler Questionnaire: 
All responders at three months (n=116) completed the Leffler questionnaire and none of the data was 




(p<0.01), with skewness of .46 (SE = .22) and kurtosis of -.39 (SE = .44). Combined results of means 
from all the statements on the Leffler questionnaires are in the table below (Table no 62) 
Table 62: Comparing CDAT scores of the responders at three months based on gender and ethnicity.  
  Gender  Ethnicity  
 Total (n=116) Male (n=30) Female (n=86)  White (n=98) Asians (n=18)  
Statements in CDAT Score Mean ± SD Mean ±SD  Mean ±SD P Mean ±SD Mean ±SD P 
Symptoms of CD        
    Low energy? 1.54 ±0.7 1.57 ± 0.7 1.53 ± 0.7 .71 1.57 ± 0.7 1.39 ± 0.6 .42 
    Headache 1.80 ± 0.9 1.53 ± 0.7 1.90 ± 0.9 .09 1.88 ± 0.9 1.39 ± 0.6 .05 
Social Issue        
    Follow GFD while dining out? 1.56 ± 0.7 1.63 ± 0.8 1.53 ± 0.6 .70 1.61 ± 0.7 1.28 ± 0.4 .09 
Psychological        
    Consider the consequences 1.52 ± 0.7 1.50 ± 0.5 1.52 ± 0.8 .44 1.55 ± 0.7 1.33 ± 0.8 .10 
   Don’t consider myself a failure 1.44 ± 0.6 1.47 ± 0.6 1.43 ± 0.6 .64 1.50 ± 0.6 1.11 ± 0.3 .01 
Gluten Exposure        
    Accidental gluten exposures? 1.34 ± 0.5 1.30 ± 0.5 1.36 ± 0.5 .52 1.37 ± 0.6 1.22 ± 0.4 .44 
    Eaten gluten on purpose? 1.04 ± 0.2 1.0 ± 0.0 1.06 ± 0.2 .17 1.05 ± 0.2 1.00 ± 0.0 .32 
Overall CDAT score 10.25 ± 2.3 10.0 ± 2.2 10.34 ± 2.4 .58 10.53 ± 2.4 8.72 ± 1.3 .00 
 
The table above shows that South Asians had significantly lower mean adherence scores (suggesting 
better adherence to a GFD) as compared to the White Caucasians on: overall score, the psychological 
dimension (don’t consider myself a failure) and the symptomatic dimension (headache).  
Comparison of CDAT scores at baseline and at three months: 
CDAT scores were compared between baseline and month three for control and intervention groups. 
Higher CDAT scores were noted in the intervention group pre intervention, which exhibited a significant 




Table 63: Comparing CDAT Scores of the study groups at baseline and three months 
 Study Groups 
 Intervention Group  Control Group 
 Baseline (n=30) Three  Months (n=30)   Baseline (95) Three  Months 
(86) 
  
Statements in CDAT Score Mdn (IQR) Mdn (IQR) Difference (z) P* Mdn (IQR) Mdn (IQR) Difference (z) P* 
Symptoms of CD         
    Low energy? 3 (2-3) 3 (2-3) 0 (-3.8) <0.01 1 (1-2) 1 (1-2.5) 0 (-2.3) .01 
    Headache 3 (2-3.25) 3 (2-3.25)  0 (-1.2) .46 1 (1-2) 1 (1-2.) 0 (-2.1) .03 
Social Issue         
    GFD while dining out? 3 (2-3) 2 (2-3) 1 (-2.2) .18 1 (1-2) 2 (1-2.5) 1 (-2.8) <0.01 
Psychological         
   Consequences 1 (1-2) 1 (1-2) 0 (-1.0) .41 1 (1-2) 1 (1-1.5) 0 (-1.4) .15 
    Failure 2 (1.75-3) 2 (1.75-3) 0 (-.78) .16 1 (1-2) 1 (1-1.5) 0 (-.09) .92 
Gluten Exposure         
    Accidental exposures? 3 (2-4) 3 (2-4)  0 (-3.0) <0.01 1 (1-1) 1 (1-1) 0 (-.04) .96 
    Gluten on purpose? 1 (1-2) 1 (1-2) 0 (-3.0) <0.01 1 (1-1) 1 (1-1) 0 (0.0) 1.0 




It is clear from the table above that, in the intervention group, there is significant improvement in the 
symptom of low energy and in gluten exposure. However, in the control group, low energy symptoms 
improved but headache symptoms deteriorated significantly. To compare the overall CDAT scores of 
the intervention group (n=30), the Wilcoxon Signed-Rank test (WSRT) was performed: there was a 
statistically significant reduction in CDAT scores from pre-intervention (Mdn = 16, n=30) to post 
intervention (Mdn = 13, n=30), Z = -4.30, p < .00, r = .79. In comparison, there was no significant 
difference in overall CDAT scores in the control group when analysed at baseline (Mdn = 16, n=95) and 
at three months (Mdn = 13, n=86), Z = -.416, p= <0.01. r=.38. The bar chart below compares these 




Figure 36: Comparison of CDAT scores (M±SD) of the groups at baseline (intervention; 
n=30, control; n=86) and then at three months. Line shows the cut-off point of the 
adherence (below the line CDAT score <13).  
The bar chart shows that the CDAT scores of the intervention group decreased significantly. Of note the 
reduction for the intervention group is above the adherence line (M=13.2). Post intervention there were 
73.3% (n=22) who had CDAT scores above 13, hence the intervention was effective in 26.7% (n=8) of 
the patients.  
The improvement in adherence was also analysed from the point of view of increasing knowledge and 




test: it did not indicate a significant effect of increasing knowledge on decreasing CDAT score, χ2 (1, 
n=30) = .66, p=.44, phi = .14.  This suggests that increasing knowledge had no significant effect on 



















CD Quality of Life questionnaire at three months: 
The CDQoL was completed and returned by 104 (83.2%) participants, which is a subset of the total 
returners (n=125) at three months. All the entries were legible and were included for analysis. The overall 
scores ranged from 43 to 91, (M = 61.1, SD = 13.0) and were not distributed normally (p<0.01), with 
skewness of .78 (SE = .23) and kurtosis of -.57 (SE = .46). Social stigma of CD was the lowest scoring 
area (58.08), followed by worries about CD (61.1); symptoms of CD was the highest scoring area (better 
quality of life). The overall index of quality of life was also compared between the two genders and for 
males scores ranged from 44 to 86 (M = 61.07, SD = 12.4) and were not distributed normally (P=0.00), 
with skewness of .76 (SE = .43) and kurtosis of -.75 (SE = .43). Similarly, the CDQoL scores for females 
ranged from 43 to 91 (M = 61.19, SD = 13.0) and were not distributed normally (P=0.00), with skewness 
of .80 (SE = .27) and kurtosis of -.51 (SE = .54). This is compared in the bar chart below (Fig No 37).  
 
 
Figure 37: Comparison of CDQoL scores of males and females at three 
months. 
MWU test showed no significant difference between the CDQoL scores of males (Mdn = 56.79, n=29) 
and females (Mdn = 58.0, n=75), Z = -.01, p= .99, r=.00. This means that quality of life between the two 
genders was not significantly different. CDQoL was next compared between patients at baseline and at 
three months and significance was calculated for individual dimensions as well as the overall index of 




*Wilcoxon Sign Rank test ** Student T test 
Table 64: Dimensions in relation to CDQoL compared as study progressed 
Study Groups 
                                           Intervention Group                                              Control Group 
 Baseline Three Months    Baseline Three Months   
Dimentions CDQoL Median IQR Median IQR Difference  P  Median IQR Median IQR Difference  P 
Stigma 46.8 37.5-60.9 46.8 39-59.3 2 0.73*  40.6 31.2-75 53.1 40.6-65.6 97 0.09* 
Dietary burden 50 40.6-68.7 56.2 50-68.7 6.2 0.24*  50 43.7-71.8 65.6 53.1-71.8 100 0.02* 
Symptoms 50 45-57.5 50 40-60 0 0.94*  70 55-80 70 60-80 100 0.30* 
Social isolation 50 40-77.5 50 40-65 0 0.65*  55 45-80 65 50-80 100 0.06* 
Worries 58.3 50-68.7 58.3 45.8-75 0 0.30**  58.3 45.8-79.1 62 50-70 92 0.86* 




The overall CDQoL was compared for both groups at baseline and three months and no significant 
difference was noted in each dimension of HRQoL at baseline and month three. In the control group, 
significant difference was noted in dietary burden, where the score improved significantly (p=0.02). The 


















CD knowledge of the study groups at three months: 
A total of 110 (88%) patients completed the knowledge questionnaires (Silvester et al., 2016) and they 
were a subset of the returners (n=125) at three months. None of the questionnaires were left blank and 
the information was legible. Silvester scores were calculated and ranged from 12 to 17 (M = 15.42, SD 
= 1.09); they were non-normally distributed (p<0.01), with skewness of -.85 (SE = .23) and kurtosis of 
.676 (SE = .54).  
A Mann-Whitney U test revealed significant difference in the Silvester score for intervention (Mdn = 13.5, 
n =30) and control groups (Mdn = 15, n = 80), U = 895, z = -2.6, p = .03, r = -.20. The results suggest 
that at three months the control group had significantly better knowledge about CD as compared to the 
intervention group. This difference, when further analysed, was found to be in certain food items such 
as: balsamic vinegar, glutinous rice, cocoa, modified starch, sausages, soy sauce and rice crisps.  
CD knowledge was compared for both intervention and control groups at baseline and then at three 
months.  Among the allowed food items, the correct responses showed improvements from base line to 
three months with regards to milk, chickpea flour and balsamic vinegar in both groups; this also reached 
significance in both groups.  
A universal increase in all components of knowledge was observed in the intervention group, except a 
marginal drop re soy sauce. Egg noodles and milk were correctly spotted by 30 (100%) patients post 
intervention. Correct identification of croutons and cocoa was still an issue, although it had increased 
from the base line of 14 to 26 and 21 to 25 respectively. In the control group there was a variable 
response and both increases and decreases in the knowledge components were observed. The groups 








Table 65: Silvester CD questionnaires compared at baseline and at three months. The number of correct answers for each item is 











 Intervention Group (n=30) Control group (n=80) 
 Baseline  Three months Baseline  Three months 
 N=30 (%) N=30 (%) N =86 (%) N =80 (%) 











Milk 26 86.7 30 100 76 88.4 73 91.3 
















Cocoa 21 70.0 
25 83.3 
81 94.2 
78  97.5 















         








Soy sauce 23 76.7 22 73.3 84 97.7 65 81.3 












Croutons 14 46.7 26 86.7 38 44.2 76  97.5 














Malt Vinegar 25 83.3 28 93.3 76 88.4 72 90 
Spelt 25 83.3 29 96.7 76 88.4 80 100 





Total Silvester scores were compared next at baseline and at three months to see if there was a 
significant difference in the scores at two points in time. The Wilcoxon Signed-Rank test (WSRT) was 
performed and it showed that, after telephonic intervention, there was a statistically significant increase 
in Silvester scores of the pre intervention (Mdn = 13, n=30) and post intervention population (Mdn = 15, 
n=30), Z = -4.230, p <0.01, r = -.77. Similarly, comparison was also drawn between the control groups 
and WSRT was performed: it showed that there was a statistically significant increase in Silvester scores 
of the control group when analysed at baseline (Mdn = 15, n=86) and at three months (Mdn = 16, n=80), 
Z = -3.84, p= .00, r=.43. The bar chart below compares the groups at baseline and then at three months 
(Fig No 38). (Appendix 4.3Jj)   
 
 
Figure 38: Comparison of Silvester scores of the population at baseline and then at three months.  
 
This means that a significant increase in Silvester score was noted in both groups, hence an increase 









Post Intervention Data at 6 Months: 
At six months post intervention, 87 completed questionnaires were received and this gives a return 
(completion) rate of 69%. The responders from baseline and at three months are compared in the table 
below (Table No 66). 
Table 66: Characteristics of the population at baseline, three months and at six months. 
  Responders 
Variables Total Baseline   Three Months  Six Months 
Invitations sent  195 125 125 
 195 125 (64.1%) 116 (92.8%) 87 (69.6%) 
Mean Age ±  SD 50.6 ± 18.9 50.5 ± 17.7 51.2 ±  20.6 50.2 ± 17.9 
Study Group  _    
       Intervention  -- 30 (24%) 30 (26%) 30 (34.5%) 
       Control  -- 95 (76%) 86 (74%) 57 (65.5%) 
Gender     
       Male 57 (29.2%) 33 (26.4%) 30 (26%) 23 (26.4%) 
       Female 138 (70.7%) 92 (73.6%) 86 (74%) 64 (73.6%) 
Ethnicity     
      White Caucasians 170 (87.2%) 106 (84.4%) 98 (84.4%) 76 (87.4%) 
      South Asians 25 (12.8%) 19 (15.2%) 18 (15.5%) 11 (12.6 %) 
 
It is clear from the table above that the drop in responders (n=9) was only noted in the control group 
from baseline (n=95) which dropped to 86 responders. There was no significant difference between the 
groups when analysed according to gender or ethnicity, which means that neither ethnicity nor gender 
had any effect on attrition rate.  
The dropouts from the study (n=38) were analysed at six months and are presented in the table below 





Table 67: Comparison of demographics, CDAT and knowledge scores of control group at baseline and six months. 
                                               Control group 
  Study Dropouts  Control group   
  Baseline (n=38) Baseline (n=95) Six months (n=57)  
Variables  Mdn (IQR) Mdn (IQR) Mdn (IQR) P* 
Age  53 (37-67) 51 (33-64) 50 (32-64)  
CDAT score  10 (8-10) 9 (8-10) 9 (8-10) <0.01 
Gender N (%) N (%) N (%)  
            Male 10 (26.3%) 26 (27.4%) 16 (28.1%)  
            Female 28 (73.7%) 69 (72.6%) 41 (71.9%)  
Ethnicity     
            White Caucasian 30 (78.9%) 76 (80%) 46 (80.7%)  
            South Asian 8 (21.1%) 19 (20%) 11 (19.3%)  
*WRT 
The table above shows that there was a significant difference between the knowledge and CDAT scores 
of the control group when compared at the two points. This means that, after attrition at six months, the 
control group showed better adherence (lower CDAT scores) and improved knowledge.  
Assessment of change in circumstances at six months: 
A total of 87 patients filled in the change in circumstances questionnaire, 30 (34%) out of which were in 
the intervention group and the remaining were in the control group. The table below shows the results 
of this analysis (Table No 68). 
A change in circumstances was only noted in relation to two criteria: appointment with doctor and ability 
to buy GFP; but there were no significant difference between the groups.  It is thus accepted that, among 







Table 68: Comparison of change in circumstances between study groups at three months. 
 Study Groups  
 Intervention Group (n=30) Control Group (n=57)  
Change in circumstance Yes No Yes No  
Change in doctor appointment 1 (4%) 29 (96%) 2 (3.5%) 5 (96.5%)  
Change in ability to buy GFP 6 (20%) 24 (80%) 14 (12.1%) 57 (87.9 %%)  
New allergy to GFP -- 30 (100%)  -- 57 (100%)  
New diagnosis of depression -- 30 (100%)  -- 57 (100%)  
Change in Coeliac Society membership? -- 30 (100%)  -- 57 (100%)  
New diagnosis of anxiety -- 30 (100%)  -- 57 (100%)  
 
Comparison of CDAT score at baseline and at six months: 
Having shown that no known factors are influencing the CDAT score at six months were similar in 
intervention and control groups, we then compared the CDAT scores from baseline (intervention Mdn= 
16, control Mdn =9), month three (intervention Mdn= 13, control Mdn =9) and at six months (intervention 
Mdn= 13, control Mdn =8). Higher mean CDAT scores were noted in the intervention group at baseline 
(M=15.7 ± 2), which then decreased post intervention at six months (M=13.23 ± 1.7). It may be noted 
that the overall CDAT scores for the intervention group increased at month six (M=13.23 ± 1.7) as 
compared to month three (M=13.20 ± 1.6).  
Analysing the domains of the CDAT score however, the mean for “symptom” (low energy and headache) 
had decreased at three months and that was maintained at month six. Similarly, on social aspects e.g. 
dining out, the score had maintained the previously achieved reduced levels. Additionally, psychological 
aspects which showed reduction at month three had increased above the baseline. Accidental gluten 
exposure had clearly improved at month three and was maintained at month six, with a slight increase 
as compared to month three. Similarly, deliberate intake of gluten had reduced at both three and six 
months. The control group generally maintained low scores and remained below the adherence 
threshold with its overall scores. The symptomatic domain showed fluctuation and the social domain 
showed clear improvement and this is in contrast to the intervention group. The psychological domain 




in this group, but accidental exposure decreased. These groups have been compared in the table below 
(Table No 69) (Appendices 4.3Kg &h) 
Table 69: Comparing CDAT scores of the intervention group (n=30) at baseline and six months in relation to gender. 
  Study Groups  
  Intervention Groups  Control Group  
  Baseline 6 Months  Baseline 6 Months  
Statements in CDAT Score  Mdn (IQR) Mdn (IQR) P* Mdn (IQR) Mdn (IQR) P* 
Symptoms of CD        
    Low energy?  3 (2-3) 2 (1-3) <0.01 2 (1-3) 1 (1-2) .59 
    Headache  3 (2-3.25) 2 (2-3) .20 2 (2-3) 1 (1-1) .58 
Social Issue        
    Follow GFD while dining out?  3 (2-3) 2 (1-2) .18 2 (1-2) 1 (1-2) <0.01 
Psychological        
    Consider the consequences  1 (1-2) 2 (1-2) .19 2 (1-2) 1 (1-1) .016 
    Don’t consider myself a failure  2 (1.75-3) 2 (2-3) 1 2 (2-3) 1 (1-1) <0.01 
Gluten Exposure        
   Accidental gluten exposures?  3 (2-4) 2 (1-2) <0.01 2 (1-2) 1 (1-1) 0.96 
    Eaten gluten on purpose?  1 (1-2) 1 (1-1) .02 1 (1-1) 1 (1-1) 0.56 
Overall CDAT score  16 (14-17) 13 (12-15) <0.01 13 (12-15) 8 (7-9) <0.01 
*WSRT 
 
The table shows low energy, accidental exposure and easting gluten on purpose showed significant 
improving. In comparison to Month three (Table No 63) It is clear  that certain aspects of the CDAT 
score in the intervention group showed a reduction at month three, but did not show sustained reduction 
at month six. The control group showed baseline fluctuations in the mean score for all domains expect 
accidental exposure, which showed clear improvement over time. The detail fluctuations of CDAT score 




Table 70: Comparing CDAT scores of the study groups at baseline, three months and six months.  
 Study Groups 
 Intervention Group Control Group 
 Baseline  Three Months Six Months Baseline  Three Months Six Months 
 Mean ±SD Mdn (IQR) Mean ±SD Mdn (IQR) Mean ±SD Mdn (IQR) Mean ±SD Mdn (IQR) Mean ±SD Mdn (IQR) Mean ±SD Mdn (IQR) 
Symptoms of CD             
    Low energy? 2.87 ± 0.93 3 (2-3) 2.13 ± 0.8 3 (2-3) 2.10 ± 0.8 2 (1-3) 1.60 ± 0.09 1 (1-2) 1.34 ±0.6 1 (1-2.5) 1.46 ±0.70 1 (1-2) 
    Headache 2.60 ± 1.03 3 (2-3.25) 2.43 ± 0.9 3 (2-3.25) 2.30 ± 0.8 2 (2-3) 1.37 ± 0.06 1 (1-2) 1.58 ± 0.8 1 (1-2.) 1.25 ± 0.54 1 (1-1) 
Social Issue             
    GFD while dining out? 2.23  ± 0.81 3 (2-3) 2.37 ± 0.8 2 (2-3) 2.0 ± 0.7 2 (1-2) 1.53 ± 0.06 1 (1-2) 1.28 ± 0.4 2 (1-2.5) 1.28 ± 0.45 1 (1-2) 
Psychological             
   Consequences 1.7  ±  0.87 1 (1-2) 1.63 ±0.8 1 (1-2) 1.87 ±0.7 2 (1-2) 1.32 ± 0.05 1 (1-2) 1.48 ± 0.7 1 (1-1.5) 1.12 ± 0.33 1 (1-1) 
    Failure 2.10 ± 0.75 2 (1.75-3) 1.83 ± 0.6 2 (1.75-3) 2.1 ± 0.75 2 (2-3) 1.31 ± 0.06 1 (1-2) 1.30 ± 0.5 1 (1-1.5) 1.07 ± 0.25 1 (1-1) 
Gluten Exposure             
    Accidental exposures? 2.83  ±  1.29 3 (2-4) 1.67 ± 0.7 3 (2-4) 1.70 ± 0.7 2 (1-2) 1.22 ± 0.04 1 (1-1) 1.23 ± 0.5 1 (1-1) 1.07 ± 0.25 1 (1-1) 
    Gluten on purpose? 1.43 ± 0.62 1 (1-2) 1.13 ± 0.3 1 (1-2) 1.17 ± 0.3 1 (1-1) 1.01 ± .10 1 (1-1) 1.01 ± 0.1 1 (1-1) 1.04 ± 0.18 1 (1-1) 
Overall CDAT score 15.77 ± 0.83 16 (14-17) 13.20 ± 1.6 16 (14-17.25) 13.23 ± 1.7 13 (12-15) 9.35 ± 1.42 9 (8 -10) 9.22 ± 1.6 10 (8.5-10.5) 8.28 ± 1.23 8 (7-9) 
 




To compare the overall CDAT scores of the intervention and control groups through time, a Wilcoxon 
Signed-Rank test (WSRT) was performed. It showed that, in the intervention group after telephonic 
intervention, there was a statistically significant reduction in CDAT score (pre-intervention (Mdn = 16, 
n=30) vs post intervention (Mdn = 13, n=30), Z = -4.30, p < .00, r = .79) at three months and this was 
sustained at six months (Mdn = 16, n=30), Z = -3.73, p < .00, r = .69. Similarly, comparison was also 
drawn between the control groups and WSRT was performed. It showed that there was no statistically 
significant reduction in CDAT scores in the control group when analysed at baseline (Mdn = 16, n=95), 
and three months (Mdn = 13, n=86), Z = -.927, p= .354, r=.1, although, at six months, a significant 
reduction was noted (Mdn = 8, n=57), Z = -7.73, p= <0.01, r=.1. The bar chart below compares these 
groups (Fig No 39) (Appendix 4.3Ki).  
 
Figure 39: CDAT scores of responders at baseline, three and six months. The line shows 
the cut-off point for adherence (CDAT score <13).  
It is clear from the chart that the overall CDAT scores decreased in the intervention group from a mean 
baseline score of 15.7 ±0.83 to 13.2 ±1.6 and remained at 13.23±1.6 at six months. This change is 
significant, which means that telephonic intervention has decreased the CDAT scores significantly, 
hence increased adherence to a GFD. The control group has shown a consistent decrease from a mean 
score of 9.35±1.42 to 9.22±1.6 at three months, but this was not significant (p=0.35). The scores 




continued to drop and at six months mean scores of 8.21±1.2 were recorded; this time the decrease 
was significant (p<0.01) as compared to the baseline. It is noteworthy that in intervention group only 
eight (26.7%) patients achieved CDAT scores below 13 at three months and six patients (20%) remained 
below 13 at six months. Furthermore at no point did the mean CDAT scores drop below 13 for the 
intervention group (Base line M= 15.7 ± 0.83, Three months M= 13.20 ± 1.6, Six months M=13.23 ±1.6) 
and similarly, at no point did the CDAT scores increase above 13 for the control group (Base line M= 
9.35 ± 1.4, Three months M= 9.22 ± 1.6, Six months M=8.21 ±1.2). Post intervention decrement in CDAT 
score was also analysed in relation to gender and the table below shows the results (Table No 71). 
Table 71: Comparing CDAT scores of the intervention group (n=30) at baseline and six months in relation to gender.  
  Gender  
  Male (7)  Female (23)  
  Baseline 6 Months  Baseline 6 Months  
Statements in CDAT Score  Mdn (IQR) Mdn (IQR) P* Mdn (IQR) Mdn (IQR) P* 
Symptoms of CD        
    Low energy?  2 (2-3) 2 (1-3) .25 3 (2-3) 2 (1-3) <0.01 
    Headache  2 (2-3) 2 (2-3) .48 3 (2-4) 2 (2-3) .09 
Social Issue        
    Follow GFD while dining out?  2 (1-3) 2 (2-3) .31 2 (2-3) 2 (1-2) .31 
Psychological        
    Consider the consequences  2 (1-3) 2 (1-3) 1 1 (1-2) 2 (1-2) .16 
    Don’t consider myself a failure  2 (2-3) 2 (2-2) .15 2 (1-3) 2 (2-3) .59 
Gluten Exposure        
   Accidental gluten exposures?  3 (2-4) 2 (1-2) .05 3 (2-4) 2 (1-2) <0.01 
    Eaten gluten on purpose?  1 (1-2) 1 (1-1) .31 1 (1-2) 1 (1-1) .03 
Overall CDAT score  16 (14-16) 14 (12-15) .04 16 (14-18) 13 (12-15) <0.01 
*WSRT 
The above table shows that females responded to the intervention more effectively as compared to 
males but the overall CDAT scores showed significant decrement in both genders. This decrement was 




noted in two areas: psychological and accidental exposure to the gluten. In contrast, males showed a 
significant improvement in accidental exposure only (Appendices 4.3K i-k). In summary, there was a 
significant reduction in CDAT score at both three and six months in relation to score at baseline. This 


























The “REST GLUTEN” telephonic intervention resulted in significant improvement in the CDAT scores in 
a group of patients with CD classified as not adhering to the GF diet, and this improvement was 
maintained at three and six months follow up, thus leading to an important clinical outcome of improving 
GF dietary adherence. The intervention also increased CD knowledge of the participating non-adherent 
CD patients. This is a seminal study, exploring the role of telephonic intervention in relation to GFD 
adherence. “REST GLUTEN” can be a clinical tool used by clinicians and dietitians to improve 
adherence to a GFD in CD patients in the future and this may be cost effective and convenient for 
patients who are non-adherent and as a result are at increased risk of complications of CD.  This, in the 
long run, may well reduce economic cost for the health service in the UK and globally.  
It was prospective controlled study and other designs, such as double blind randomised controlled trials, 
are not valid in this case and, although considered the gold standard of empirical research, placebo 
intervention is hypothetical and somewhat facetious in this context. Equally, face to face clinical 
interaction is a superior method of intervention, but it is already in vogue in clinical practice and was not 
the subject of this PhD. To ascertain the efficacy of telephonic/Skype® intervention in comparison to 
face to face interaction, a randomised study could be designed and conducted in the future. It is felt that 
adding another layer of human interaction i.e. Skype® may be a further improvement in this area, as it 
has been used in studies with variable results (Bruce et al., 2018, Max, 2017, McDade et al., 2007, 
Askling et al., 2002, Petrovski et al., 2015) and recommended in a review article (Armfield et al., 2015).  
Study Aims and Objectives 
The study met the primary aim of using a telephonic clinic to improve adherence to a GFD. The clinical 
relevance of the study is evident by the sustenance of low CDAT scores at three and six months follow 
up. But how exactly it translates into long term clinical improvement will only be evident with long term 
follow up of such patients. One would be looking for improvement in CD related parameters such as: 
improved adherence (as evidenced by dietitian and serological assessments including novel methods 
of GFD adherence assessment) and reduction in symptoms and complication of CD such as 




osteoporosis, anaemia and mitotic disorder. This study, as an intervention, showed similar 
improvements at three months in CDAT scores as reported earlier by Sainsbury and colleagues (2013). 
The main difference and a strength of the study, however, is the selection of patients, as in this study 
the patients were selected from a pathological database as opposed to Sainsbury and colleagues 
(2013), who selected patients from online resources and an advocacy group.  
The study also met the second aim of increasing knowledge of a GFD, which may enable patients to 
avoid inadvertent consumption of gluten containing food items, whilst at the same time not over 
restricting themselves from items which are gluten free. Although increasing knowledge has been linked 
to adherence to a GFD (Olsson et al., 2008, Hall et al., 2009, Halmos, Deng et al., 2018), our study did 
not find a significant link between increasing knowledge and reduction in CDAT scores (i.e. better 
adherence to a GFD); this is in agreement with a similar prospective randomised study by Sainsbury 
and colleagues (2013).     
In contrast to this, Halmos and colleagues (2018), in a cross sectional survey, concluded that poor 
knowledge leads to incorrect identification of gluten free foods. This means that although they avoid 
gluten containing foods correctly (are adherent to a GFD), they wrongly identify many gluten free foods 
as gluten containing, thus restricts choices of food in day to day consumption (over restricting).   
Similarly, an earlier cross sectional study (n=82) reported possible non-adherence in patients with 
relatively deficient knowledge about a GFD (Silvester et al., 2016). In contrast to these studies, our study 
was prospective and measured GFD knowledge at two points (baseline and post intervention) and it is 
felt that a higher powered prospective study may well be needed to see the true effect of increasing 
knowledge. This theoretical improvement, if applied by the patients and if gluten containing food items 
are avoided, may in the long run both improve symptoms and prevent complications.  
The final aim of the study, however, could not be met and no significant improvement was noticed in the 
HRQoL of patients in the intervention group, although, it is also evident that the HRQoL did not reduce 
with intervention as dietary intervention may lead to regression in HRQoL (Hauser et al., 2007).   HRQoL 
in CD was found to significantly increased in patients in a study (n=62) by Haas et al., (2017) where 45 
unique messages were sent to CD patients and HRQoL was measured by the Patients Reported 
Outcomes Measurement Information System (PROMIS). There are notable differences with our study, 
where we used a recently developed validated instrument by Croker and colleagues (20018). 




Additionally, the control group in our study showed improved HRQoL and this suggests that this is a 
complex area (Sainsbury et al., 2013c, Ramírez-Cervantes et al., 2015, Paavola et al., 2012) and 
HRQoL may have been affected by unmeasured confounders. It is felt that the tool developed by Croker 
and colleagues (20018) to assess HRQoL in CD patients is useful and may be used in future research 
involving high power randomised control studies.  
Study population, diagnosis of CD and return rate 
The study population was all inclusive except for the paediatric age group (which was outside the scope 
of this research) and the number of CD patients evaluated in this research study was lower than 
originally planned. Our final count for participants of the study (n= 125), where 30 were randomised to 
the intervention group and the remaining served as a control group is comparable to Sainsbury and 
colleagues (2013), who randomised 101 patients in their intervention arm and 88 were included in the 
waitlist control arm; only 50 completed the intervention and 46 provided 3 month data. Similarly Haas 
and colleagues (2017) had 30 patients in their intervention group and Rajpoot et al., (2015) had 43 
patients in their intervention study.  
There was a female predominance in our study population, which reflected the previous trend of CD 
presentation in the general population (Murray et al., 2003a, Green et al., 2001) and this point has been 
explained in detail in relation to study I. A strength of the study was the combination of histological 
diagnosis of CD coupled with positive serology for increased sensitivity and specificity (Donaldson et 
al., 2008). This is discussed in detail in previous section (Pages 42-43). The study thus approached the 
diagnosis from an objective standpoint and the cohort composition was in accordance with previous 
research in this area. 
The return rate (64%) in this study was higher than both study I and study II and this may be explained 
by sending repeated reminders (Silva et al., 2002, Nakash et al., 2006). Furthermore, the patients were 
selected from a dietitian database of patients who are under regular follow up and this too may have 
increased the return rate. Moreover, the return rate in this survey was not affected by age or gender 
(Table No 14). Our return rate compared favourably with that reported by Sainsbury and colleagues 
(2013) in their web based survey (14%).  




Recruitment of South Asian patients was a challenging issue in this study. This was partly due to the 
fact that adherence was significantly higher in South Asians (comparatively less number of patients 
available to recruit) in our cohort, but besides this, it is the same trend which was observed in study II. 
Research studies involving Asians and ethnic minorities have reported low rates of Asians, especially 
the Muslim population in the UK (Szczepura et al., 2008). Sheldon and colleagues (2007) found that 
response rate was low for black and ethnic minorities, but this was in a report to NHS authorities and 
was poorly referenced.  
Similarly, a Danish study reported the return rate in ethnic minorities be low (24%) as well (Bodewes & 
Kunst, 2016). Yet another UK based study (n=9,100), involving South Asians, reported a recruitment 
rate of 8% in a questionnaire based study (Malavige et al., 2015), which is very low. In contrast, a 
systematic review did not find any difference (Sykes et al., 2010) in the return rate for all non-white 
minorities. The low response rate among South Asians has affected the overall aims of this study, as it 
aimed to recruit South Asian patients as well. The question of return rate among South Asians is an 
under researched area and needs research by conducting interviews involving a large cohort to 













Study population at baseline  
The difference in CDAT scores in both groups is self-explanatory, as those who had CDAT scores above 
13 formed the intervention group. The median CDAT score of the whole population was 10.8; in study 
I, the mean CDAT score was 14.4. This discrepancy may be explained by the fact that the data from 
study I was from the pathology department, whereas the data from this study came from the dietetics 
department i.e. patients who were already under follow-up with a registered dietitian. Similarly, 
Sainsbury and colleagues (2013) reported a mean CDAT score of 12.2 which is marginally higher than 
our score; one reported by Haas et al., (2017) is 11, which is close to our score. The difference was 
present in all statements of CDAT score and this follows the previous research by the original author of 
the CDAT score (Leffler et al., 2009, Leffler et al., 2007). The reported variability in CDAT scores may 
be explained by differences in methodology between the studies and may well be dependent on more 
than one factor.  
The adherence rate of our study population (76%) is much better than in study I (45%), where CDAT 
was used to measure the adherence rate. Adherence to a GFD was reported to be 75.8% by Villafuerte‐
Galvez et al., (2015) and 72.3% by Fueyo-Diaz et al., (2016), who also used CDAT as an instrument to 
measure the adherence rate. Variability between study I and study III may be explained by the data 
source as explained in the above paragraph. There is reported variability in the adherence rate (39-
76%) (Leffler et al., 2009, Whitaker et al., 2009, Barratt et al., 2011, Holmes & Moor, 2012, Hall et al., 
2013, Villafuerte‐Galvez et al., 2015, Casellas et al., 2015, Rajpoot et al., 2015, J. Silvester et al., 2016, 
Sainsbury et al., 2018, Leffler et al., 2008, Muhammad et al., 2017) but this again may be explained by 
the methodologies used to measure the adherence. It is thus difficult to say if the reported adherence 
rate in our study (76%) is truly representative of the CD population, as research has also shown that, 
apart from differences in methodology, other factors such as ethnicity (Butterworth et al., 2004), country 
of origin (Fueyo-Diaz et al., 2016) and membership of advocacy groups (Hall et al., 2009, Leffler et al., 
2008, Muhammad et al., 2017) may also play some role. 
This study found major differences in the median CDAT score in both Caucasian and South Asian 
populations and this is contrary to the index study (Butterworth et al; 2005 ): where Asians were reported 
to be less adherent, we report better adherence in South Asians. Only those Asians under dietitian follow 
up were contacted and may well be better motivated, whilst the non-adherent South Asians are not 




being followed up by a dietitian. A review of the histopathological data would have helped to clarify this 
issue, but equally this finding cannot be rejected based on this educated conjecture and future research 
is needed to clarify this point.   
Reduction in CDAT score post intervention 
The study observed a significant reduction in CDAT score at three months and six months post 
intervention, which was maintained at 6 months. The control group, in contrast to the intervention group, 
did not show any significant improvement in their CDAT scores (p=0.35). Our study therefore suggests 
that telephonic intervention may reduce CDAT score: a surrogate of adherence to a GFD. Furthermore, 
studies examining this area directly or indirectly related increment or decrement in CDAT scores to GFD 
adherence (Sainsbury et al., 2013b, Haas et al., 2017). Sainsbury et al., (2013b) evaluated their web 
based methodology “Bread and Butter” and Haas et al., (2017) evaluated text messaging and changes 
in CDAT score. Our study is similar in results to the former but different in results from the latter study 
especially in terms of length of follow up and patient’s selection. The original proposal for our study 
follow up was planned to be 12 months but because of time constrains this was not possible and only 
data for six months is presented in the PhD although follow up data (12 months) was collected latter and 
is being analysed.  
Although Haas et al., (2017) used mobile phone similar to us, the medium used was text messaging, 
which is different from our telephonic conversation. Mobile text messages have been used before with 
some success in relation to: weight loss (Gerber et al., 2009), as appointment reminders (Dyer, 2003) 
and in diabetes management (Franklin et al., 2006). Yet the authors admitted that there were limitations 
such as: low power of the study, selection bias and short duration of the study. In contrast to this, our 
study reported the same outcome of the intervention as Sainsbury et al., (2013), although different in 
methodology but similar in power. We feel that, among other factors (e.g. methodology, selection of 
patients, power of the study), it is the duration of interaction with patients which may have made “REST-
Gluten” and “Bread and Butter” successful. Text messages, although instantly delivered, may lack the 
long term effect which comes with clinical interaction. This notion is further supported by the clinical and 
dietitian follow up used in the study by Rajpoot et al. (2115).  
In our study, similar to the above two studies (Haas et al., 2017, Sainsbury, et al., 2013b), CDAT score 
was used as a surrogate of adherence to a GFD and this point is important, as novel research tools 




have been developed such as: serum anti-DGP (Spatola et al., 2014), a more sensitive tool than IgA 
tTG (Monzani et al., 2011, Volta et al., 2008) and urine GIP (Comino et al., 2012, Moreno et al., 2017). 
Additionally, other experimental tools include: citrulline (Blasco Alonso et al., 2011), intestinal fatty acid-
binding proteins (Oldenburger et al., 2018), autoantibodies against pancreatic secretory-granule 
membrane glycoprotein 2 (GP2) (Laass et al., 2015), REG Iα (Planas et al., 2011) and plasma total 
alkylresorcinols (Lind et al., 2016) and CDAT has not been evaluated against them.  It is thus important 
that at some stage, the efficacy of CDAT as a research tool is evaluated in the light of a robust 
randomised trial to re-evaluate the use of CDAT as a research tool.  It is also suggested that the novel 
tools such as anti-DGP should be used in research in relation to interventions aiming to increase 
adherence to a GFD.  
CDAT is currently the best tool available and has reliability to detect adherence to a GFD as shown by 
several studies since its publication (Villafuerte‐Galvez et al., 2015, Sainsbury et al., 2013b, Fueyo-Diaz 
et al., 2016, Hære et al., 2016, Nazareth et al., 2015). It is noteworthy that symptomatic, gluten exposure 
and psychological aspects of CDAT scores showed improvements. Among symptomatic improvement, 
fatigue showed significant improvement in the intervention group. Although fatigue is a well-established 
symptom of CD as suggested by Siniscalchi and colleagues (2005b), it is equally reported for a variety 
of other causes in general practice such as: depression, chronic fatigue syndrome and organic illnesses 
e.g. cancers, anaemia and neuro-muscular conditions. More importantly, a significant reduction was 
noted in the accidental and deliberate exposure to a gluten containing food item and this is relatively 
objective improvement in adherence to a GFD. It is interesting to note that in our study, despite an 
increase in the knowledge score (Silvester et al., 2016), there was no significant correlation between 
improvement in knowledge and adherence to a GFD.   
It is noteworthy that, although significant reduction was observed in CDAT scores at month three, the 
median scores in the intervention group did not fall below 13, which is considered the adherence 
threshold by Leffler et al., (2009). They noticed that 92.2% of the study population (n=113 of 200) who 
exhibited excellent to very good adherence had a combined score of lower than 13. This was later used 
in studies by (Villafuerte‐Galvez et al., 2015, Sainsbury et al., 2013b). It is not clear if this represents a 
true threshold for analysis of adherence, although it is accepted that rising CDAT score is related to non-
adherence and vice versa. Determining such a cut off score by Leffler et al., (2009) was based on IgA 




tTG used as an objective serological assessment for non-adherence, but it is interesting to note that the 
study did not analyse the IgA levels of any of their patients. Selective IgA deficiency is the most common 
immunoglobulin deficiency (Yel, 2010), affects 2% of CD patients (Chow et al., 2012) and leads to false 
negative results (McGowan et al., 2008) which may have missed a few non-adherent patients and this 
limitation was admitted by the authors. Additionally, anti tTG is not 100% specific and may also be found 
falsely elevated in other conditions such as: primary biliary cirrhosis (Bizzaro et al., 2003), rheumatoid 
arthritis (Picarelli et al., 2003) and chronic liver disease (Villalta et al., 2005); again comorbidity data was 
not available in the study. Furthermore, our study has demonstrated baseline variability in the CDAT 
scores in the non-adherent group. Whilst non-significant, it is important to demonstrate the fact that the 
score itself may mislead if any cut off values are used to determine adherence level without sensitive 
and specific serology as an overarching verification method.  
It is felt that, although increasing CDAT score has been associated with non-adherence, the cut-off 
number is not easily generalizable to all populations with CD and further research is required in this area 
to tailor cut-off limits according to differing demographics. This could be further explored by designing a 
prospective study where different age and ethnic groups are followed and CDAT is measured at different 
points along with detailed interview and other serum and urine bio-markers at each point, to look at the 
baseline fluctuation of CDAT scores and possible confounders affecting this fluctuation.  
At six months the intervention group still showed a significant reduction of CDAT score, although mean 
scores were slightly higher than the scores at three months. This means that the decrease achieved as 
a result of the intervention was sustained at six months. The length of follow up in this study is greater 
than Sainsbury and colleagues (2013) and similar to Rajpoot et al., (2015). It is the first controlled study 
with in the UK with longer follow up.    
Interestingly, the CDAT scores of the control group, which were not significantly different than the 
baseline at three months, were significantly lower (improved adherence) at six months and this is despite 
the fact that no significant changes were noted in the circumstances to explain this. There is no simple 
explanation for this observation and may possibly be multifactorial or a placebo effect (Flik et al., 2017).  
One such confounder may well be the “continual” educational and behavioural input from the Coeliac 
Society UK, although there is no data to report about the membership status of these patients. Outside 




this speculation, objectively speaking, this may well be a “non-response bias” (Barclay et al., 2002, Berg, 
2005), as the control group lost 38 patients and, when compared in sub-analysis, the remaining control 
group (n=57) showed better adherence (lower CDAT scores) and improved knowledge (better Silvester 
scores) when compared to baseline (n=95). Other possible causes may well be attending an educational 
event and bassline line fluctuation in the score, but none of these factors is likely to have caused this in 
isolation and a prospective cohort study of patients with higher power is needed, coupled with dietitian 


















Knowledge and Health related Quality of Life in CD 
 
Knowledge score at baseline and three months 
Our study found a significant difference in the gluten foods knowledge between the adherent and non-
adherent groups. Silvester et al., (2016) also noted such a difference, but our study went further and 
reported that differences in knowledge vary between food items, such as: balsamic vinegar, glutinous 
rice, cocoa, modified starch, sausages, soy sauce and rice crisps; and this is the first report of variability 
based on knowledge score. Knowledge per se might not achieve the desirable change(s) in behaviour 
if there exists a lack of motivation or lack of resources to effect such change(s). In a simple model, 
intervention coupled with necessary skills which lead to self-efficacy above a threshold level may bring 
about behavioural change(s) (Schwarzer, 2014). It is important to note that the knowledge questionnaire 
by Silvester at al., (2016) targets the adult audience.as opposed to Hopeman and colleagues (2012) 
who developed a comprehensive gluten consumption questionnaire but targeted for infants and young 
children. Our study demonstrated that an increase in knowledge in the intervention group at three 
months showed improvement in CDAT score, although this was not significant.  
Knowledge about CD is attained in multiple ways, including at the time of diagnosis (in the clinician’s 
office), follow up appointments, dietitian interactions, self-directed information gathering and 
membership of an advocacy group for maintenance and new information. Additionally, food packaging, 
gluten free signs and clear information on suitable GF foods and gluten containing foods as a public 
health policy may be a source of ongoing knowledge for patients. Furthermore, answers to GFP related 
questions made available to patients through a booklet, website or app may help achieve adherence in 
non-adherent patients. Knowledge may not be limited to patients, as restaurant chefs, food item 
handlers and providers are equally important in this context.  
This whole area is under researched and apart from a few studies (Zarkadas et al., 2013, Silvester et 
al., 2016, Leffler et al., 2008, Sainsbury et al.,2013b, Elkin et al., 2018, Young & Thaivalappil, 2018) no 
major exploration has been done. Similarly, Zabolotsky and colleagues (2017) assessed the roel of an 
educational programme on CDAT and CDQoL and reported improvement in score post education. The 
details of educational strategy was not explained in the conference presentation. These studies, thus, 
have targeted patients as well as healthcare professionals and restaurant staff and conflicting results 
have been reported. Increasing knowledge has been linked to adherence to a GFD by Olson and 




colleagues (2008) and Halmos et al., (2018). In contrast to this, no significant effect has been reported 
by Hall and colleagues (2009) in their systematic review, or by Sainsbury and colleagues (2103) in their 
randomised control study. It is felt that epidemiological studies need to be done to ascertain the 
knowledge gaps in the relevant groups and interventions designed to improve this knowledge. This may 
then be followed up to see its effect on adherence to a GFD. These studies may include measuring 
adherence in certain situations such as travelling and eating out, as CD affects everyday life. 
Since the intervention group, along with improvement in knowledge, also received counselling including: 
motivation for the dietary modification, advice on special situations such as travelling, eating out and 
eating at a friend’s house, it is difficult to ascertain which component of the intervention caused reduction 
in the CDAT score i.e. knowledge or counselling. It is, however, accepted that counselling per se is also 
a part of increasing knowledge about coping with certain situations. 
In our study, we selectively excluded severe depression and in the intervention group no patient was 
given psychological counselling other than motivation. We however accept that the psychological state 
of the patient has an impact on adherence to a GFD (Halmos, Deng et al., 2018, Sainsbury et al., 2013a, 
Sainsbury et al., 2015). A meta-analysis of eight studies conducted by Sainsbury and colleagues (2017) 
suggested an association between self-reported depressive symptoms and poor adherence and another 
study also reported an association between intention and adherence to a GFD and perceived 
behavioural control (Kothe et al., 2015). It is suggested that in future research this issue is addressed 
and data regarding the psychological status of patients is gathered at each point in the follow up. In 
conclusion, there are knowledge gaps in terms of the effect of increasing knowledge on adherence and 
prospective cohort based research with high power is needed to see exactly how increasing Silvester 
scores may reduce CDAT scores and if this relationship is linear. It is suggested that the knowledge 
questionnaire may be modified according to cultural background and inclusion of words such as chapatti, 
daal and other ethnic meals may be included in future questionnaires to assess gluten knowledge.    
 




CDQoL score at baseline and three months 
 
Our study also did not report any significant relationship between increasing HRQoL and improvement 
in adherence to a GFD, even though a positive relationship between HRQoL and adherence to a GFD 
has been reported (Casellas et al., 2015, Nachman et al., 2009, S. D. Johnston et al., 2004). In contrast, 
there are studies where no consistent relationship between the two has been reported (Cranney et al., 
2007, Viljamaa et al., 2005, Hallert et al., 2002, Zarkadas et al., 2013), but these studies have used 
different methods of HRQoL and measurement of adherence to a GFD. Additionally it is accepted that 
HRQoL is a multifactorial construct (Barratt et al., 2011). Haas et al., (2017) who used CDAT as a 
measure of adherence and Patient-Reported Outcomes Measurement Information System (PROMIS) 
as HRQoL measure, reported no relationship between HRQoL and CDAT score. It is thus concluded 
that, in view of the conflicting results in previously reported literature, our study has not established a 
relationship between improving HRQoL and adherence to a GFD and interventional studies are needed. 
It is further suggested that such intervention in future would benefit from validation by an additional 
objective method of adherence assessment such as dietitian assessment and newer sensitive bio-
markers such a urinary GIP. Additionally, results should be interpreted in the light of patients’ 
socioeconomic background and co-morbidities.  
Several studies have reported HRQoL in CD and variable results have been reported (Zysk et al., 2018, 
Fera et al., 2003, Barrio et al., 2018, Cossu et al., 2017), mainly due to diversity in the choice of 
methodology and populations examined. In this study the Patient Reported Outcome Measure (PROM) 
of CDQoL detected a significant difference between the genders at baseline. Our study reported CD 
disease as stigma and dietary burden as the main issues reducing HRQoL in the study population. 
Symptomatic issues, social isolation and worries about CD were not reported to affect HRQoL in our 
study. One reason for this might be the fact that the patients were under regular dietitian follow up which 
shows improved HRQoL (Hall et al., 2009) and this is partly related to improved adherence to a GFD 
(Nachman et al., 2009). Dietary burden has been reported to be an issue in relation to a GFD as reported 
previously (Shah et al., 2014) and our findings are in accordance to that. Additionally, the gender 
discrepancy in HRQoL among females has also been reported in the literature (Hallert et al., 2003, 
Rodríguez Almagro et al., 2017) and this too is consistent with our findings. Our findings on increased 




CDQoL in females three months after intervention may be related to non-responder bias as described 
above in relation to CD knowledge.  
Our study did not detect any significant difference between the adherent and non-adherent groups 
based on CDQoL. This point needs more elaboration as HRQoL in CD has dual meanings i.e. potentially 
improved QoL because of fewer symptoms with adherence to a GFD (Mustalahti et al., 2002, Murray et 
al., 2004) but strict adherence to a GFD may bring social (Olsson et al., 2008) and economic issues ( 
Zivin & Green, 2007c) which could worsen HRQoL. In our study, the domain relating to symptoms was 
significantly different between the groups, where the control (adherent) group had better HRQoL 
presumably due to better symptomatic control and in remaining four domains Stigma, and social 
isolation had better domains in the intervention (non-adherent) group. Our evidence in this regard may, 
however, be regarded as just a preliminary suggestion and as such it is accepted that this area needs 
high powered cohort studies with longer follow up, preferably recruiting treatment naïve patients and 
using CDQoL as the measuring instrument at baseline and at follow up, along with serological and 
urinary evidence of adherence or otherwise.  
The QoL remained stable pre and post intervention as determined by the similar CDQoL values. Our 
main finding of similar overall CDQoL scores after the intervention denotes that either the intervention 
does not affect CDQoL, or there is a lag between the improvement in CDAT and CDQoL. The latter 
presumption needs a prospective study with longer follow up (Deepak et al., 2018). It is thus suggested 
that CDQoL, which has been developed by the Oxford team (Crocker et al., 2018a, Crocker et al., 2013), 
is easy to use and a valid instrument, but its use in studies needs long-term follow up (preferably 12 
months and longer) in relation to an intervention programme to detect any change. In summary CDQoL 
did not change significantly as a result of our intervention and longer follow up and high powered studies 
are needed in the future.  
 
 




Strengths and limitations of the research 
 
Strengths 
The main strength of our research lies in the sample selection to minimise the possibility of selection 
bias, which may be introduced at both participant identification and later at the participation level (Tripepi 
et al., 2010) and may threaten the external validity of the study (Yang et al., 2017). Findings can be 
generalised if the selection process is well-designed and the sample is representative of the study 
population. Subjects were thus identified from a hospital database instead of an advocacy group e.g. 
Coeliac Society. Selecting patients from an advocacy group was one of the weaknesses admitted by 
Sainsbury and colleagues (2013) in their randomised controlled study to increase adherence to a GFD. 
Additionally, instead of relying on patient reported diagnosis, objective histological and serological 
criteria were used to confirm the diagnosis; such a combination is more sensitive and specific for the 
diagnosis of CD (Watson, 2005, Green et al., 2005, Zevit & Shamir, 2014, Husby et al., 2012). Although 
group randomisation was adopted, a non-adherent control group could not be included in the study for 
the reasons stated above. Furthermore, one important strength of the current study is the recruitment 
of participants who are not adhering to the gluten free diet and a careful balance is required to capture 
data from this sub population of patients with coeliac disease. 
Several potential biases were identified and efforts were made to minimise them. Inclusion of change in 
circumstances, for example, minimised confounder bias, as uncontrolled confounding in studies may 
affect results. We think that in doing so we have minimised this effect. In addition to that, severe 
depression was also excluded from the study population. Furthermore, the data collected in this study 
was through a previously used questionnaire and the methodology was adapted in the light of current 
research, thus increasing both internal and external reliability and reducing outcome misclassification 
and citation bias. The diagnosis of CD was made by the same pathologists and using the same 
standards, thus reducing inter-individual bias.  Furthermore, the demographics of the population were 
compared in terms of age, ethnicity and gender, with a previously reported population in a similar survey 
targeting patients with CD.  





In this area of research, a consistent limitation is the difficulty in objectively measuring dietary adherence 
(Muhammad et al., 2019). The study could be strengthened by inclusion of laboratory data to increase 
the validity of the study findings, although this would impact upon participant burden. Forty percent 
attrition from the control group may have affected the data quality.  
The lack of ethnic minority patients in the intervention arm is evident, although every effort was made to 
include ethnic minority patients in this subset of data. Indeed, such an intervention should involve ethnic 
communities outside the English-speaking community and ethnic patients should also be recruited, 
preferably in their own language, to decrease barriers to knowledge transfer, understanding and 
subsequent behavioural changes. As explained earlier, there were significantly more adherent ethnic 
minority patients, thus reducing the number of non-adherent patients for recruitment. Non participation 
of South Asians in research has been explained above, but this is being mentioned again to suggest 
that if we had had access to the larger histopathology database (estimated to be 700 patients), we could 
have increased the number of ethnic minority patients in the intervention group. Previous studies 
examining this question had either no ethnic participants or they did not report it (Sainsbury, et al., 
2013b, Sainsbury et al., 2014, Haas et al., 2017, Pekki et al., 2018). One exception may be the India 
based study by Rajpoot et al., (2015), which only used ethnic data, but lacked White Caucasian 
participants. A substantial proportion of migrants to the UK are South Asians (Peach, 2006) and it is felt 
that inclusion of ethnic minority data is important in such studies as this will help tailor treatments 
according socio-cultural and religious needs.  
Our study gave due importance to the linguistic needs of patients and language support was available 
to patients in seven languages other than English. As explained earlier, there were significantly more 
adherent ethnic minority patients, thus reducing the number of non-adherent patients for recruitment. 
Non participation of South Asians in research has been explained above, but this is being mentioned 
again to suggest that if we had had access to the larger histopathology database (estimated to be 700 
patients), we could have increased the number of ethnic minority patients in the intervention group.  
It is accepted that our data collection may have been selective and inadequate to fully explain complex 
issues of non-adherence to a GFD as this construct (a dietary habit) is affected by a variety of social, 




cultural and cognitive issues; high powered studies may overcome this. In addition, the choice of a 
questionnaire as the research method can have serious effects on data quality (Bowling, 2005) and, 
despite efforts, sampling may be selective (Andrews et al., 2003).  
Our study may also have a low return rate but this per se is not synonymous with unreliable results 
(Holbrook et al., 2007, Keeter et al., 2006, Curtin et al., 2000). A study comparing relative risk estimation 
from two studies with different return rates reported comparable and consistent results (Mealing et al., 
2010) and this notion is also supported by a meta-analysis (Cook et al., 2000). It is accepted that there 
may be some selection bias, since the participants who responded may be more motivated and perhaps 
therefore more likely to adhere to a GFD. Furthermore, participants may change their behaviour when 
they know they are being observed; this is known as the Hawthorne effect (McCarney et al., 2007, Adair, 
1984) and it may affect the results. The questionnaire method of survey excludes certain groups such 
as blind and visually impaired people, as special arrangements were not in place (such as the tactile 
reading system, Braille (Kaczmarski & Wolff, 2007) or audio supported questionnaires (Kirchner & 
Schmeidler, 2001)) but it is assumed that we might have missed just a few patients, which should not 
have affected the data quality. Finally, the authenticity of this type of research is always in question, as 
it is difficult to ascertain who completed each questionnaire. We acknowledge that this is one of the 
limitations of the study and this phenomenon may be avoided by the use of Skype or telephone 
administered questionnaires.  
Implications of this research 
The study findings must be interpreted with caution and must be taken in context before generalisation 
about the effective role of a telephonic clinic in the management of adherence rate is suggested. A 
detailed cost analysis and further research is needed to see if improved adherence rate to a GFD is 
indeed related to reduction in complications and improved HRQoL in a subset of previously non-
adherent CD patients. A strength of our study is how its conception and design were informed by people 
with CD who were not adhering to a GFD. 
A future direction could involve telephonic conversation and supplementing it with video link software 
and this could be adapted as an educational and motivational strategy.  There is evidence from CD and 
IBS related webinars developed by the Somerset group (2018) that it has increased confidence by 84%, 




has 100% acceptability and has reduced the need for clinical appointments by 50%. Additionally, it is 
felt that any future interventional strategy should have a focus group discussion involving motivated 
representatives from gastroenterology and dietetic departments who have special interest in CD and a 
broad spectrum of patients with CD. Further research could compare the effectiveness of a telephone 
clinic compared with standard face-to-face consultation. 
Conclusions  
This study has demonstrated that a telephonic clinic can impact upon GF knowledge and GF dietary 
adherence score, and maintain the improvement for 6 months. This is a novel finding globally and has 
potential far-reaching clinical relevance.  The study findings must be interpreted with caution and the 
limitations of the study must be taken in context. Extending this study would be feasible with more 
participants, employing mixed methods of delivery, supplementing information provided by the patients 
with clinical letters and computerised data and external validation with sero-pathological evidence. A 
limitation is relatively low power and a lack of resources to support the engagement of ethnic patients. 
The research field of increasing adherence to a GFD is a complex area and there is a paucity of research 
and grants. This study has address the research aim. 
Although it was a well-designed study, future improvements in this research may include: recruiting a 
high powered sample from a pathology database, assessing adherence to a GFD with the CDAT 
questionnaire coupled with novel urinary and serum bio-markers, inclusion of a non-adherent control 













General conclusion and overall discussion  
Studies presented in this PhD holistically evaluated different aspects of CD in mixed cohorts i.e. 
demographic evaluation, measurement of adherence to a GFD, design and delivery of intervention to 
increase adherence to a gluten free diet. This has not only added to the knowledge gap but has also 
opened the role of telephonic clinic in the follow up of CD, which may have both clinical and economic 
implications in the future. It is, however, possible that not all answers may have been conclusive and 
further research is needed to explore these areas. This section will summarise each study and consider 
the future prospects of each study 
STUDY I 
 
The study revisited the adherence to a GFD in the Leicester area my previous research (Muhammad, 
2013), even with a larger cohort  no major differences were identified. The study findings were published 
in Nutrients at a time (2017) when public consultation in relation to gluten free products was at a 
preliminary stages and our study was cited as one of the strongest pieces of evidence by NHS England 
for a link between prescribing and adherence in their recent document (NHS, 2018a). As a result, this 
may affect access to GFP for certain patients groups and this may also affect adherence to a GFD but 
higher powered studies are needed to explore this point of immense practical importance. Since long-
term adherence is related to CD in remission and equally affected by cost and availability of GFP on 
prescription, as suggested by our study, a logical recommendation from our study is to make GFD 
available on prescription and within the reach of all patients. One of the other findings was related to 
food labelling and again the logical recommendation from our study will be to revise the way we present 
nutritional information as well as well as the gluten content of food items. It is suggested that the gluten 
free industry may follow the organic food industry in presenting their gluten free products with a clear 
and prominent message on all food items as it is possible that pictorial message of a food item being 
gluten free may not be enough, but more research is needed in this particular area.  
Management of CD in South Asians, although not a direct focus of this study, also came under 
discussion. The availability of CD related literature and tailored advice, preferably in a person’s own 
language, about the hidden gluten in ethnic meals may evolve as a specialist area in dietetics where 




ethnicity specific advice may be given to patients. It is anticipated that future studies will aim to conduct 
research in this area.  
Membership of the Coeliac UK, although an important factor in maintaining adherence to a GFD, was 
not universally accepted, as found by our study. This area too needs further research to evaluate the 
causes behind lack of membership of the Coeliac UK among CD patients. Although there is a minimal 
subscription fee for patients, it still needs evaluation if this may be made optional for certain patient 
groups such as those in changing economic situations as this may increase the membership of the body 
and as a result may well improve the adherence to a GFD among affected patients.  
The main lesson from this study is perhaps that the adherence rate in the Leicestershire area is very 
close to the national average and there are definitive reasons behind that. Addressing these reasons 
will include: educating patients in outpatient departments about food labelling, encouraging joining the 
CS and, last but not least, providing them with support when needed. This study also provides a base 
for the design of future questionnaire studies in this area. It is perceived that despite its shortcomings, 
this study evaluated basic demographics and adherence rates in a mixed cohort of CD patients in 
Leicestershire and may well be a milestone for CD research for future studies.    
STUDY II and III 
 
This group of studies, combined in a logical sequence, designed and delivered a unique and successful 
intervention plan in relation to CD. Study II has given a distinctive view of a multi-ethnic population to 
design interventions aimed at increasing adherence to a GFD. Whilst acknowledging its limitations, this 
study has strengthened the viewpoint that patients are valuable assets in all aspects of the treatment 
and management of chronic diseases, including the design of interventions and service development. 
Additionally, the design of the intervention was developed in one geographical area and the intervention 
was conducted in another geographical area and this illustrates the general applicability of the 
interventional plan which is devoid of geographical bounds.  
The study adapted a methodology for intervention which was patient centred and this methodology may 
well be a way forward for the design of such interventions in CD. The concept of involving patients in 
their care is not novel but its use in the design of intervention through an interview process is both 
innovative and practical. This study could be extended in a variety of ways, such as: including more 
participants (e.g. members of the Coeliac Society and paediatric patients), employing Skype® or other 




video based interfaces, changing the questioning strategy, providing information about possible 
interventions to patients pre-interview, providing funding for the proposed intervention and combining 
different methods such as CD day conference followed by individual advice and motivational work.  
Study III, although used a different cohort, is inseparable from study II. This highlights the general 
applicability or generalisation of an intervention where an idea was developed in one geographic region 
and was tested in another geographic region. The successful result, thus, contributed to knowledge and 
this is a stronger case for rolling out telephonic clinics in an already stretched NHS, where physicians, 
in their own time may conduct follow up clinics for selected groups of patents. This may be economically 
suitable to both patients as well as the NHS as an organisation.  
A detailed economic analysis of telephonic clinic is the first step in such business plans and this should 
take into consideration the time taken by physician and dietitian. Most NHS trusts, usually, offer 15 to 
20 minutes per outpatient’s clinic in a follow up and structuring the whole discussion in this timeframe is 
possible. Such clinics may also use a tele-video interface such as Skype® which is already in use in the 
NHS for business meetings and interviews.  Furthermore, in such clinics there is no need for outpatient 
nurses time, which may be freed up for other clinics, hence a saving in the long term. Although some 
degree of clerical support is required for running such clinics, it is perceived that it is less intense. 
Although it was a well-designed study, future improvements in this research may include: recruiting a 
higher powered sample from a pathology database, assessing adherence to a GFD with the CDAT 
questionnaire coupled with novel urinary and serum bio-markers, inclusion of a non-adherent control 
group and longer follow up e.g. for twelve months.  
Conclusion 
 
This research has opened a new avenue for design of interventions in relation to improving adherence 
to a GFD which is both cost effective and less dependent on technology. It is also felt that this may have 
a positive role in the long term control of CD and preventing complications of CD. Equally, this may also 
be cost effective although formal cost analysis will be required.  It is recommended that future research 
should refine the methodology we have used by incorporating a video interface i.e. Skype® or Zoom® 
in the telephonic clinic and assessment of post intervention adherence should include clinical, 
serological and novel urinary tests so that greater objectivity may be achieved in ascertaining adherence 
to a GFD. We also think that the sequence of studies in this PhD may well provide guidance targeting 




other area in healthcare where adherence to certain therapeutic and dietetic advice is deemed 
necessary i.e. diabetes and caloric intake or even following a prescribed dietary regimen or exercise in 
such patients. Keeping in view the protean nature of adherence in CD, major recommendations from 
this PhD will be to individually tailor dietary advice to each patient with CD, preferably in a language 
(s)he  understands and to monitor adherence to a GFD by adapting both clinical and laboratory methods. 
Furthermore complete dietary assessment of non-adherent patients’ needs to be done formally along 
with causes for non-adherence i.e. social, dietary and or cultural and they need to be addressed on their 
merits. These causes may then be approached through a one to one or group telephonic intervention 
which may or may not include video interface. Although the studies in this PhD attempted to evaluate a 
cohort of mixed ethnicities and was successful in recruiting South Asians in the first two studies but was 
not able to recruit any South Asian people for the third study and further work should investigate the 
effectiveness of such an intervention in different ethnic minorities.  
The publication associated with this research has already been cited in recent literature (n=15) in relation 
to several themes including the availability of GFD on prescription (Walker et al., 2019), accessibility of 
a GFD to patients (Jeans & Hanci, 2019), CD related QoL (Zysk et al., 2019) and a systematic review 
by Xhakollari and colleagues (2018).  
In conclusion, it is possible to say that the PhD has achieved the main aim of improving adherence to a 
GFD in patients with CD approaching this issue in a methodical way by selecting patients with CD who 
were objectively diagnosed, by arranging interviews to ascertain a cost effective and easily deliverable 
intervention which showed a sustained improvement. The methods described and the results achieved 
however may now be formally tried in day to day clinical practice to see its practical application and cost 
effectiveness to the NHS in log run. 
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